0% ont trouvé ce document utile (0 vote)
36 vues108 pages

Innovert RDF Msds

Transféré par

Mohamed Elokda
Copyright
© © All Rights Reserved
Nous prenons très au sérieux les droits relatifs au contenu. Si vous pensez qu’il s’agit de votre contenu, signalez une atteinte au droit d’auteur ici.
Formats disponibles
Téléchargez aux formats PDF, TXT ou lisez en ligne sur Scribd
0% ont trouvé ce document utile (0 vote)
36 vues108 pages

Innovert RDF Msds

Transféré par

Mohamed Elokda
Copyright
© © All Rights Reserved
Nous prenons très au sérieux les droits relatifs au contenu. Si vous pensez qu’il s’agit de votre contenu, signalez une atteinte au droit d’auteur ici.
Formats disponibles
Téléchargez aux formats PDF, TXT ou lisez en ligne sur Scribd

Fabricant/fournisseur

Expiration Date:

ADAPTA®
Energy Services
14th Floor, CitiBank Tower, Al-
Qutayat Street
Dubai, UAE
Telephone Number : +971 43036666
Numér od’ appel d’
urgence
1-760-476-3962 Date de révision : 07-01-2019
Coded’ accèsdel ’
i
nterventionen
‫�ﯾ�ﺢ‬
‫�ر�ﺷ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ّ�ض‬
‫�ﻔ‬
‫�ﻣ�ﺧ‬

:�
‫�ﯾ�ﻖ‬
‫�ﺑ‬
‫�ﺗ�ط‬
‫�ﻟ‬
‫�ا‬ �
:�
‫�ﺗ�ﺞ‬
‫�ﻧ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

‫�ة‬
‫�ر‬
‫�ﻔ‬
‫� �ﺷ‬
‫�و‬
‫�أ‬

‫�ز‬
‫�ﻣ‬
‫�ر‬casd’ incidentgénér al
isé:334305 AR: Arabic & FR: Français
Application Réducteur de filtrats Code produit : HM004609 Numéro de contrat : 14012

Contient ‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�و�ي‬
‫�ﺗ‬
‫�ﯾ�ﺣ‬
Mention d'avertissement Aucun(e) ‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬
‫�ﮫ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻧ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﻣ‬
‫�ﻠ‬
‫�ﻛ‬
Chemical Name CAS Number
Pictogrammes de danger ‫�ر‬
‫�ﻠ�ﺧ�ط‬
‫�ﻟ‬

‫�ﺔ‬
‫�ﯾ‬
‫�ﯾ�ﺣ‬
‫�و�ﺿ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ر‬
‫�و‬
‫�ﻟ�ﺻ‬
‫�ا‬
Mentions de danger : Intervention �
Selon l'autorité compétente, ce NA
‫�ﺔ‬
‫�ﺑ‬
‫�ﺎ‬
‫�ﺗ�ﺟ‬
‫�ﻻ�ﺳ‬
‫�ا‬ :�
‫�ر‬
‫�ﺎ‬
‫�ﻷ�ﺧ�ط‬
‫�ا‬

‫�ﺎ�ت‬
‫�ﻧ‬
‫�ﺎ‬
‫�ﯾ‬
‫�ﺑ‬ produit ne contient pas de
Non dangereux Aucun(e)
‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬ ‫�ا‬
‫� �ﺧ�ط�ر‬
‫�ﻛ�ل‬
‫�ﺗ�ﺷ‬

‫� �ﻻ‬ substances dangereuses à des
Prévention Stockage concentrations supérieures aux

Aucun(e) Aucun(e) ‫�ﯾ�ن‬


‫�ز‬
‫�ﺗ�ﺧ‬
� ‫�ﻊ‬
‫�ﻧ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬
� valeurs limites.

Élimination �
‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬ ‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬
Aucun(e) ‫�ﺎ‬
‫�ﮭ‬
‫�ﻧ‬
‫�ﻣ‬

‫�ﻠ�ص‬
‫�ﺗ�ﺧ‬
‫�ﻟ‬
‫�ا‬

‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬

Chemical Name CAS Number



‫�ﻠ�ﻰ‬
‫�أ�ﻋ‬

‫�ا�ت‬
‫�ز‬
‫�ﯾ‬
‫�ﻛ‬
‫�ر‬
‫�ﺗ‬

‫�ﻓ�ﻲ‬

‫�ة‬
‫�ر‬
‫� �ﺧ�ط‬
‫�د‬
‫�ا‬
‫�و‬‫�ﻣ‬

‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�و�ي‬
‫�ﺗ‬
‫�ﯾ�ﺣ‬

‫�ﻻ‬ �
NA

.�‫�ﺔ‬
‫�ﺗ�ﺻ‬
‫�ﻣ�ﺧ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﮭ‬
‫�ﻟ�ﺟ‬
‫�ا‬

‫�ﺎ‬
‫�ﮭ‬
‫�ﺗ‬
‫�ﱠ‬
‫�د‬‫�د‬
‫� �ﺣ‬
‫�ﺗ�ﻲ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﯾ‬
‫�د‬
‫�ﻟ�ﺣ‬
‫�ا‬

‫�م‬
‫�ﯾ‬
‫�ﻘ‬
‫�ﻟ‬
‫�ا‬

‫�ﻣ�ن‬

‫�ة‬
‫�د‬
‫�ﺎ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

‫�م‬‫�ر‬Balícek Hrubá hmotnost
‫�ﻗ‬

:�
‫�و�ط‬
‫�ﻠ‬
‫�ﻟ‬
‫�ا‬

‫�م‬‫�ر‬Numéro de lot :
‫�ﻗ‬


‫�ﻟ�ﻲ‬
‫�ﺎ‬
‫�ﻣ‬
‫�ا�ﻹ�ﺟ‬

/�

‫�ﻓ�ﻲ‬
‫�ﺎ‬
‫�ﻟ�ﺻ‬
‫�ا‬

‫�ز�ن‬
‫�و‬‫�ا‬Poids Net/Brut du colis :
‫�ﻟ‬

Nom d’ expédi ti
ondesNat i
onsuni es �


‫�د‬
‫�ﯾ‬
‫�ﻘ‬
‫�ﻣ‬

‫�ر‬‫�ﯾ‬
‫� �ﻏ‬
:�
UN � ‫�ﯾ�ﺢ‬
‫�ﻟ�ﺻ�ﺣ‬
‫�ا‬

‫�ﻘ�ل‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�م‬
‫�إ�ﺳ‬Classification de transport ADR, IATA/ICAO et IMO: �
‫�د‬
‫�ﺎ‬
‫�ﺗ�ﺣ‬
‫�ا‬

/�

(�
IATA)�

‫�ﺔ‬
‫�ﯾ‬
‫�ﻟ‬
‫�و‬
‫�د‬‫�ﻟ‬
‫�ا‬

‫�ﻧ�ﻲ‬
‫�د‬
‫�ﻣ‬‫�ﻟ‬
‫�ا‬

‫�ا�ن‬
‫�ر‬
‫�ﯾ‬
‫�ﻟ�ط‬
‫�ا‬

‫�ﺔ‬
‫�ﻣ‬
‫�ﻧ�ظ‬
‫�ﻣ‬
‫�و‬ �
(�
ADR)�

‫�ر�ق‬
‫�ﻟ�ط‬
‫�ا‬

‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�ة‬
‫�ر‬
‫�ﻟ�ﺧ�ط‬
‫�ا‬

‫�ﻊ‬
‫�ﺋ‬
‫�ﺎ‬
‫�ﺑ�ﺿ‬
‫�ﻠ‬
‫�ﻟ‬

‫�ﻟ�ﻲ‬
‫�و‬‫�د‬
‫�ﻟ‬
‫�ا‬

‫�ل‬
‫�ﻘ‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﯾ‬
‫�ﻗ‬
‫�ﺎ‬
‫�ﻔ‬
‫�ﺗ‬
‫�ﻻ‬

‫�ﺎ‬
‫�ﻘ‬
ً�
‫�ﻓ‬
‫�و‬

‫�ل‬
‫�ﻘ‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�ﯾ�ف‬
‫�ﻧ‬
‫�ﺗ�ﺻ‬
:�
(�
IMO)� �‫�ﺔ‬
‫�ﯾ‬
‫�ﻟ‬
‫�و‬
‫�د‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﯾ‬
‫�ر‬
‫�ﺑ�ﺣ‬
‫�ﻟ‬
‫�ا‬
�‫�ﺔ‬
‫�ﻣ‬‫�ﻧ�ظ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬
‫�و‬

،�
(�
ICAO)� �
‫�ﻟ�ﻲ‬
‫�و‬
‫�د‬
‫�ﻟ‬
‫�ا‬

‫�و�ي‬
‫�ﻟ�ﺟ‬
‫�ا‬

‫�ل‬
‫�ﻘ‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬
Aucune restriction Classes de danger



‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﻘ�ل‬
‫�ﻧ‬

‫�ﺋ�ط‬
‫�ﺎ‬
‫�و�ﺳ‬

‫�ة‬
‫�ر‬‫�و‬
‫� �ﺧ�ط‬
‫�ﺔ‬‫�ﺑ‬
‫�ﺗ‬
‫�ر‬

‫�د‬
‫�ﯾ‬
‫�ﻘ‬
‫�ﻣ‬

‫�ر‬
‫�ﯾ‬
‫�ﻏ‬
pour le transport Sans objet Groupe
d'emballage: Sans objet Dangers pour �
‫�ر‬‫�ﺎ�ط‬
‫�ﻣ�ﺧ‬
‫�ﻟ‬
‫�ا‬

‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﺔ‬
‫�ﺋ‬
‫�ﺑ‬
‫�ﻌ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�و�ﻋ‬‫�ﻣ‬
‫�ﻣ�ﺟ‬
l’
environnementSans objet �
‫�ﺔ‬‫�ﺎ�ﺻ‬
‫� �ﺧ‬
‫�ﺎ�ت‬‫�ﺎ�ط‬
‫�ﯾ‬
‫�ﺗ‬
‫�إ�ﺣ‬

‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﺔ‬
‫�ﯾ‬
‫�ﺋ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻟ‬
‫�ا‬
Précautions particulières à prendre

‫�ة‬
‫�ر‬‫�ﯾ‬
‫�ﺑ‬
‫�ﻛ‬

‫�ﺎ�ت‬‫�ﯾ‬
‫�ﻣ‬
‫�ﻛ‬
‫�ﺑ‬

‫�ﻘ�ل‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬
:�
‫�م‬
‫�د‬‫�ﺗ�ﺧ‬
‫�ﻣ�ﺳ‬
‫�ﻠ‬
‫�ﻟ‬
parl ’
utilisat eurAucun(e) Transport en
vracconf ormémentàl ’
annexeI Ide �
(�
MARPOL )� �
‫�ﻣ�ن‬

‫�ﻧ�ﻲ‬
‫�ﺎ‬
‫�ﺛ‬
‫�ﻟ‬
‫�ا‬

‫�ﻓ�ﻖ‬
‫�ر‬‫�ﻣ‬‫�ﻠ‬
‫�ﻟ‬

‫�ﺎ‬
‫�ﻘ‬
‫�ﻓ‬
‫�و‬
la convention Marpol 73/78 et au �
‫� �ﻻ‬
:�
IBC � ‫�ﺔ‬
‫�ﻧ‬
‫�و‬
‫�د‬‫�ﻣ‬

‫�و‬ �
7�3�/�
7�8� �
‫�و�ل‬‫�ﺑ‬
‫�ر‬
‫�ﺎ‬
‫�ﻣ‬
recueil IBC Sans objet ‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬
‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫و‬
‫تج‪:‬‬
‫ن‬‫م‬
‫ل‬‫ريل‬
‫ا‬‫تج‬
‫ل‬‫ا‬‫م‬
‫إلس‬
‫ا‬
‫®‪ADAPTA‬‬
‫ة‪:‬‬
‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫م‬‫ق‬‫ر‬ ‫ة‬‫ع‬‫اج‬‫ر‬‫م‬
‫ل‬‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪23‬‬ ‫‪15-08-2016‬‬

‫وع‬
‫ر‬‫مش‬
‫ل‬‫ا‬‫ة‬
‫ك‬‫ر‬‫لش‬
‫ا‬‫رو‬
‫ي‬‫ةتحض‬
‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫يف‬
‫ر‬‫ع‬‫ت‬
‫‪1.‬‬
‫تج‬‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬‫ي‬
‫و‬‫ه‬
‫تج‪:‬‬
‫ن‬‫م‬
‫ل‬‫ريل‬‫ا‬
‫تج‬‫ل‬‫ا‬‫م‬
‫إلس‬‫ا‬
‫®‪ADAPTA‬‬
‫ات‪:‬‬‫ف‬
‫د‬‫ا‬
‫ر‬‫م‬
‫يئ‬
‫الش‬
‫ة‬‫ي‬‫ئ‬
‫ا‬‫م‬‫ي‬
‫ةك‬ ‫ل‬
‫ئ‬‫ا‬
‫ع‬
‫ر‬‫م‬‫ي‬
‫ل‬‫و‬‫ب‬
‫لي‬
‫اخ‬‫د‬‫ل‬
‫ا‬‫رف‬‫ع‬‫م‬‫ل‬‫ا‬
‫ز‬‫م‬‫ر‬
‫‪HM004609‬‬

‫ه‬
‫ي‬‫ل‬
‫ةع‬‫وض‬
‫ر‬‫ف‬‫م‬
‫ل‬‫ا‬‫د‬
‫و‬‫ي‬‫ق‬
‫ل‬‫ا‬
‫هو‬‫وصىب‬‫م‬‫ل‬‫ا‬‫م‬‫ا‬
‫د‬‫تخ‬
‫الس‬‫ا‬
‫يق‪:‬‬‫ب‬
‫تط‬‫ل‬‫ا‬
‫يح‬
‫رش‬ ‫ت‬
‫ل‬
‫ا‬‫ّض‬ ‫ف‬
‫مخ‬
‫‪Uses advised against‬‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬‫الت‬

‫ل‬ ‫ا‬‫تص‬‫إل‬
‫ا‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬‫ةو‬ ‫ع‬‫ن‬
‫مص‬ ‫ل‬
‫ا‬ ‫ة‬‫ك‬
‫ر‬‫لش‬ ‫ا‬
‫زع‬ ‫و‬‫تجم‬‫ن‬
‫م‬
‫‪Halliburton Energy Services‬‬
‫‪14th Floor, CitiBank Tower‬‬
‫‪Al-Qutayat Street‬‬
‫‪Dubai, UAE‬‬

‫‪Telephone Number : +971 43036666‬‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬

‫ة‬‫اسط‬
‫و‬‫رب‬‫حض‬
‫‪Chemical Stewardship‬‬
‫‪Telephone: 1-281-871-6107‬‬
‫‪e-mail: fdunexchem@[Link]‬‬

‫رئ‬‫ا‬‫و‬
‫لط‬‫ا‬‫تف‬‫ا‬
‫مه‬‫ق‬‫ر‬
‫‪1-760-476-3959‬‬
‫د‪14012 :‬‬‫ق‬
‫ع‬‫ل‬
‫ا‬‫م‬‫ق‬
‫ر‬
‫دث‪334305 :‬‬
‫ا‬‫و‬
‫لح‬‫ل‬
‫ة‬‫ي‬‫م‬
‫ل‬‫ا‬
‫ع‬‫ل‬
‫ا‬‫ة‬‫ب‬
‫ا‬
‫تج‬‫لالس‬‫ول‬
‫وص‬ ‫ل‬
‫ا‬‫ز‬‫م‬‫ر‬

‫ر‬
‫ا‬‫ألخط‬
‫ا‬‫ان‬
‫ي‬‫ب‬
‫‪2.‬‬
‫يف‬
‫ن‬‫تص‬
‫ل‬‫ا‬

‫ة‬
‫ف‬‫ن‬
‫ُص‬‫رم‬
‫ي‬‫غ‬

‫ر‬
‫لخط‬
‫ةل‬‫ي‬
‫يح‬‫وض‬
‫ت‬‫ل‬
‫ا‬‫ر‬‫و‬
‫لص‬‫ا‬

‫ه‬
‫ي‬‫ب‬
‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫م‬‫ل‬‫ك‬
‫ة‬
‫ف‬‫ن‬
‫ُص‬‫رم‬‫ي‬
‫غ‬

‫ر‬
‫ا‬‫ألخط‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/1‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪ADAPTA‬‬
‫‪15-08-2016‬‬
‫_____________________________________________________________________________________________‬
‫ا‬‫ر‬‫كلخط‬
‫التش‬

‫ة‬
‫ي‬‫ر‬‫ي‬
‫ذ‬‫تح‬
‫ل‬‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬

‫ع‬
‫ن‬‫م‬‫ل‬
‫ا‬
‫ء‬‫الشي‬
‫ة‬
‫ب‬‫ا‬
‫تج‬‫الس‬
‫ا‬
‫ء‬‫الشي‬
‫ين‬‫ز‬‫تخ‬
‫ء‬‫الشي‬
‫ا‬
‫ه‬‫ن‬
‫لصم‬ ‫تخ‬‫ل‬
‫ا‬
‫ء‬‫الشي‬

‫لى‬
‫ويع‬ ‫ت‬
‫يح‬
‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬‫ا‬
‫‪NA‬‬ ‫ة‬
‫ه‬‫لج‬
‫ا‬‫ا‬
‫ه‬‫ت‬
‫َّ‬
‫د‬‫د‬‫تيح‬
‫ل‬
‫ا‬‫ة‬‫ي‬
‫د‬‫لح‬
‫ا‬‫م‬‫ي‬
‫ق‬‫ل‬
‫ا‬‫لىمن‬
‫أع‬‫ات‬
‫ز‬‫ي‬
‫ك‬‫ر‬‫ةفيت‬
‫ر‬‫دخط‬
‫ا‬‫و‬
‫لىم‬
‫ويع‬‫ت‬
‫اليح‬
‫ة‪.‬‬
‫تص‬‫مخ‬‫ل‬‫ا‬

‫ة‬‫ي‬‫ف‬
‫ا‬‫إض‬‫ات‬
‫م‬‫و‬‫ل‬‫ع‬
‫م‬
‫ة )‪.(PBT‬‬
‫م‬‫ا‬‫ًوالس‬
‫ا‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫أح‬‫م‬‫ك‬‫ا‬
‫ر‬‫ت‬
‫‪،‬ت‬‫ة‬
‫ر‬‫م‬‫ت‬
‫ونمس‬
‫ك‬‫أنت‬
‫ة‬‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ه‬‫ذ‬
‫ره‬‫ب‬
‫ت‬‫ع‬‫الت‬
‫ة )‪.(vPvB‬‬
‫ي‬‫ا‬
‫غ‬‫ل‬‫ل‬
‫ئي‬‫ا‬‫ي‬
‫أح‬ ‫م‬
‫ك‬‫ا‬
‫ر‬‫ت‬
‫اتوالت‬‫ب‬
‫ث‬
‫ل‬‫ا‬‫ة‬
‫د‬‫ي‬
‫د‬‫ونش‬
‫ك‬‫أنت‬
‫ة‬‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ه‬‫ذ‬
‫ره‬‫ب‬
‫ت‬‫ع‬‫الت‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ا‬‫اتعن‬
‫م‬‫و‬‫ل‬
‫ع‬‫يب ‪/‬م‬
‫ك‬‫ر‬‫ت‬
‫ل‬‫ا‬
‫‪3.‬‬
‫يف ‪GHS‬‬ ‫ن‬‫تص‬ ‫زن )‪(%‬‬
‫و‬ ‫ل‬
‫ا‬‫ة‬‫ب‬
‫نس‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬‫ا‬
‫‪Not classified‬‬ ‫‪NF‬‬ ‫‪NA‬‬ ‫لىمن‬
‫أع‬‫ات‬‫ز‬
‫ي‬‫ك‬‫ر‬
‫ةفيت‬‫ر‬‫دخط‬‫ا‬
‫و‬‫لىم‬‫ويع‬‫ت‬‫اليح‬
‫ة‪.‬‬
‫تص‬‫مخ‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫لج‬‫ا‬‫ا‬
‫ه‬‫ت‬
‫َّ‬
‫د‬‫د‬‫تيح‬‫ل‬
‫ا‬‫ة‬‫ي‬
‫د‬‫لح‬
‫ا‬‫م‬‫ي‬
‫ق‬‫ل‬‫ا‬

‫ة‬
‫ي‬‫ل‬
‫و‬‫أل‬
‫ا‬‫ات‬
‫ف‬‫ا‬
‫ع‬‫إلس‬
‫ا‬‫ر‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪4.‬‬
‫ة‬‫ي‬‫ل‬
‫و‬‫أل‬
‫ا‬‫ات‬‫ف‬‫ا‬‫ع‬
‫إلس‬‫ا‬‫ر‬‫ي‬‫ب‬
‫ا‬‫د‬‫ت‬
‫اق‬
‫نش‬‫ت‬‫إلس‬‫ا‬
‫فسي‪.‬‬‫ن‬
‫ت‬
‫ل‬‫ا‬‫ز‬‫ا‬
‫ه‬‫لج‬
‫ا‬‫يج‬
‫ه‬‫وت‬‫أ‬‫فس‬
‫ن‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫ب‬
‫و‬‫ع‬‫ةص‬‫ل‬
‫ا‬‫يبفيح‬ ‫ب‬
‫لط‬‫ا‬‫ر‬
‫تش‬‫إس‬‫د‪.‬‬
‫د‬‫تج‬
‫ءم‬‫ا‬‫و‬
‫ةه‬‫ق‬‫نط‬‫لىم‬‫إ‬‫قل‬‫ن‬‫إ‬‫اق‬‫نش‬
‫ت‬‫اإلس‬
‫ة‬‫ل‬‫ا‬
‫فيح‬
‫ة‬‫ر‬‫بش‬ ‫ل‬
‫ا‬
‫يج‪.‬‬
‫ه‬‫ت‬
‫ل‬‫ا‬‫ر‬‫م‬‫ت‬
‫إس‬‫ة‬‫ل‬
‫ا‬‫يبفيح‬‫ب‬
‫لط‬‫ا‬‫ر‬‫تش‬‫إس‬‫ون‪.‬‬‫ب‬
‫ا‬‫لص‬ ‫ا‬
‫ءو‬‫ا‬‫م‬‫ل‬
‫ا‬‫إغسلب‬
‫ون‬‫ي‬‫ع‬
‫ين‪.‬‬
‫ن‬
‫ي‬‫ع‬‫ل‬
‫ا‬‫يج‬
‫ه‬‫رت‬ ‫م‬
‫ت‬‫إس‬‫ا‬
‫ذ‬‫إ‬‫ة‬
‫ي‬‫لصح‬‫ا‬
‫ة‬‫ي‬‫ا‬
‫رع‬‫ل‬
‫ا‬‫لى‬
‫أحصلع‬‫قلو‬
‫األ‬
‫لى‬‫ةع‬‫ق‬‫ي‬
‫ق‬‫ة ‪25‬د‬
‫د‬‫م‬‫ل‬‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ةمن‬‫ر‬
‫ي‬‫ف‬‫ةو‬‫ي‬‫م‬‫ك‬
‫الب‬‫لح‬‫ا‬‫ينفي‬‫ن‬‫ي‬‫ع‬
‫ل‬‫ا‬‫إغسل‬
‫تالع‬
‫ب‬‫إل‬
‫ا‬
‫ات‪.‬‬
‫ر‬ ‫ةم‬‫د‬‫ءع‬ ‫ا‬
‫م‬‫ل‬
‫ا‬‫مب‬‫ف‬
‫ل‬‫ا‬‫إغسل‬

‫ة‬
‫ر‬‫أخ‬
‫ت‬‫م‬
‫ل‬‫ا‬
‫و‬‫أ‬‫ة‬
‫د‬‫ا‬
‫لح‬
‫ا‬‫نت‬
‫ا‬‫ءك‬
‫ا‬‫و‬‫ة‪,‬س‬
‫م‬‫ا‬‫ه‬
‫ل‬ ‫ا‬
‫ات‬‫ر‬‫ي‬
‫ث‬‫أ‬
‫ت‬‫ل‬
‫ا‬
‫اضو‬‫ر‬‫ألع‬
‫ا‬‫م‬‫عظ‬‫م‬
‫ة‪.‬‬‫ع‬
‫ق‬‫و‬‫ت‬
‫رم‬‫ي‬
‫ةغ‬‫غ‬
‫ل‬‫ا‬
‫ب‬‫ل‬
‫ا‬‫ة‬
‫ر‬‫و‬ ‫لخط‬
‫ا‬

‫ة‬
‫اص‬‫ةخ‬
‫لج‬‫ا‬
‫ع‬‫م‬‫و‬
‫أ‬‫ة‬‫ي‬
‫ر‬‫و‬‫ةف‬
‫ي‬‫ب‬
‫ةط‬‫ي‬
‫ا‬‫ن‬
‫ةأليع‬
‫اج‬‫لح‬
‫ا‬ ‫لى‬
‫إ‬‫ة‬‫ر‬‫ا‬
‫إش‬
‫يب‬‫ب‬
‫لط‬‫اتل‬‫مالحظ‬
‫اض‪.‬‬‫ر‬
‫األع‬
‫لجحسب‬ ‫ا‬‫ع‬

‫ئق‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬‫ك‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪5.‬‬
‫يق‬
‫ر‬‫لح‬
‫ا‬ ‫ة‬
‫فح‬‫ا‬‫ك‬‫م‬‫ةل‬‫ب‬‫اس‬‫ن‬
‫دم‬‫ا‬‫و‬
‫م‬
‫ة‪.‬‬
‫ف‬‫ا‬
‫لج‬
‫ا‬‫ة‬‫ئ‬
‫ي‬
‫ا‬‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫ة‪,‬‬
‫و‬‫رغ‬
‫ل‬‫ا‬‫ون‪,‬‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬‫أ‬‫ني‬‫ا‬‫ء‪,‬ث‬‫ا‬
‫م‬‫ل‬‫ا‬
‫اب‬‫ب‬‫ض‬
‫يق‬
‫ر‬‫لح‬
‫ا‬‫د‬‫ا‬
‫م‬‫اسبإلخ‬ ‫ن‬‫رم‬‫ي‬‫وسطغ‬
‫وف‪.‬‬ ‫ر‬‫ع‬‫ئىم‬‫الش‬

‫ة‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬ ‫أمن‬‫نش‬‫ةت‬
‫ن‬‫ي‬
‫ع‬‫رم‬‫ا‬
‫أخط‬
‫د‬
‫ي‬‫لج‬
‫ا‬‫ري‬
‫ا‬‫د‬‫اإل‬
‫ر‬‫ي‬‫ب‬
‫د‬‫ت‬
‫ل‬‫ا‬
‫ات‬‫رس‬
‫ا‬‫م‬‫ة‪.‬م‬
‫ي‬‫ل‬
‫ا‬‫ع‬
‫ل‬‫ا‬‫ز‬
‫ي‬‫ك‬‫ا‬
‫ر‬‫ت‬
‫ل‬‫ا‬
‫ًفي‬
‫ا‬
‫ر‬‫فج‬
‫ّ‬‫ت‬‫بحم‬
‫انيص‬
‫مل‬‫ت‬
‫مح‬‫ل‬
‫ا‬‫من‬
‫ال‪,‬‬
‫ع‬‫ت‬
‫إش‬‫ر‬
‫د‬‫دمص‬
‫و‬‫وج‬
‫ويب‬
‫رعض‬
‫ا‬‫ب‬
‫ة‪.‬غ‬
‫م‬‫ا‬‫اتس‬
‫ز‬‫ا‬
‫ونغ‬
‫ك‬‫أني‬‫كن‬‫م‬‫يقي‬
‫ر‬‫لح‬‫ا‬ ‫ء‬
‫ا‬‫ن‬
‫ث‬‫أ‬‫ري‬‫ا‬
‫ر‬‫لح‬
‫ا‬‫لل‬‫تح‬
‫ل‬
‫ا‬
‫ات‪.‬‬‫ن‬
‫ا‬
‫ك‬‫م‬‫اإل‬‫ه‬
‫ذ‬‫دمنه‬‫لح‬‫ل‬‫ة‬
‫ب‬‫و‬‫ل‬
‫مط‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/2‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪ADAPTA‬‬
‫‪15-08-2016‬‬
‫_____________________________________________________________________________________________‬
‫ء‬‫ا‬
‫ف‬‫إلط‬
‫ا‬‫ل‬‫ا‬
‫رج‬‫ةل‬‫اص‬
‫ةخ‬‫ي‬‫ئ‬
‫ا‬‫ق‬
‫اتو‬‫ء‬
‫ا‬‫ر‬‫إج‬
‫ئق‪.‬‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬‫ك‬
‫دم‬‫ا‬
‫ر‬‫ف‬‫ةأل‬
‫م‬‫ز‬‫ةال‬
‫د‬‫م‬‫ت‬
‫ع‬‫ةم‬
‫ل‬‫ق‬
‫ت‬‫فسمس‬ ‫ن‬
‫ةت‬‫ز‬
‫ه‬‫أج‬
‫ةو‬‫ل‬
‫م‬‫ا‬
‫ةك‬‫ي‬‫ق‬
‫ا‬
‫بسو‬‫مال‬

‫رض‬
‫ا‬‫ع‬‫ل‬
‫ا‬‫رب‬
‫تس‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫اج‬‫و‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪6.‬‬
‫رئ‬‫ا‬
‫و‬ ‫لط‬
‫ا‬‫ات‬
‫ء‬‫ا‬‫ر‬‫إج‬
‫ةو‬‫ي‬
‫ا‬‫ق‬
‫و‬‫ل‬
‫ا‬‫ات‬‫د‬‫ع‬
‫م‬ ‫ة‪,‬‬
‫ي‬‫لشخص‬ ‫ا‬‫ات‬‫اط‬
‫ي‬‫ت‬
‫إلح‬
‫ا‬
‫بس‪.‬‬
‫مال‬
‫ل‬‫ا‬
‫ينو‬
‫ن‬
‫ي‬‫ع‬‫ل‬
‫ا‬
‫دو‬‫ل‬
‫لج‬
‫ا‬‫ة‬‫مس‬
‫نبمال‬
‫ة‪.‬تج‬
‫ي‬‫ف‬
‫ا‬‫ةك‬
‫ي‬‫و‬‫ه‬
‫دت‬‫و‬
‫دمنوج‬
‫ك‬‫أ‬
‫ه‪.‬ت‬
‫فس‬‫ن‬
‫روت‬
‫ا‬‫ب‬
‫غ‬‫ل‬
‫ا‬‫ين‬
‫و‬‫ك‬‫نبت‬
‫ة‪.‬تج‬
‫ب‬‫اس‬‫ن‬
‫م‬‫ل‬
‫ا‬‫ة‬‫ي‬
‫ا‬
‫ق‬‫و‬‫ل‬‫ا‬
‫ات‬‫د‬
‫ع‬‫مم‬‫د‬
‫تخ‬‫إس‬‫ال‪.‬‬
‫ع‬‫ت‬‫اإلش‬
‫ر‬‫د‬‫ا‬‫ةمص‬‫ل‬‫ا‬
‫ز‬‫إ‬

‫ة‬‫ي‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬‫اط‬
‫ي‬‫ت‬
‫إلح‬
‫ا‬
‫ة‪.‬‬
‫فض‬‫نخ‬
‫م‬‫ل‬
‫ا‬‫اطق‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫و‬‫أ‬‫ة‬
‫ي‬‫ئ‬
‫ا‬‫م‬
‫ل‬‫ا‬‫ري‬
‫ا‬‫مج‬
‫ل‬‫ا‬‫يف‪,‬‬
‫ر‬‫تص‬
‫ل‬
‫ا‬‫ري‬
‫ا‬‫لىمج‬‫إ‬
‫ا‬‫ه‬‫ل‬
‫و‬‫عدخ‬‫ن‬
‫م‬‫إ‬

‫يف‬
‫نظ‬‫ت‬
‫ل‬‫ا‬
‫ءو‬‫ا‬
‫و‬‫ت‬
‫ةلالح‬‫م‬‫ز‬
‫لال‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫يبو‬‫ل‬
‫ا‬‫ألس‬
‫ا‬
‫ة‪.‬‬
‫ف‬‫ر‬‫غ‬‫ةم‬‫اسط‬
‫و‬‫ةب‬‫ل‬
‫ا‬
‫ز‬‫اإل‬
‫مب‬‫ق‬

‫ة‬‫ي‬
‫ف‬‫ا‬
‫إض‬‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫لىم‬
‫ولع‬
‫لحص‬
‫ل‬‫ات ‪8‬و ‪13‬‬
‫ر‬‫ق‬
‫ف‬‫ل‬
‫ا‬‫ع‬‫اج‬
‫ر‬

‫ين‬
‫ز‬‫تخ‬
‫ل‬‫ا‬
‫ةو‬‫ل‬
‫و‬‫ا‬
‫ن‬‫م‬
‫ل‬‫ا‬
‫‪7.‬‬
‫من‬‫اآل‬
‫ل‬‫م‬‫ا‬‫ع‬‫ت‬‫ل‬
‫اتل‬‫اط‬
‫ي‬‫ت‬
‫إلح‬‫ا‬
‫نب‬
‫رىتج‬
‫أخ‬‫لى‬
‫إ‬‫ة‬‫ي‬
‫و‬‫أ‬
‫قلمنح‬
‫ن‬‫ل‬
‫ا‬‫د‬‫ن‬
‫رضع‬
‫األ‬
‫ع‬‫اتم‬
‫ي‬
‫و‬‫أ‬‫لح‬
‫ا‬‫لك‬
‫ة‪ .‬صلس‬
‫ي‬‫ف‬
‫ا‬‫ةك‬
‫ي‬‫و‬‫ه‬
‫دت‬‫و‬
‫دمنوج‬
‫ك‬‫أ‬
‫ر‪.‬ت‬
‫ا‬‫ب‬
‫غ‬‫ل‬
‫ا‬‫ات‬
‫ع‬‫م‬‫نبتج‬‫ر‪.‬تج‬
‫ا‬‫ب‬
‫غ‬‫ل‬
‫ا‬‫اق‬‫نش‬
‫ت‬‫وإس‬‫أ‬‫ين‬
‫و‬‫ك‬‫نبت‬‫ال‪.‬تج‬‫ع‬‫ت‬
‫اإلش‬‫ر‬‫د‬
‫ا‬‫ةمص‬‫ل‬‫ا‬‫ز‬‫إ‬
‫ة‪.‬‬
‫ب‬‫اس‬
‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬
‫ي‬‫ا‬
‫ق‬‫و‬
‫ل‬‫ا‬‫ات‬‫د‬
‫ع‬‫مم‬‫د‬
‫تخ‬‫إس‬
‫بس‪.‬‬‫مال‬
‫ل‬‫ا‬‫و‬‫أ‬‫د‪,‬‬‫ل‬
‫لج‬
‫ا‬ ‫ين‪,‬‬
‫ع‬‫ل‬
‫ا‬‫ة‬‫مس‬‫مال‬

‫ا‬
‫ً‬
‫ع‬‫ينم‬
‫ز‬‫تخ‬
‫ل‬‫ا‬
‫نب‬ ‫تييجبتج‬ ‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫لك‬‫افيذ‬
‫م‬ ‫من‪,‬ب‬
‫اآل‬
‫ين‬‫ز‬‫تخ‬
‫ل‬‫ا‬‫وط‬‫ر‬‫ش‬
‫ً‪.‬‬
‫ا‬
‫ر‬‫ه‬‫رف ‪36‬ش‬
‫ل‬‫ا‬‫لى‬
‫تجع‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫ر‬‫م‬‫ة‪.‬ع‬
‫ي‬‫و‬‫ه‬
‫ت‬‫ل‬
‫ا‬‫د‬‫ي‬
‫انج‬
‫ك‬‫زنفيم‬
‫ة‪.‬خ‬
‫ر‬‫ا‬
‫ر‬‫لح‬
‫ا‬
‫ات‪,‬و‬‫م‬
‫د‬‫لص‬‫ا‬‫اك‪,‬‬
‫ك‬‫ت‬‫اإلح‬
‫ًعن‬‫ا‬
‫د‬‫ي‬
‫ع‬‫فظب‬‫إح‬‫ات‪.‬‬
‫د‬‫كس‬‫ؤ‬‫م‬‫ل‬
‫ا‬‫ًعن‬‫ا‬
‫د‬‫ي‬
‫ع‬‫ينب‬‫ز‬
‫تخ‬‫ل‬
‫ا‬

‫ة‬
‫ي‬‫لشخص‬
‫ا‬‫ة‬‫ي‬
‫ا‬‫م‬
‫لح‬‫ا‬
‫رض ‪/‬‬
‫ع‬‫ت‬‫ل‬
‫ا‬‫بط‬
‫ا‬
‫و‬‫‪8.‬ض‬
‫م‬‫ك‬
‫تح‬‫ل‬
‫ا‬‫ر‬‫ي‬
‫ي‬‫ا‬
‫ع‬‫م‬
‫رض‬‫ع‬‫ت‬
‫ل‬‫ا‬‫د‬
‫و‬‫د‬‫ح‬

‫ة‬‫ب‬
‫اس‬‫ن‬
‫م‬‫ل‬‫ا‬
‫ة‬‫ي‬‫دس‬
‫ن‬‫ه‬‫ل‬
‫ا‬‫بط‬
‫ا‬‫و‬‫لض‬‫ا‬
‫د‪.‬‬
‫ا‬‫و‬
‫م‬‫ل‬‫ا‬
‫ه‬‫ذ‬‫مه‬
‫ا‬‫د‬
‫تخ‬‫اس‬
‫اتخالل‬
‫ر‬‫م‬‫و‬
‫ن‬‫و‬‫ةمنم‬
‫ل‬‫ي‬
‫ئ‬‫ات ض‬
‫ي‬
‫م‬‫رك‬
‫د‬‫ديص‬
‫ة‪.‬ق‬
‫د‬‫ي‬
‫اج‬‫ه‬‫ت‬
‫ي‬
‫و‬‫ه‬‫ةت‬‫ق‬
‫نط‬‫مفيم‬
‫د‬‫تخ‬‫إس‬

‫ة‬‫ي‬‫لشخص‬‫ا‬‫ة‬‫ي‬
‫ا‬‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬‫د‬
‫ع‬‫لم‬ ‫ث‬‫م‬
‫ة‪,‬‬‫ي‬‫د‬
‫ر‬‫ف‬‫ل‬‫ا‬‫ة‬‫ي‬
‫ا‬‫م‬‫لح‬
‫ا‬ ‫ر‬
‫ي‬‫ب‬‫ا‬‫د‬
‫ت‬
‫و‬‫أ‬‫ة‬
‫ي‬ ‫اع‬
‫ن‬
‫ةص‬ ‫ئي صح‬‫ا‬
‫أخص‬‫بل‬
‫ةمنق‬‫ي‬‫لشخص‬‫ا‬‫ة‬‫ي‬
‫ا‬‫ق‬
‫و‬‫ل‬
‫ا‬ ‫ات‬
‫د‬‫ع‬‫م‬‫ل‬‫م‬‫ي‬
‫ل‬‫لس‬
‫ا‬‫م‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫رو‬ ‫ا‬‫ي‬
‫ت‬
‫اإلخ‬‫د‬
‫ي‬‫د‬
‫غيتح‬‫ب‬
‫ن‬
‫ي‬‫رط‪,‬‬‫ف‬
‫م‬‫ل‬
‫ا‬‫رض‬ ‫ع‬ ‫ت‬
‫ل‬
‫ا‬‫ع‬‫ن‬‫م‬‫أنت‬‫كن‬‫م‬‫ملالي‬
‫ع‬‫ل‬‫ا‬‫ات‬‫رس‬‫ا‬
‫م‬‫م‬‫ةو‬ ‫ي‬
‫دس‬‫ن‬‫ه‬
‫ل‬‫ا‬‫بط‬‫ا‬‫و‬
‫لض‬ ‫ا‬‫نت‬‫ا‬
‫اك‬ ‫ذ‬
‫إ‬
‫تج‪.‬‬‫ن‬‫م‬‫ل‬
‫ا‬‫ا‬‫ذ‬
‫ه‬‫ل‬‫د‬‫د‬‫مح‬‫ل‬
‫ا‬‫يق‬‫ب‬
‫تط‬‫ل‬‫ا‬
‫لى‬‫إ‬‫د‬‫ن‬‫ت‬
‫يثيس‬‫ينح‬ ‫ل‬
‫ه‬‫ؤ‬‫م‬‫ل‬
‫ا‬‫ين‬ ‫ي‬
‫ن‬‫ف‬
‫ل‬‫ا‬
‫امن‬ ‫ه‬‫ر‬‫ي‬‫غ‬
‫فسي‬‫ن‬‫ت‬‫ل‬
‫ا‬‫ز‬‫ا‬‫ه‬‫لح‬
‫ا‬ ‫ة‬
‫ي‬‫ا‬‫م‬‫ح‬
‫دمن‬‫م‬
‫ت‬‫ع‬‫اعيم‬‫ن‬
‫فس ص‬‫ن‬‫زت‬‫ا‬
‫ه‬‫ءج‬‫ا‬
‫د‬‫ت‬
‫ر‬‫إ‬‫يجب‬
‫وف‪,‬‬‫ر‬ ‫ع‬
‫م‬‫ل‬
‫ا‬‫ر‬‫ي‬‫رضغ‬ ‫ع‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ل‬
‫ا‬‫وفيح‬‫أ‬‫ني‬‫ه‬‫م‬‫ل‬‫ا‬‫رض‬ ‫ع‬‫ت‬
‫ل‬
‫ا‬‫د‬‫و‬
‫د‬‫قلمنح‬‫أ‬‫رض‬ ‫ع‬‫ت‬‫اظب‬‫ف‬
‫ت‬‫لإلح‬‫ة‬
‫ي‬‫ف‬
‫ا‬‫رك‬‫ملغ‬‫ع‬‫ل‬‫ا‬‫ات‬‫رس‬‫ا‬
‫م‬‫م‬‫ةو‬ ‫ي‬
‫دس‬‫ن‬‫ه‬
‫ل‬‫ا‬‫بط‬‫ا‬‫و‬
‫لض‬ ‫ا‬‫نت‬‫ا‬
‫اك‬ ‫ذ‬
‫إ‬
‫افي‬
‫م‬‫ب‬‫ة‪,‬‬‫ي‬
‫لشخص‬‫ا‬
‫ة‬‫ي‬‫ا‬
‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬
‫د‬‫ع‬
‫عم‬ ‫ي‬
‫م‬‫مج‬‫ا‬
‫د‬‫تخ‬
‫اتإلس‬‫م‬‫ي‬
‫ل‬
‫ع‬ ‫ت‬
‫ل‬‫ا‬
‫رو‬‫ا‬‫ي‬
‫ت‬‫اإلخ‬
‫تج‪.‬‬
‫ن‬‫م‬‫ل‬
‫ا‬‫ا‬
‫ذ‬‫مه‬ ‫ا‬
‫د‬‫تخ‬‫إس‬
‫ا‬‫ه‬‫ل‬
‫د‬‫ا‬
‫ع‬‫اي‬
‫وم‬‫أ‬
‫ة ‪,EN 149,AS / NZS 1715: 2009‬‬ ‫ي‬
‫ب‬‫و‬
‫ر‬‫و‬‫األ‬‫ة‬‫ي‬
‫اس‬‫ي‬
‫ق‬‫ل‬
‫ا‬‫بي‬ ‫ل‬
‫وت‬‫أ‬
‫‪NIOSH‬‬
‫ذ‪(N95, P2/P3) .‬‬
‫ا‬‫ذ‬
‫ر‬‫ل‬‫ا‬‫ز‬
‫ا‬‫ب‬
‫غ‬‫ل‬‫ل‬‫اعي‬‫ن‬
‫فس ص‬ ‫ن‬
‫زت‬‫ا‬
‫ه‬‫ين‪.‬ج‬‫ل‬
‫ه‬‫ؤ‬‫م‬
‫ل‬‫ا‬‫ين‬
‫ي‬ ‫ن‬
‫ف‬‫ل‬
‫ا‬‫همن‬ ‫ر‬‫ي‬
‫وغ‬ ‫أ‬‫ة‬‫ئي صح‬‫ا‬
‫أخص‬ ‫ا‬‫ه‬
‫مب‬‫و‬‫ق‬‫أني‬‫يجب‬‫فس‪,‬‬ ‫ن‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ز‬‫ه‬‫أج‬‫لك‬‫ذ‬
‫د‬‫ي‬‫ل‬
‫ا‬ ‫ة‬
‫ي‬‫ا‬‫م‬‫ح‬
‫دي‪.‬‬ ‫ا‬
‫ع‬‫ل‬
‫ا‬‫مل‬‫ع‬‫ل‬‫ل‬‫ز‬‫ا‬‫ف‬
‫ق‬
‫د‬
‫ل‬‫لج‬‫ا‬‫ة‬‫ي‬
‫ا‬‫ق‬‫و‬
‫ة‪.‬‬‫ي‬
‫د‬‫ا‬‫ملع‬‫اطفع‬ ‫ع‬‫م‬
‫ين‬‫ع‬‫ل‬
‫ا‬ ‫ة‬
‫ي‬‫ا‬‫م‬‫ح‬
‫ة‪.‬‬
‫ي‬‫ا‬‫ق‬
‫اتو‬ ‫ر‬‫ا‬‫ونظ‬‫أ‬‫ة‬‫ي‬
‫ن‬
‫ه‬‫م‬‫ل‬‫ا‬
‫ة‬‫م‬‫لسال‬
‫ا‬‫ات‬‫ر‬‫ا‬‫عنظ‬‫رض ض‬ ‫ع‬‫ت‬‫ل‬
‫ا‬‫ةمن‬ ‫ي‬
‫ا‬‫م‬‫لح‬
‫ل‬
‫رى‬‫أخ‬‫ات‬‫اط‬‫ي‬
‫ت‬‫إح‬
‫وف‪.‬‬‫ر‬‫ع‬‫ئىم‬ ‫الش‬

‫ة‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ةو‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫ز‬‫ي‬
‫ف‬‫ل‬
‫ا‬‫ئص‬
‫ا‬‫لخص‬
‫ا‬
‫‪9.‬‬
‫ة‪:‬‬
‫ي‬‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬ ‫ة‬
‫ل‬‫ا‬
‫لح‬
‫ا‬
‫وق‬‫مسح‬
‫ون‪:‬‬
‫ل‬
‫ر‬‫ف‬
‫يضمص‬ ‫ب‬‫أ‬
‫ة‪:‬‬
‫ئح‬‫ا‬
‫ر‬
‫ة‬
‫ئح‬‫ا‬
‫هر‬ ‫ل‬‫يس‬‫ل‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/3‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪ADAPTA‬‬
‫‪15-08-2016‬‬
‫_____________________________________________________________________________________________‬
‫ة‪:‬‬‫ئح‬ ‫ا‬
‫ر‬‫ل‬‫نىل‬‫د‬‫أل‬
‫ا‬ ‫د‬‫لح‬
‫ا‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫‪pH:‬‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ء ‪:(= 1‬‬‫ا‬
‫م‬‫ة)‬ ‫ي‬‫و‬ ‫ئ‬
‫ةم‬ ‫رج‬ ‫ة @ ‪20‬د‬ ‫ي‬‫وع‬‫ن‬‫ل‬
‫ا‬ ‫ة‬‫ف‬‫ا‬
‫ث‬‫ك‬‫ل‬
‫ا‬
‫‪1.03‬‬
‫ة(‪:‬‬ ‫ي‬‫و‬‫ئ‬‫م‬‫دى )‬ ‫د ‪/‬م‬‫م‬‫تج‬‫ل‬‫ا‬‫ة‬‫قط‬‫ن‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ة(‪:‬‬ ‫ي‬‫و‬‫ئ‬‫ةم‬ ‫رج‬‫د‬‫دى )‬ ‫م‬ ‫ل‬
‫ا‬‫ان‬‫ي‬‫ل‬
‫ةغ‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ة(‪:‬‬‫ي‬‫و‬ ‫ئ‬
‫م‬ ‫دى )‬ ‫م‬‫ل‬
‫ا‬ ‫يض ‪/‬‬ ‫م‬‫و‬‫ل‬‫ا‬‫ة‬‫قط‬‫ن‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫يض‪:‬‬ ‫م‬‫و‬ ‫ل‬
‫ا‬‫ة‬‫قط‬‫ةن‬ ‫ق‬‫ي‬‫ر‬‫ط‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫فض )‪(%‬‬ ‫نخ‬
‫دم‬ ‫و ‪-‬ح‬ ‫لج‬‫ا‬ ‫لفي‬ ‫ا‬
‫ع‬‫ت‬‫إلش‬‫ا‬ ‫ة‬
‫ي‬‫ل‬‫ب‬
‫ا‬‫دق‬ ‫و‬‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫وي )‪(%‬‬ ‫ل‬
‫دع‬ ‫و ‪-‬ح‬ ‫لج‬‫ا‬ ‫لفي‬ ‫ا‬
‫ع‬‫ت‬‫إلش‬‫ا‬ ‫ة‬
‫ي‬‫ل‬‫ب‬
‫ا‬‫دق‬ ‫و‬‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ة(‪:‬‬
‫ي‬‫و‬‫ئ‬
‫ةم‬ ‫رج‬ ‫د‬‫تي )‬‫ا‬‫ذ‬ ‫ل‬
‫ا‬ ‫ل‬‫ا‬‫ع‬
‫ت‬‫الش‬ ‫ا‬‫ة‬‫ر‬‫ا‬
‫ر‬‫ةح‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ل ‪:(= 1‬‬ ‫ي‬‫ت‬‫و‬ ‫ي‬‫ب‬
‫ل‬‫ا‬‫ر )خالت‬ ‫بخ‬‫ت‬‫ل‬
‫ا‬ ‫ة‬‫رع‬ ‫س‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫بق(‬‫ئ‬‫مز‬ ‫ل‬
‫م‬ ‫ة)‬‫ي‬
‫و‬‫ئ‬‫ة ‪20‬م‬ ‫ر‬‫ا‬‫ر‬‫ةح‬ ‫رج‬ ‫ة @د‬ ‫ر‬‫بخ‬‫أل‬
‫ا‬ ‫غط‬‫ض‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ء‪=1‬‬ ‫ا‬‫و‬ ‫ر)ه‬ ‫ا‬
‫بخ‬‫ل‬
‫ا‬ ‫ة‬‫ف‬‫ا‬‫ث‬‫ك‬
‫(‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ء‬ ‫ا‬‫م‬
‫ل‬‫ا‬‫انفي‬ ‫ب‬‫و‬‫ذ‬‫ل‬
‫ا‬
‫ء‬ ‫ا‬‫م‬
‫ل‬‫ا‬ ‫انفي‬ ‫ب‬
‫و‬‫ذ‬‫ل‬
‫ل‬ ‫ة‬
‫ل‬‫ب‬‫ا‬
‫رق‬ ‫ي‬‫غ‬
‫ة (‪:‬‬‫ي‬‫و‬ ‫ئ‬‫ل )م‬ ‫ل‬‫تح‬‫ل‬‫ا‬‫ة‬‫ر‬‫ا‬
‫ر‬‫ةح‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ز(‪:‬‬
‫و‬ ‫ي‬‫ب‬‫ي‬
‫ت‬‫ن‬
‫ة )س‬‫ي‬‫و‬
‫ئ‬‫ةم‬ ‫رج‬ ‫ة ‪‌@ 20‬د‬ ‫ي‬‫ك‬‫ي‬
‫م‬ ‫ا‬
‫ن‬‫ي‬
‫ة‪,‬د‬ ‫وج‬ ‫ز‬
‫ل‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫وك(‪:‬‬ ‫ر‬
‫ت‬‫يس‬ ‫ت‬
‫ن‬‫ة )س‬‫ي‬
‫و‬‫ئ‬‫ةم‬ ‫رج‬ ‫ة ‪‌‌@ 20‬د‬ ‫ي‬‫ك‬‫ر‬‫ة‪,‬ح‬ ‫وج‬ ‫ز‬
‫ل‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ء‪:‬‬ ‫ا‬
‫لم‬ ‫و‬‫ن‬‫ا‬‫ت‬
‫ك‬ ‫أ‬‫عن‪-‬‬ ‫ي‬
‫ز‬‫و‬‫ت‬‫ل‬‫ا‬‫ل‬‫م‬ ‫ا‬
‫ع‬‫م‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫زئ (‪:‬‬ ‫ئى )غج‬ ‫ي‬‫ز‬‫لج‬‫ا‬‫زن‬ ‫و‬‫ل‬
‫ا‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬

‫ة‬
‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬‫اتو‬
‫ب‬‫ث‬
‫ل‬‫ا‬
‫‪10.‬‬
‫ة‬‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬
‫يط‬
‫نش‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫د‬
‫ا‬‫إع‬
‫ع‬‫ق‬‫و‬
‫ت‬‫م‬‫ل‬
‫ا‬‫يسمن‬‫ل‬

‫ئي‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ات‬
‫ب‬‫ث‬‫ل‬
‫ا‬
‫ر‬‫ق‬
‫ت‬‫مس‬

‫ة‬
‫ر‬‫لخط‬
‫ا‬‫اعالت‬
‫ف‬‫ت‬
‫ل‬‫ا‬‫ل‬
‫ا‬‫م‬‫ت‬
‫اح‬
‫دث‬‫لنيح‬

‫ا‬
‫ه‬‫ب‬
‫ن‬‫تييجبتج‬
‫ل‬‫ا‬‫وف‬
‫ر‬‫لظ‬‫ا‬
‫ع‪.‬‬‫ق‬
‫و‬‫ت‬
‫يئم‬‫الش‬

‫ا‬‫ه‬‫ن‬
‫ب‬‫ديجبتج‬
‫ا‬‫و‬‫م‬
‫ة‪.‬‬
‫ي‬‫و‬‫ةق‬
‫د‬‫كس‬‫ؤ‬‫ملم‬
‫ا‬‫و‬‫ع‬

‫ة‬‫ر‬
‫لخط‬
‫ا‬‫كك‬‫ف‬
‫ت‬‫ل‬
‫ا‬‫ات‬‫تج‬‫ن‬
‫م‬
‫ون‪.‬‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬
‫أ‬‫ني‬
‫ا‬
‫ث‬‫ونو‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬
‫ا‬ ‫ول‬
‫أ‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫ه‬‫ي‬
‫وج‬ ‫ت‬
‫بق‬
‫نط‬‫الت‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/4‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪ADAPTA‬‬
‫‪15-08-2016‬‬
‫_____________________________________________________________________________________________‬

‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪11.‬‬
‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬ ‫ات‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫اتعنت‬ ‫م‬‫و‬‫ل‬
‫ع‬‫م‬
‫ة‬‫د‬‫ا‬‫لح‬‫ا‬‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫اق‬‫نش‬‫ت‬‫إس‬
‫فسي‪.‬‬
‫ن‬‫ت‬
‫ل‬
‫ا‬‫ز‬‫ا‬
‫ه‬‫لج‬
‫ا‬‫يطفي‬
‫يجبس‬‫ه‬‫أنت‬ ‫كن‬‫م‬‫ي‬
‫ين‬
‫ع‬‫ل‬‫ا‬‫ة‬‫مس‬‫مال‬
‫وف‪.‬‬ ‫ر‬
‫ع‬‫ءم‬ ‫الشي‬
‫د‬‫ل‬
‫لج‬‫ا‬‫ة‬‫مس‬‫مال‬
‫وف‪.‬‬‫ر‬‫ع‬‫يئم‬ ‫الش‬
‫تالع‬
‫ب‬‫إل‬
‫ا‬
‫وف‬‫ر‬‫ع‬‫يئم‬ ‫الش‬

‫ة‬
‫ي‬‫ن‬‫ا‬
‫رط‬‫ةس‬‫ن‬
‫م‬‫ز‬‫اتم‬
‫ر‬‫ي‬‫ث‬
‫أ‬‫ت‬
‫ة‪.‬‬
‫لصح‬
‫ا‬‫لى‬
‫منع‬
‫ز‬‫ةم‬
‫ر‬‫و‬‫رخط‬
‫د‬‫همص‬
‫ن‬‫أ‬
‫ر‬‫ب‬
‫ك‬‫أ‬‫و‬
‫أ‬‫ة ‪1%‬‬
‫ب‬‫نس‬
‫ةب‬‫ت‬
‫ا‬
‫ن‬‫و‬‫ك‬
‫دىم‬
‫إح‬‫و‬
‫أ‬‫تج‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫د‬‫و‬‫أنوج‬
‫لى‬‫إ‬
‫ر‬‫ي‬‫اتتش‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ةل‬‫ي‬
‫م‬‫لس‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ة‬
‫ي‬‫يس‬
‫ئ‬
‫ر‬‫ل‬‫ا‬

‫اق ‪LC50‬‬
‫نش‬‫ت‬
‫إس‬ ‫د‬
‫ل‬‫لج‬
‫ا‬‫يق‬
‫ر‬‫‪LD50‬عنط‬ ‫م‬
‫ف‬‫ل‬
‫ا‬ ‫يق‬
‫ر‬‫‪LD50‬عنط‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫ن‬
‫ا‬
‫ي‬‫دب‬
‫وج‬‫الت‬ ‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫ن‬‫ا‬
‫ي‬‫دب‬
‫وج‬‫الت‬ ‫ة‬‫اح‬‫ت‬
‫اتم‬
‫ن‬‫ا‬
‫ي‬‫دب‬
‫وج‬‫الت‬ ‫‪NA‬‬ ‫ةفي‬
‫ر‬‫دخط‬
‫ا‬‫و‬
‫لىم‬
‫ويع‬
‫ت‬‫اليح‬
‫تي‬
‫ل‬
‫ا‬‫ة‬‫ي‬
‫د‬‫لح‬
‫ا‬‫م‬‫ي‬
‫ق‬‫ل‬
‫ا‬‫لىمن‬
‫أع‬‫ات‬‫ز‬‫ي‬‫ك‬
‫ر‬ ‫ت‬
‫ة‪.‬‬
‫تص‬‫مخ‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫لج‬‫ا‬
‫ا‬‫ه‬‫ت‬
‫َّ‬
‫د‬‫د‬‫ح‬

‫ة‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬
‫ن‬‫و‬
‫ل‬‫ع‬‫م‬
‫‪12.‬‬
‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫ات‬
‫ي‬‫ر‬‫ا‬
‫ق‬‫ف‬
‫ةال‬
‫ي‬‫م‬‫س‬ ‫ة‬‫ق‬
‫ي‬‫ق‬
‫د‬‫ل‬
‫ا‬‫ات‬
‫ن‬‫ئ‬‫ا‬
‫ك‬‫ل‬
‫ةل‬‫ي‬
‫م‬‫س‬ ‫مك‬‫لس‬‫ةل‬‫ي‬
‫م‬‫لس‬‫ا‬ ‫لب‬
‫ا‬
‫لطح‬‫ةل‬‫ي‬
‫م‬‫لس‬‫ا‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬‫وج‬‫الت‬ ‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬
‫الت‬ ‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬‫الت‬ ‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬‫وج‬‫الت‬ ‫‪NA‬‬ ‫ةفي‬‫ر‬
‫دخط‬ ‫ا‬
‫و‬‫لىم‬‫ويع‬‫ت‬
‫اليح‬
‫تي‬
‫ل‬‫ا‬
‫ة‬‫ي‬‫د‬
‫لح‬‫ا‬
‫م‬‫ي‬‫ق‬
‫ل‬‫ا‬
‫لىمن‬‫أع‬‫ات‬
‫ز‬‫ي‬‫ك‬
‫ر‬ ‫ت‬
‫ة‪.‬‬‫تص‬‫مخ‬
‫ل‬‫ا‬‫ة‬
‫ه‬‫لج‬
‫ا‬‫ا‬
‫ه‬‫ت‬
‫َّ‬
‫د‬‫د‬‫ح‬

‫ل‬
‫ل‬‫تح‬
‫ل‬‫ا‬
‫ءو‬‫ا‬
‫ق‬‫ب‬
‫ل‬‫ا‬

‫ل‬‫ل‬
‫تح‬‫ل‬
‫ا‬‫اتو‬‫ب‬
‫ث‬‫ل‬
‫ا‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬
‫الت‬ ‫ة ‪NA‬‬‫ه‬
‫لج‬‫ا‬
‫ا‬‫ه‬‫ت‬
‫َّ‬
‫د‬‫د‬‫تيح‬
‫ل‬
‫ا‬‫ة‬‫ي‬
‫د‬‫لح‬
‫ا‬‫م‬‫ي‬
‫ق‬‫ل‬
‫ا‬‫لىمن‬
‫أع‬‫ات‬
‫ز‬‫ي‬
‫ك‬‫ر‬‫ةفيت‬
‫ر‬‫دخط‬
‫ا‬‫و‬
‫لىم‬
‫ويع‬‫ت‬
‫اليح‬
‫ة‪.‬‬
‫تص‬‫مخ‬‫ل‬‫ا‬

‫ئي‬
‫ا‬‫ي‬
‫ألح‬
‫ا‬‫م‬‫ك‬
‫ا‬‫ر‬‫ت‬
‫ل‬‫ا‬‫لى‬
‫ةع‬‫ر‬
‫د‬‫ق‬‫ل‬
‫ا‬

‫‪Log Pow‬‬ ‫م ‪CAS‬‬


‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬
‫الت‬ ‫ة ‪NA‬‬‫ه‬
‫لج‬‫ا‬
‫ا‬‫ه‬‫ت‬
‫َّ‬
‫د‬‫د‬‫تيح‬
‫ل‬
‫ا‬‫ة‬‫ي‬
‫د‬‫لح‬
‫ا‬‫م‬‫ي‬
‫ق‬‫ل‬
‫ا‬‫لىمن‬
‫أع‬‫ات‬
‫ز‬‫ي‬
‫ك‬‫ر‬‫ةفيت‬
‫ر‬‫دخط‬
‫ا‬‫و‬
‫لىم‬
‫ويع‬‫ت‬
‫اليح‬
‫ة‪.‬‬
‫تص‬‫مخ‬‫ل‬‫ا‬

‫ة‬
‫ب‬‫ر‬‫ت‬
‫ل‬‫ا‬‫ةفي‬
‫ك‬‫ر‬‫لح‬
‫ا‬

‫ل‬
‫ق‬‫ن‬‫ت‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/5‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪ADAPTA‬‬
‫‪15-08-2016‬‬
‫_____________________________________________________________________________________________‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ة ‪NA‬‬
‫ه‬‫لج‬
‫ا‬‫ا‬
‫ه‬‫ت‬
‫َّ‬
‫د‬‫د‬‫تيح‬
‫ل‬
‫ا‬‫ة‬‫ي‬
‫د‬‫لح‬
‫ا‬‫م‬‫ي‬
‫ق‬‫ل‬
‫ا‬‫لىمن‬
‫أع‬‫ات‬
‫ز‬‫ي‬
‫ك‬‫ر‬‫ةفيت‬
‫ر‬‫دخط‬
‫ا‬‫و‬
‫لىم‬
‫ويع‬‫ت‬
‫اليح‬
‫ة‪.‬‬
‫تص‬‫مخ‬‫ل‬‫ا‬

‫رى‬‫ألخ‬
‫ا‬‫ة‬‫ي‬‫ب‬
‫ل‬‫لس‬
‫ا‬‫ر‬‫ا‬
‫ث‬‫اآل‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬ ‫و‬
‫ل‬‫ع‬‫دم‬
‫وج‬‫الت‬

‫ات‬
‫ي‬‫ا‬
‫ف‬‫ن‬
‫ل‬‫ا‬‫اصمن‬
‫تخ‬‫ل‬
‫ا‬‫ات‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إع‬‫‪13.‬‬
‫ات‬
‫ي‬‫ا‬
‫ف‬‫ن‬‫ل‬
‫ا‬‫ة‬‫لج‬‫ا‬
‫ع‬‫رقم‬ ‫ط‬
‫لص‬‫تخ‬‫ل‬
‫ا‬‫ةفي‬ ‫م‬‫د‬
‫تخ‬‫مس‬‫ل‬‫ا‬‫ة‬‫ق‬‫ي‬
‫ر‬‫لط‬‫ا‬
‫ة‪.‬‬
‫ي‬‫ل‬
‫مح‬‫ل‬
‫ا‬‫ة‬
‫ر‬‫ا‬
‫د‬‫اإل‬
‫ةو‬‫ي‬
‫وال‬
‫ل‬‫ا‬
‫ة‪,‬و‬
‫ي‬‫ل‬
‫ا‬‫ر‬
‫د‬‫ي‬‫ف‬
‫ل‬
‫ا‬‫ة‬‫م‬
‫و‬‫ك‬‫لح‬
‫ا‬‫د‬‫اع‬
‫و‬‫ق‬
‫ل‬‫ا‬
‫ً‬
‫ق‬‫ب‬
‫هط‬‫ل‬
‫رخص‬
‫وم‬‫أ‬
‫د‬‫م‬‫ت‬
‫ع‬‫اتم‬
‫ي‬
‫ا‬‫ف‬
‫عت‬‫ي‬
‫م‬‫فضتج‬
‫نح‬‫فنفيم‬
‫د‬‫إ‬‫ة‪.‬‬
‫ث‬‫و‬‫ل‬‫رم‬‫ي‬
‫نتغ‬‫ا‬‫اك‬‫ذ‬‫إ‬
‫تج‬‫ن‬‫م‬
‫ل‬‫ا‬‫م‬‫ا‬
‫د‬‫تخ‬‫إس‬‫د‬‫أع‬
‫وث‬ ‫ل‬‫يفم‬‫ل‬‫غ‬‫ت‬
‫ة‪.‬‬‫ي‬
‫ل‬
‫مح‬‫ل‬
‫ا‬‫ةو‬‫ي‬‫م‬‫و‬‫ق‬
‫ل‬‫ا‬
‫ئح‬‫ا‬
‫و‬‫ل‬‫ل‬
‫ا‬‫ع‬ ‫ي‬
‫م‬‫عج‬ ‫ب‬‫ت‬
‫إ‬
‫رى‬ ‫أخ‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬‫م‬
‫ة‪.‬‬‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫الت‬

‫ل‬
‫ق‬‫ن‬‫ل‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪14.‬‬
‫ة"‬
‫د‬‫تح‬
‫م‬‫ل‬
‫ا‬‫م‬‫م‬
‫أل‬
‫ا‬‫م ‪"UN‬‬‫ق‬
‫ر‬
‫د‬‫ي‬
‫ق‬‫رم‬
‫ي‬‫غ‬

‫يح ‪UN:‬‬
‫لصح‬
‫ا‬‫ل‬‫ق‬
‫ن‬‫ل‬
‫ا‬‫م‬‫إس‬
‫د‬‫ي‬
‫ق‬‫رم‬‫ي‬
‫غ‬

‫ل‪:‬‬
‫ق‬‫ئطن‬
‫ا‬‫ةوس‬
‫ر‬‫و‬‫ةخط‬‫ب‬‫ت‬
‫ر‬
‫بق‬
‫نط‬‫الت‬

‫ة‪:‬‬
‫ئ‬‫ب‬
‫ع‬‫ت‬
‫ل‬‫ا‬‫ة‬‫وع‬‫م‬
‫مج‬
‫بق‬‫نط‬
‫الت‬

‫ة‪:‬‬
‫ي‬‫ئ‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫اط‬‫مخ‬‫ل‬‫ا‬
‫بق‬‫نط‬‫الت‬

‫م‪:‬‬
‫د‬‫تخ‬
‫مس‬‫ل‬
‫ةل‬‫اص‬
‫اتخ‬
‫اط‬‫ي‬
‫ت‬‫إح‬
‫ء‬
‫الشي‬

‫ة ‪IBC:‬‬
‫ن‬‫و‬‫د‬
‫ل ‪78/73‬وم‬
‫و‬‫ب‬‫ر‬
‫ا‬‫نيمن )‪(MARPOL‬م‬
‫ا‬‫ث‬
‫ل‬‫ا‬
‫فق‬‫ر‬
‫م‬‫ل‬‫ال‬
‫ق‬‫ف‬
‫ةو‬‫ر‬
‫ي‬‫ب‬
‫اتك‬
‫ي‬‫م‬‫ك‬
‫لب‬‫ق‬‫ن‬
‫ل‬‫ا‬
‫بق‬‫نط‬
‫الت‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫اتت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪15.‬‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫ت‬
‫ل‬‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬
‫ا‪.‬‬
‫ه‬‫ت‬
‫يال‬
‫د‬‫ع‬
‫ت‬‫ا )‪"(GHS‬و‬
‫ه‬‫م‬‫وس‬
‫ةو‬‫ي‬
‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫يف‬
‫ن‬
‫تص‬‫ل‬
‫ا‬
‫ً‬‫ي‬
‫م‬‫ل‬
‫ا‬‫نسقع‬
‫م‬‫ل‬
‫ا‬‫م‬‫ا‬
‫نظ‬‫ل‬
‫ا‬
‫ة"‬‫د‬
‫تح‬‫م‬
‫ل‬‫ا‬‫م‬
‫م‬‫لأل‬
‫ا‬‫ق‬
‫ف‬‫ه ‪SDS‬و‬‫ذ‬‫ده‬
‫ا‬‫د‬
‫إع‬‫م‬‫ت‬

‫رى‬
‫أخ‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪16.‬‬
‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫د‬‫ا‬‫مص‬
‫ةو‬‫ي‬
‫يس‬‫ئ‬
‫ر‬‫ل‬
‫ا‬‫ات‬
‫ي‬‫ب‬
‫د‬‫أل‬
‫ا‬‫ع‬‫اج‬
‫ر‬‫م‬
‫‪[Link]/‬‬

‫ة‬‫ع‬‫اج‬‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪15-08-2016‬‬
‫يح‬‫ق‬‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫وظ‬‫لح‬‫م‬
‫ا‪2‬‬
‫ه‬‫د‬‫ي‬
‫د‬‫متج‬
‫تيت‬‫ل‬
‫ا‬ ‫م ‪SDS‬‬‫ا‬
‫قس‬‫أ‬

‫ة‬‫ي‬
‫ل‬‫و‬
‫ؤ‬‫مس‬‫ل‬
‫ا‬‫ء‬‫إخال‬‫ان‬
‫ي‬‫ب‬
‫دال‬
‫اق‬‫يض‬
‫أ‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬‫ل‬‫ا‬‫رى‪.‬‬‫األخ‬
‫اف‬‫ر‬‫األط‬
‫عض‬ ‫ب‬
‫تج‪,‬و‬‫ن‬
‫م‬‫ل‬‫ا‬‫مل‬
‫تىتش‬‫ل‬
‫ا‬ ‫ر‬
‫د‬‫ا‬‫مص‬‫ل‬
‫ا‬‫ةمن‬‫ف‬‫ل‬
‫ت‬
‫ةمخ‬‫وع‬‫م‬
‫امنمج‬
‫ه‬‫ي‬
‫ل‬‫ولع‬‫لحص‬‫ا‬
‫م‬‫ةت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬‫أن‬‫يث‬‫ةح‬‫د‬
‫و‬‫ز‬‫م‬‫ل‬
‫ا‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬‫م‬
‫ل‬‫ا‬‫ال‬
‫م‬‫ت‬
‫ك‬‫إ‬‫و‬
‫أ‬‫ة‬‫ق‬‫د‬
‫انب‬
‫م‬‫دض‬ ‫وج‬
‫الي‬
‫م‪.‬‬‫د‬
‫تخ‬‫مس‬‫ل‬‫ا‬
‫ة‬‫ي‬‫ل‬
‫و‬ ‫ؤ‬
‫ةهيمس‬ ‫د‬‫ا‬
‫أيم‬‫ة‬
‫م‬‫ء‬‫مال‬
‫ل‬‫ئي‬‫ا‬
‫ه‬‫ن‬‫ل‬
‫ا‬‫د‬‫ي‬
‫د‬‫تح‬
‫ل‬‫ا‬‫رى‪.‬‬
‫األخ‬
‫ات‬‫لج‬
‫ا‬‫ع‬
‫م‬‫ل‬
‫ا‬‫وفي‬‫أ‬
‫رى‬‫أخ‬‫د‬
‫ا‬‫و‬
‫دم‬‫و‬‫وفيوج‬‫أ‬‫ع‬
‫متم‬ ‫د‬
‫تخ‬‫إس‬‫ا‬
‫ذ‬‫إ‬‫و‬
‫أ‬‫م‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫وف‬ ‫ر‬‫ةتحتكلظ‬‫يح‬
‫ون صح‬ ‫ك‬‫ت‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/6‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪ADAPTA‬‬
‫‪15-08-2016‬‬
‫_____________________________________________________________________________________________‬

‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫ةو‬
‫ي‬‫ا‬
‫ه‬‫ن‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/7‬‬
‫فح‬‫ص‬
SAFETY DATA SHEET
Product Trade Name: ADAPTA®
Revision Date: 09-May-2017 Revision Number: 26

1. Identification
1.1. Product Identifier
Product Trade Name: ADAPTA®
Synonyms None
Chemical Family: Polymer
Internal ID Code HM004609

1.2 Recommended use and restrictions on use


Application: Filtrate Reducer
Uses advised against No information available

1.3 Manufacturer's Name and Contact Details


Manufacturer/Supplier
Baroid Fluid Services
Product Service Line of Halliburton Energy Services, Inc.
P.O. Box 1675
Houston, TX 77251
Telephone: (281) 871-4000

Halliburton Energy Services, Inc.


645 - 7th Ave SW Suite 1800
Calgary, AB
T2P 4G8
Canada

Prepared By Chemical Stewardship


Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

1.4. Emergency telephone number


Emergency Telephone Number: 1-866-519-4752 or 1-760-476-3962
Global Incident Response Access Code: 334305
Contract Number: 14012

2. Hazards Identification
2.1 Classification in accordance with paragraph (d) of §1910.1200

Combustible dust Combustible dust

2.2. Label Elements

Hazard Pictograms

Signal Word: Warning

Hazard Statements
May form combustible dust concentrations in air.

_____________________________________________________________________________________________
Page 1 / 8
ADAPTA® Revision Date: 09-May-2017
_____________________________________________________________________________________________

Precautionary Statements

Prevention None
Response None
Storage None
Disposal None

2.3 Hazards not otherwise classified


None known

3. Composition/information on Ingredients
Substances CAS Number PERCENT (w/w) GHS Classification - US
Methylstyrene/Acrylate copolymer Proprietary 60 - 100% Combustible Dust

The exact percentage (concentration) of the composition has been withheld as proprietary.

4. First Aid Measures


4.1. Description of first aid measures
Inhalation If inhaled, remove from area to fresh air. Get medical attention if respiratory
irritation develops or if breathing becomes difficult.
Eyes In case of contact, immediately flush eyes with plenty of water for at least 15
minutes and get medical attention if irritation persists.
Skin Wash with soap and water. Get medical attention if irritation persists.
Ingestion Rinse mouth with water many times.

4.2 Most important symptoms/effects, acute and delayed


No significant hazards expected.

4.3. Indication of any immediate medical attention and special treatment needed
Notes to Physician Treat symptomatically.

5. Fire-fighting measures
5.1. Extinguishing media
Suitable Extinguishing Media
Water fog, carbon dioxide, foam, dry chemical.
Extinguishing media which must not be used for safety reasons
None known.

5.2 Specific hazards arising from the substance or mixture


Special exposure hazards in a fire
Decomposition in fire may produce harmful gases. Organic dust in the presence of an ignition source can be explosive in high
concentrations. Good housekeeping practices are required to minimize this potential.

5.3 Special protective equipment and precautions for fire-fighters


Special protective equipment for firefighters
Full protective clothing and approved self-contained breathing apparatus required for fire fighting personnel.

6. Accidental release measures

_____________________________________________________________________________________________
Page 2 / 8
ADAPTA® Revision Date: 09-May-2017
_____________________________________________________________________________________________
6.1. Personal precautions, protective equipment and emergency procedures
Remove sources of ignition. Use appropriate protective equipment. Avoid creating and breathing dust. Ensure
adequate ventilation. Avoid contact with skin, eyes and clothing.
See Section 8 for additional information

6.2. Environmental precautions


Prevent from entering sewers, waterways, or low areas.

6.3. Methods and material for containment and cleaning up


Scoop up and remove.

7. Handling and storage


7.1. Precautions for safe handling
Handling Precautions
Remove sources of ignition. Avoid creating or inhaling dust. Avoid dust accumulations. Ensure adequate ventilation.
Ground and bond containers when transferring from one container to another. Avoid contact with eyes, skin, or
clothing. Use appropriate protective equipment.
Hygiene Measures
Handle in accordance with good industrial hygiene and safety practice.

7.2. Conditions for safe storage, including any incompatibilities


Storage Information
Store away from oxidizers. Keep away from friction, impact, and heat. Store in a well ventilated area. Product has a
shelf life of 36 months.

8. Exposure Controls/Personal Protection


8.1 Occupational Exposure Limits
Substances CAS Number OSHA PEL-TWA ACGIH TLV-TWA
Methylstyrene/Acrylate Proprietary Not applicable Not applicable
copolymer

8.2 Appropriate engineering controls


Engineering Controls Use in a well ventilated area. Trace amounts of monomers may be released
during use of this material.

8.3 Individual protection measures, such as personal protective equipment


Personal Protective Equipment If engineering controls and work practices cannot prevent excessive exposures,
the selection and proper use of personal protective equipment should be
determined by an industrial hygienist or other qualified professional based on the
specific application of this product.
Respiratory Protection If engineering controls and work practices cannot keep exposure below
occupational exposure limits or if exposure is unknown, wear a NIOSH certified,
European Standard EN 149, AS/NZS 1715:2009, or equivalent respirator when
using this product. Selection of and instruction on using all personal protective
equipment, including respirators, should be performed by an Industrial Hygienist or
other qualified professional.
Dust/mist respirator. (N95, P2/P3)
Hand Protection Normal work gloves.
Skin Protection Normal work coveralls.
Eye Protection Wear safety glasses or goggles to protect against exposure.
Other Precautions None known.

9. Physical and Chemical Properties

_____________________________________________________________________________________________
Page 3 / 8
ADAPTA® Revision Date: 09-May-2017
_____________________________________________________________________________________________

9.1. Information on basic physical and chemical properties


Physical State: Powder Color Off white
Odor: Odorless Odor No information available
Threshold:

Property Values
Remarks/ - Method
pH: No data available
Freezing Point / Range No data available
Melting Point / Range No data available
Boiling Point / Range No data available
Flash Point No data available
Flammability (solid, gas) No data available
Upper flammability limit No data available
Lower flammability limit No data available
Evaporation rate No data available
Vapor Pressure No data available
Vapor Density No data available
Specific Gravity 1.03
Water Solubility Insoluble in water
Solubility in other solvents No data available
Partition coefficient: n-octanol/water No data available
Autoignition Temperature No data available
Decomposition Temperature No data available
Viscosity No data available
Explosive Properties No information available
Oxidizing Properties No information available

9.2. Other information


VOC Content (%) No data available
Bulk Density 33 lbs/ft3 @ 20

10. Stability and Reactivity


10.1. Reactivity
Not expected to be reactive.

10.2. Chemical stability


Stable

10.3. Possibility of hazardous reactions


Will Not Occur

10.4. Conditions to avoid


None anticipated

10.5. Incompatible materials


Strong oxidizers.

10.6. Hazardous decomposition products


Carbon monoxide and carbon dioxide.

11. Toxicological Information


11.1 Information on likely routes of exposure
Principle Route of Exposure Eye or skin contact, inhalation.

_____________________________________________________________________________________________
Page 4 / 8
ADAPTA® Revision Date: 09-May-2017
_____________________________________________________________________________________________

11.2 Symptoms related to the physical, chemical and toxicological characteristics


Acute Toxicity
Inhalation May cause mild respiratory irritation.
Eye Contact None known.
Skin Contact None known.
Ingestion None known.

Chronic Effects/Carcinogenicity No data available to indicate product or components present at greater than 0.1%
are chronic health hazards.

11.3 Toxicity data

Toxicology data for the components


Substances CAS Number LD50 Oral LD50 Dermal LC50 Inhalation
Methylstyrene/Acrylate Proprietary No data available No data available No data available
copolymer

12. Ecological Information


12.1. Toxicity

Substance Ecotoxicity Data


Substances CAS Number Toxicity to Algae Toxicity to Fish Toxicity to Toxicity to Invertebrates
Microorganisms
Methylstyrene/Acrylate Proprietary No information available No information available No information available No information available
copolymer

12.2. Persistence and degradability

Substances CAS Number Persistence and Degradability


Methylstyrene/Acrylate copolymer Proprietary No information available

12.3. Bioaccumulative potential

Substances CAS Number Log Pow


Methylstyrene/Acrylate copolymer Proprietary No information available

12.4. Mobility in soil

Substances CAS Number Mobility


Methylstyrene/Acrylate copolymer Proprietary No information available

12.5 Other adverse effects


No information available

13. Disposal Considerations

_____________________________________________________________________________________________
Page 5 / 8
ADAPTA® Revision Date: 09-May-2017
_____________________________________________________________________________________________
13.1. Waste treatment methods
Disposal methods If not contaminated, reuse product. Bury in a licensed landfill according to federal,
state, and local regulations.
Contaminated Packaging Follow all applicable national or local regulations.

14. Transport Information

US DOT
UN Number Not restricted
UN proper shipping name: Not restricted
Transport Hazard Class(es): Not applicable
Packing Group: Not applicable
Environmental Hazards: Not applicable

Canadian TDG
UN Number Not restricted
UN proper shipping name: Not restricted
Transport Hazard Class(es): Not applicable
Packing Group: Not applicable
Environmental Hazards: Not applicable

IMDG/IMO
UN Number Not restricted
UN proper shipping name: Not restricted
Transport Hazard Class(es): Not applicable
Packing Group: Not applicable
Environmental Hazards: Not applicable

IATA/ICAO
UN Number Not restricted
UN proper shipping name: Not restricted
Transport Hazard Class(es): Not applicable
Packing Group: Not applicable
Environmental Hazards: Not applicable

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code Not applicable
Special Precautions for User None

15. Regulatory Information

US Regulations
US TSCA Inventory All components listed on inventory or are exempt.

TSCA Significant New Use Rules - S5A2


Substances CAS Number TSCA Significant New Use Rules - S5A2
Methylstyrene/Acrylate copolymer Proprietary Not applicable

EPA SARA Title III Extremely Hazardous Substances


Substances CAS Number EPA SARA Title III Extremely Hazardous
Substances
Methylstyrene/Acrylate copolymer Proprietary Not applicable

EPA SARA (311,312) Hazard Class


None

_____________________________________________________________________________________________
Page 6 / 8
ADAPTA® Revision Date: 09-May-2017
_____________________________________________________________________________________________
EPA SARA (313) Chemicals
Substances CAS Number Toxic Release Inventory (TRI) - Toxic Release Inventory (TRI) -
Group I Group II
Methylstyrene/Acrylate copolymer Proprietary Not applicable Not applicable

EPA CERCLA/Superfund Reportable Spill Quantity


Substances CAS Number CERCLA RQ
Methylstyrene/Acrylate copolymer Proprietary Not applicable

EPA RCRA Hazardous Waste Classification


If product becomes a waste, it does NOT meet the criteria of a hazardous waste as defined by the US EPA.

California Proposition 65
Substances CAS Number California Proposition 65
Methylstyrene/Acrylate copolymer Proprietary Not applicable

U.S. State Right-to-Know Regulations


Substances CAS Number MA Right-to-Know Law NJ Right-to-Know Law PA Right-to-Know Law
Methylstyrene/Acrylate copolymer Proprietary Not applicable Not applicable Not applicable

NFPA Ratings: Health 1, Flammability 1, Reactivity 0


HMIS Ratings: Health 1, Flammability 1, Reactivity 0 , PPE: B

Canadian Regulations
Canadian Domestic Substances All components listed on inventory or are exempt.
List (DSL)

16. Other information


Preparation Information
Prepared By Chemical Stewardship
Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

Revision Date: 09-May-2017

Reason for Revision SDS sections updated:


2

Additional information
For additional information on the use of this product, contact your local Halliburton representative.

For questions about the Safety Data Sheet for this or other Halliburton products, contact Chemical Stewardship at
1-580-251-4335.

Key or legend to abbreviations and acronyms used in the safety data sheet
bw–bodywei ght
CAS–Chemi calAbstractsSer vi
ce
d - day
EC50–Ef f
ectiveConcent rati
on50%
ErC50–Ef fectiveConcent rat
iongrowthrate50%
h - hour
LC50–Let halConcent r
ati
on50%
LD50–Let halDose50%
LL50–Let halLoading50%
mg/ kg–mi ll
igram/ki
logram

_____________________________________________________________________________________________
Page 7 / 8
ADAPTA® Revision Date: 09-May-2017
_____________________________________________________________________________________________
mg/L–mi ll
i
gr am/li
ter
mg/m3 - milligram/cubic meter
mm - millimeter
mmHg - millimeter mercury
NIOSH–Nat i
onalInsti
tuteforOccupat
ionalSaf
etyandHeal
t
h
NTP–Nat i
onalTox i
cologyPr ogr
am
OEL–Occupat i
onalEx posureLimit
PEL–Per mi ssibl
eEx posureLi mit
ppm –par tspermi l
li
on
STEL–Shor tTer m ExposureLi mit
TWA–Ti me- WeightedAver age
UN–Uni tedNat i
ons
w/w - weight/weight

Key literature references and sources for data


[Link]/

Disclaimer Statement
This information is furnished without warranty, expressed or implied, as to accuracy or completeness. The
information is obtained from various sources including the manufacturer and other third party sources. The
information may not be valid under all conditions nor if this material is used in combination with other materials or in
any process. Final determination of suitability of any material is the sole responsibility of the user.

End of Safety Data Sheet

_____________________________________________________________________________________________
Page 8 / 8
Hazard Pictograms
Halliburton Energy Services
Halliburton House, Howemoss

BaraFLC® IE-513
Place
Kirkhill Industrial Estate
Dyce
Aberdeen, AB21 0GN
United Kingdom
+44 1224 776888

[Link]
Emergency Telephone
Application: Additive Number : +44 8 08 189 0979 / Revision Date:
1-760-476-3961 12-Apr-2018
Global Incident Response
Denmark PR No. 2450612 Access Code: 334305
Contract Number: 14012
EUROPEAN LABEL

Signal Word: None Contains


Chemical Name CAS Number
Hazard Statements:
Contains no hazardous NA
Not Classified
substances in concentrations
above cut-off values
Precautionary Statements: according to the competent
None authority

Net/Gross Package Weight:

SAP Part Number(s): Lot Number:

UN proper shipping name: Transport Classification:

Not restricted Transport


Hazard Class(es): Not
applicable Packing Group Not
applicable Environmental
Not restricted
Hazards: Not applicable
SAFETY DATA SHEET
Product Trade Name:
BaraFLC® IE-513
Revision Date: Revision Number:
21-Apr-2017 11

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE


COMPANY/UNDERTAKING
Product Identifier
Product Trade Name:
BaraFLC® IE-513
Synonyms
None
Chemical Family
Polymer
Internal ID Code
HM007962

Recommended use and restrictions on use


Application:
Additive
Uses advised against
No information available

Manufacturer's Name and Contact Details


Manufacturer/Supplier
Halliburton Energy Services
14th Floor, CitiBank Tower, Al-Qutayat Street
Dubai, UAE
Telephone Number : +971 43036666

Additional Information

Prepared By
Chemical Stewardship
Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

Emergency Telephone Number


1-760-476-3959
Global Incident Response Access Code: 334305
Contract Number: 14012

2. HAZARDS IDENTIFICATION
Classification

Not classified

Hazard Pictograms

Signal Word
Not Classified

Hazard Statements
Not Hazardous

_____________________________________________________________________________________________
Page 1 / 6
BaraFLC® IE-513 Revision Date:
21-Apr-2017
_____________________________________________________________________________________________

Precautionary Statements

Prevention
None
Response
None
Storage
None
Disposal
None

Contains

Additional Information
None known

3. COMPOSITION/INFORMATION ON INGREDIENTS

4. FIRST AID MEASURES


First-aid Measures
Inhalation
If inhaled, remove from area to fresh air. Get medical attention if respiratory irritation develops or if breathing becomes difficult.
Skin
Wash with soap and water. Get medical attention if irritation persists.
Eyes
In case of contact, immediately flush eyes with plenty of water for at least 15 minutes and get medical attention if irritation persists.
Ingestion
Do NOT induce vomiting. Give nothing by mouth. Obtain immediate medical attention.

Most important symptoms and effects, both acute and delayed


No significant hazards expected.

Indication of any immediate medical attention and special treatment needed


Notes to Physician
Not Applicable

5. FIRE FIGHTING MEASURES


Suitable Extinguishing Media
Water fog, carbon dioxide, foam, dry chemical.
Extinguishing media which must not be used for safety reasons
None known.

Specific hazards arising from the chemical


Decomposition in fire may produce harmful gases.

Special protective actions for fire-fighters


Full protective clothing and approved self-contained breathing apparatus required for fire fighting personnel.

6. ACCIDENTAL RELEASE MEASURES


Personal precautions, protective equipment and emergency procedures
Use appropriate protective equipment. Avoid contact with skin, eyes and clothing. Avoid creating and breathing dust. Ensure
adequate ventilation.

_____________________________________________________________________________________________
Page 2 / 6
BaraFLC® IE-513 Revision Date:
21-Apr-2017
_____________________________________________________________________________________________

Environmental Precautions
Prevent from entering sewers, waterways, or low areas.

Methods and material for containment and cleaning up


Remove ignition sources and work with non-sparking tools. Scoop up and remove.

Additional Information
See Section 8 and 13 for additional information.

7. HANDLING AND STORAGE


Precautions for safe handling
Use appropriate protective equipment. Avoid contact with eyes, skin, or clothing. Avoid creating or inhaling dust. Ensure adequate
ventilation. Wash hands after use. Launder contaminated clothing before reuse. Ground and bond containers when transferring
from one container to another.

Conditions for safe storage, including any incompatibilities


Store away from oxidizers. Keep from excessive heat. Use good housekeeping in storage and work areas to prevent accumulation
of dust. Close container when not in use. Store in a dry location. Store in a well ventilated area. Keep from heat, sparks, and open
flames. Product has a shelf life of 36 months.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION


Control parameters
Exposure Limits

Appropriate engineering controls


Use approved industrial ventilation and local exhaust as required to maintain exposures below applicable exposure limits.

Individual protection measures, such as personal protective equipment


If engineering controls and work practices cannot prevent excessive exposures, the selection and proper use of personal protective
equipment should be determined by an industrial hygienist or other qualified professional based on the specific application of this
product.
Respiratory Protection
If engineering controls and work practices cannot keep exposure below occupational exposure limits or if exposure is unknown,
wear a NIOSH certified, European Standard EN 149, AS/NZS 1715:2009, or equivalent respirator when using this product.
Selection of and instruction on using all personal protective equipment, including respirators, should be performed by an Industrial
Hygienist or other qualified professional.
Dust masks.
Hand Protection
Normal work gloves.
Skin Protection
Normal work coveralls.
Eye Protection
Wear safety glasses or goggles to protect against exposure.
Other Precautions
None known.

9. PHYSICAL AND CHEMICAL PROPERTIES


Physical State:
Powder
Color
Off white
Odor:
Odorless
Odor Threshold:
No information available

_____________________________________________________________________________________________
Page 3 / 6
BaraFLC® IE-513 Revision Date:
21-Apr-2017
_____________________________________________________________________________________________
pH:
No information available
Specific Gravity
1.03
Freezing Point/Range (°C):
No information available
Boiling Point/Range (C):
No information available
Flash Point/Range (°C):
No information available
Flash Point Method:
No information available
Flammability Limits in Air - Lower (%):
No information available
Flammability Limits in Air - Upper (%):
No information available
Autoignition Temperature (°C):
No information available
Evaporation Rate (Butyl Acetate=1):
No information available
Vapor Pressure @ 20 C (mmHg):
No information available
Vapor Density (Air=1):
No information available
Water Solubility
Insoluble in water
Decomposition Temperature (C):
No information available
Viscosity, Dynamic @ 20 C (centipoise):
No information available
Viscosity, Kinematic @ 20 C (centistokes):
No information available
Partition Coefficient/n-Octanol/Water:
No information available
Molecular Weight (g/mole):
No information available

10. STABILITY AND REACTIVITY


Reactivity
Not expected to be reactive.

Chemical Stability
Stable

Possibility of hazardous reactions


Will Not Occur

Conditions to Avoid
None anticipated

Incompatible materials
Strong oxidizers. Reducing agents.

Hazardous decomposition products


Oxides of nitrogen. Carbon monoxide and carbon dioxide.

Additional Guidelines
Not Applicable

_____________________________________________________________________________________________
Page 4 / 6
BaraFLC® IE-513 Revision Date:
21-Apr-2017
_____________________________________________________________________________________________

11. TOXICOLOGICAL INFORMATION


Information on Toxicological Effects
Acute Toxicity
Inhalation
May cause mild respiratory irritation.
Eye Contact
May cause mechanical irritation to eye.
Skin Contact
None known.
Ingestion
None known.

Chronic Effects/Carcinogenicity
No data available to indicate product or components present at greater than 0.1% are chronic health hazards.

Toxicology data for the components

12. ECOLOGICAL INFORMATION


Toxicity

Persistence and degradability


Not readily biodegradable

Bioaccumlation potential
Bioaccumulation is unlikely

Mobility in soil

Other adverse effects


No information available

13. DISPOSAL CONSIDERATIONS


Waste treatment methods
Disposal methods
Disposal should be made in accordance with federal, state, and local regulations.
Contaminated Packaging
Follow all applicable national or local regulations.
Other Information
No information available

14. TRANSPORT INFORMATION

_____________________________________________________________________________________________
Page 5 / 6
BaraFLC® IE-513 Revision Date:
21-Apr-2017
_____________________________________________________________________________________________

UN Number
Not restricted

UN proper shipping name:


Not restricted

Transport Hazard Class(es):


Not applicable

Packing Group:
Not applicable

Environmental Hazards:
Not applicable

Special Precautions for User


None

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
Not applicable

15. REGULATORY INFORMATION

Regulatory Information
This SDS was prepared in accordance with United Nations "Globally Harmonized System of Classification and Labelling of
Chemicals (GHS)" and its revisions.

16. OTHER INFORMATION


Key literature references and sources for data
[Link]/
NZ CCID

Revision Date:
21-Apr-2017
Revision Note
SDS sections updated: 2

Disclaimer Statement
This information is furnished without warranty, expressed or implied, as to accuracy or completeness. The information is obtained
from various sources including the manufacturer and other third party sources. The information may not be valid under all
conditions nor if this material is used in combination with other materials or in any process. Final determination of suitability of any
material is the sole responsibility of the user.

End of Safety Data Sheet

_____________________________________________________________________________________________
Page 6 / 6
FACTANT™
Manufacturer/Supplier Emergency Telephone
Halliburton Energy Services Number:
14th Floor, CitiBank Tower, Al-Qutayat 1-760-476-3959
Global Incident Response
Street
Access Code: 334305
Dubai, UAE
Contract Number: 14012
AR: Arabic & EN: English
Telephone Number : +971 43036666
Revision Date: 19-04-2017
‫�ﺗ�ﺣ�ﻼ�ب‬
‫�ﻟ�ﻼ�ﺳ‬

‫�د‬
‫�ﺎ�ﻋ‬
‫�ﻣ�ﺳ‬

‫�ل‬
‫�ﻣ‬
‫�ﺎ‬
‫�ﻋ‬ �
:�
‫�ﺗ�ﺞ‬
‫�ﻧ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

‫�ة‬
‫�ر‬
‫�ﻔ‬
‫� �ﺷ‬
‫�و‬
‫�أ‬

‫�ز‬
‫�ﻣ‬
‫�ر‬
Hazardous Material Number: HM004607
Emulsifier Hazard Pictograms ‫�ر‬
‫�ﻠ�ﺧ�ط‬
‫�ﻟ‬

‫�ﺔ‬
‫�ﯾ‬
‫�ﯾ�ﺣ‬
‫�و�ﺿ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ر‬
‫�و‬
‫�ﻟ�ﺻ‬
‫�ا‬
Signal Word Warning ‫�ر‬
‫�ﯾ‬
‫�ذ‬
‫�ﺗ�ﺣ‬

‫�ﮫ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻧ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﻣ‬
‫�ﻠ‬
‫�ﻛ‬ Contains ‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�و�ي‬
‫�ﺗ‬
‫�ﯾ�ﺣ‬
Chemical Name CAS Number
Hazard Prevention Response Storage ‫�ﯾ�ن‬
‫�ز‬
‫�ﺗ�ﺧ‬ ‫�ﺔ‬‫�ﺑ‬
‫�ﺎ‬
‫�ﺗ�ﺟ‬
‫�ﻻ�ﺳ‬
‫�ا‬ ‫�ﻊ‬‫�ﻧ‬
‫�ﻣ‬
‫�ﻟ‬
‫� �ا‬ ‫�ﺎ�ت‬
‫�ﻧ‬
‫�ﺎ‬
‫�ﯾ‬
‫�ﺑ‬ Fatty acid, tall-oil, reaction product 68990-47-6
Statements : P261 - Avoid P302 + P352 - None �

P302 + P352

‫�ء‬
‫� �ﺷ�ﻲ‬
‫�ﻻ‬ �

‫�ﻧ�ب‬
‫�ﺗ�ﺟ‬

� �
:�
‫�ر‬‫�ﺎ‬
‫�ﻷ�ﺧ�ط‬
‫�ا‬
with diethylenetriamine, maleic
breathing IF ON SKIN: P261 anhydride, tetraethylenepentamine,
H317 - May cause �
:�
‫�د‬‫�ﻠ‬
‫�ﻟ�ﺟ‬
‫�ا‬

‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�ا‬
‫�ذ‬
‫�إ‬
‫�ﺎ‬
‫�ﮭ‬
‫�ﻧ‬
‫�ﻣ‬ �
‫�ﻠ�ص‬‫�ﺗ�ﺧ‬
‫�ﻟ‬
‫�ا‬ ‫� �ﯾ‬
‫�ر‬‫�ﺎ‬
‫�ﺑ‬
‫�ﻐ‬‫�ﻟ‬
‫�ا‬

‫�ﺎ�ق‬
‫�ﻧ�ﺷ‬
‫�ﺗ‬
‫�ﺳ‬

‫�إ‬
‫�ﻛ�ن‬
‫�ﻣ‬‫�ﯾ‬


and triethylenetetramine
an allergic skin dust/fume/gas/mis Wash with Disposal H317
reaction t/vapors/spray plenty of soap P501 - Dispose of �
‫�ﻣ�ن‬ �
‫�ر‬‫�ﯾ‬
‫�ﺛ‬
‫�ﻛ‬ �
‫�ﻊ‬‫�ﻣ‬

‫�ﻐ�ﺳ�ل‬ Hydrotreated light petroleum distillate -

H319 - Causes P264 - Wash face, and water contents/containe �



P501 .� ‫�و�ن‬‫�ﺑ‬
‫�ﺎ‬
‫�ﻟ�ﺻ‬
‫�ا‬
‫�و‬ �
‫�ء‬
‫�ﺎ‬
‫�ﻣ‬
‫�ﻟ‬ �
‫�ا‬‫�ز‬
‫�ﺎ‬
‫�ﻐ‬‫�ﻟ‬
‫�ا‬

/�

‫�ﺎ�ن‬
‫�د�ﺧ‬
‫�ﻟ‬
‫�ا‬

/� � ‫�ﺑ�ب‬‫�ﯾ�ﺳ‬
�‫�أ�ن‬ Tall oil -

serious eye hands and any P333 + P313 - If r to an approved �


‫�ﻣ�ن‬ �
‫�ﻠ�ص‬ �
‫�ﺗ�ﺧ‬ �
P333 + P313 �
/�

‫�ﺎ�ب‬‫�ﺑ‬
‫�ﻟ�ﺿ‬
‫�ا‬

/�.�
‫�د‬
‫�ﻠ‬
‫�ﻠ�ﺟ‬
‫�ﻟ‬

‫�ﺔ‬‫�ﯾ‬
‫�ﺎ�ﺳ‬
‫�ﺣ�ﺳ‬
irritation exposed skin skin irritation or waste disposal �
‫�و�ث‬‫�د‬
‫� �ﺣ‬
‫�ﺔ‬
‫�ﻟ‬
‫�ﺎ‬
‫� �ﺣ‬
‫�ﻓ�ﻲ‬
thoroughly after rash occurs: plant �
/�

‫�ﺎ�ت‬
‫�ﯾ‬
‫�و‬‫�ﺗ‬
‫�ﻣ�ﺣ‬‫�ﻟ‬
‫� �ا‬ ‫�ﻔ�ﺢ‬
‫� �ط‬
‫�و‬
‫�أ‬

‫�ﯾ�ﺞ‬
‫�ﮭ‬
‫�ﺗ‬

/�

‫�ة‬
‫�ر‬‫�ﺑ�ﺧ‬
‫� �ا�ﻷ‬ �
H319
handling Get medical �
‫�ﻟ�ﻰ‬
‫�إ‬

‫�ﺎ�ت‬
‫�ﯾ‬
‫�و‬‫�ﺄ‬
‫�ﻟ�ﺣ‬
‫� �ا‬ ‫�إ�ﺣ�ﺻ�ل‬ �
:�
‫�د�ي‬
‫�ﻠ‬
‫�ﺟ‬ .�
‫�ذ‬
‫�ا‬
‫�ذ‬
‫�ر‬‫�ﻟ‬
‫� �ا‬
‫�ﯾ�ﺞ‬
‫�ﮭ‬
‫�ﺗ‬

‫�ﺑ�ب‬
‫�ﯾ�ﺳ‬
P272 - advice/attention
Contaminated P305 + P351 + �
‫�ﻠ�ص‬‫�ﺗ�ﺧ‬
‫�ﻟ‬
‫�ا‬

‫�ز‬‫�ﻛ‬
‫�ر‬‫� �ﻣ‬ ‫�ة‬
‫�ر‬‫�و‬
‫�ﻣ�ﺷ‬‫�ﻟ‬
‫�ا‬
� ‫� �ﻋ‬
‫�ﻠ�ﻰ‬ ‫�إ�ﻏ�ﺳ�ل‬


P264 .� ‫�ﯾ�ن‬
‫�ﻌ‬‫�ﻠ‬
‫�ﻟ‬

ً�
‫�ا‬
‫�ر‬‫�ﯾ‬
‫�ﺧ�ط‬
work clothing P338 - IF IN �
‫�ﺎ�ت‬‫�ﯾ‬
‫�ﺎ‬
‫�ﻔ‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�ﻣ�ن‬ ‫�ﺔ‬‫�ﯾ‬
‫�ﺎ‬
‫�ﻧ‬
‫�ﻋ‬ �
/�

‫�ﺔ‬‫�ﯾ‬
‫�ﺑ‬
‫�ط‬‫�ﻟ‬
‫�ا‬

‫�و‬

‫�ﯾ�ن‬
‫�د‬
‫�ﯾ‬
‫�ﻟ‬
‫�ا‬
‫�و‬ �
‫�ﮫ‬
‫�و�ﺟ‬‫�ﻟ‬
‫�ا‬
should not be EYES: Rinse P305 + P351
allowed out of the cautiously with .�
‫�د‬‫�ﻣ‬
‫�ﺗ‬
‫�ﻌ‬
‫�ﻣ‬‫�ﻟ‬
‫� �ا‬ ‫�ﻓ�ﻲ‬


+ P338

‫�ﺔ‬
‫�ر�ﺿ‬ ‫�ﻌ‬
‫�ﻣ‬‫�ﻟ‬
‫�ا‬

‫�د‬
‫�ﻠ‬
‫�ﻟ�ﺟ‬
‫�ا‬ Chemical Name CAS Number
workplace water for several

:�
‫�ﯾ�ن‬
‫�ﻌ‬‫�ﻟ‬
‫�ا‬

‫�و�ل‬
‫�د�ﺧ‬

‫�ﺔ‬‫�ﻟ‬
‫�ﺎ‬
‫�ﺣ‬ �
‫�د‬
‫�ﻌ‬‫�ﺑ‬

ً�
‫�ا‬
‫�د‬
‫�ﯾ‬
‫�ﺟ‬ �
‫�ﺔ‬
‫�ﯾ‬
‫�ﻠ‬
‫�ﺎ�ﻋ‬
‫�ﻔ‬
‫�ﺗ‬

‫�ة‬
‫�د‬
‫�ﺎ‬
‫�ﻣ‬ �
،�
‫�ﻧ�ﺟ�ﻲ‬
‫�ﺗ‬
‫�ا‬
‫�ر‬
‫�ﻟ‬
‫�ا‬

‫�ر‬‫�ﺑ‬
‫�و‬

‫�ﻧ‬
‫�ﻧ�ﺟ�ﻲ‬
‫�ﻟ�ﺻ‬
‫�ا‬
‫�ﺗ‬

‫�ا‬
‫�ر‬
‫�ﻟ‬
‫�ﯾ�ت‬
‫�ا‬
‫�ز‬


‫�ر‬
،�
‫�ﺑ‬
‫�و‬
‫�ﻧ‬
‫�ﻧ�ﻲ‬
‫�ھ‬
‫�ﻟ�ﺻ‬
‫�د‬

‫�ا‬

‫�ﯾ�ت‬
‫�ﻣ �ض‬
‫�ز‬
‫�ﺎ‬
‫�ﺣ‬ �

-
6�8�9�9�0�-4�7�-6�
P280 - Wear minutes.
protective Remove contact �
‫�ﻊ‬‫�ﻣ‬ �
‫�ر‬‫�ذ‬
‫�ﺑ�ﺣ‬

‫�ﺗ�ﺷ�ط�ف‬ .�
‫�ﺎ�ل‬
‫�ﻣ‬‫�ﻌ‬
‫�ﺗ‬
‫�ا�ﻹ�ﺳ‬ �
‫�ﯾ�ن‬
‫�ﻣ‬‫�ﺗ‬
‫�ﻧ‬
‫�و‬
‫�ﺑ‬

‫�ﯾ�ن‬
‫�ﻠ‬
‫�ﯾ‬
‫�ﺛ‬
‫�ﯾ‬
‫�إ‬


‫�ر‬
‫�ء‬
‫�ﺗ‬
‫�ﺗ‬
‫�ﺎ‬
‫�ﻣ‬

،�
‫�ﻟ‬
‫�ﺎ‬
‫�ﯾ�ك‬
‫�ﺑ‬

‫�ﻠ‬
‫�ﺔ‬
‫�ﻣ‬ �
‫�ﻟ�ﺟ‬
‫�ﺎ‬
‫�د‬
‫�ﻌ‬
‫�ﯾ‬
‫�ر‬
‫�ﻣ‬
‫�د‬

‫�ﯾ‬
‫�ﮭ‬
‫�ﺔ‬
‫�ﻔ‬
‫�ﯾ‬
‫�ﻧ‬
‫�أ‬
‫�ﻔ‬

،�
‫�ﯾ�ن‬
‫� �ﺧ‬
‫�ﺔ‬
‫�ﯾ‬
‫�ﻟ‬
‫�ﻣ‬
‫�و‬
‫�ﯾ‬
‫�ر‬
‫�ر‬
‫�ﺗ‬
‫�ﺗ‬
‫�ﺑ‬
‫�ﻧ‬
‫�ﻠ‬

‫�ﯾ‬
‫�ﺛ‬
‫�ﯾ‬
‫�د‬
‫�ا�ت‬

‫�ر‬
‫�ﻊ‬
‫�ﻣ‬
‫�ﻘ�ط‬
‫�ﻣ‬ �
-
gloves/protective lenses, if �
.�
‫�ﺋ�ﻖ‬
‫�ﺎ‬
‫�ﻗ‬
‫�د‬

‫�ة‬
‫�د‬
‫�ﻌ‬‫�ﻟ‬

‫�ء‬
‫�ﺎ‬
‫�ﻣ‬
‫�ﻟ‬
‫� �ا‬ ‫� �ﻻ‬

P272
clothing/eye present and �
‫�ﺎ�ت‬‫�د�ﺳ‬
‫�ﻌ‬
‫�ﻟ‬
‫�ا‬

‫�ز�ع‬
‫�ﻧ‬
‫�ﺗ‬
protection/face easy to do. �
‫�ﻧ�ت‬‫�ﺎ‬
‫�ﻛ‬

‫�ا‬
‫�ذ‬‫�إ‬

‫�ﺔ‬‫�ﻘ‬
‫�ﻟ�ﻼ�ﺻ‬‫� �ا‬
‫�ﻣ�ﺢ‬
‫�ﯾ�ﺳ‬

‫�أ�ن‬

‫�ﻐ�ﻲ‬‫�ﺑ‬
‫�ﻧ‬
‫�ﯾ‬
protection Continue rinsing
P337 + P313 - If

‫�ﮭ�ل‬
‫�و�ﺳ‬ �
‫�ة‬
‫�د‬
‫�و‬
‫�و�ﺟ‬‫� �ﻣ‬
‫�ﺑ�س‬‫�ﻣ�ﻼ‬
�‫�ء‬
‫�ا‬
‫�د‬
‫�ﺗ‬
‫�ر‬
‫�ﺈ‬
‫�ﺑ‬
eye irritation �‫�ر‬
‫�ﻣ‬‫�ﺗ‬
‫�ﯾ�ﺳ‬

.�
‫�ﮫ‬
‫�ﺑ‬

‫�م‬
‫�ﺎ‬
‫�ﯾ‬‫� �ا‬
‫�ﻘ‬
‫�ﻟ‬ ‫�ﺔ‬
‫�ﺛ‬
‫�و‬‫�ﻠ‬
‫�ﻣ‬‫�ﻟ‬
‫�ا‬

‫�ﻣ�ل‬
‫�ﻌ‬‫�ﻟ‬
‫�ا‬
persists: Get .�
‫�ﻟ�ﺷ�ط�ف‬
‫� �ا‬ ‫�ﺎ�ن‬
‫�ﻛ‬
‫�ﻣ‬ �
‫�ر�ج‬
‫�ﺎ‬
‫�ﺧ‬
medical �

P337 + P313
advice/attention �
‫�ﯾ�ﺞ‬
‫�ﮭ‬‫�ﺗ‬
�‫�ر‬
‫�ﻣ‬‫�ﺗ‬
‫�ا�ﺳ‬

‫�ا‬
‫�ذ‬
‫�إ‬ .�
‫�ﻣ�ل‬
‫�ﻌ‬‫�ﻟ‬
‫�ا‬
P321 - Specific

‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�إ�ﺣ�ﺻ�ل‬ �
:�
‫�ﯾ�ن‬
‫�ﻌ‬‫� �ا‬
‫�ﻟ‬ ‫�ﺑ�س‬‫�ﻠ‬
‫�ﺗ‬


P280
treatment (see ‫�ة‬
‫�د‬
‫�ﺎ‬
‫�ﻣ‬‫�ﻟ‬
‫�ا‬
�‫�م‬
‫�ﻗ‬‫�ر‬Material Number(s):
supplemental �
/�

‫�ﺔ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻟ�ط‬
‫�ا‬

‫�ة‬
‫�ر‬‫�و‬
‫�ﻣ�ﺷ‬
‫�ﻟ‬ �
‫�ا‬‫�ﺔ‬‫�ﯾ‬
‫�ﻗ‬
‫�ا‬
‫�و‬
‫�ﻟ‬
‫�ا‬

‫�ا�ت‬
‫�ز‬‫�ﺎ‬
‫�ﻔ‬
‫�ﻘ‬
‫�ﻟ‬
‫�ا‬
first aid ‫�ﺔ‬
‫�ﯾ‬
‫�ﺎ‬
‫�ﻧ‬
‫�ﻋ‬ �
‫�ﺑ�س‬‫�ﻣ�ﻼ‬‫�ﻟ‬
‫�ا‬

/�
instructions on �‫�ﻊ‬
‫�ا�ﺟ‬
‫�ر‬)�


P321
this label) �
‫�ﺎ�ت‬
‫�ﻓ‬
‫�ﺎ‬
‫�ﻌ‬‫�ا�ﻹ�ﺳ‬

‫�ﺎ�ت‬‫�ﻣ‬
‫�ﯾ‬
‫�ﻠ‬‫� �ﺗ‬
‫�ﻌ‬ ‫�ﺔ‬
‫�ﯾ‬
‫�ﺎ‬
‫�ﻣ‬
‫� �ﺣ‬
/�

‫�ﺔ‬‫�ﯾ‬
‫�ﻗ‬
‫�ا‬
‫�و‬‫�ﻟ‬
‫�ا‬
P362 + P364 - �
‫�ﺔ‬
‫�ﯾ‬
‫�ﻓ‬
‫�ﺎ‬
‫�ا�ﻹ�ﺿ‬ �
‫�ﺔ‬
‫�ﯾ‬
‫�ﻟ‬‫� �ا�ﻷ‬
‫�و‬ ‫�ﺎ�ع‬
‫�ﻧ‬
‫�ﻗ‬

/�

‫�ﯾ�ن‬
‫�ﻌ‬‫�ﻠ‬
‫�ﻟ‬
Take off :�‫�و�ط‬‫�ﻠ‬
‫�ﻟ‬
‫�ا‬

‫�م‬‫�ر‬Lot Number:
‫�ﻗ‬
contaminated

(�‫�م‬
‫�و�ﺳ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬‫�ﻗ‬
‫�ﺎ‬
‫�ﺑ�ط‬

‫�ﻠ�ﻰ‬
‫ �ﻋ‬.� ‫�ﮫ‬
‫�و�ﺟ‬‫�ﻟ‬
‫�ا‬

‫�ﺔ‬‫�ﯾ‬
‫�ﺎ‬
‫�ﻣ‬‫�ﻟ�ﺣ‬
clothing and .�
‫�ﺔ‬
‫�ﺎ�ﺻ‬‫� �ﺧ‬
‫�ﺔ‬
‫�ﻟ�ﺟ‬
‫�ﺎ‬
‫�ﻌ‬
‫�ﻣ‬
wash before �

P362 + P364
reuse �
‫�ﺑ�س‬‫�ﻣ�ﻼ‬
‫�ﻟ‬
‫�ا‬

‫�ﻊ‬‫�ﻠ‬
‫�إ�ﺧ‬

‫�ﺑ�ل‬
‫�ﻗ‬

‫�إ�ﻏ�ﺳ�ل‬
‫�و‬ �
‫�ﺔ‬
‫�ﺛ‬
‫�و‬
‫�ﻠ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬
‫�ﺎ‬
‫�ﮭ‬‫�ﻣ‬
‫�ا‬
‫�د‬
‫�ﺗ�ﺧ‬
‫�إ�ﺳ‬

‫�ة‬
‫�د‬‫�ﺎ‬
‫�إ�ﻋ‬ �
‫�ﻟ�ﻲ‬
‫�ﺎ‬
‫�ﻣ‬
‫�ا�ﻹ�ﺟ‬

/�

‫�ﻓ�ﻲ‬
‫�ﺎ‬
‫�ﻟ�ﺻ‬
‫�ا‬

‫�ز�ن‬
‫�و‬‫�ا‬Net/Gross Package Weight:
‫�ﻟ‬

UN proper shipping name: Not �




‫�د‬
‫�ﯾ‬
‫�ﻘ‬
‫�ﻣ‬

‫�ر‬‫�ﯾ‬
‫� �ﻏ‬
:�
UN � ‫�ﯾ�ﺢ‬
‫�ﻟ�ﺻ�ﺣ‬
‫�ا‬

‫�ﻘ�ل‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�م‬
‫�إ�ﺳ‬ ‫�ر�ق‬
‫�ﻟ�ط‬
‫�ا‬

‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�ة‬
‫�ر‬
‫�ﻟ�ﺧ�ط‬
‫�ا‬

‫�ﻊ‬
‫�ﺋ‬
‫�ﺎ‬
‫�ﺑ�ﺿ‬
‫�ﻠ‬
‫�ﻟ‬

‫�ﻟ�ﻲ‬
‫�و‬
‫�د‬
‫�ﻟ‬
‫�ا‬

‫�ل‬‫�ﻘ‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﯾ‬
‫�ﻗ‬
‫�ﺎ‬
‫�ﻔ‬
‫�ﺗ‬
‫�ﻻ‬

‫�ﺎ‬
‫�ﻘ‬
ً�
‫�ﻓ‬
‫�و‬

‫�ل‬
‫�ﻘ‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�ﯾ�ف‬
‫�ﻧ‬
‫(�ﺗ�ﺻ‬ADR) ‫�ﺔ‬ ‫�ﯾ‬
‫�ﻟ‬
‫�و‬
‫�د‬
‫�ﻟ‬
‫�ا‬

‫�ﻧ�ﻲ‬
‫�د‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

‫�ا�ن‬
‫�ر‬
‫�ﯾ‬‫�ﻟ�ط‬
‫�ا‬

‫�ﺔ‬
‫�ﻣ‬
‫�ﻧ�ظ‬
‫�ﻣ‬
‫(�و‬IATA) / ‫�ﻟ�ﻲ‬
‫�و‬
‫�د‬‫�ﻟ‬
‫�ا‬

‫�و�ي‬
‫�ﻟ�ﺟ‬
‫�ا‬

‫�ل‬
‫�ﻘ‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�د‬
‫�ﺎ‬
‫�ﺗ�ﺣ‬
‫�ا‬
restricted Transport Hazard (ICAO)‫�ﺔ‬ ‫�ﯾ‬
‫�ﻟ‬
‫�و‬
‫�د‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﯾ‬
‫�ر‬
‫�ﺑ�ﺣ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﻣ‬
‫�ﻧ�ظ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬
‫�و‬

،�(IMO): | � Transport Classification:



‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﻘ�ل‬
‫�ﻧ‬

‫�ﺋ�ط‬
‫�ﺎ‬
‫�و�ﺳ‬

‫�ة‬
‫�ر‬‫�و‬
‫� �ﺧ�ط‬
‫�ﺔ‬‫�ﺑ‬
‫�ﺗ‬
‫�ر‬
Class(es): Not applicable Packing

‫�ر‬‫�ﺎ�ط‬
‫�ﻣ�ﺧ‬
‫�ﻟ‬
‫�ا‬

‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﺔ‬
‫�ﺋ‬
‫�ﺑ‬
‫�ﻌ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�و�ﻋ‬‫�ﻣ‬
‫�ﻣ�ﺟ‬

Not restricted
Group: Not applicable Environmental
Hazards: Not applicable Special �
‫�ﺔ‬‫�ﺎ�ﺻ‬
‫� �ﺧ‬
‫�ﺎ�ت‬‫�ﺎ�ط‬
‫�ﯾ‬
‫�ﺗ‬
‫�إ�ﺣ‬

‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﺔ‬
‫�ﯾ‬
‫�ﺋ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻟ‬
‫�ا‬
Precautions for User None �
‫�ة‬
‫�ر‬‫�ﯾ‬
‫�ﺑ‬
‫�ﻛ‬

‫�ﺎ�ت‬‫�ﯾ‬
‫�ﻣ‬
‫�ﻛ‬
‫�ﺑ‬

‫�ﻘ�ل‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬
:�
‫�م‬
‫�د‬‫�ﺗ�ﺧ‬
‫�ﻣ�ﺳ‬
‫�ﻠ‬
‫�ﻟ‬
Transport in bulk according to �
(�
MARPOL )� �
‫�ﻣ�ن‬

‫�ﻧ�ﻲ‬
‫�ﺎ‬
‫�ﺛ‬
‫�ﻟ‬
‫�ا‬

‫�ﻓ�ﻖ‬
‫�ر‬‫�ﻣ‬‫�ﻠ‬
‫�ﻟ‬

‫�ﺎ‬
‫�ﻘ‬
‫�ﻓ‬
‫�و‬
Annex II of MARPOL 73/78 and
the IBC Code Not applicable

‫� �ﻻ‬
:�
IBC � ‫�ﺔ‬
‫�ﻧ‬
‫�و‬
‫�د‬‫�ﻣ‬

‫�و‬ �
7�3�/�
7�8� �
‫�و�ل‬‫�ﺑ‬
‫�ر‬
‫�ﺎ‬
‫�ﻣ‬
‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬
‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫و‬
‫تج‪:‬‬
‫ن‬‫م‬
‫ل‬‫ريل‬
‫ا‬‫تج‬
‫ل‬‫ا‬‫م‬
‫إلس‬
‫ا‬
‫™‪FACTANT‬‬
‫ة‪:‬‬
‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫م‬‫ق‬‫ر‬ ‫ة‬‫ع‬‫اج‬‫ر‬‫م‬
‫ل‬‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪22‬‬ ‫‪26-10-2016‬‬

‫وع‬
‫ر‬‫مش‬
‫ل‬‫ا‬‫ة‬
‫ك‬‫ر‬‫لش‬
‫ا‬‫رو‬
‫ي‬‫ةتحض‬
‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫يف‬
‫ر‬‫ع‬‫ت‬
‫‪1.‬‬
‫تج‬‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬‫ي‬
‫و‬‫ه‬
‫تج‪:‬‬
‫ن‬‫م‬
‫ل‬‫ريل‬‫ا‬
‫تج‬‫ل‬‫ا‬‫م‬
‫إلس‬‫ا‬
‫™‪FACTANT‬‬
‫ات‪:‬‬‫ف‬
‫د‬‫ا‬
‫ر‬‫م‬
‫يئ‬
‫الش‬
‫ة‬‫ي‬‫ئ‬
‫ا‬‫م‬‫ي‬
‫ةك‬ ‫ل‬
‫ئ‬‫ا‬
‫ع‬
‫يط‬‫ل‬
‫خ‬
‫لي‬
‫اخ‬‫د‬‫ل‬
‫ا‬‫رف‬‫ع‬‫م‬‫ل‬‫ا‬
‫ز‬‫م‬‫ر‬
‫‪HM004607‬‬

‫ه‬
‫ي‬‫ل‬
‫ةع‬‫وض‬
‫ر‬‫ف‬‫م‬
‫ل‬‫ا‬‫د‬
‫و‬‫ي‬‫ق‬
‫ل‬‫ا‬
‫هو‬‫وصىب‬ ‫م‬‫ل‬
‫ا‬‫م‬‫ا‬‫د‬
‫تخ‬‫الس‬
‫ا‬
‫يق‪:‬‬‫ب‬
‫تط‬‫ل‬
‫ا‬
‫تحالب‬‫لالس‬‫د‬
‫اع‬‫ملمس‬‫ا‬
‫ع‬
‫‪Uses advised against‬‬
‫ة‪.‬‬
‫اح‬‫ت‬‫اتم‬ ‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬
‫الت‬

‫ل‬ ‫ا‬‫تص‬‫إل‬
‫ا‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬‫ةو‬ ‫ع‬‫ن‬
‫مص‬ ‫ل‬
‫ا‬ ‫ة‬‫ك‬
‫ر‬‫لش‬ ‫ا‬
‫زع‬ ‫و‬‫تجم‬‫ن‬
‫م‬
‫‪Halliburton Energy Services‬‬
‫‪14th Floor, CitiBank Tower‬‬
‫‪Al-Qutayat Street‬‬
‫‪Dubai, UAE‬‬

‫‪Telephone Number : +971 43036666‬‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬

‫ة‬‫اسط‬
‫و‬‫رب‬‫حض‬
‫‪Chemical Stewardship‬‬
‫‪Telephone: 1-281-871-6107‬‬
‫‪e-mail: fdunexchem@[Link]‬‬

‫رئ‬‫ا‬‫و‬
‫لط‬‫ا‬‫تف‬‫ا‬
‫مه‬‫ق‬‫ر‬
‫‪1-760-476-3962‬‬
‫د‪14012 :‬‬‫ق‬
‫ع‬‫ل‬
‫ا‬‫م‬‫ق‬
‫ر‬
‫دث‪334305 :‬‬
‫ا‬‫و‬
‫لح‬‫ل‬
‫ة‬‫ي‬‫م‬
‫ل‬‫ا‬
‫ع‬‫ل‬
‫ا‬‫ة‬‫ب‬
‫ا‬
‫تج‬‫لالس‬‫ول‬
‫وص‬ ‫ل‬
‫ا‬‫ز‬‫م‬‫ر‬

‫ر‬
‫ا‬‫ألخط‬
‫ا‬‫ان‬
‫ي‬‫ب‬
‫‪2.‬‬
‫يف‬
‫ن‬‫تص‬
‫ل‬‫ا‬

‫ة ‪H319 - 2‬‬
‫ئ‬‫ف‬ ‫ين‬
‫ع‬‫ل‬
‫ا‬‫يج‬
‫ه‬‫ين ‪/‬ت‬
‫ع‬‫ل‬
‫ا‬‫يب‬
‫تيتص‬
‫ل‬
‫ا‬‫ة‬‫ر‬
‫ي‬‫لخط‬‫ا‬
‫ر‬‫ا‬‫ر‬‫األض‬
‫ة ‪H317 - 1‬‬
‫ئ‬‫ف‬ ‫ة‬
‫ي‬‫د‬‫ل‬
‫لج‬
‫ا‬‫ة‬‫ي‬‫اس‬
‫لحس‬‫ا‬

‫ر‬
‫لخط‬
‫ةل‬‫ي‬
‫يح‬‫وض‬
‫ت‬‫ل‬
‫ا‬‫ر‬‫و‬
‫لص‬‫ا‬

‫_____________________________________________________________________________________________‬
‫ة ‪8/1‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪FACTANT‬‬
‫‪26-10-2016‬‬
‫_____________________________________________________________________________________________‬

‫ه‬
‫ي‬‫ب‬
‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫م‬‫ل‬‫ك‬
‫ر‬‫ي‬
‫ذ‬‫تح‬

‫ر‬‫ا‬
‫ألخط‬
‫ا‬‫ات‬
‫ن‬‫ا‬‫ي‬
‫ب‬
‫د‪.‬‬
‫ل‬‫لج‬
‫ل‬ ‫ة‬
‫ي‬‫اس‬
‫ببحس‬‫أنيس‬‫كن‬‫م‬‫ي‬
‫‪H317‬‬
‫ين‪.‬‬
‫ع‬‫ل‬‫ل‬
‫ا‬
‫ً‬‫ر‬‫ي‬
‫يجخط‬‫ه‬‫ببت‬
‫يس‬‫‪H319‬‬

‫ة‬
‫ي‬‫ر‬‫ي‬
‫ذ‬‫تح‬
‫ل‬‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬

‫ع‬‫ن‬‫م‬‫ل‬
‫ا‬
‫ذ‪.‬‬
‫ا‬‫ذ‬‫ر‬‫ل‬
‫ا‬‫ة‪/‬‬ ‫ر‬‫بخ‬‫األ‬‫اب ‪/‬‬‫ب‬
‫لض‬ ‫ا‬ ‫ز‪/‬‬‫ا‬‫غ‬
‫ل‬‫ا‬‫ان ‪/‬‬
‫دخ‬ ‫ل‬‫ا‬
‫ر‪/‬‬ ‫ا‬‫ب‬‫غ‬
‫ل‬‫ا‬‫اق‬‫نش‬‫ت‬
‫نبإس‬ ‫تج‬‫‪P261‬‬
‫ال‪.‬‬‫م‬‫ع‬‫ت‬‫اإلس‬‫د‬‫ع‬‫ًب‬
‫ا‬‫د‬‫ي‬
‫ةج‬ ‫رض‬ ‫ع‬ ‫م‬‫ل‬
‫ا‬‫د‬‫ل‬‫لج‬
‫ا‬ ‫ينو‬ ‫د‬‫ي‬
‫ل‬‫ا‬
‫هو‬‫وج‬‫ل‬‫ا‬‫إغسل‬ ‫‪P264‬‬
‫مل‪.‬‬‫ع‬‫ل‬‫ا‬‫ان‬‫ك‬‫رجم‬ ‫ا‬‫ةخ‬‫ث‬‫و‬‫ل‬‫م‬‫ل‬
‫ا‬ ‫مل‬‫ع‬
‫ل‬‫ا‬‫بس‬ ‫ءمال‬‫ا‬‫د‬‫ت‬‫ر‬‫إ‬
‫محب‬ ‫أنيس‬‫غي‬‫ب‬‫ن‬‫‪P272‬الي‬
‫ه‪.‬‬‫وج‬‫ل‬‫ا‬‫ة‬‫ي‬
‫ا‬‫م‬‫لح‬‫اع‬ ‫ن‬
‫ين ‪/‬ق‬ ‫ع‬‫ل‬
‫ل‬‫ة‬‫ي‬‫ا‬‫م‬‫ة ‪/‬ح‬‫ي‬‫ق‬
‫ا‬
‫و‬‫ل‬‫ا‬ ‫بس‬‫مال‬‫ل‬
‫ا‬ ‫ة‪/‬‬‫ي‬‫ق‬
‫ا‬‫و‬‫ل‬
‫ا‬‫ات‬‫ز‬ ‫ا‬
‫ف‬
‫ق‬‫ل‬
‫ا‬ ‫بس‬ ‫ل‬
‫ت‬‫‪P280‬‬
‫ة‬‫ب‬‫ا‬
‫تج‬‫الس‬
‫ا‬
‫ون‪.‬‬ ‫ب‬
‫ا‬‫لص‬ ‫ا‬
‫ءو‬ ‫ا‬‫م‬‫ل‬
‫ا‬ ‫رمن‬ ‫ي‬‫ث‬
‫عك‬‫غسلم‬ ‫د‪:‬ي‬‫ل‬‫لج‬‫ا‬‫لى‬‫اع‬‫ذ‬‫إ‬
‫‪P302 + P352‬‬
‫ة‬‫ي‬
‫ا‬
‫ن‬‫ة ‪/‬ع‬‫ي‬‫ب‬‫لط‬‫ا‬
‫ة‬ ‫ر‬‫و‬
‫مش‬ ‫ل‬
‫ا‬‫لى‬ ‫إحصلع‬ ‫دي‪:‬‬ ‫ل‬
‫فحج‬ ‫وط‬ ‫أ‬‫يج‬‫ه‬‫وثت‬ ‫د‬‫ةح‬‫ل‬‫ا‬‫فيح‬‫‪P333 + P313‬‬
‫لشطف‪.‬‬
‫ا‬‫ر‬‫م‬
‫ت‬‫ه‪.‬يس‬
‫مب‬‫ا‬
‫ي‬
‫ق‬‫ل‬
‫ا‬‫هل‬
‫ةوس‬
‫د‬‫و‬‫وج‬
‫نتم‬
‫ا‬
‫اك‬‫ذ‬
‫إ‬‫ة‬‫ق‬
‫لالص‬
‫ا‬‫ات‬
‫دس‬‫ع‬
‫ل‬‫ا‬‫زع‬
‫ن‬‫ئق‪.‬ت‬‫ا‬
‫ق‬‫ةد‬ ‫د‬
‫ع‬ ‫ل‬
‫ء‬‫ا‬‫م‬‫ل‬
‫ا‬‫ع‬ ‫رم‬ ‫ذ‬‫ين‪:‬تشطفبح‬ ‫ع‬‫ل‬‫ا‬
‫ول‬‫ةدخ‬ ‫ل‬‫ا‬‫فيح‬ ‫‪P305 + P351 + P338‬‬
‫ة‬ ‫ي‬
‫ا‬‫ن‬
‫ة ‪/‬ع‬‫ي‬‫ب‬‫لط‬‫ا‬‫ة‬‫ر‬‫و‬ ‫مش‬‫ل‬
‫ا‬ ‫لى‬‫إحصلع‬ ‫ين‪:‬‬‫ع‬‫ل‬‫ا‬‫يج‬‫ه‬‫رت‬ ‫م‬‫ت‬
‫اس‬ ‫ا‬
‫ذ‬‫إ‬
‫‪P337 + P313‬‬
‫ة‪.‬‬
‫اص‬ ‫ةخ‬‫لج‬‫ا‬
‫ع‬‫م(م‬ ‫وس‬‫ل‬‫ا‬‫ة‬‫ق‬‫ا‬‫لىبط‬‫ةع‬ ‫ي‬
‫ف‬‫ا‬‫اإلض‬‫ة‬‫ي‬‫ل‬
‫و‬‫األ‬‫ات‬ ‫ف‬
‫ا‬‫ع‬‫اإلس‬‫ات‬‫م‬
‫ي‬‫ل‬‫ع‬
‫عت‬‫اج‬‫ر‬ ‫( ‪P321‬‬
‫ا‬
‫ه‬ ‫م‬‫ا‬
‫د‬‫تخ‬‫إس‬ ‫ة‬‫د‬‫ا‬
‫إع‬ ‫بل‬‫إغسلق‬‫ةو‬ ‫ث‬‫و‬‫ل‬
‫م‬ ‫ل‬
‫ا‬‫بس‬ ‫مال‬
‫ل‬‫ا‬‫ع‬‫ل‬‫إخ‬
‫‪P362 + P364‬‬
‫ين‬‫ز‬‫تخ‬
‫ء‬
‫الشي‬
‫ا‬‫ه‬‫ن‬‫لصم‬ ‫تخ‬‫ل‬
‫ا‬
‫د‪.‬‬‫م‬‫ت‬
‫ع‬‫م‬‫ل‬‫ا‬‫ات‬‫ي‬
‫ا‬‫ف‬‫ن‬
‫ل‬‫ا‬‫لصمن‬ ‫تخ‬‫ل‬
‫ا‬ ‫ز‬‫ك‬‫ر‬ ‫لىم‬‫إ‬‫ات‬ ‫ي‬
‫و‬‫أ‬‫لح‬‫ا‬‫ات ‪/‬‬‫ي‬
‫و‬ ‫ت‬
‫مح‬‫ل‬‫ا‬‫لصمن‬ ‫تخ‬‫‪P501‬‬

‫لى‬‫ويع‬ ‫ت‬
‫يح‬
‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ر ‪68990-47-6‬‬‫ت‬
‫‪،‬ت‬‫يك‬
‫ل‬
‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬‫‪،‬‬‫ين‬
‫م‬‫ي‬
‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬‫ةم‬
‫ي‬‫ل‬
‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬
‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬‫ا‬
‫ر‬‫ب‬‫و‬
‫ن‬‫لص‬‫ا‬‫يت‬
‫‪،‬ز‬ ‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫ين‬
‫م‬ ‫ت‬
‫ن‬
‫و‬‫ينب‬
‫ل‬‫ي‬
‫ث‬‫ي‬
‫إ‬
‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ةب‬
‫لج‬‫ا‬
‫ع‬‫ةم‬‫ف‬
‫ي‬‫ف‬
‫ةخ‬‫ي‬‫ل‬
‫و‬‫ر‬ ‫ت‬
‫اتب‬‫ر‬‫قط‬
‫م‬
‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬‫ا‬
‫ر‬‫ب‬‫و‬‫ن‬‫لص‬‫ا‬‫يت‬‫ز‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬
‫وف‬‫ر‬‫ع‬
‫ءم‬‫الشي‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ا‬‫اتعن‬
‫م‬‫و‬‫ل‬
‫ع‬‫يب ‪/‬م‬
‫ك‬‫ر‬‫ت‬
‫ل‬‫ا‬
‫‪3.‬‬
‫يف ‪GHS‬‬ ‫ن‬‫تص‬ ‫زن )‪(%‬‬ ‫و‬
‫ل‬‫ا‬‫ة‬
‫ب‬‫نس‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫)‪Skin Sens. 1 (H317‬‬ ‫‪10 - 30%‬‬ ‫‪68990-47-6‬‬ ‫ة‬
‫ي‬‫ل‬
‫اع‬‫ف‬
‫ةت‬‫د‬
‫ا‬‫‪،‬م‬‫نجي‬‫ت‬
‫ا‬
‫ر‬‫ل‬‫ا‬‫ر‬‫ب‬‫و‬
‫ن‬‫لص‬
‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫ين‬
‫م‬‫ت‬‫ن‬
‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬‫ر‬‫ت‬‫‪،‬ت‬‫يك‬
‫ل‬‫دم‬
‫ي‬‫ر‬‫د‬
‫ي‬‫ه‬
‫ن‬‫أ‬‫‪،‬‬
‫ين‬‫م‬‫ي‬‫ر‬
‫ت‬‫ن‬
‫ل‬‫ي‬
‫ث‬‫ي‬
‫عد‬‫م‬
‫)‪STOT SE 3 (H336‬‬ ‫‪1 - 5%‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ةب‬‫لج‬‫ا‬
‫ع‬‫ةم‬
‫ف‬‫ي‬
‫ف‬‫ةخ‬‫ي‬
‫ل‬‫و‬
‫ر‬‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬
‫)‪Asp. Tox. 1 (H304‬‬
‫)‪Eye Irrit. 2A (H319‬‬ ‫‪60 - 100%‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫ة‬
‫ي‬‫ل‬
‫و‬‫أل‬
‫ا‬‫ات‬
‫ف‬‫ا‬
‫ع‬‫إلس‬
‫ا‬‫ر‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪4.‬‬
‫ة‬
‫ي‬‫ل‬
‫و‬‫أل‬
‫ا‬‫ات‬‫ف‬‫ا‬
‫ع‬‫إلس‬
‫ا‬‫ر‬‫ي‬‫ب‬
‫ا‬‫د‬
‫ت‬
‫اق‬‫نش‬‫ت‬
‫إلس‬
‫ا‬
‫فسي‪.‬‬
‫ن‬‫ت‬
‫ل‬
‫ا‬‫ز‬‫ا‬
‫ه‬‫لج‬
‫ا‬‫يج‬
‫ه‬‫وت‬
‫أ‬‫فس‬
‫ن‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫ب‬
‫و‬‫ع‬‫ةص‬
‫ل‬‫ا‬
‫يبفيح‬
‫ب‬
‫لط‬‫ا‬
‫ر‬‫تش‬
‫إس‬‫د‪.‬‬
‫د‬‫تج‬
‫ءم‬‫ا‬
‫و‬‫ةه‬
‫ق‬‫نط‬
‫لىم‬
‫إ‬‫قل‬
‫ن‬‫إ‬‫اق‬‫نش‬
‫ت‬
‫اإلس‬‫ة‬‫ل‬
‫ا‬‫فيح‬
‫ة‬‫ر‬
‫بش‬‫ل‬
‫ا‬

‫_____________________________________________________________________________________________‬
‫ة ‪8/2‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪FACTANT‬‬
‫‪26-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫يج‪.‬‬
‫ه‬‫ت‬
‫ل‬‫ا‬‫ر‬‫م‬
‫ت‬‫إس‬
‫ة‬‫ل‬‫ا‬
‫يبفيح‬‫ب‬‫لط‬‫ا‬
‫ر‬‫تش‬‫إس‬
‫ون‪.‬‬‫ب‬
‫ا‬‫لص‬‫ا‬
‫ءو‬ ‫ا‬
‫م‬‫ل‬
‫ا‬‫إغسلب‬
‫ون‬‫ي‬‫ع‬
‫يب‪.‬‬‫ب‬
‫لط‬‫ا‬
‫لى‬‫فسكع‬ ‫رضن‬ ‫إع‬‫ين‬
‫ن‬‫ي‬
‫ع‬‫ل‬
‫ا‬‫يج‬
‫ه‬‫رت‬‫م‬
‫ت‬‫إس‬‫ا‬
‫ذ‬‫إ‬‫تج‪.‬‬
‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬
‫مس‬‫ةمال‬‫ل‬
‫ا‬‫قلفيح‬
‫األ‬
‫لى‬‫ةع‬‫ق‬
‫ي‬‫ق‬
‫ة ‪15‬د‬‫د‬
‫م‬‫ل‬‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ةمن‬‫ر‬‫ي‬
‫ف‬‫ةو‬‫ي‬
‫م‬‫ك‬‫ينب‬‫ن‬
‫ي‬‫ع‬‫ل‬
‫ا‬‫إغسل‬
‫تالع‬
‫ب‬‫إل‬
‫ا‬
‫لشخص‬‫م‬‫ف‬
‫ل‬
‫ا‬‫يق‬‫ر‬‫ءعنط‬‫أيشي‬ ‫ء‬‫ا‬
‫إعط‬‫ر‬‫م‪.‬يحظ‬‫ف‬
‫ل‬
‫ا‬‫غسل‬‫َّىب‬
‫وص‬ ‫ة‪.‬ي‬
‫ُ‬ ‫ي‬‫ئ‬
‫ا‬‫و‬
‫ه‬ ‫ل‬
‫ا‬‫ة‬‫ب‬
‫قص‬‫ل‬
‫ا‬‫ءفي‬‫قي‬
‫ل‬
‫ا‬ ‫د‬
‫ا‬‫و‬
‫ولم‬ ‫عدخ‬‫ن‬
‫م‬‫ل‬‫ين‬‫ك‬‫ر‬
‫و‬‫ل‬‫ا‬‫فل‬
‫أس‬‫أس‬‫ر‬‫ل‬
‫ا‬‫فض‬‫اخ‬‫‪،‬‬‫ء‬‫وثقي‬‫د‬‫ةح‬‫ل‬
‫ا‬‫ة!فيح‬
‫ي‬‫ب‬
‫لط‬‫ا‬
‫ة‬‫د‬‫اع‬‫مس‬‫ل‬
‫ا‬‫لب‬‫اط‬
‫وعي‪.‬‬‫ل‬
‫ا‬ ‫د‬
‫ق‬‫ا‬‫ف‬

‫ة‬
‫ر‬‫أخ‬
‫ت‬‫م‬
‫ل‬‫ا‬
‫و‬ ‫أ‬‫ة‬
‫د‬‫ا‬
‫لح‬‫ا‬
‫نت‬‫ا‬
‫ءك‬‫ا‬‫و‬
‫ة‪,‬س‬‫م‬
‫ا‬‫ه‬‫ل‬
‫ا‬‫ات‬‫ر‬
‫ي‬‫ث‬
‫أ‬‫ت‬
‫ل‬‫ا‬‫اضو‬
‫ر‬‫ألع‬
‫ا‬‫م‬‫عظ‬‫م‬
‫ين‪.‬‬
‫ع‬‫ل‬
‫ا‬‫يجفي‬
‫ه‬‫ببت‬
‫د‪.‬يس‬
‫ل‬‫لج‬
‫ا‬‫ةفي‬‫ي‬
‫اس‬‫ببحس‬
‫أنيس‬ ‫كن‬
‫م‬‫ي‬

‫ة‬
‫اص‬‫ةخ‬
‫لج‬‫ا‬
‫ع‬‫م‬‫و‬
‫أ‬‫ة‬‫ي‬
‫ر‬‫و‬‫ةف‬
‫ي‬‫ب‬
‫ةط‬‫ي‬
‫ا‬‫ن‬
‫ةأليع‬
‫اج‬‫لح‬
‫ا‬ ‫لى‬
‫إ‬‫ة‬‫ر‬‫ا‬
‫إش‬
‫يب‬‫ب‬
‫لط‬‫اتل‬‫مالحظ‬
‫اض‪.‬‬‫ر‬
‫األع‬
‫لجحسب‬ ‫ا‬‫ع‬

‫ئق‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬‫ك‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪5.‬‬
‫يق‬‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬‫ا‬‫ك‬
‫م‬‫ةل‬‫ب‬
‫اس‬‫ن‬
‫دم‬‫ا‬‫و‬
‫م‬
‫ة‪.‬‬
‫و‬‫رغ‬
‫ل‬‫ا‬‫ة‪,‬‬
‫ف‬‫ا‬
‫لج‬
‫ا‬‫ة‬‫ئ‬
‫ي‬
‫ا‬‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫ون‪,‬‬‫ب‬
‫ر‬‫ك‬‫ل‬
‫ا‬‫د‬‫ي‬
‫كس‬‫أ‬‫ني‬
‫ا‬‫ث‬
‫يق‬‫ر‬‫لح‬
‫ا‬‫د‬‫ا‬
‫م‬‫اسبإلخ‬‫ن‬
‫رم‬‫ي‬‫وسطغ‬
‫وف‪.‬‬‫ر‬‫ع‬‫ئىم‬‫الش‬

‫ة‬‫ي‬
‫ئ‬‫ا‬
‫ي‬‫م‬
‫ي‬‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫أمن‬ ‫نش‬
‫ةت‬‫ن‬
‫ي‬‫ع‬
‫رم‬‫ا‬‫أخط‬
‫ة‪.‬‬
‫م‬‫ا‬
‫اتس‬
‫ز‬‫ا‬
‫ونغ‬
‫ك‬‫أني‬
‫كن‬‫م‬
‫يقي‬
‫ر‬‫لح‬
‫ا‬‫ء‬‫ا‬
‫ن‬
‫ث‬‫أ‬‫ري‬
‫ا‬‫ر‬‫لح‬
‫ا‬‫لل‬
‫تح‬
‫ل‬‫ا‬
‫يق‪.‬‬
‫ر‬‫لح‬
‫ل‬‫ة‬‫رض‬‫ع‬‫م‬
‫ل‬‫ا‬‫األسطح‬
‫د‬‫ي‬‫ر‬‫ب‬
‫ت‬
‫ل‬‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫م‬‫د‬
‫تخ‬‫إس‬

‫ء‬‫ا‬
‫ف‬‫إلط‬
‫ا‬‫ل‬‫ا‬
‫رج‬‫ةل‬‫اص‬
‫ةخ‬‫ي‬‫ئ‬
‫ا‬‫ق‬
‫اتو‬‫ء‬
‫ا‬‫ر‬‫إج‬
‫ئق‪.‬‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬
‫ك‬‫دم‬
‫ا‬‫ر‬‫ف‬
‫ةأل‬
‫م‬‫ز‬‫ةال‬
‫د‬‫م‬‫ت‬
‫ع‬‫ةم‬
‫ل‬‫ق‬
‫ت‬‫فسمس‬ ‫ن‬
‫ةت‬‫ز‬
‫ه‬‫أج‬
‫ةو‬‫ل‬
‫م‬‫ا‬
‫ةك‬‫ي‬‫ق‬
‫ا‬
‫بسو‬‫مال‬

‫رض‬
‫ا‬‫ع‬‫ل‬
‫ا‬‫رب‬
‫تس‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫اج‬‫و‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪6.‬‬
‫رئ‬‫ا‬
‫و‬‫لط‬
‫ا‬‫ات‬
‫ء‬‫ا‬
‫ر‬‫إج‬
‫ةو‬‫ي‬
‫ا‬‫ق‬
‫و‬‫ل‬‫ا‬
‫ات‬‫د‬‫ع‬
‫م‬‫ة‪,‬‬
‫ي‬‫لشخص‬‫ا‬
‫ات‬‫اط‬
‫ي‬‫ت‬‫إلح‬
‫ا‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫ةك‬
‫ي‬‫و‬‫ه‬
‫دت‬‫و‬
‫دمنوج‬
‫ك‬‫أ‬
‫ة‪.‬ت‬
‫ر‬‫بخ‬
‫األ‬
‫فس‬‫ن‬
‫نبت‬
‫بس‪.‬تج‬
‫مال‬
‫ل‬‫ا‬
‫ينو‬
‫ن‬
‫ي‬‫ع‬‫ل‬
‫ا‬
‫دو‬‫ل‬
‫لج‬
‫ا‬‫ة‬‫مس‬
‫نبمال‬
‫ة‪.‬تج‬
‫ق‬‫ل‬
‫غ‬‫م‬
‫ل‬‫ا‬‫كن‬
‫ا‬‫م‬‫األ‬
‫ًفي‬
‫ا‬
‫ي‬
‫ت‬‫ا‬
‫فيذ‬‫ت‬
‫ك‬‫فسم‬‫ن‬
‫زت‬‫ا‬
‫ه‬‫مج‬
‫د‬‫تخ‬
‫إس‬‫ة‪.‬‬
‫ب‬‫اس‬
‫ن‬
‫م‬‫ل‬‫ا‬‫ة‬
‫ي‬‫ا‬
‫ق‬‫و‬
‫ل‬‫ا‬‫ات‬
‫د‬‫ع‬‫مم‬
‫د‬‫تخ‬‫إس‬

‫ة‬‫ي‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬‫اط‬
‫ي‬‫ت‬
‫إلح‬
‫ا‬
‫ة‪.‬‬
‫فض‬‫نخ‬
‫م‬‫ل‬
‫ا‬‫اطق‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫و‬‫أ‬‫ة‬
‫ي‬‫ئ‬
‫ا‬‫م‬
‫ل‬‫ا‬‫ري‬
‫ا‬‫مج‬
‫ل‬‫ا‬‫يف‪,‬‬
‫ر‬‫تص‬
‫ل‬
‫ا‬‫ري‬
‫ا‬‫لىمج‬‫إ‬
‫ا‬‫ه‬‫ل‬
‫و‬‫عدخ‬‫ن‬
‫م‬‫إ‬

‫يف‬‫نظ‬
‫ت‬‫ل‬
‫ا‬‫ءو‬‫ا‬
‫و‬‫ت‬
‫ةلالح‬
‫م‬‫ز‬‫لال‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫يبو‬ ‫ل‬
‫ا‬‫ألس‬
‫ا‬
‫ة‪.‬‬
‫ف‬‫ر‬‫غ‬
‫ةم‬‫اسط‬
‫و‬‫ةب‬
‫ل‬‫ا‬
‫ز‬‫اإل‬
‫مب‬‫رى‪.‬ق‬
‫أخ‬‫ة‬
‫ل‬‫م‬
‫ا‬‫ةخ‬
‫د‬‫ا‬
‫أيم‬
‫و‬‫أ‬‫مل‬
‫ر‬‫ل‬‫ا‬
‫م‬‫ا‬‫د‬
‫تخ‬‫إس‬
‫ةب‬‫ب‬
‫ر‬‫تس‬
‫م‬‫ل‬
‫ا‬‫ة‬
‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫وي‬
‫ت‬‫إح‬
‫من‪.‬‬
‫آ‬‫ا‬‫ذ‬
‫انه‬‫اك‬
‫ذ‬‫إ‬‫رب‬‫تس‬
‫ل‬‫ا‬‫قف‬‫و‬‫أ‬‫ةو‬‫ب‬‫ر‬‫تس‬
‫م‬‫ل‬
‫ا‬‫ة‬‫د‬
‫ا‬‫م‬
‫ل‬‫ا‬‫زل‬‫إع‬

‫ة‬‫ي‬
‫ف‬‫ا‬
‫إض‬‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫لىم‬
‫ولع‬
‫لحص‬
‫ل‬‫ات ‪8‬و ‪13‬‬
‫ر‬‫ق‬
‫ف‬‫ل‬
‫ا‬‫ع‬‫اج‬
‫ر‬

‫ين‬
‫ز‬‫تخ‬
‫ل‬‫ا‬
‫ةو‬‫ل‬
‫و‬‫ا‬
‫ن‬‫م‬
‫ل‬‫ا‬
‫‪7.‬‬
‫من‬‫اآل‬
‫ل‬‫م‬‫ا‬
‫ع‬‫ت‬‫ل‬
‫اتل‬‫اط‬‫ي‬
‫ت‬‫إلح‬
‫ا‬
‫ة‬
‫د‬‫ا‬
‫إع‬‫بل‬
‫ةق‬‫ث‬
‫و‬‫ل‬
‫م‬‫ل‬
‫ا‬‫بس‬
‫مال‬
‫ل‬‫ا‬‫إغسل‬
‫م‪.‬‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫د‬‫ع‬‫ينب‬
‫د‬‫ي‬
‫ل‬‫ا‬
‫إغسل‬
‫ة‪.‬‬‫ي‬
‫ف‬‫ا‬
‫ةك‬‫ي‬
‫و‬‫ه‬‫دت‬
‫و‬‫دمنوج‬
‫ك‬‫أ‬
‫ة‪.‬ت‬
‫ر‬‫بخ‬
‫األ‬
‫فس‬‫ن‬
‫نبت‬
‫بس‪.‬تج‬
‫مال‬
‫ل‬‫ا‬‫و‬
‫أ‬‫د‪,‬‬
‫ل‬‫لج‬
‫ا‬‫ين‪,‬‬
‫ع‬‫ل‬
‫ا‬‫ة‬‫مس‬
‫نبمال‬
‫ة‪.‬تج‬
‫ب‬‫اس‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫ة‬ ‫ي‬
‫ا‬
‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬‫د‬
‫ع‬‫مم‬‫د‬‫تخ‬‫إس‬
‫م‪.‬‬
‫ا‬‫د‬‫تخ‬
‫اإلس‬

‫ا‬
‫ً‬‫ع‬
‫ينم‬‫ز‬‫تخ‬
‫ل‬‫ا‬
‫نب‬‫تييجبتج‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫لك‬
‫افيذ‬
‫م‬ ‫من‪,‬ب‬
‫اآل‬
‫ين‬‫ز‬‫تخ‬
‫ل‬‫ا‬‫وط‬‫ر‬‫ش‬
‫ً‪.‬‬
‫ا‬
‫ر‬‫ه‬‫رف ‪12‬ش‬
‫ل‬‫ا‬‫لى‬
‫تجع‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫ر‬‫م‬‫م‪.‬ع‬
‫ا‬‫د‬
‫تخ‬‫اإلس‬
‫م‬‫د‬‫ةع‬
‫ل‬‫ا‬
‫ةفيح‬
‫ق‬‫ل‬
‫غ‬‫ةم‬
‫ي‬‫و‬‫ا‬
‫لح‬
‫ا‬‫فظب‬
‫ت‬‫إح‬
‫ة‪.‬‬‫ي‬
‫و‬‫ه‬‫ت‬
‫ل‬‫ا‬
‫د‬‫ي‬‫دج‬
‫ر‬‫ا‬‫انب‬
‫ك‬‫زنفيم‬‫ات‪.‬خ‬
‫د‬‫كس‬‫ؤ‬‫م‬‫ل‬
‫ا‬‫ًعن‬‫ا‬
‫د‬‫ي‬
‫ع‬‫ينب‬‫ز‬
‫تخ‬‫ل‬
‫ا‬

‫ة‬
‫ي‬‫لشخص‬
‫ا‬‫ة‬‫ي‬
‫ا‬‫م‬
‫لح‬‫ا‬
‫رض ‪/‬‬
‫ع‬‫ت‬‫ل‬
‫ا‬‫بط‬
‫ا‬
‫و‬‫‪8.‬ض‬
‫م‬‫ك‬
‫تح‬‫ل‬
‫ا‬‫ر‬‫ي‬
‫ي‬‫ا‬
‫ع‬‫م‬
‫رض‬‫ع‬‫ت‬
‫ل‬‫ا‬‫د‬
‫و‬‫د‬‫ح‬

‫ة‬‫ب‬
‫اس‬‫ن‬
‫م‬‫ل‬‫ا‬
‫ة‬‫ي‬‫دس‬
‫ن‬‫ه‬‫ل‬
‫ا‬‫بط‬
‫ا‬‫و‬‫لض‬‫ا‬
‫ة‪.‬‬
‫د‬‫ي‬
‫اج‬‫ه‬‫ت‬
‫ي‬
‫و‬‫ه‬‫ةت‬‫ق‬
‫نط‬‫مفيم‬
‫د‬‫تخ‬‫إس‬

‫_____________________________________________________________________________________________‬
‫ة ‪8/3‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪FACTANT‬‬
‫‪26-10-2016‬‬
‫_____________________________________________________________________________________________‬

‫ة‬‫ي‬‫لشخص‬‫ا‬‫ة‬‫ي‬‫ا‬
‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬‫د‬
‫ع‬‫لم‬ ‫ث‬
‫م‬ ‫ة‪,‬‬‫ي‬
‫د‬‫ر‬‫ف‬‫ل‬‫ا‬‫ة‬‫ي‬‫ا‬‫م‬‫لح‬‫ا‬‫ر‬ ‫ي‬‫ب‬
‫ا‬‫د‬
‫ت‬
‫و‬‫أ‬ ‫ة‬
‫ي‬‫اع‬
‫ن‬‫ةص‬ ‫ئي صح‬‫ا‬‫أخص‬‫بل‬‫ةمنق‬‫ي‬‫لشخص‬‫ا‬‫ة‬
‫ي‬‫ا‬‫ق‬‫و‬‫ل‬
‫ا‬ ‫ات‬‫د‬‫ع‬‫م‬
‫ل‬‫م‬‫ي‬
‫ل‬‫لس‬
‫ا‬‫م‬‫ا‬‫د‬
‫تخ‬‫اإلس‬
‫رو‬ ‫ا‬
‫ي‬‫ت‬
‫اإلخ‬‫د‬
‫ي‬‫د‬‫غيتح‬‫ب‬
‫ن‬‫ي‬ ‫رط‪,‬‬ ‫ف‬‫م‬‫ل‬
‫ا‬‫رض‬ ‫ع‬‫ت‬
‫ل‬
‫ا‬ ‫ع‬‫ن‬
‫م‬‫أنت‬‫كن‬‫م‬‫ملالي‬‫ع‬‫ل‬
‫ا‬‫ات‬‫رس‬‫ا‬
‫م‬‫م‬‫ةو‬‫ي‬‫دس‬ ‫ن‬‫ه‬
‫ل‬‫ا‬‫بط‬‫ا‬‫و‬‫لض‬ ‫ا‬‫نت‬ ‫ا‬‫اك‬‫ذ‬
‫إ‬
‫تج‪.‬‬
‫ن‬‫م‬‫ل‬
‫ا‬ ‫ا‬
‫ذ‬‫ه‬
‫ل‬‫د‬‫د‬‫مح‬‫ل‬
‫ا‬‫يق‬‫ب‬‫تط‬‫ل‬
‫ا‬‫لى‬‫إ‬
‫د‬‫ن‬‫ت‬
‫يثيس‬‫ينح‬ ‫ل‬
‫ه‬ ‫ؤ‬‫م‬‫ل‬
‫ا‬‫ين‬ ‫ي‬‫ن‬
‫ف‬‫ل‬‫ا‬‫امن‬ ‫ه‬‫ر‬‫ي‬‫غ‬
‫فسي‬‫ن‬‫ت‬‫ل‬
‫ا‬ ‫ز‬‫ا‬‫ه‬‫لح‬‫ا‬‫ة‬ ‫ي‬
‫ا‬‫م‬‫ح‬
‫ة‪.‬‬
‫ي‬‫و‬‫عض‬‫ل‬‫ا‬
‫ة‬‫ر‬‫بخ‬‫لأل‬
‫اعي‬‫ن‬‫فس ص‬‫ن‬
‫زت‬‫ا‬‫ه‬‫د‪:‬ج‬
‫ر‬‫ا‬‫غو‬ ‫ل‬‫ا‬
‫ب‬
‫ل‬‫ا‬ ‫رض‬ ‫ع‬‫ت‬
‫ل‬‫ا‬‫وث‬‫د‬‫الح‬‫م‬‫ت‬
‫إح‬ ‫ان‬‫اك‬
‫ذ‬‫إ‬‫ة‬‫ي‬‫ت‬
‫اآل‬‫ة‬
‫ز‬‫ه‬‫األج‬ ‫م‬‫ا‬‫د‬‫تخ‬‫إس‬
‫وصىب‬ ‫كني‬‫ل‬
‫ةو‬ ‫ي‬
‫د‬‫ا‬
‫ع‬‫ل‬
‫ا‬ ‫وف‬ ‫ر‬
‫لظ‬‫ا‬‫اعيفي‬‫ن‬
‫لص‬ ‫ا‬‫فس‬ ‫ن‬‫ت‬
‫ل‬‫ا‬‫ز‬‫ا‬‫ه‬‫لىج‬ ‫إ‬ ‫ة‬
‫اج‬ ‫الح‬
‫د‬‫ي‬
‫ل‬‫ا‬‫ة‬ ‫ي‬
‫ا‬‫م‬‫ح‬
‫للحسب ‪: (EN 374‬‬ ‫قتتخ‬‫ةو‬‫ق‬‫ي‬
‫ق‬‫دل‪> 480‬د‬‫ا‬
‫ع‬‫اي‬‫أيم‬ ‫ة ‪,6‬‬‫ي‬
‫ا‬‫م‬
‫رح‬ ‫ؤش‬‫ه‪:‬م‬‫وصىب‬ ‫م‬‫ل‬‫ا‬
‫ر)‬‫اش‬‫ب‬‫م‬
‫ل‬‫ا‬‫ال‬‫تص‬‫اإل‬‫و‬‫ول‪,‬‬ ‫أط‬‫ة‬‫ر‬‫ت‬‫ف‬
‫ل‬‫ة‬‫ب‬
‫اس‬‫ن‬‫م‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫ة )‪(EN 374‬‬‫ي‬‫ئ‬
‫ا‬
‫ي‬‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬ ‫د‬
‫ا‬‫و‬‫م‬ ‫ل‬
‫ل‬‫ة‬‫م‬‫و‬‫ا‬‫ق‬‫ةم‬ ‫ي‬
‫ق‬‫ا‬‫اتو‬ ‫ز‬‫ا‬‫ف‬
‫ق‬
‫ة‬‫ي‬‫ل‬
‫م‬‫ع‬
‫ل‬‫ا‬‫ة‬‫رس‬‫ا‬‫م‬
‫م‬‫ل‬
‫ا‬‫ة‪.‬في‬‫ل‬‫ث‬‫ا‬
‫م‬‫دم‬‫ا‬
‫و‬‫لىم‬‫ًع‬‫ا‬
‫اس‬
‫ي‬‫دق‬‫م‬
‫ت‬‫وتس‬‫أ‬‫ات‪,‬‬‫ز‬‫ا‬‫ف‬‫ق‬
‫ل‬
‫ل‬ ‫ة‬
‫ع‬‫ن‬‫مص‬‫ل‬‫ا‬‫ات‬
‫ك‬ ‫ر‬
‫لش‬‫ا‬‫بل‬‫ةمنق‬ ‫م‬‫د‬
‫ق‬‫م‬‫ل‬‫ا‬
‫ات‬‫م‬‫و‬‫ل‬‫ع‬ ‫م‬‫ل‬‫ا‬‫لى‬‫عوع‬ ‫اج‬‫ر‬
‫م‬ ‫ل‬
‫ا‬‫لى‬‫اتع‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬ ‫ل‬
‫ا‬‫ه‬‫ذ‬
‫ده‬‫ن‬‫ت‬
‫ة ‪(<=0.4‬تس‬ ‫ك‬‫ا‬
‫م‬‫مس‬ ‫م‬‫يل‪) .‬‬‫ر‬‫ت‬‫ي‬‫زن‬‫ا‬‫ف‬
‫ق‬
‫ة‬‫رج‬‫ثلد‬‫م‬‫ة)‬‫ر‬‫ث‬
‫ؤ‬‫م‬‫ل‬
‫ا‬‫مل‬ ‫ا‬
‫و‬‫ع‬‫ل‬
‫ا‬‫دمن‬‫ي‬‫د‬
‫ع‬‫ل‬
‫ا‬‫ة‬‫يج‬‫ت‬
‫لى ‪EN 374‬ن‬ ‫ًإ‬
‫ا‬‫ق‬
‫ف‬‫ذو‬‫ا‬‫ف‬
‫ن‬‫ل‬
‫ا‬‫قت‬‫و‬‫ل‬
‫ا‬‫رمن‬ ‫ي‬‫ث‬‫ك‬
‫رب‬ ‫قص‬‫أ‬‫ون‬‫ك‬‫دت‬‫ةق‬ ‫ي‬
‫ئ‬‫ا‬‫ي‬‫م‬
‫ي‬‫ك‬‫ل‬
‫ا‬ ‫د‬
‫ا‬‫و‬‫م‬‫ل‬
‫ل‬‫ة‬‫م‬‫و‬‫ا‬
‫ق‬‫م‬‫ل‬
‫ا‬‫ة‬‫ي‬
‫ق‬‫ا‬
‫و‬‫ل‬‫ا‬‫ات‬‫ز‬‫ا‬
‫ف‬‫ق‬
‫ل‬‫ل‬‫ة‬
‫ي‬‫ل‬
‫م‬‫ع‬‫ل‬
‫ا‬‫ة‬‫ا‬
‫ي‬‫لح‬
‫ا‬ ‫هفي‬ ‫ن‬‫أ‬ ‫ة‬‫مالحظ‬ ‫ل‬
‫ا‬‫رجى‬ ‫ي‬
‫ر‪.‬‬‫ي‬
‫ب‬‫ك‬
‫ل‬‫ا‬‫وع‬ ‫ن‬
‫ت‬‫ل‬‫ا‬‫بب‬‫مبس‬‫ا‬
‫د‬‫تخ‬
‫لإلس‬‫ع‬‫ن‬
‫مص‬ ‫ل‬‫ا‬‫ات‬‫ه‬‫ي‬
‫وج‬‫ةت‬‫ا‬‫اع‬
‫ر‬‫غيم‬ ‫ب‬‫ن‬‫ات‪.‬ي‬ ‫ز‬
‫ا‬‫ف‬‫ق‬
‫ل‬‫ا‬‫ال‬
‫د‬‫ب‬‫ت‬
‫إس‬‫م‬‫ت‬
‫أني‬‫زقيجب‬ ‫م‬‫ت‬
‫ل‬‫ا‬
‫كلو‬‫آ‬
‫ت‬‫ل‬
‫ا‬‫ات‬ ‫م‬
‫االحظتعال‬ ‫ذ‬‫إ‬‫ة(‪.‬‬
‫ر‬ ‫ا‬‫ر‬‫لح‬
‫ا‬
‫د‬‫ل‬
‫لج‬‫ا‬ ‫ة‬‫ي‬‫ا‬
‫ق‬‫و‬
‫اط‪.‬‬‫عطفمط‬ ‫م‬
‫ين‬‫ع‬‫ل‬‫ا‬‫ة‬ ‫ي‬
‫ا‬‫م‬‫ح‬
‫د‪.‬‬‫إنوج‬ ‫ذ‬‫ا‬‫ذ‬
‫ر‬‫ل‬‫ا‬‫ر‬‫ةمنخط‬ ‫ي‬‫ا‬
‫م‬‫لح‬‫ل‬‫ة‬‫وج‬‫ل‬
‫ل‬‫قي‬‫ا‬
‫اعو‬‫ن‬
‫عق‬‫ة‪ :‬ض‬ ‫ي‬‫ئ‬‫ا‬
‫ي‬‫م‬
‫ي‬‫ك‬‫ل‬‫ا‬‫ة‬‫ي‬‫ا‬‫ق‬
‫و‬ ‫ل‬
‫ا‬‫ر‬ ‫ي‬‫اظ‬‫ن‬
‫م‬
‫رى‬‫أخ‬ ‫ات‬ ‫اط‬‫ي‬‫ت‬
‫إح‬
‫وف‪.‬‬ ‫ر‬‫ع‬ ‫ئىم‬ ‫الش‬

‫ة‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ةو‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫ز‬‫ي‬
‫ف‬‫ل‬
‫ا‬‫ئص‬
‫ا‬‫لخص‬
‫ا‬
‫‪9.‬‬
‫ة‪:‬‬‫ي‬‫د‬‫ا‬‫م‬‫ل‬‫ا‬‫ة‬‫ل‬‫ا‬‫لح‬
‫ا‬
‫ئل‬‫ا‬‫س‬
‫ون‪:‬‬‫ل‬
‫اضح‬ ‫نيو‬ ‫ا‬‫م‬‫ر‬‫ه‬‫ك‬
‫ة‪:‬‬‫ئح‬ ‫ا‬
‫ر‬
‫ون‬‫ب‬‫ر‬ ‫ك‬
‫و‬ ‫ر‬‫د‬‫ي‬‫دله‬ ‫ت‬
‫ع‬‫م‬
‫ة‪:‬‬‫ئح‬ ‫ا‬
‫ر‬‫ل‬‫نىل‬ ‫د‬‫أل‬
‫ا‬ ‫د‬‫لح‬
‫ا‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫‪pH:‬‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫ء ‪:(= 1‬‬‫ا‬
‫م‬‫ة)‬ ‫ي‬‫و‬ ‫ئ‬
‫ةم‬ ‫رج‬ ‫ة @ ‪20‬د‬ ‫ي‬‫وع‬ ‫ن‬‫ل‬
‫ا‬ ‫ة‬‫ف‬‫ا‬
‫ث‬‫ك‬‫ل‬
‫ا‬
‫‪0.96‬‬
‫ة(‪:‬‬ ‫ي‬‫و‬‫ئ‬‫م‬‫دى )‬ ‫د ‪/‬م‬‫م‬ ‫تج‬‫ل‬‫ا‬‫ة‬‫قط‬‫ن‬
‫‪-5 - -4‬‬
‫ة(‪:‬‬ ‫ي‬‫و‬‫ئ‬‫ةم‬ ‫رج‬‫د‬‫دى )‬ ‫م‬ ‫ل‬
‫ا‬‫ان‬ ‫ي‬‫ل‬
‫ةغ‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫ة(‪:‬‬‫ي‬‫و‬ ‫ئ‬
‫م‬ ‫دى )‬ ‫م‬‫ل‬
‫ا‬ ‫يض ‪/‬‬ ‫م‬ ‫و‬‫ل‬‫ا‬‫ة‬‫قط‬‫ن‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫يض‪:‬‬ ‫م‬‫و‬ ‫ل‬
‫ا‬‫ة‬‫قط‬ ‫ةن‬ ‫ق‬‫ي‬‫ر‬‫ط‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫فض )‪(%‬‬ ‫نخ‬
‫دم‬ ‫و ‪-‬ح‬ ‫لج‬‫ا‬ ‫لفي‬ ‫ا‬‫ع‬
‫ت‬‫إلش‬‫ا‬ ‫ة‬
‫ي‬ ‫ل‬‫ب‬
‫ا‬‫دق‬ ‫و‬‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫وي )‪(%‬‬ ‫ل‬
‫دع‬ ‫و ‪-‬ح‬ ‫لج‬‫ا‬ ‫لفي‬ ‫ا‬‫ع‬
‫ت‬‫إلش‬‫ا‬ ‫ة‬
‫ي‬ ‫ل‬‫ب‬
‫ا‬‫دق‬ ‫و‬‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫ة(‪:‬‬
‫ي‬‫و‬‫ئ‬
‫ةم‬ ‫رج‬ ‫د‬‫تي )‬‫ا‬‫ذ‬ ‫ل‬
‫ا‬ ‫ل‬‫ا‬‫ع‬‫ت‬
‫الش‬ ‫ا‬‫ة‬‫ر‬‫ا‬‫ر‬‫ةح‬ ‫رج‬‫د‬
‫‪> 220‬‬
‫ل ‪:(= 1‬‬ ‫ي‬‫ت‬‫و‬ ‫ي‬‫ب‬
‫ل‬‫ا‬‫ر )خالت‬ ‫بخ‬ ‫ت‬‫ل‬
‫ا‬ ‫ة‬‫رع‬ ‫س‬
‫‪< 0.01‬‬
‫بق(‬‫ئ‬‫مز‬ ‫ل‬
‫م‬ ‫ة)‬‫ي‬
‫و‬‫ئ‬‫ة ‪20‬م‬ ‫ر‬‫ا‬‫ر‬‫ةح‬ ‫رج‬ ‫ة @د‬ ‫ر‬‫بخ‬ ‫أل‬
‫ا‬ ‫غط‬‫ض‬
‫‪< 0.2‬‬
‫ء‪=1‬‬ ‫ا‬
‫و‬ ‫ر)ه‬ ‫ا‬
‫بخ‬ ‫ل‬
‫ا‬ ‫ة‬‫ف‬‫ا‬‫ث‬‫ك‬
‫(‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫ء‬ ‫ا‬‫م‬
‫ل‬‫ا‬‫انفي‬ ‫ب‬‫و‬‫ذ‬‫ل‬
‫ا‬
‫ء‬ ‫ا‬‫م‬
‫ل‬‫ا‬ ‫انفي‬ ‫ب‬
‫و‬‫ذ‬‫ل‬
‫ل‬ ‫ة‬‫ل‬‫ب‬‫ا‬
‫رق‬ ‫ي‬‫غ‬
‫ة (‪:‬‬‫ي‬‫و‬ ‫ئ‬‫ل )م‬ ‫ل‬‫تح‬‫ل‬‫ا‬‫ة‬‫ر‬‫ا‬‫ر‬‫ةح‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫ز(‪:‬‬
‫و‬ ‫ي‬‫ب‬‫ي‬
‫ت‬‫ن‬
‫ة )س‬‫ي‬‫و‬
‫ئ‬‫ةم‬ ‫رج‬ ‫ة ‪‌@ 20‬د‬ ‫ي‬‫ك‬‫ي‬
‫م‬ ‫ا‬
‫ن‬‫ي‬‫ة‪,‬د‬ ‫وج‬ ‫ز‬
‫ل‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫وك(‪:‬‬ ‫ر‬
‫ت‬‫يس‬ ‫ت‬
‫ن‬‫ة )س‬‫ي‬
‫و‬‫ئ‬‫ةم‬ ‫رج‬ ‫ة ‪‌‌@ 20‬د‬ ‫ي‬‫ك‬‫ر‬‫ة‪,‬ح‬ ‫وج‬ ‫ز‬
‫ل‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫ء‪:‬‬ ‫ا‬
‫لم‬ ‫و‬‫ن‬‫ا‬‫ت‬
‫ك‬ ‫أ‬‫عن‪-‬‬ ‫ي‬
‫ز‬‫و‬ ‫ت‬‫ل‬‫ا‬‫ل‬‫م‬ ‫ا‬
‫ع‬‫م‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬ ‫دم‬ ‫وج‬‫الت‬
‫زئ (‪:‬‬ ‫ئى )غج‬ ‫ي‬‫ز‬‫لج‬ ‫ا‬‫زن‬ ‫و‬‫ل‬
‫ا‬

‫_____________________________________________________________________________________________‬
‫ة ‪8/4‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪FACTANT‬‬
‫‪26-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬‫م‬
‫و‬ ‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬

‫ة‬
‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬‫اتو‬
‫ب‬‫ث‬
‫ل‬‫ا‬
‫‪10.‬‬
‫ة‬‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬
‫يط‬
‫نش‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫د‬
‫ا‬‫إع‬
‫ع‬‫ق‬‫و‬
‫ت‬‫م‬‫ل‬
‫ا‬‫يسمن‬‫ل‬

‫ئي‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ات‬
‫ب‬‫ث‬‫ل‬
‫ا‬
‫ر‬‫ق‬
‫ت‬‫مس‬

‫ة‬
‫ر‬‫لخط‬
‫ا‬‫اعالت‬
‫ف‬‫ت‬
‫ل‬‫ا‬‫ل‬
‫ا‬‫م‬‫ت‬
‫اح‬
‫دث‬‫لنيح‬

‫ا‬
‫ه‬‫ب‬
‫ن‬‫تييجبتج‬
‫ل‬‫ا‬‫وف‬
‫ر‬‫لظ‬‫ا‬
‫ع‪.‬‬‫ق‬
‫و‬‫ت‬
‫يئم‬‫الش‬

‫ا‬‫ه‬‫ن‬
‫ب‬‫ديجبتج‬
‫ا‬‫و‬‫م‬
‫ة‪.‬‬
‫ي‬‫و‬‫ةق‬
‫د‬‫كس‬‫ؤ‬‫ملم‬
‫ا‬‫و‬‫ع‬

‫ة‬‫ر‬
‫لخط‬
‫ا‬‫كك‬‫ف‬
‫ت‬‫ل‬
‫ا‬‫ات‬‫تج‬‫ن‬
‫م‬
‫ون‪.‬‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬
‫أ‬‫ني‬
‫ا‬
‫ث‬‫ونو‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬
‫ا‬ ‫ول‬
‫أ‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫ه‬‫ي‬
‫وج‬ ‫ت‬
‫بق‬
‫نط‬‫الت‬

‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪11.‬‬
‫ة‬‫ي‬‫م‬‫لس‬‫ا‬‫ات‬‫ر‬‫ي‬‫ث‬
‫أ‬‫اتعنت‬ ‫م‬‫و‬‫ل‬
‫ع‬‫م‬
‫ة‬
‫د‬‫ا‬‫لح‬
‫ا‬ ‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫اق‬‫نش‬‫ت‬‫إس‬
‫م‬
‫ث‬‫ع‬‫ل‬
‫ت‬
‫ل‬‫ا‬‫عل‪,‬‬
‫ف‬‫ل‬
‫ا‬‫د‬‫ءر‬
‫ال‪,‬يط‬‫ع‬‫ف‬
‫ن‬‫اإل‬
‫ةو‬‫ك‬
‫ر‬‫لح‬
‫ا‬‫فق‬‫ا‬
‫و‬‫مت‬
‫د‬‫ول‪,‬ع‬‫م‬‫لخ‬
‫ا‬‫ر‪,‬‬
‫ا‬‫و‬‫د‬
‫ل‬‫ا‬‫اع ‪,‬‬‫د‬
‫لص‬‫ا‬‫مل‬‫ذىبش‬‫ل‬‫ا‬‫زى‬‫ك‬
‫ر‬‫م‬‫ل‬
‫ا‬‫بى‬‫عص‬‫ل‬‫ا‬
‫ز‬‫ا‬‫ه‬
‫لج‬‫ا‬‫عف‬ ‫بب ض‬
‫أنيس‬‫كن‬‫م‬‫فسي‪.‬ي‬
‫ن‬‫ت‬
‫ل‬‫ا‬‫ز‬‫ا‬
‫ه‬‫لج‬‫ا‬‫يطفي‬‫يجبس‬ ‫ه‬
‫أنت‬ ‫كن‬‫م‬‫ي‬
‫وعى‪.‬‬ ‫ل‬
‫ا‬‫ان‬
‫د‬‫ق‬‫ف‬
‫هن‪,‬و‬ ‫ذ‬
‫ل‬‫ا‬‫وش‬ ‫يث‪,‬تش‬‫د‬‫لح‬‫ا‬
‫في‬
‫ين‬‫ع‬
‫ل‬‫ا‬‫ة‬‫مس‬‫مال‬
‫ين‪.‬‬‫ع‬‫ل‬
‫ا‬‫يجفي‬ ‫ه‬
‫ببت‬ ‫يس‬
‫د‬‫ل‬
‫لج‬‫ا‬‫ة‬‫مس‬‫مال‬
‫د‪.‬‬
‫ل‬‫لج‬ ‫ل‬‫يط‬
‫يجبس‬‫ه‬
‫ببت‬ ‫أنيس‬‫كن‬‫م‬
‫د‪.‬ي‬
‫ل‬‫لج‬
‫ا‬‫ر‬‫و‬‫م‬‫بب ض‬‫أنيس‬‫كن‬‫م‬
‫ةي‬‫ل‬
‫ي‬
‫و‬‫ةط‬ ‫د‬
‫م‬‫ل‬ ‫رض‬ ‫ع‬‫ت‬
‫ل‬
‫ا‬‫د‪.‬‬
‫ل‬‫لج‬‫ل‬‫ة‬‫ي‬
‫اس‬‫ببحس‬ ‫أنيس‬ ‫كن‬‫م‬‫ي‬
‫تالع‬
‫ب‬‫إل‬
‫ا‬
‫ذى‬‫ل‬
‫ا‬ ‫وي‬
‫ئ‬‫ر‬‫ل‬
‫ا‬‫اب‬
‫ه‬‫ت‬
‫ل‬‫اإل‬
‫مو‬‫د‬
‫ل‬‫ا‬‫وبب‬‫مصح‬‫ل‬
‫ا‬‫ال‬
‫ع‬‫لس‬
‫ا‬‫ر‪,‬و‬‫ي‬
‫ف‬‫لص‬‫ا‬
‫فس‪,‬‬‫ن‬‫ت‬
‫ل‬‫ا‬ ‫ة‬‫ب‬
‫و‬‫ع‬‫ال‪ ,‬ص‬
‫ع‬‫لس‬‫ا‬
‫مل‬ ‫ذىيش‬
‫ل‬‫ا‬
‫ويو‬ ‫ا‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ة‬‫ئ‬
‫ر‬‫ل‬
‫ا‬ ‫اب‬‫ه‬
‫ت‬‫ل‬
‫إ‬‫بب‬‫أنيس‬
‫كن‬‫م‬‫ةي‬‫ئ‬‫ر‬‫ل‬
‫ا‬‫فطفي‬‫لس‬‫ا‬‫ة‪.‬‬
‫د‬‫ع‬‫م‬‫ل‬
‫ا‬‫لق‪,‬و‬‫لح‬
‫ا‬‫م‪,‬‬‫ف‬
‫ل‬‫ا‬‫هب‬ ‫ل‬
‫ي‬
‫ة‪.‬‬‫ا‬
‫ف‬‫و‬‫ل‬
‫ل‬‫د‬‫و‬‫ق‬
‫أني‬ ‫كن‬‫م‬‫ي‬

‫ة‬
‫ي‬‫ن‬‫ا‬
‫رط‬‫ةس‬‫ن‬
‫م‬‫ز‬‫اتم‬
‫ر‬‫ي‬‫ث‬
‫أ‬‫ت‬
‫ة‪.‬‬
‫لصح‬
‫ا‬‫لى‬
‫منع‬
‫ز‬‫ةم‬
‫ر‬‫و‬‫رخط‬
‫د‬‫همص‬
‫ن‬‫أ‬
‫ر‬‫ب‬
‫ك‬‫أ‬‫و‬
‫أ‬‫ة ‪1%‬‬
‫ب‬‫نس‬
‫ةب‬‫ت‬
‫ا‬
‫ن‬‫و‬‫ك‬
‫دىم‬
‫إح‬‫و‬
‫أ‬‫تج‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫د‬‫و‬‫أنوج‬
‫لى‬‫إ‬
‫ر‬‫ي‬‫اتتش‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ةل‬‫ي‬
‫م‬‫لس‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ة‬
‫ي‬‫يس‬
‫ئ‬
‫ر‬‫ل‬‫ا‬

‫اق ‪LC50‬‬
‫نش‬‫ت‬
‫إس‬ ‫د‬
‫ل‬‫لج‬
‫ا‬‫يق‬‫ر‬‫‪LD50‬عنط‬ ‫م‬‫ف‬‫ل‬
‫ا‬‫يق‬‫ر‬‫‪LD50‬عنط‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫ن‬
‫ا‬
‫ي‬‫دب‬
‫وج‬‫الت‬ ‫)‪>2000 mg/kg-bw (rat‬‬ ‫)‪>2020 mg/kg-bw (rat‬‬ ‫‪68990-47-6‬‬ ‫ر‬‫ب‬‫و‬‫ن‬
‫لص‬ ‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫ع‬‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬‫ا‬
‫ر‬‫ت‬‫‪،‬ت‬‫يك‬
‫ل‬‫دم‬‫ي‬
‫ر‬ ‫د‬
‫ي‬‫ه‬‫ن‬
‫أ‬‫‪،‬‬‫ين‬
‫م‬‫ي‬‫ر‬‫ت‬
‫ن‬
‫ل‬‫ي‬
‫ث‬‫ي‬
‫د‬
‫ين‬‫م‬‫ت‬
‫ن‬
‫و‬‫ينب‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫‪>5.2 mg/L (rat, 4 h, vapor) >2000 mg/kg-bw (rabbit) (similar‬‬ ‫‪>5000 mg/kg-bw (rat) (similar‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫ة مسجل‬
‫لج‬‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬‫ت‬
‫اتب‬‫ر‬‫قط‬‫م‬
‫)‪(similar substance‬‬ ‫)‪substance‬‬ ‫)‪substance‬‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ب‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫ن‬
‫ا‬‫ي‬
‫دب‬‫وج‬
‫الت‬ ‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫ن‬
‫ا‬‫ي‬
‫دب‬‫وج‬
‫الت‬ ‫)‪6600 mg/kg (rat‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫نجي‬‫ت‬
‫ا‬
‫ر‬‫ل‬‫ا‬‫ر‬‫ب‬‫و‬
‫ن‬‫لص‬‫ا‬‫يت‬‫ز‬

‫يج‬
‫ه‬‫د ‪/‬ت‬
‫ل‬‫لج‬
‫ا‬‫ل‬‫ك‬
‫آ‬‫ت‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫د‬
‫ل‬‫لج‬
‫ل‬‫ة‬‫يج‬
‫ه‬‫رم‬
‫ُ‬ ‫ي‬
‫‪ 68990-47-6‬غ‬ ‫ر‬
‫ب‬‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫‪،‬ز‬
‫ني‬‫ه‬
‫مضد‬
‫ا‬‫ح‬

‫_____________________________________________________________________________________________‬
‫ة ‪8/5‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪FACTANT‬‬
‫‪26-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬ ‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬
‫ا‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬ ‫ر‬
‫ت‬‫‪،‬ت‬‫يك‬
‫ل‬‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫د)‬
‫ل‬‫لج‬
‫ل‬‫ة‬‫يج‬
‫ه‬‫رم‬
‫ُ‬ ‫ي‬
‫غ‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬
‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬

‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫يج‬‫ه‬‫ين ‪/‬ت‬‫ع‬
‫ل‬‫ا‬‫ر‬
‫ر‬‫تض‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫نب‪.‬‬‫ر‬
‫األ‬‫ين‬‫ع‬‫ل‬
‫زعج‬‫رم‬‫ي‬
‫‪ 68990-47-6‬غ‬ ‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬ ‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬
‫ا‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬ ‫ر‬
‫ت‬‫‪،‬ت‬‫يك‬‫ل‬
‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫نب‪) .‬‬
‫ر‬‫األ‬
‫ين‬‫ع‬
‫ل‬‫زعج‬
‫رم‬‫ي‬
‫غ‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬
‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬

‫ين‪.‬‬
‫ع‬‫ل‬
‫ا‬‫دفي‬
‫و‬‫د‬‫دلمح‬
‫ت‬‫ع‬
‫ببم‬
‫تس‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫ة‬‫ي‬
‫د‬‫ل‬
‫لج‬
‫ا‬‫ة‬‫ي‬
‫اس‬‫لحس‬
‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ا‪.‬‬
‫ي‬
‫ن‬‫ي‬
‫رغ‬‫ي‬
‫ز‬‫ن‬
‫دفيخ‬‫ل‬
‫لج‬
‫ل‬‫‪ 68990-47-6‬محسس‬ ‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬ ‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬
‫ا‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬ ‫ر‬
‫ت‬‫‪،‬ت‬‫يك‬‫ل‬
‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫ا( )‬
‫ي‬
‫ن‬‫ي‬
‫رغ‬‫ي‬
‫ز‬‫ن‬
‫ر )خ‬
‫ب‬‫ت‬
‫مخ‬‫ل‬
‫ا‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لىح‬
‫ةع‬‫ي‬
‫اس‬‫ببحس‬
‫متس‬
‫ل‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬
‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬

‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫فسي‬
‫ن‬‫ت‬
‫ل‬‫ا‬‫تحسس‬‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫‪ 68990-47-6‬الت‬ ‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬ ‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬
‫ا‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬ ‫ر‬
‫ت‬‫‪،‬ت‬‫يك‬‫ل‬
‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬
‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬

‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫ة‬‫ي‬‫ر‬
‫ف‬‫لط‬
‫ا‬‫ر‬‫ا‬
‫ث‬‫اآل‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‬
‫ي‬‫ر‬‫ف‬
‫اتط‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫يب "‪"In vitro‬‬
‫ب‬
‫ا‬‫ن‬
‫األ‬
‫ات‬‫اس‬
‫ر‬‫اتد‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬‫ةفي‬
‫ي‬‫ر‬‫ف‬
‫اتط‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫لحي "‪"In vivo‬‬
‫ا‬‫م‬‫لجس‬
‫ا‬‫اتفي‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬‫‪ 68990-47-6‬في‬ ‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬ ‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬
‫ا‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬ ‫ر‬
‫ت‬‫‪،‬ت‬‫يك‬‫ل‬
‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬
‫د‬
‫ا‬‫و‬
‫م‬‫ة)‬
‫ي‬‫ر‬‫ف‬
‫اتط‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫لحي "‪"In vivo‬‬
‫ا‬‫م‬‫لجس‬
‫ا‬‫اتفي‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬‫ةفي‬
‫ي‬‫ر‬‫ف‬
‫اتط‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫يب "‪"In vitro‬‬
‫ب‬
‫ا‬‫ن‬
‫األ‬‫ات‬
‫اس‬‫ر‬
‫اتد‬‫ر‬ ‫ا‬
‫ب‬
‫ت‬‫إخ‬‫في‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬
‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬
‫ة(‬‫ل‬
‫ث‬
‫ا‬‫م‬‫م‬
‫ة‬‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬
‫الت‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫ة‬‫ن‬‫رط‬
‫اتمس‬ ‫ر‬
‫ي‬‫ث‬‫أ‬
‫ت‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬‫وج‬‫‪ 68990-47-6‬الت‬ ‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬ ‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬
‫ا‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬ ‫ر‬
‫ت‬‫‪،‬ت‬‫يك‬‫ل‬
‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫ات )‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬‫ةفي‬
‫ن‬‫رط‬
‫اتمس‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬
‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬

‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫ة‬‫ي‬‫ل‬
‫اس‬‫ن‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ي‬
‫م‬‫لس‬
‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬‫قيفي‬
‫ل‬
‫هخ‬‫و‬
‫اتتش‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫ة‪.‬‬
‫ب‬‫و‬‫لخص‬
‫ا‬‫لى‬
‫رع‬‫ا‬
‫ث‬
‫آ‬‫أي‬
‫ر‬‫ه‬‫متظ‬
‫ل‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬‫ا‬‫تج‬
‫ل‬
‫‪ 68990-47-6‬ا‬ ‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬ ‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬
‫ا‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬ ‫ر‬
‫ت‬‫‪،‬ت‬‫يك‬‫ل‬
‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫ات )‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬‫قيفي‬
‫ل‬
‫هخ‬‫و‬
‫اتتش‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫ة‪.‬‬
‫ب‬‫و‬‫لخص‬
‫ا‬‫لى‬
‫رع‬‫ا‬
‫ث‬
‫آ‬‫أي‬
‫ر‬‫ه‬‫متظ‬
‫ل‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬
‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬

‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫ة‬
‫د‬‫اح‬
‫ةو‬‫ر‬
‫رضم‬
‫ع‬‫ت‬‫م ‪STOT-CAS‬‬
‫ل‬
‫ا‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫‪ 68990-47-6‬الت‬ ‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬ ‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬
‫ا‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬ ‫ر‬
‫ت‬‫‪،‬ت‬‫يك‬‫ل‬
‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫زي )‪) (CNS‬‬
‫ك‬‫ر‬‫م‬
‫ل‬‫ا‬‫بي‬
‫عص‬‫ل‬
‫ا‬‫ز‬‫ا‬
‫ه‬‫لج‬
‫ا‬‫لف‬
‫ت‬
‫ابو‬
‫ر‬‫اضط‬
‫بب‬‫دتس‬
‫ق‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬
‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬

‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫ر‬‫ر‬
‫ك‬‫ت‬‫م‬‫ل‬
‫ا‬‫رض‬ ‫ع‬
‫ت‬‫ل‬
‫ا‬‫‪STOT -‬‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫ةك‬
‫د‬‫و‬‫اتج‬‫اتذ‬
‫ن‬‫ا‬
‫ي‬
‫ةب‬‫ي‬
‫أ‬‫ر‬‫ف‬
‫و‬‫ت‬
‫‪ 68990-47-6‬الت‬ ‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬‫يت‬
‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬‫ا‬‫ح‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬
‫ل‬‫ي‬
‫ث‬‫ي‬
‫عد‬‫ةم‬‫ي‬
‫ل‬
‫اع‬‫ف‬
‫ةت‬‫د‬
‫ا‬‫‪،‬م‬
‫نجي‬‫ت‬
‫ا‬
‫ر‬‫ل‬‫ا‬

‫_____________________________________________________________________________________________‬
‫ة ‪8/6‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪FACTANT‬‬
‫‪26-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬
‫ل‬‫ي‬
‫ث‬‫ي‬
‫إ‬‫ر‬‫ت‬
‫‪،‬ت‬‫يك‬
‫ل‬‫دم‬
‫ي‬‫ر‬‫د‬
‫ي‬‫ه‬
‫ن‬‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫يف‪) .‬‬
‫ن‬
‫تص‬‫ل‬
‫ا‬‫لب‬
‫تط‬‫زت‬
‫ي‬‫ك‬‫ر‬
‫ةفيت‬
‫ي‬‫ن‬
‫ا‬‫و‬
‫ي‬‫لح‬
‫ا‬‫ات‬
‫اس‬
‫ر‬‫د‬‫ل‬
‫ا‬‫ةفي‬
‫ر‬‫ي‬‫ب‬
‫ةك‬‫ي‬
‫م‬‫أيس‬
‫ميالحظ‬
‫ل‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬‫ي‬‫ل‬
‫و‬‫ر‬‫ت‬
‫اتب‬‫ر‬
‫قط‬‫م‬

‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫فط‬
‫لس‬‫ا‬
‫ر‬‫خط‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫بق‬
‫نط‬‫‪ 68990-47-6‬الت‬ ‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫‪،‬‬
‫ين‬‫م‬
‫ي‬‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬ ‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬
‫ا‬
‫ين‬
‫م‬‫ت‬
‫ن‬‫و‬‫ينب‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬ ‫ر‬
‫ت‬‫‪،‬ت‬‫يك‬‫ل‬
‫دم‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬
‫وي‬
‫ئ‬‫ر‬‫ل‬
‫ا‬‫اب‬
‫ه‬‫ت‬
‫ل‬‫اإل‬
‫مو‬‫د‬
‫ل‬‫ا‬
‫وبب‬
‫مصح‬
‫ل‬‫ا‬‫ال‬
‫ع‬‫لس‬
‫ا‬
‫ر‪,‬و‬
‫ي‬‫ف‬
‫لص‬‫ا‬
‫فس‪,‬‬
‫ن‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫ب‬
‫و‬‫ع‬‫ال‪ ,‬ص‬
‫ع‬‫لس‬
‫ا‬‫مل‬
‫ذىيش‬
‫ل‬‫ا‬
‫ويو‬
‫ا‬‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ة‬‫ئ‬
‫ر‬‫ل‬
‫ا‬‫اب‬
‫ه‬‫ت‬
‫ل‬‫إ‬
‫بب‬‫أنيس‬‫كن‬‫م‬‫ةي‬‫ئ‬
‫ر‬‫ل‬‫ا‬‫فطفي‬‫لس‬‫ا‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ةب‬‫لج‬
‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬
‫ت‬‫اتب‬‫ر‬‫قط‬
‫م‬
‫ة‪.‬‬
‫ا‬‫ف‬
‫و‬‫ل‬‫ل‬
‫د‬‫و‬‫ق‬‫أني‬‫كن‬‫م‬‫ذىي‬‫ل‬‫ا‬
‫ة‬‫اح‬
‫ت‬‫اتم‬ ‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫الت‬ ‫نجي‬
‫ت‬
‫ا‬‫ر‬‫ل‬
‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬
‫لص‬‫ا‬
‫يت‬‫ز‬

‫ة‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬
‫ن‬‫و‬
‫ل‬‫ع‬‫م‬
‫‪12.‬‬
‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫ات‬
‫ي‬‫ر‬‫ا‬‫ق‬‫ف‬‫ةال‬
‫ي‬‫م‬‫س‬ ‫ة‬‫ق‬‫ي‬
‫ق‬‫د‬‫ل‬
‫ا‬ ‫ات‬‫ن‬‫ئ‬
‫ا‬‫ك‬‫ل‬
‫ةل‬ ‫ي‬
‫م‬‫س‬ ‫مك‬‫لس‬‫ةل‬
‫ي‬‫م‬‫لس‬ ‫ا‬ ‫لب‬‫ا‬
‫لطح‬‫ةل‬ ‫ي‬
‫م‬‫لس‬ ‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬‫ا‬
‫‪LL50 (48 h) >2000 mg/L‬‬ ‫‪EC50 (3h) > 100 mg/L LL50 (96 h) >1000 mg/L EL50 (72 h) =23.8 mg/L‬‬ ‫‪68990-47-6‬‬ ‫ر‬‫ب‬‫و‬‫ن‬
‫لص‬ ‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬ ‫ا‬
‫ح‬
‫)‪(Acartia tonsa‬‬ ‫)‪(Activated sludge) (Scophthalmus maximus) (Skeletonema costatum‬‬ ‫ع‬‫ةم‬‫ي‬
‫ل‬‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬‫ا‬
‫)‪(respiration rate‬‬ ‫‪EC50 (72 h) >100 mg/L‬‬ ‫ر‬‫ت‬‫‪،‬ت‬‫يك‬
‫ل‬‫دم‬‫ي‬
‫ر‬ ‫د‬
‫ي‬‫ه‬‫ن‬
‫أ‬‫‪،‬‬‫ين‬
‫م‬‫ي‬‫ر‬‫ت‬
‫ن‬
‫ل‬‫ي‬
‫ث‬‫ي‬
‫د‬
‫‪(Pseudokirchneriella‬‬ ‫ين‬‫م‬‫ت‬
‫ن‬
‫و‬‫ينب‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫)‪subcapitata‬‬
‫‪LC50 (48h) > 10,000‬‬ ‫ة‬ ‫اح‬
‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫الت‬ ‫‪LC50 (96h) > 10,000 EC50 (72h) > 1,000 mg/L‬‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫ة مسجل‬
‫لج‬‫ا‬‫ع‬
‫ةم‬ ‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬‫ر‬‫ت‬
‫اتب‬‫ر‬‫قط‬‫م‬
‫)‪mg/L (Acartia tonsa‬‬ ‫)‪mg/L (Scophthalmus (Skeletonema costatum‬‬ ‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬
‫ب‬
‫‪EC50 (48h) 1100 mg/L‬‬ ‫‪maximus) ErL50 (72h) > 1000 mg/L‬‬
‫)‪(Daphnia pulex‬‬ ‫‪LL50 (96h) > 1000 mg/L‬‬ ‫‪(Pseudokirchneriella‬‬
‫‪LC50 (48h) 0.12 mg/L‬‬ ‫)‪(Oncorhynchus mykiss‬‬ ‫)‪subcapitata‬‬
‫)‪(Daphnia magna‬‬ ‫‪EbL50 (72h) > 1000 mg/L‬‬
‫‪EL50 (48h) > 1000 mg/L‬‬ ‫‪(Pseudokirchneriella‬‬
‫)‪(Daphnia magna‬‬ ‫)‪subcapitata‬‬
‫‪NOELR (72h) 1000 mg/L‬‬
‫‪(Pseudokirchneriella‬‬
‫)‪subcapitata‬‬
‫‪EC50(48): >100 mg/l‬‬ ‫ة‬ ‫اح‬
‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫الت‬ ‫‪LC50(96): >25 mg/l‬‬ ‫ة‬
‫اح‬‫ت‬‫اتم‬‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫نجي‬‫ت‬
‫ا‬‫ر‬
‫ل‬‫ا‬‫ر‬‫ب‬‫و‬
‫ن‬‫لص‬‫ا‬‫يت‬‫ز‬
‫)‪(Pimephales promelas‬‬

‫ل‬
‫ل‬‫تح‬
‫ل‬‫ا‬
‫ءو‬‫ا‬
‫ق‬‫ب‬
‫ل‬‫ا‬

‫ل‬‫ل‬
‫تح‬‫ل‬
‫ا‬
‫اتو‬‫ب‬‫ث‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ا )‪(d28 @ 71%‬‬
‫ي‬
‫ئ‬‫ا‬
‫ق‬‫ل‬
‫للت‬
‫تح‬‫ل‬
‫ل‬‫بل‬
‫ا‬
‫ق‬ ‫د ‪68990-47-6‬‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬‫‪،‬‬‫ين‬
‫م‬‫ي‬
‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬‫ةم‬
‫ي‬‫ل‬
‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬
‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬‫ا‬
‫ر‬‫ب‬‫و‬
‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬‫ا‬‫ح‬
‫ين‬‫م‬‫ت‬
‫ن‬‫و‬
‫ينب‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ر‬‫ت‬
‫‪،‬ت‬‫يك‬
‫ل‬
‫م‬
‫)‪(40% @ 28d‬‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ةب‬
‫لج‬‫ا‬
‫ع‬‫ةم‬‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬
‫ر‬‫ت‬‫اتب‬
‫ر‬‫قط‬‫م‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫نجي‬
‫ت‬‫ا‬‫ر‬
‫ل‬‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬
‫يت‬‫ز‬

‫ئي‬
‫ا‬‫ي‬
‫ألح‬
‫ا‬‫م‬‫ك‬
‫ا‬‫ر‬‫ت‬
‫ل‬‫ا‬‫لى‬
‫ةع‬‫ر‬
‫د‬‫ق‬‫ل‬
‫ا‬

‫‪Log Pow‬‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬


‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫‪2.4‬‬ ‫د ‪68990-47-6‬‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬‫‪،‬‬‫ين‬
‫م‬‫ي‬
‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬‫ةم‬
‫ي‬‫ل‬
‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬
‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬‫ا‬
‫ر‬‫ب‬‫و‬
‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬‫ا‬‫ح‬
‫ين‬‫م‬‫ت‬
‫ن‬‫و‬
‫ينب‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ر‬‫ت‬
‫‪،‬ت‬‫يك‬
‫ل‬
‫م‬
‫‪Log Pow Weighted Average7.5‬‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ةب‬
‫لج‬‫ا‬
‫ع‬‫ةم‬‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬
‫ر‬‫ت‬‫اتب‬
‫ر‬‫قط‬‫م‬
‫ة‬‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬‫الت‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫نجي‬
‫ت‬‫ا‬‫ر‬
‫ل‬‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬
‫يت‬‫ز‬

‫ة‬
‫ب‬‫ر‬‫ت‬
‫ل‬‫ا‬‫ةفي‬
‫ك‬‫ر‬‫لح‬
‫ا‬

‫ل‬‫ق‬
‫ن‬‫ت‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫د ‪68990-47-6‬‬‫ي‬
‫ر‬‫د‬‫ي‬
‫ه‬‫ن‬
‫أ‬‫‪،‬‬‫ين‬
‫م‬‫ي‬
‫ر‬‫ت‬
‫ن‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫عد‬‫ةم‬
‫ي‬‫ل‬
‫اع‬
‫ف‬‫ةت‬
‫د‬‫ا‬
‫‪،‬م‬‫نجي‬
‫ت‬‫ا‬
‫ر‬‫ل‬‫ا‬
‫ر‬‫ب‬‫و‬
‫ن‬‫لص‬‫ا‬‫يت‬‫‪،‬ز‬‫ني‬‫ه‬‫مضد‬‫ا‬‫ح‬
‫ين‬‫م‬‫ت‬
‫ن‬‫و‬
‫ينب‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ر‬‫ت‬
‫‪،‬ت‬‫يك‬
‫ل‬
‫م‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ةب‬
‫لج‬‫ا‬
‫ع‬‫ةم‬‫ف‬
‫ي‬‫ف‬
‫ةخ‬ ‫ي‬
‫ل‬‫و‬
‫ر‬‫ت‬‫اتب‬
‫ر‬‫قط‬‫م‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫نجي‬
‫ت‬‫ا‬‫ر‬
‫ل‬‫ا‬‫ر‬‫ب‬
‫و‬‫ن‬‫لص‬‫ا‬
‫يت‬‫ز‬

‫رى‬‫ألخ‬
‫ا‬‫ة‬‫ي‬‫ب‬
‫ل‬‫لس‬
‫ا‬‫ر‬‫ا‬
‫ث‬‫اآل‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬ ‫و‬
‫ل‬‫ع‬‫دم‬
‫وج‬‫الت‬

‫_____________________________________________________________________________________________‬
‫ة ‪8/7‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪FACTANT‬‬
‫‪26-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫ات‬
‫ي‬‫ا‬
‫ف‬‫ن‬
‫ل‬‫ا‬‫اصمن‬
‫تخ‬‫ل‬
‫ا‬‫ات‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إع‬‫‪13.‬‬
‫ات‬‫ي‬
‫ا‬‫ف‬‫ن‬
‫ل‬‫ا‬‫ة‬‫لج‬
‫ا‬‫ع‬
‫رقم‬ ‫ط‬
‫لص‬ ‫تخ‬‫ل‬
‫ا‬‫ةفي‬‫م‬‫د‬‫تخ‬
‫مس‬ ‫ل‬
‫ا‬‫ة‬‫ق‬‫ي‬
‫ر‬‫لط‬‫ا‬
‫ة‪.‬‬
‫ي‬‫ل‬
‫مح‬‫ل‬
‫ا‬‫ة‬
‫ر‬‫ا‬
‫د‬‫اإل‬
‫ة‪,‬و‬
‫ي‬‫وال‬
‫ل‬‫ا‬
‫ة‪,‬و‬
‫ي‬‫ل‬
‫ا‬‫ر‬
‫د‬‫ي‬‫ف‬
‫ل‬
‫ا‬‫ة‬‫م‬
‫و‬‫ك‬‫لح‬
‫ا‬‫د‬‫اع‬
‫و‬‫ق‬‫ل‬
‫ا‬
‫ً‬‫ق‬‫ب‬
‫مط‬‫ت‬‫اتي‬‫ي‬
‫ا‬‫ف‬‫ن‬
‫ل‬
‫ا‬‫لصمن‬ ‫تخ‬‫ل‬‫ا‬
‫وث‬‫ل‬‫يفم‬‫ل‬‫غ‬‫ت‬
‫ة‪.‬‬‫ي‬
‫ل‬
‫مح‬‫ل‬‫ا‬‫ةو‬‫ي‬
‫م‬‫و‬‫ق‬
‫ل‬‫ا‬‫ئح‬‫ا‬
‫و‬‫ل‬
‫ل‬‫ا‬‫ع‬‫ي‬
‫م‬‫عج‬ ‫ب‬
‫ت‬‫إ‬
‫رى‬‫أخ‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬ ‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬‫الت‬

‫ل‬
‫ق‬‫ن‬‫ل‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪14.‬‬
‫ة"‬
‫د‬‫تح‬
‫م‬‫ل‬
‫ا‬‫م‬‫م‬
‫أل‬
‫ا‬‫م ‪"UN‬‬‫ق‬
‫ر‬
‫د‬‫ي‬
‫ق‬‫رم‬
‫ي‬‫غ‬

‫يح ‪UN:‬‬
‫لصح‬
‫ا‬‫ل‬‫ق‬
‫ن‬‫ل‬
‫ا‬‫م‬‫إس‬
‫د‬‫ي‬
‫ق‬‫رم‬‫ي‬
‫غ‬

‫ل‪:‬‬
‫ق‬‫ئطن‬
‫ا‬‫ةوس‬
‫ر‬‫و‬‫ةخط‬‫ب‬‫ت‬
‫ر‬
‫بق‬
‫نط‬‫الت‬

‫ة‪:‬‬
‫ئ‬‫ب‬
‫ع‬‫ت‬
‫ل‬‫ا‬‫ة‬‫وع‬‫م‬
‫مج‬
‫بق‬‫نط‬
‫الت‬

‫ة‪:‬‬
‫ي‬‫ئ‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫اط‬‫مخ‬‫ل‬‫ا‬
‫بق‬‫نط‬‫الت‬

‫م‪:‬‬
‫د‬‫تخ‬
‫مس‬‫ل‬
‫ةل‬‫اص‬
‫اتخ‬
‫اط‬‫ي‬
‫ت‬‫إح‬
‫ء‬
‫الشي‬

‫ة ‪IBC:‬‬
‫ن‬‫و‬‫د‬
‫ل ‪78/73‬وم‬
‫و‬‫ب‬‫ر‬
‫ا‬‫نيمن )‪(MARPOL‬م‬
‫ا‬‫ث‬
‫ل‬‫ا‬
‫فق‬‫ر‬
‫م‬‫ل‬‫ال‬
‫ق‬‫ف‬
‫ةو‬‫ر‬
‫ي‬‫ب‬
‫اتك‬
‫ي‬‫م‬‫ك‬
‫لب‬‫ق‬‫ن‬
‫ل‬‫ا‬
‫بق‬‫نط‬
‫الت‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫اتت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪15.‬‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫ت‬
‫ل‬‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬
‫ا‪.‬‬
‫ه‬‫ت‬
‫يال‬
‫د‬‫ع‬
‫ت‬‫ا )‪"(GHS‬و‬
‫ه‬‫م‬‫وس‬
‫ةو‬‫ي‬
‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫يف‬
‫ن‬
‫تص‬‫ل‬
‫ا‬
‫ً‬‫ي‬
‫م‬‫ل‬
‫ا‬‫نسقع‬
‫م‬‫ل‬
‫ا‬‫م‬‫ا‬
‫نظ‬‫ل‬
‫ا‬
‫ة"‬‫د‬
‫تح‬‫م‬
‫ل‬‫ا‬‫م‬
‫م‬‫لأل‬
‫ا‬‫ق‬
‫ف‬‫ه ‪SDS‬و‬‫ذ‬‫ده‬
‫ا‬‫د‬
‫إع‬‫م‬‫ت‬

‫رى‬
‫أخ‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪16.‬‬
‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫د‬‫ا‬‫مص‬
‫ةو‬‫ي‬
‫يس‬‫ئ‬
‫ر‬‫ل‬
‫ا‬‫ات‬
‫ي‬‫ب‬
‫د‬‫أل‬
‫ا‬‫ع‬‫اج‬
‫ر‬‫م‬
‫‪[Link]/‬‬
‫‪OSHA‬‬
‫‪ECHA C&L‬‬

‫ة‬‫ع‬‫اج‬‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪26-10-2016‬‬
‫يح‬‫ق‬‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫وظ‬‫لح‬‫م‬
‫ا‪2‬‬
‫ه‬‫د‬‫ي‬
‫د‬‫متج‬
‫تيت‬‫ل‬
‫ا‬ ‫م ‪SDS‬‬‫ا‬
‫قس‬‫أ‬

‫ة‬‫ي‬
‫ل‬‫و‬
‫ؤ‬‫مس‬‫ل‬
‫ا‬‫ء‬‫إخال‬‫ان‬
‫ي‬‫ب‬
‫دال‬
‫اق‬‫يض‬
‫أ‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬‫ل‬‫ا‬‫رى‪.‬‬‫األخ‬
‫اف‬‫ر‬‫األط‬
‫عض‬ ‫ب‬
‫تج‪,‬و‬‫ن‬
‫م‬‫ل‬‫ا‬‫مل‬
‫تىتش‬‫ل‬
‫ا‬ ‫ر‬
‫د‬‫ا‬‫مص‬‫ل‬
‫ا‬‫ةمن‬‫ف‬‫ل‬
‫ت‬
‫ةمخ‬‫وع‬‫م‬
‫امنمج‬
‫ه‬‫ي‬
‫ل‬‫ولع‬‫لحص‬‫ا‬
‫م‬‫ةت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬‫أن‬‫يث‬‫ةح‬‫د‬
‫و‬‫ز‬‫م‬‫ل‬
‫ا‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬‫م‬
‫ل‬‫ا‬‫ال‬
‫م‬‫ت‬
‫ك‬‫إ‬‫و‬
‫أ‬‫ة‬‫ق‬‫د‬
‫انب‬
‫م‬‫دض‬ ‫وج‬
‫الي‬
‫م‪.‬‬‫د‬
‫تخ‬‫مس‬‫ل‬‫ا‬
‫ة‬‫ي‬‫ل‬
‫و‬ ‫ؤ‬
‫ةهيمس‬ ‫د‬‫ا‬
‫أيم‬‫ة‬
‫م‬‫ء‬‫مال‬
‫ل‬‫ئي‬‫ا‬
‫ه‬‫ن‬‫ل‬
‫ا‬‫د‬‫ي‬
‫د‬‫تح‬
‫ل‬‫ا‬‫رى‪.‬‬
‫األخ‬
‫ات‬‫لج‬
‫ا‬‫ع‬
‫م‬‫ل‬
‫ا‬‫وفي‬‫أ‬
‫رى‬‫أخ‬‫د‬
‫ا‬‫و‬
‫دم‬‫و‬‫وفيوج‬‫أ‬‫ع‬
‫متم‬ ‫د‬
‫تخ‬‫إس‬‫ا‬
‫ذ‬‫إ‬‫و‬
‫أ‬‫م‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫وف‬ ‫ر‬‫ةتحتكلظ‬‫يح‬
‫ون صح‬ ‫ك‬‫ت‬

‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫ةو‬
‫ي‬‫ا‬
‫ه‬‫ن‬

‫_____________________________________________________________________________________________‬
‫ة ‪8/8‬‬
‫فح‬‫ص‬
SAFETY DATA SHEET
Product Trade Name:
FACTANT™
Revision Date: Revision Number:
26-Oct-2016 22

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE


COMPANY/UNDERTAKING
Product Identifier
Product Trade Name:
FACTANT™
Synonyms
None
Chemical Family:
Blend
Internal ID Code
HM004607

Recommended use and restrictions on use


Application:
Emulsifier
Uses advised against
No information available

Manufacturer's Name and Contact Details


Manufacturer/Supplier
Halliburton Energy Services
14th Floor, CitiBank Tower, Al-Qutayat Street
Dubai, UAE
Telephone Number : +971 43036666

Additional Information

Prepared By
Chemical Stewardship
Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

Emergency Telephone Number


+1-760-476-3962
Global Incident Response Access Code: 334305
Contract Number: 14012

2. HAZARDS IDENTIFICATION
Classification

Serious Eye Damage / Eye Irritation Category 2 - H319


Skin Sensitization Category 1 - H317

Hazard Pictograms

_____________________________________________________________________________________________
Page 1 / 9
FACTANT™ Revision Date:
26-Oct-2016
_____________________________________________________________________________________________

Signal Word
Warning

Hazard Statements
H317 - May cause an allergic skin reaction
H319 - Causes serious eye irritation

Precautionary Statements

Prevention
P261 - Avoid breathing dust/fume/gas/mist/vapors/spray
P264 - Wash face, hands and any exposed skin thoroughly after handling
P272 - Contaminated work clothing should not be allowed out of the workplace
P280 - Wear protective gloves/protective clothing/eye protection/face protection
Response
P302 + P352 - IF ON SKIN: Wash with plenty of soap and water
P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention
P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and
easy to do. Continue rinsing
P337 + P313 - If eye irritation persists: Get medical advice/attention
P321 - Specific treatment (see supplemental first aid instructions on this label)
P362 + P364 - Take off contaminated clothing and wash before reuse
Storage
None
Disposal
P501 - Dispose of contents/container to an approved waste disposal plant

Contains
Substances CAS Number
Fatty acid, tall-oil, reaction product with diethylenetriamine, 68990-47-6
maleic anhydride, tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum distillate Proprietary
Tall oil Proprietary

Additional Information
None known

3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances CAS Number PERCENT (w/w) GHS Classification
Fatty acid, tall-oil, reaction product 68990-47-6 10 - 30% Skin Sens. 1 (H317)
with diethylenetriamine, maleic
anhydride, tetraethylenepentamine,
and triethylenetetramine
Hydrotreated light petroleum distillate Proprietary 1 - 5% STOT SE 3 (H336)
Asp. Tox. 1 (H304)
Tall oil Proprietary 60 - 100% Eye Irrit. 2A (H319)

4. FIRST AID MEASURES

_____________________________________________________________________________________________
Page 2 / 9
FACTANT™ Revision Date:
26-Oct-2016
_____________________________________________________________________________________________
First-aid Measures
Inhalation
If inhaled, remove from area to fresh air. Get medical attention if respiratory irritation develops or if breathing becomes difficult.
Skin
Wash with soap and water. Get medical attention if irritation persists.
Eyes
In case of contact, immediately flush eyes with plenty of water for at least 15 minutes and get medical attention if irritation persists.
Ingestion
Get medical attention! If vomiting occurs, keep head lower than hips to prevent aspiration. Rinse mouth. Never give anything by
mouth to an unconscious person.

Most important symptoms and effects, both acute and delayed


May cause allergic skin reaction. Causes eye irritation.

Indication of any immediate medical attention and special treatment needed


Notes to Physician
Treat symptomatically.

5. FIRE FIGHTING MEASURES


Suitable Extinguishing Media
Carbon dioxide, dry chemical, foam.
Extinguishing media which must not be used for safety reasons
None known.

Specific hazards arising from the chemical


Use water spray to cool fire exposed surfaces. Decomposition in fire may produce harmful gases.

Special protective actions for fire-fighters


Full protective clothing and approved self-contained breathing apparatus required for fire fighting personnel.

6. ACCIDENTAL RELEASE MEASURES


Personal precautions, protective equipment and emergency procedures
Use appropriate protective equipment. Wear self-contained breathing apparatus in enclosed areas. Avoid contact with skin, eyes
and clothing. Avoid breathing vapors. Ensure adequate ventilation.

Environmental Precautions
Prevent from entering sewers, waterways, or low areas.

Methods and material for containment and cleaning up


Isolate spill and stop leak where safe. Contain spill with sand or other inert materials. Scoop up and remove.

Additional Information
See Section 8 and 13 for additional information.

7. HANDLING AND STORAGE


Precautions for safe handling
Use appropriate protective equipment. Avoid contact with eyes, skin, or clothing. Avoid breathing vapors. Ensure adequate
ventilation. Wash hands after use. Launder contaminated clothing before reuse.

Conditions for safe storage, including any incompatibilities


Store away from oxidizers. Store in a cool well ventilated area. Keep container closed when not in use. Product has a shelf life of
12 months.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION

_____________________________________________________________________________________________
Page 3 / 9
FACTANT™ Revision Date:
26-Oct-2016
_____________________________________________________________________________________________

Control parameters
Exposure Limits

Appropriate engineering controls


Use in a well ventilated area.

Individual protection measures, such as personal protective equipment


If engineering controls and work practices cannot prevent excessive exposures, the selection and proper use of personal protective
equipment should be determined by an industrial hygienist or other qualified professional based on the specific application of this
product.
Respiratory Protection
Not normally needed. But if significant exposures are possible then the following respirator is recommended:
Organic vapor respirator.

Hand Protection
Chemical-resistant protective gloves (EN 374) Suitable materials for longer, direct contact (recommended: protection index 6,
corresponding to > 480 minutes permeation time as per EN 374): Nitrile gloves. (>= 0.4 mm thickness)
This information is based on literature references and on information provided by glove manufacturers, or is derived by analogy
with similar substances. Please note that in practice the working life of chemical-resistant protective gloves may be considerably
shorter than the permeation time determined in accordance with EN 374 as a result of the many influencing factors (e.g.
temperature). If signs of wear and tear are noticed then the gloves should be replaced. Manufacturer's directions for use should be
observed because of great diversity of types.
Skin Protection
Rubber apron.
Eye Protection
Chemical goggles; also wear a face shield if splashing hazard exists.
Other Precautions
None known.

9. PHYSICAL AND CHEMICAL PROPERTIES


Physical State:
Liquid
Color
Clear amber
Odor:
Mild Hydrocarbon
Odor Threshold:
No information available
pH:
No information available
Specific Gravity @ 20 C (Water=1):
0.96
Freezing Point/Range (°C):
-5 - -4
Boiling Point/Range (C):
No information available
Flash Point/Range (°C):
No information available
Flash Point Method:
No information available
Flammability Limits in Air - Lower (%):
No information available
Flammability Limits in Air - Upper (%):
No information available
Autoignition Temperature (°C):
> 220
Evaporation Rate (Butyl Acetate=1):
< 0.01
Vapor Pressure @ 20 C (mmHg):
< 0.2
Vapor Density (Air=1):

_____________________________________________________________________________________________
Page 4 / 9
FACTANT™ Revision Date:
26-Oct-2016
_____________________________________________________________________________________________
No information available
Water Solubility
Insoluble in water
Decomposition Temperature (C):
No information available
Viscosity, Dynamic @ 20 C (centipoise):
No information available
Viscosity, Kinematic @ 20 C (centistokes):
No information available
Partition Coefficient/n-Octanol/Water:
No information available
Molecular Weight (g/mole):
No information available

10. STABILITY AND REACTIVITY


Reactivity
Not expected to be reactive.

Chemical Stability
Stable

Possibility of hazardous reactions


Will Not Occur

Conditions to Avoid
None anticipated

Incompatible materials
Strong oxidizers.

Hazardous decomposition products


Carbon monoxide and carbon dioxide.

Additional Guidelines
Not Applicable

11. TOXICOLOGICAL INFORMATION


Information on Toxicological Effects
Acute Toxicity
Inhalation
May cause mild respiratory irritation. May cause central nervous system depression including headache, dizziness,
drowsiness, incoordination, slowed reaction time, slurred speech, giddiness and unconsciousness.
Eye Contact
Causes eye irritation.
Skin Contact
May cause an allergic skin reaction. May cause skin defatting with prolonged exposure. May cause mild skin irritation.
Ingestion
Irritation of the mouth, throat, and stomach. Aspiration into the lungs may cause chemical pneumonitis including coughing,
difficulty breathing, wheezing, coughing up blood and pneumonia, which can be fatal.

Chronic Effects/Carcinogenicity
No data available to indicate product or components present at greater than 0.1% are chronic health hazards.

Toxicology data for the components

_____________________________________________________________________________________________
Page 5 / 9
FACTANT™ Revision Date:
26-Oct-2016
_____________________________________________________________________________________________

Substances CAS Number LD50 Oral LD50 Dermal LC50 Inhalation


Fatty acid, tall-oil, 68990-47-6 >2020 mg/kg-bw (rat) >2000 mg/kg-bw (rat) No data available
reaction product with
diethylenetriamine,
maleic anhydride,
tetraethylenepentamine,
and triethylenetetramine
Hydrotreated light Proprietary >5000 mg/kg-bw (rat) (similar >2000 mg/kg-bw (rabbit) (similar >5.2 mg/L (rat, 4 h, vapor)
petroleum distillate substance) substance) (similar substance)
Tall oil Proprietary 6600 mg/kg (rat) No data available No data available

Substances CAS Number Skin corrosion/irritation


Fatty acid, tall-oil, reaction 68990-47-6 Non-irritating to the skin
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum Non-irritating to the skin (similar substances)
distillate
Tall oil No information available

Substances CAS Number Serious eye damage/irritation


Fatty acid, tall-oil, reaction 68990-47-6 Non-irritating to rabbit's eye
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum Non-irritating to rabbit's eye (similar substances)
distillate
Tall oil Causes moderate eye irritation

Substances CAS Number Skin Sensitization


Fatty acid, tall-oil, reaction 68990-47-6 Skin sensitizer in guinea pig.
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum Did not cause sensitization on laboratory animals (guinea pig) (similar substances)
distillate
Tall oil No information available

Substances CAS Number Respiratory Sensitization


Fatty acid, tall-oil, reaction 68990-47-6 No information available
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum No information available
distillate
Tall oil No information available

Substances CAS Number Mutagenic Effects


Fatty acid, tall-oil, reaction 68990-47-6 In vivo tests did not show mutagenic effects. In vitro tests did not show mutagenic effects.
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum In vitro tests did not show mutagenic effects. In vivo tests did not show mutagenic effects. (similar
distillate substances)
Tall oil No information available

_____________________________________________________________________________________________
Page 6 / 9
FACTANT™ Revision Date:
26-Oct-2016
_____________________________________________________________________________________________

Substances CAS Number Carcinogenic Effects


Fatty acid, tall-oil, reaction 68990-47-6 No information available
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum Did not show carcinogenic effects in animal experiments (similar substances)
distillate
Tall oil No information available

Substances CAS Number Reproductive toxicity


Fatty acid, tall-oil, reaction 68990-47-6 Animal testing did not show any effects on fertility. Did not show teratogenic effects in animal
product with experiments.
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum Animal testing did not show any effects on fertility. Did not show teratogenic effects in animal
distillate experiments. (similar substances)
Tall oil No information available

Substances CAS Number STOT - single exposure


Fatty acid, tall-oil, reaction 68990-47-6 No information available
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum May cause disorder and damage to the Central Nervous System (CNS) (similar substances)
distillate
Tall oil No information available

Substances CAS Number STOT - repeated exposure


Fatty acid, tall-oil, reaction 68990-47-6 No data of sufficient quality are available.
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum No significant toxicity observed in animal studies at concentration requiring classification. (similar
distillate substances)
Tall oil No information available

Substances CAS Number Aspiration hazard


Fatty acid, tall-oil, reaction 68990-47-6 Not applicable
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine
Hydrotreated light petroleum Aspiration into the lungs may cause chemical pneumonitis including coughing, difficulty breathing,
distillate wheezing, coughing up blood and pneumonia, which can be fatal.
Tall oil No information available

12. ECOLOGICAL INFORMATION


Toxicity
Substances CAS Number Toxicity to Algae Toxicity to Fish
Toxicity to Toxicity to Invertebrates
Microorganisms
Fatty acid, tall-oil, 68990-47-6 EL50 (72 h) =23.8 mg/L LL50 (96 h) >1000 mg/L EC50 (3h) > 100 mg/L LL50 (48 h) >2000 mg/L
reaction product with (Skeletonema costatum) (Scophthalmus maximus) (Activated sludge) (Acartia tonsa)
diethylenetriamine, EC50 (72 h) >100 mg/L (respiration rate)

_____________________________________________________________________________________________
Page 7 / 9
FACTANT™ Revision Date:
26-Oct-2016
_____________________________________________________________________________________________
maleic anhydride, (Pseudokirchneriella
tetraethylenepentamine, subcapitata)
and triethylenetetramine
Hydrotreated light Proprietary EC50 (72h) > 1,000 mg/L LC50 (96h) > 10,000 No information available LC50 (48h) > 10,000
petroleum distillate (Skeletonema costatum) mg/L (Scophthalmus mg/L (Acartia tonsa)
ErL50 (72h) > 1000 mg/L maximus) EC50 (48h) 1100 mg/L
(Pseudokirchneriella LL50 (96h) > 1000 mg/L (Daphnia pulex)
subcapitata) (Oncorhynchus mykiss) LC50 (48h) 0.12 mg/L
EbL50 (72h) > 1000 mg/L (Daphnia magna)
(Pseudokirchneriella EL50 (48h) > 1000 mg/L
subcapitata) (Daphnia magna)
NOELR (72h) 1000 mg/L
(Pseudokirchneriella
subcapitata)
Tall oil Proprietary No information available LC50(96): >25 mg/l No information available EC50(48): >100 mg/l
(Pimephales promelas)

Persistence and degradability

Substances CAS Number Persistence and Degradability


Fatty acid, tall-oil, reaction product with 68990-47-6 Readily biodegradable (71% @ 28d)
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine
Hydrotreated light petroleum distillate Proprietary (40% @ 28d)
Tall oil Proprietary No information available

Bioaccumlation potential

Substances CAS Number Log Pow


Fatty acid, tall-oil, reaction product with 68990-47-6 2.4
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine
Hydrotreated light petroleum distillate Proprietary Log Pow Weighted Average7.5
Tall oil Proprietary No information available

Mobility in soil

Substances CAS Number Mobility


Fatty acid, tall-oil, reaction product with 68990-47-6 No information available
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine
Hydrotreated light petroleum distillate Proprietary No information available
Tall oil Proprietary No information available

Other adverse effects


No information available

13. DISPOSAL CONSIDERATIONS


Waste treatment methods
Disposal methods
Disposal should be made in accordance with federal, state, and local regulations.
Contaminated Packaging
Follow all applicable national or local regulations.
Other Information
No information available

14. TRANSPORT INFORMATION


UN Number
Not restricted

UN proper shipping name:


Not restricted

_____________________________________________________________________________________________
Page 8 / 9
FACTANT™ Revision Date:
26-Oct-2016
_____________________________________________________________________________________________

Transport Hazard Class(es):


Not applicable

Packing Group:
Not applicable

Environmental Hazards:
Not applicable

Special Precautions for User


None

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
Not applicable

15. REGULATORY INFORMATION

Regulatory Information
This SDS was prepared in accordance with United Nations "Globally Harmonized System of Classification and Labelling of
Chemicals (GHS)" and its revisions.

16. OTHER INFORMATION


Key literature references and sources for data
[Link]/
OSHA
ECHA C&L

Revision Date:
26-Oct-2016
Revision Note
SDS sections updated: 2

Disclaimer Statement
This information is furnished without warranty, expressed or implied, as to accuracy or completeness. The information is obtained
from various sources including the manufacturer and other third party sources. The information may not be valid under all
conditions nor if this material is used in combination with other materials or in any process. Final determination of suitability of any
material is the sole responsibility of the user.

End of Safety Data Sheet

_____________________________________________________________________________________________
Page 9 / 9
SAFETY DATA SHEET
Product Trade Name: FACTANT™
Revision Date: 19-Apr-2017 Revision Number: 23

1. Identification
1.1. Product Identifier
Product Trade Name: FACTANT™
Synonyms None
Chemical Family: Blend
Internal ID Code HM004607

1.2 Recommended use and restrictions on use


Application: Emulsifier
Uses advised against No information available

1.3 Manufacturer's Name and Contact Details


Manufacturer/Supplier
Baroid Fluid Services
Product Service Line of Halliburton
P.O. Box 1675
Houston, TX 77251

Halliburton Energy Services


645 - 7th Ave SW Suite 1800
Calgary, AB
T2P 4G8
Canada

Prepared By Chemical Stewardship


Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

1.4. Emergency telephone number


Emergency Telephone Number: 1-866-519-4752 or 1-760-476-3962
Global Incident Response Access Code: 334305
Contract Number: 14012

2. Hazards Identification
2.1 Classification in accordance with paragraph (d) of §1910.1200

Skin Sensitization Category 1 - H317

2.2. Label Elements

Hazard Pictograms

_____________________________________________________________________________________________
Page 1 / 10
FACTANT™ Revision Date: 19-Apr-2017
_____________________________________________________________________________________________

Signal Word: Warning

Hazard Statements H317 - May cause an allergic skin reaction

Precautionary Statements

Prevention P261 - Avoid breathing dust/fume/gas/mist/vapors/spray


P272 - Contaminated work clothing should not be allowed out of the workplace
P280 - Wear protective gloves
Response P302 + P352 - IF ON SKIN: Wash with plenty of soap and water
P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention
P363 - Wash contaminated clothing before reuse
Storage None
Disposal P501 - Dispose of contents/container in accordance with
local/regional/national/international regulations

2.3 Hazards not otherwise classified


None known

3. Composition/information on Ingredients
Substances CAS Number PERCENT (w/w) GHS Classification - US
Fatty acid, tall-oil, reaction product with 68990-47-6 10 - 30% Skin Sens. 1 (H317)
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and
triethylenetetramine

The exact percentage (concentration) of the composition has been withheld as proprietary.

4. First Aid Measures


4.1. Description of first aid measures
Inhalation If inhaled, remove from area to fresh air. Get medical attention if respiratory
irritation develops or if breathing becomes difficult.
Eyes In case of contact, immediately flush eyes with plenty of water for at least 15
minutes and get medical attention if irritation persists.
Skin Wash with soap and water. Get medical attention if irritation persists.
Ingestion Get medical attention! If vomiting occurs, keep head lower than hips to prevent
aspiration. Rinse mouth. Never give anything by mouth to an unconscious person.

4.2 Most important symptoms/effects, acute and delayed


May cause allergic skin reaction.

4.3. Indication of any immediate medical attention and special treatment needed
Notes to Physician Treat symptomatically.

5. Fire-fighting measures

_____________________________________________________________________________________________
Page 2 / 10
FACTANT™ Revision Date: 19-Apr-2017
_____________________________________________________________________________________________

5.1. Extinguishing media


Suitable Extinguishing Media
Carbon dioxide, dry chemical, foam.
Extinguishing media which must not be used for safety reasons
None known.

5.2 Specific hazards arising from the substance or mixture


Special exposure hazards in a fire
Use water spray to cool fire exposed surfaces. Decomposition in fire may produce harmful gases.

5.3 Special protective equipment and precautions for fire-fighters


Special protective equipment for firefighters
Full protective clothing and approved self-contained breathing apparatus required for fire fighting personnel.

6. Accidental release measures


6.1. Personal precautions, protective equipment and emergency procedures
Use appropriate protective equipment. Wear self-contained breathing apparatus in enclosed areas. Avoid contact with
skin, eyes and clothing. Avoid breathing vapors. Ensure adequate ventilation.
See Section 8 for additional information

6.2. Environmental precautions


Prevent from entering sewers, waterways, or low areas.

6.3. Methods and material for containment and cleaning up


Isolate spill and stop leak where safe. Contain spill with sand or other inert materials. Scoop up and remove.

7. Handling and storage


7.1. Precautions for safe handling
Handling Precautions
Use appropriate protective equipment. Avoid contact with eyes, skin, or clothing. Avoid breathing vapors. Ensure
adequate ventilation. Wash hands after use. Launder contaminated clothing before reuse.
Hygiene Measures
Handle in accordance with good industrial hygiene and safety practice.

7.2. Conditions for safe storage, including any incompatibilities


Storage Information
Store away from oxidizers. Store in a cool well ventilated area. Keep container closed when not in use. Product has a
shelf life of 12 months.

8. Exposure Controls/Personal Protection


8.1 Occupational Exposure Limits
Substances CAS Number OSHA PEL-TWA ACGIH TLV-TWA
Fatty acid, tall-oil, reaction 68990-47-6 Not applicable Not applicable
product with diethylenetriamine,
maleic anhydride,
tetraethylenepentamine, and
triethylenetetramine

8.2 Appropriate engineering controls


Engineering Controls Use in a well ventilated area.

_____________________________________________________________________________________________
Page 3 / 10
FACTANT™ Revision Date: 19-Apr-2017
_____________________________________________________________________________________________
8.3 Individual protection measures, such as personal protective equipment
Personal Protective Equipment If engineering controls and work practices cannot prevent excessive exposures,
the selection and proper use of personal protective equipment should be
determined by an industrial hygienist or other qualified professional based on the
specific application of this product.
Respiratory Protection Not normally needed. But if significant exposures are possible then the following
respirator is recommended:
Organic vapor respirator.

Hand Protection Chemical-resistant protective gloves (EN 374) Suitable materials for longer, direct
contact (recommended: protection index 6, corresponding to > 480 minutes
permeation time as per EN 374): Nitrile gloves. (>= 0.4 mm thickness)
This information is based on literature references and on information provided by
glove manufacturers, or is derived by analogy with similar substances. Please
note that in practice the working life of chemical-resistant protective gloves may be
considerably shorter than the permeation time determined in accordance with EN
374 as a result of the many influencing factors (e.g. temperature). If signs of wear
and tear are noticed then the gloves should be replaced. Manufacturer's directions
for use should be observed because of great diversity of types.
Skin Protection Rubber apron.
Eye Protection Chemical goggles; also wear a face shield if splashing hazard exists.
Other Precautions None known.

9. Physical and Chemical Properties


9.1. Information on basic physical and chemical properties
Physical State: Liquid Color Clear amber
Odor: Mild Hydrocarbon Odor No information available
Threshold:

Property Values
Remarks/ - Method
pH: No data available
Freezing Point / Range -5 - -4 °C / 23 - 24.8 °F
Melting Point / Range No data available
Boiling Point / Range No data available
Flash Point > 104 °C / > 220 °F PMCC
Flammability (solid, gas) No data available
Upper flammability limit No data available
Lower flammability limit No data available
Evaporation rate No data available
Vapor Pressure No data available
Vapor Density No data available
Specific Gravity 0.96
Water Solubility Insoluble in water
Solubility in other solvents No data available
Partition coefficient: n-octanol/water No data available
Autoignition Temperature No data available
Decomposition Temperature No data available
Viscosity No data available
Explosive Properties No information available
Oxidizing Properties No information available

9.2. Other information


VOC Content (%) No data available

_____________________________________________________________________________________________
Page 4 / 10
FACTANT™ Revision Date: 19-Apr-2017
_____________________________________________________________________________________________
10. Stability and Reactivity
10.1. Reactivity
Not expected to be reactive.

10.2. Chemical stability


Stable

10.3. Possibility of hazardous reactions


Will Not Occur

10.4. Conditions to avoid


None anticipated

10.5. Incompatible materials


Strong oxidizers.

10.6. Hazardous decomposition products


Carbon monoxide and carbon dioxide.

11. Toxicological Information


11.1 Information on likely routes of exposure
Principle Route of Exposure Eye or skin contact, inhalation.

11.2 Symptoms related to the physical, chemical and toxicological characteristics


Acute Toxicity
Inhalation May cause mild respiratory irritation.
Eye Contact May cause mild eye irritation.
Skin Contact May cause an allergic skin reaction. May cause skin defatting with prolonged
exposure. May cause mild skin irritation.
Ingestion Irritation of the mouth, throat, and stomach. Aspiration can be a hazard if this
material is swallowed.

Chronic Effects/Carcinogenicity No data available to indicate product or components present at greater than 0.1%
are chronic health hazards.

11.3 Toxicity data

Toxicology data for the components


Substances CAS Number LD50 Oral LD50 Dermal LC50 Inhalation
Fatty acid, tall-oil, 68990-47-6 >2020 mg/kg-bw (rat) >2000 mg/kg-bw (rat) No data available
reaction product with
diethylenetriamine,
maleic anhydride,
tetraethylenepentamine,
and triethylenetetramine

Substances CAS Number Skin corrosion/irritation


Fatty acid, tall-oil, reaction 68990-47-6 Non-irritating to the skin
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

Substances CAS Number Serious eye damage/irritation


Fatty acid, tall-oil, reaction 68990-47-6 Non-irritating to rabbit's eye
product with

_____________________________________________________________________________________________
Page 5 / 10
FACTANT™ Revision Date: 19-Apr-2017
_____________________________________________________________________________________________
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

Substances CAS Number Skin Sensitization


Fatty acid, tall-oil, reaction 68990-47-6 Skin sensitizer in guinea pig.
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

Substances CAS Number Respiratory Sensitization


Fatty acid, tall-oil, reaction 68990-47-6 No information available
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

Substances CAS Number Mutagenic Effects


Fatty acid, tall-oil, reaction 68990-47-6 In vivo tests did not show mutagenic effects. In vitro tests did not show mutagenic effects.
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

Substances CAS Number Carcinogenic Effects


Fatty acid, tall-oil, reaction 68990-47-6 No information available
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

Substances CAS Number Reproductive toxicity


Fatty acid, tall-oil, reaction 68990-47-6 Animal testing did not show any effects on fertility. Did not show teratogenic effects in animal
product with experiments.
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

Substances CAS Number STOT - single exposure


Fatty acid, tall-oil, reaction 68990-47-6 No information available
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

Substances CAS Number STOT - repeated exposure


Fatty acid, tall-oil, reaction 68990-47-6 No data of sufficient quality are available.
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

Substances CAS Number Aspiration hazard


Fatty acid, tall-oil, reaction 68990-47-6 Not applicable
product with
diethylenetriamine, maleic
anhydride,
tetraethylenepentamine, and
triethylenetetramine

_____________________________________________________________________________________________
Page 6 / 10
FACTANT™ Revision Date: 19-Apr-2017
_____________________________________________________________________________________________

12. Ecological Information


12.1. Toxicity

Substance Ecotoxicity Data


Substances CAS Number Toxicity to Algae Toxicity to Fish Toxicity to Toxicity to Invertebrates
Microorganisms
Fatty acid, tall-oil, 68990-47-6 EL50 (72 h) =23.8 mg/L LL50 (96 h) >1000 mg/L No information available LL50 (48 h) >2000 mg/L
reaction product with (Skeletonema costatum) (Scophthalmus maximus) (Acartia tonsa)
diethylenetriamine, EC50 (72 h) >100 mg/L
(Pseudokirchneriella
maleic anhydride,
subcapitata)
tetraethylenepentamin
e, and
triethylenetetramine

12.2. Persistence and degradability

Substances CAS Number Persistence and Degradability


Fatty acid, tall-oil, reaction product with 68990-47-6 Inherently biodegradable (34% @ 56d)
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine

12.3. Bioaccumulative potential

Substances CAS Number Log Pow


Fatty acid, tall-oil, reaction product with 68990-47-6 No information available
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine

12.4. Mobility in soil

Substances CAS Number Mobility


Fatty acid, tall-oil, reaction product with 68990-47-6 No information available
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine

12.5 Other adverse effects


No information available

13. Disposal Considerations


13.1. Waste treatment methods
Disposal methods Disposal should be made in accordance with federal, state, and local regulations.
Contaminated Packaging Follow all applicable national or local regulations.

14. Transport Information

US DOT
UN Number Not restricted
UN proper shipping name: Not restricted
Transport Hazard Class(es): Not applicable
Packing Group: Not applicable
Environmental Hazards: Not applicable

Canadian TDG
UN Number Not restricted

_____________________________________________________________________________________________
Page 7 / 10
FACTANT™ Revision Date: 19-Apr-2017
_____________________________________________________________________________________________
UN proper shipping name: Not restricted
Transport Hazard Class(es): Not applicable
Packing Group: Not applicable
Environmental Hazards: Not applicable

IMDG/IMO
UN Number Not restricted
UN proper shipping name: Not restricted
Transport Hazard Class(es): Not applicable
Packing Group: Not applicable
Environmental Hazards: Not applicable

IATA/ICAO
UN Number Not restricted
UN proper shipping name: Not restricted
Transport Hazard Class(es): Not applicable
Packing Group: Not applicable
Environmental Hazards: Not applicable

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code Not applicable
Special Precautions for User None

15. Regulatory Information

US Regulations
US TSCA Inventory All components listed on inventory or are exempt.

TSCA Significant New Use Rules - S5A2


Substances CAS Number TSCA Significant New Use Rules - S5A2
Fatty acid, tall-oil, reaction product with 68990-47-6 Not applicable
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine

EPA SARA Title III Extremely Hazardous Substances


Substances CAS Number EPA SARA Title III Extremely Hazardous
Substances
Fatty acid, tall-oil, reaction product with 68990-47-6 Not applicable
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine

EPA SARA (311,312) Hazard Class


Acute Health Hazard

EPA SARA (313) Chemicals


Substances CAS Number Toxic Release Inventory (TRI) - Toxic Release Inventory (TRI) -
Group I Group II
Fatty acid, tall-oil, reaction product with 68990-47-6 Not applicable Not applicable
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and
triethylenetetramine

EPA CERCLA/Superfund Reportable Spill Quantity


Substances CAS Number CERCLA RQ
Fatty acid, tall-oil, reaction product with 68990-47-6 Not applicable
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine

EPA RCRA Hazardous Waste Classification


If product becomes a waste, it does NOT meet the criteria of a hazardous waste as defined by the US EPA.

_____________________________________________________________________________________________
Page 8 / 10
FACTANT™ Revision Date: 19-Apr-2017
_____________________________________________________________________________________________

California Proposition 65
Substances CAS Number California Proposition 65
Fatty acid, tall-oil, reaction product with 68990-47-6 Not applicable
diethylenetriamine, maleic anhydride,
tetraethylenepentamine, and triethylenetetramine

U.S. State Right-to-Know Regulations


Substances CAS Number MA Right-to-Know Law NJ Right-to-Know Law PA Right-to-Know Law
Fatty acid, tall-oil, reaction product 68990-47-6 Not applicable Not applicable Not applicable
with diethylenetriamine, maleic
anhydride, tetraethylenepentamine,
and triethylenetetramine

NFPA Ratings: Health 1, Flammability 1, Reactivity 0


HMIS Ratings: Health 1, Flammability 1, Reactivity 0

Canadian Regulations
Canadian Domestic Substances All components listed on inventory or are exempt.
List (DSL)

16. Other information


Preparation Information
Prepared By Chemical Stewardship
Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

Revision Date: 19-Apr-2017

Reason for Revision SDS sections updated:


2

Additional information
For additional information on the use of this product, contact your local Halliburton representative.

For questions about the Safety Data Sheet for this or other Halliburton products, contact Chemical Stewardship at
1-580-251-4335.

Key or legend to abbreviations and acronyms used in the safety data sheet
bw–bodywei ght
CAS–Chemi calAbst ractsSer vi
ce
d - day
EC50–Ef fectiveConcent rati
on50%
ErC50–Ef fectiveConcent rat
iongrowt
hrate50%
h - hour
LC50–Let halConcent r
ati
on50%
LD50–Let halDose50%
LL50–Let halLoadi ng50%
mg/ kg–mi lli
gram/ kil
ogram
mg/ L–mi l
ligram/ l
it
er
mg/m3 - milligram/cubic meter
mm - millimeter
mmHg - millimeter mercury
NIOSH–Nat i
onalI nsti
tut
ef orOccupat
ionalSaf
etyandHeal th
NTP–Nat ionalTox icol
ogyPr ogram
OEL–Occupat ionalEx posureLimit

_____________________________________________________________________________________________
Page 9 / 10
FACTANT™ Revision Date: 19-Apr-2017
_____________________________________________________________________________________________
PEL–Per missibleEx posureLimit
ppm –par t
spermi lli
on
STEL–Shor tTerm Ex posureLimi
t
TWA–Ti me- Wei ghtedAverage
UN–Uni t
edNat i
ons
w/w - weight/weight

Key literature references and sources for data


[Link]/
OSHA
ECHA C&L

Disclaimer Statement
This information is furnished without warranty, expressed or implied, as to accuracy or completeness. The
information is obtained from various sources including the manufacturer and other third party sources. The
information may not be valid under all conditions nor if this material is used in combination with other materials or in
any process. Final determination of suitability of any material is the sole responsibility of the user.

End of Safety Data Sheet

_____________________________________________________________________________________________
Page 10 / 10
LESUPERMUL™
Manufacturer/Supplier
Expiration Date:
Energy Services
14th Floor, CitiBank Tower, Al-
Qutayat Street
Dubai, UAE
Telephone Number : +971 43036666
Emergency Telephone Number
1-760-476-3959 Revision Date: 20-11-2017
Global Incident Response Access
‫�ﺗ�ﺣ�ﻼ�ب‬
‫�ﻟ�ﻼ�ﺳ‬

‫�د‬
‫�ﺎ�ﻋ‬
‫�ﻣ�ﺳ‬

‫�ﻣ�ل‬
‫�ﺎ‬
‫� �ﻋ‬
:�
‫�ﯾ�ﻖ‬
‫�ﺑ‬
‫�ﺗ�ط‬
‫�ﻟ‬
‫�ا‬ �
:�
‫�ﺗ�ﺞ‬
‫�ﻧ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

‫�ة‬
‫�ر‬
‫�ﻔ‬
‫� �ﺷ‬
‫�و‬
‫�أ‬

‫�ز‬
‫�ﻣ‬
‫�ر‬Code: 334305
AR: Arabic & EN: English
Application Emulsifier Hazardous Material Number: HM003680 Contract Number: 14012

Contains ‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�و�ي‬
‫�ﺗ‬
‫�ﯾ�ﺣ‬
Signal Word Warning ‫�ر‬
‫�ﯾ‬
‫�ذ‬
‫�ﺗ�ﺣ‬

‫�ﮫ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻧ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﻣ‬
‫�ﻠ‬
‫�ﻛ‬
Chemical Name CAS Number Hazard Pictograms ‫�ر‬
‫�ﻠ�ﺧ�ط‬
‫�ﻟ‬

‫�ﺔ‬
‫�ﯾ‬
‫�ﯾ�ﺣ‬
‫�و�ﺿ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ر‬
‫�و‬
‫�ﻟ�ﺻ‬
‫�ا‬
Hazard Statements : Response �
Diethylene glycol monobutyl 112-34-5
‫�ﺔ‬
‫�ﺑ‬
‫�ﺎ‬
‫�ﺗ�ﺟ‬
‫�ﻻ�ﺳ‬
‫�ا‬ :�
‫�ر‬
‫�ﺎ‬
‫�ﻷ�ﺧ�ط‬
‫�ا‬

‫�ﺎ�ت‬
‫�ﻧ‬
‫�ﺎ‬
‫�ﯾ‬
‫�ﺑ‬ ether
H316 - Causes mild skin irritation P302 + P352 - IF ON SKIN: Wash

‫�ﻊ‬‫�ﻣ‬

‫�ﻐ�ﺳ�ل‬
‫�ﯾ‬

:�
‫�د‬
‫�ﻠ‬
‫�ﻟ�ﺟ‬
‫�ا‬

‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�ا‬
‫�ذ‬
‫�إ‬


P302 + P352 � .�
‫�د‬‫�ﻠ‬
‫�ﻠ�ﺟ‬
‫�ﻟ‬

‫�ﯾ�ط‬
‫�ﺑ�ﺳ‬

‫�ﯾ�ﺞ‬
‫�ﮭ‬
‫�ﺗ‬

‫�ﺑ�ب‬‫�ﯾ�ﺳ‬


H316 � Ethylene glycol monobutyl 111-76-2
H317 - May cause an allergic skin with plenty of water. ether

reaction P333 + P313 - If skin irritation or


.�
‫�و�ن‬
‫�ﺑ‬
‫�ﺎ‬
‫�ﻟ�ﺻ‬‫�ا‬
‫�و‬ �
‫�ء‬
‫�ﺎ‬
‫�ﻣ‬‫�ﻟ‬
‫�ا‬

‫�ﻣ�ن‬ �
‫�ﯾ�ر‬
‫�ﺛ‬
‫ �ﻛ‬.�
‫�د‬‫�ﻠ‬
‫�ﻠ�ﺟ‬
‫�ﻟ‬

‫�ﺔ‬‫�ﯾ‬
‫�ﺎ�ﺳ‬
‫� �ﺣ�ﺳ‬
‫�ﺑ�ب‬
‫�ﯾ�ﺳ‬ �
‫�أ�ن‬

‫�ﻛ�ن‬
‫�ﻣ‬‫�ﯾ‬


H317 Carboxylic acid terminated -

Prevention rash occurs: Get medical �


‫�و‬‫�أ‬

‫�ﯾ�ﺞ‬
‫�ﮭ‬
‫�ﺗ‬

‫�و�ث‬‫�د‬‫� �ﺣ‬
‫�ﺔ‬
‫�ﻟ‬
‫�ﺎ‬
‫� �ﺣ‬
‫�ﻓ�ﻲ‬


P333 + P313 ‫�ﻊ‬ ‫�ﻧ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬
� fatty polyamide
Isomerized internal olefins -
P261 - Avoid breathing advice/attention �
/�

‫�ﺔ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻟ�ط‬
‫�ا‬

‫�ة‬
‫�و�ر‬‫�ﻣ�ﺷ‬
‫�ﻟ‬
‫�ا‬

‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�إ�ﺣ�ﺻ�ل‬ �
:�
‫�د�ي‬
‫�ﻠ‬
‫� �ﺟ‬
‫�ﻔ�ﺢ‬
‫�ط‬ �
/�

‫�ﺎ�ر‬
‫�ﺑ‬
‫�ﻐ‬
‫�ﻟ‬
‫�ا‬

‫�ﺎ�ق‬‫�ﻧ�ﺷ‬
‫�ﺗ‬
‫�إ�ﺳ‬


‫�ﻧ�ب‬
‫�ﺗ�ﺟ‬


P261 � Octadecene 27070-58-2
dust/fume/gas/mist/vapors/spray P362 + P364 - Take off ‫�ﺔ‬
‫�ﯾ‬
‫�ﺎ‬
‫�ﻧ‬
‫� �ﻋ‬ /�

‫�ة‬
‫�ﺑ�ﺧ�ر‬
‫�ا�ﻷ‬

/�

‫�ﺎ�ب‬
‫�ﺑ‬
‫�ﻟ�ﺿ‬‫�ا‬

/�

‫�ﺎ�ز‬
‫�ﻐ‬‫�ﻟ‬
‫�ا‬

/�

‫�ﺎ�ن‬
‫�د�ﺧ‬
‫�ﻟ‬
‫�ا‬
P272 - Contaminated work clothing contaminated clothing and wash �
‫�ﺔ‬‫�ﺛ‬
‫�و‬‫�ﻠ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

‫�ﺑ�س‬
‫�ﻣ�ﻼ‬‫�ﻟ‬
‫�ا‬

‫�ﻊ‬‫�ﻠ‬
‫�إ�ﺧ‬


P362 + P364 .�
‫�ذ‬
‫�ا‬
‫�ذ‬
‫�ﻟ�ر‬
‫�ا‬
should not be allowed out of the before reuse ‫�ﺎ‬
‫�ﮭ‬
‫�ﻣ‬‫�ا‬
‫�د‬
‫�ﺗ�ﺧ‬
‫�إ�ﺳ‬

‫�ة‬
‫�د‬
‫�ﺎ‬
‫�إ�ﻋ‬

‫�ﺑ�ل‬
‫�ﻗ‬

‫�إ�ﻏ�ﺳ�ل‬
‫� �و‬ ‫�ء‬
‫�ا‬
‫�د‬
‫�ﺗ‬
‫�ﺈ�ر‬
‫�ﺑ‬

‫�ﻣ�ﺢ‬‫�ﯾ�ﺳ‬

‫�أ�ن‬

‫�ﻐ�ﻲ‬‫�ﺑ‬
‫�ﻧ‬
‫�ﯾ‬

‫� �ﻻ‬ �
P272
workplace P332 + P313 - If skin irritation �
‫�ﯾ�ﺞ‬
‫�ﮭ‬
‫�ﺗ‬

‫�و�ث‬‫�د‬‫� �ﺣ‬
‫�ﺔ‬
‫�ﻟ‬
‫�ﺎ‬
‫� �ﺣ‬
‫�ﻓ�ﻲ‬


P332 + P313 .� ‫�ﻣ�ل‬
‫�ﻌ‬
‫�ﻟ‬
‫�ا‬

‫�ﺎ�ن‬
‫�ﻛ‬‫�ﻣ‬

‫�ﺎ�ر�ج‬
‫� �ﺧ‬
‫�ﺔ‬‫�ﺛ‬
‫�و‬
‫�ﻠ‬
‫�ﻣ‬‫�ﻟ‬
‫�ا‬

‫�ﻣ�ل‬
‫�ﻌ‬
‫�ﻟ‬
‫�ا‬

‫�ﺑ�س‬‫�ﻣ�ﻼ‬
occurs: Get medical
P280 - Wear protective gloves ‫�ﺔ‬
‫�ﯾ‬
‫�ﺎ‬
‫�ﻧ‬
‫� �ﻋ‬
/�

‫�ﺔ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻟ�ط‬
‫�ا‬

‫�ة‬
‫�و�ر‬‫�ﻣ�ﺷ‬
‫�ﻟ‬
‫�ا‬

‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�إ�ﺣ�ﺻ�ل‬ �
:�
‫�د‬
‫�ﻠ‬
‫�ﻟ�ﺟ‬
‫�ا‬ .�
‫�ﺔ‬‫�ﯾ‬
‫�ﻗ‬
‫�ا‬
‫�و‬‫�ﻟ‬
‫�ا‬

‫�ا�ت‬
‫�ﺎ�ز‬
‫�ﻔ‬
‫�ﻘ‬
‫�ﻟ‬
‫�ا‬

‫�ﺑ�س‬‫�ﻠ‬
‫�ﺗ‬


P280
P280 - Wear protective advice/attention
gloves/protective clothing/eye Storage ‫�ﯾ�ن‬
‫�ز‬‫�ﺗ�ﺧ‬ �

‫�ﺑ�س‬‫�ﻣ�ﻼ‬
‫�ﻟ‬
‫�ا‬

/�

‫�ﺔ‬‫�ﯾ‬
‫�ﻗ‬
‫�ا‬
‫�و‬‫�ﻟ‬
‫�ا‬

‫�ا�ت‬
‫�ﺎ�ز‬
‫�ﻔ‬
‫�ﻘ‬
‫�ﻟ‬
‫�ا‬

‫�ﺑ�س‬‫�ﻠ‬
‫�ﺗ‬


P280
protection/face protection None �‫�ء‬‫� �ﺷ�ﻲ‬
‫� � �ﻻ‬ ‫�ﺔ‬
‫�ﯾ‬
‫�ﺎ‬
‫�ﻣ‬‫�ﻟ�ﺣ‬

‫�ﺎ�ع‬‫�ﻧ‬
‫�ﻗ‬

/�

‫�ﯾ�ن‬
‫�ﻌ‬‫�ﻠ‬
‫�ﻟ‬

‫�ﺔ‬
‫�ﯾ‬
‫�ﺎ‬
‫�ﻣ‬‫� �ﺣ‬
/�

‫�ﺔ‬
‫�ﯾ‬
‫�ﻗ‬
‫�ا‬
‫�و‬‫�ﻟ‬
‫�ا‬ Chemical Name CAS Number
Disposal ‫�ﺎ‬
‫�ﮭ‬‫�ﻧ‬
‫�ﻣ‬ �
‫�ﻠ�ص‬ ‫�ﺗ�ﺧ‬‫�ﻟ‬
‫�ا‬
� .�
‫�ﮫ‬‫�ﺟ‬
‫�و‬‫�ﻟ‬
‫�ا‬ �
‫�ر‬‫�ﺛ‬
‫�ﯾ‬
‫�إ‬

‫�ﯾ�ل‬
‫�ﺗ‬
‫�و‬
‫�ﯾ‬
‫�ﺑ‬

‫�د�ى‬
‫�ﺎ‬
‫�أ�ﺣ‬

‫�و�ل‬
‫�ﻛ‬‫�ﯾ‬
‫�ﻠ‬
‫� �ﺟ‬
‫�ﯾ�ن‬
‫�ﻠ‬
‫�ﯾ‬
‫�ﺛ‬
‫�ﯾ‬
‫�إ‬ �
1�1�1�-7�6�-2�
�‫�ﯾ�ن‬
‫�د�ﺳ‬
‫�ﻟ‬
‫�ا‬

‫�ﻧ�ﻲ‬
‫�ﺎ‬
‫�ﻣ‬‫�ﺛ‬ �
2�7�0�7�0�-5�8�-2�
P501 - Dispose of �
‫�ﺎ�ت‬
‫�ﯾ‬
‫�و‬‫�ﺎ‬
‫�ﻟ�ﺣ‬
‫�ا‬

/�

‫�ﺎ�ت‬
‫�ﯾ‬
‫�و‬‫�ﺗ‬
‫�ﻣ�ﺣ‬
‫�ﻟ‬
‫�ا‬

‫�ﻣ�ن‬ �
‫�ﻠ �ص‬‫�ﺗ�ﺧ‬


P501 � �‫�ر‬
‫�ﺛ‬
‫�ﯾ‬
‫�إ‬

‫�ﯾ�ل‬
‫�ﺗ‬
‫�و‬‫�ﯾ‬
‫�ﺑ‬

‫�د�ى‬
‫�ﺎ‬
‫�أ�ﺣ‬

‫�و�ل‬
‫�ﻛ‬‫�ﯾ‬
‫�ﻠ‬
‫� �ﺟ‬
‫�ﯾ�ن‬
‫�ﻠ‬
‫�ﯾ‬
‫�ﺛ‬
‫�ﯾ‬
‫�إ‬

‫�ﺋ�ﻰ‬
‫�ﺎ‬
‫�ﻧ‬
‫�ﺛ‬ �
1�1�2�-3�4�-5�
contents/container in accordance �
/�

‫�ﺔ‬‫�ﯾ‬
‫�ﻧ‬
‫�و�ط‬
‫�ﻟ‬
‫�ا‬

/�

‫�ﺔ‬
‫�ﯾ‬
‫�ﻣ‬
‫�ﯾ‬
‫�ﻠ‬
‫�ﻗ‬
‫�ا�ﻹ‬

/�

‫�ﺔ‬
‫�ﯾ‬
‫�ﻠ‬
‫�ﻣ�ﺣ‬
‫�ﻟ‬
‫�ا‬

‫�ﺋ�ﺢ‬
‫�ا‬
‫�و‬‫�ﻠ‬
‫�ﻟ‬

ً�
‫�ﺎ‬
‫�ﻘ‬
‫�ﻓ‬
‫�و‬ �
‫�ﮭ�ﻲ‬
‫�ﺗ‬
‫�ﻧ‬
‫�ﻣ‬ �
‫�ﻧ�ﻲ‬
‫�ھ‬
‫�د‬ �
‫�د‬
‫�ﯾ‬
‫�ﻣ‬‫�أ‬

‫�د‬
‫�د‬
‫�ﻌ‬
‫�ﺗ‬
‫�ﻣ‬

‫�ﻠ�ﻲ‬
‫�ﯾ‬
‫�ﻛ�ﺳ‬
‫�و‬‫�ﺑ‬
‫�ر‬
‫�ﻛ‬

‫�ﻣ �ض‬‫�ﺎ‬
‫�ﺣ‬ �
-
with
.�
‫�ﺔ‬
‫�ﯾ‬
‫�ﻟ‬
‫�و‬‫�د‬
‫�ﻟ‬
‫�ا‬ �
‫�ﯾ�ب‬
‫�ﻛ‬
‫�ر‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﮭ‬‫�ﺑ‬
‫�ﺎ‬
‫�ﺗ�ﺷ‬
‫�ﻣ‬ �
‫�ﺎ‬
‫�ﻔ‬
‫�ﻟ‬
‫�أ‬

‫�ﺎ�ت‬
‫�ﻧ‬
‫�ﯾ‬
‫�ﻔ‬
‫�ﻟ‬
‫�و‬‫�أ‬ �
-
local/regional/national/international
regulations

‫�ة‬
‫�د‬
‫�ﺎ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

‫�م‬‫�ر‬SAP Part Number(s):
‫�ﻗ‬

:�
‫�و�ط‬
‫�ﻠ‬
‫�ﻟ‬
‫�ا‬

‫�م‬‫�ر‬Lot Number:
‫�ﻗ‬


/�

‫�ﻓ�ﻲ‬
‫�ﺎ‬
‫�ﻟ�ﺻ‬
‫�ا‬

‫�ز�ن‬
‫�و‬‫�ا‬Net/Gross Package Weight:
‫�ﻟ‬

UN proper shipping name: Not �




‫�د‬
‫�ﯾ‬
‫�ﻘ‬
‫�ﻣ‬

‫�ر‬‫�ﯾ‬
‫� �ﻏ‬
:�
UN � ‫�ﯾ�ﺢ‬
‫�ﻟ�ﺻ�ﺣ‬
‫�ا‬

‫�ﻘ�ل‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�م‬
‫�إ�ﺳ‬ Transport Classification: �
‫�د‬
‫�ﺎ‬
‫�ﺗ�ﺣ‬
‫�ا‬

/�

(�
IATA)�

‫�ﺔ‬
‫�ﯾ‬
‫�ﻟ‬
‫�و‬
‫�د‬‫�ﻟ‬
‫�ا‬

‫�ﻧ�ﻲ‬
‫�د‬
‫�ﻣ‬‫�ﻟ‬
‫�ا‬

‫�ا�ن‬
‫�ر‬
‫�ﯾ‬
‫�ﻟ�ط‬
‫�ا‬

‫�ﺔ‬
‫�ﻣ‬
‫�ﻧ�ظ‬
‫�ﻣ‬
‫�و‬ �
(�
ADR)�

‫�ر�ق‬
‫�ﻟ�ط‬
:�
(�
‫�ا‬

‫�ﻠ�ﻰ‬
IMO)�
‫� �ﻋ‬

‫�ة‬
‫�ر‬
‫�ﺔ‬
‫�ﻟ�ﺧ�ط‬
‫�ﯾ‬
‫�ﻟ‬
‫�و‬
‫�د‬
‫�ﻟ‬
‫�ا‬
‫�ا‬


‫�ﻊ‬
‫�ﺔ‬
‫�ﺋ‬
‫�ﯾ‬
‫�ﺎ‬
‫�ﺑ�ﺿ‬
‫�ر‬
‫�ﻠ‬
‫�ﺑ�ﺣ‬
‫�ﻟ‬
‫�ﻟ‬
‫�ا‬


‫�ﻟ�ﻲ‬
‫�ﺔ‬
‫�ﻣ‬
‫�و‬‫�د‬
‫�ﻟ‬
‫�ا‬
‫�ﻧ�ظ‬
‫�ﻣ‬

‫�ﻟ‬
‫�ل‬
‫�ا‬
‫�ﻘ‬
‫�و‬
‫�ﻧ‬

‫�ﻟ‬
‫�ا‬
،�

(�
‫�ﺔ‬
‫�ﯾ‬
‫�ﻗ‬
‫�ﺎ‬
‫�ﻔ‬
‫�ﺗ‬
ICAO)�
‫�ﻻ‬

‫�ﺎ‬

‫�ﻘ‬
ً�
‫�ﻓ‬
‫�و‬
‫�ﻟ�ﻲ‬

‫�و‬
‫�ل‬
‫�د‬
‫�ﻘ‬
‫�ﻟ‬
‫�ﻧ‬
‫�ا‬

‫�ﻟ‬
‫�ا‬

‫�ﯾ�ف‬
‫�و�ي‬
‫�ﻧ‬
‫�ﺗ�ﺻ‬
‫�ﻟ�ﺟ‬
‫�ا‬

‫�ل‬
‫�ﻘ‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬
restricted Transport Hazard



‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﻘ�ل‬
‫�ﻧ‬

‫�ﺋ�ط‬
‫�ﺎ‬
‫�و�ﺳ‬

‫�ة‬
‫�ر‬‫�و‬
‫� �ﺧ�ط‬
‫�ﺔ‬‫�ﺑ‬
‫�ﺗ‬
‫�ر‬
Class(es): Not applicable Packing

‫�ر‬‫�ﺎ�ط‬
‫�ﻣ�ﺧ‬
‫�ﻟ‬
‫�ا‬

‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﺔ‬
‫�ﺋ‬
‫�ﺑ‬
‫�ﻌ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�و�ﻋ‬‫�ﻣ‬
‫�ﻣ�ﺟ‬

Not restricted
Group: Not applicable
Environmental Hazards: Not �
‫�ﺔ‬‫�ﺎ�ﺻ‬
‫� �ﺧ‬
‫�ﺎ�ت‬‫�ﺎ�ط‬
‫�ﯾ‬
‫�ﺗ‬
‫�إ�ﺣ‬

‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﺔ‬
‫�ﯾ‬
‫�ﺋ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻟ‬
‫�ا‬
applicable Special Precautions for �
‫�ة‬
‫�ر‬‫�ﯾ‬
‫�ﺑ‬
‫�ﻛ‬

‫�ﺎ�ت‬‫�ﯾ‬
‫�ﻣ‬
‫�ﻛ‬
‫�ﺑ‬

‫�ﻘ�ل‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬
:�
‫�م‬
‫�د‬‫�ﺗ�ﺧ‬
‫�ﻣ�ﺳ‬
‫�ﻠ‬
‫�ﻟ‬
User None Transport in bulk �
(�
MARPOL )� �
‫�ﻣ�ن‬

‫�ﻧ�ﻲ‬
‫�ﺎ‬
‫�ﺛ‬
‫�ﻟ‬
‫�ا‬

‫�ﻓ�ﻖ‬
‫�ر‬‫�ﻣ‬‫�ﻠ‬
‫�ﻟ‬

‫�ﺎ‬
‫�ﻘ‬
‫�ﻓ‬
‫�و‬
according to Annex II of MARPOL
73/78 and the IBC Code Not

‫� �ﻻ‬
:�
IBC � ‫�ﺔ‬
‫�ﻧ‬
‫�و‬
‫�د‬‫�ﻣ‬

‫�و‬ �
7�3�/�
7�8� �
‫�و�ل‬‫�ﺑ‬
‫�ر‬
‫�ﺎ‬
‫�ﻣ‬
applicable ‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬
‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫و‬
‫تج‪:‬‬
‫ن‬‫م‬
‫ل‬‫ريل‬
‫ا‬‫تج‬
‫ل‬‫ا‬‫م‬
‫إلس‬
‫ا‬
‫™‪LESUPERMUL‬‬
‫ة‪:‬‬
‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫م‬‫ق‬‫ر‬ ‫ة‬‫ع‬‫اج‬‫ر‬‫م‬
‫ل‬‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪22‬‬ ‫‪19-10-2016‬‬

‫وع‬
‫ر‬‫مش‬
‫ل‬‫ا‬‫ة‬
‫ك‬‫ر‬‫لش‬
‫ا‬‫رو‬
‫ي‬‫ةتحض‬
‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫يف‬
‫ر‬‫ع‬‫ت‬
‫‪1.‬‬
‫تج‬‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬‫ي‬
‫و‬‫ه‬
‫تج‪:‬‬
‫ن‬‫م‬
‫ل‬‫ريل‬‫ا‬
‫تج‬‫ل‬‫ا‬‫م‬
‫إلس‬‫ا‬
‫™‪LESUPERMUL‬‬
‫ات‪:‬‬‫ف‬
‫د‬‫ا‬
‫ر‬‫م‬
‫يئ‬
‫الش‬
‫ة‬‫ي‬‫ئ‬
‫ا‬‫م‬‫ي‬
‫ةك‬ ‫ل‬
‫ئ‬‫ا‬
‫ع‬
‫يط‬‫ل‬
‫خ‬
‫لي‬
‫اخ‬‫د‬‫ل‬
‫ا‬‫رف‬‫ع‬‫م‬‫ل‬‫ا‬
‫ز‬‫م‬‫ر‬
‫‪HM003680‬‬

‫ه‬
‫ي‬‫ل‬
‫ةع‬‫وض‬
‫ر‬‫ف‬‫م‬
‫ل‬‫ا‬‫د‬
‫و‬‫ي‬‫ق‬
‫ل‬‫ا‬
‫هو‬‫وصىب‬ ‫م‬‫ل‬
‫ا‬‫م‬‫ا‬‫د‬
‫تخ‬‫الس‬
‫ا‬
‫يق‪:‬‬‫ب‬
‫تط‬‫ل‬
‫ا‬
‫تحالب‬‫لالس‬‫د‬
‫اع‬‫ملمس‬‫ا‬
‫ع‬
‫‪Uses advised against‬‬
‫ة‪.‬‬
‫اح‬‫ت‬‫اتم‬ ‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬
‫الت‬

‫ل‬ ‫ا‬‫تص‬‫إل‬
‫ا‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬‫ةو‬ ‫ع‬‫ن‬
‫مص‬ ‫ل‬
‫ا‬ ‫ة‬‫ك‬
‫ر‬‫لش‬ ‫ا‬
‫زع‬ ‫و‬‫تجم‬‫ن‬
‫م‬
‫‪Halliburton Energy Services‬‬
‫‪14th Floor, CitiBank Tower‬‬
‫‪Al-Qutayat Street‬‬
‫‪Dubai, UAE‬‬

‫‪Telephone Number : +971 43036666‬‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬

‫ة‬‫اسط‬
‫و‬‫رب‬‫حض‬
‫‪Chemical Stewardship‬‬
‫‪Telephone: 1-281-871-6107‬‬
‫‪e-mail: fdunexchem@[Link]‬‬

‫رئ‬‫ا‬‫و‬
‫لط‬‫ا‬‫تف‬‫ا‬
‫مه‬‫ق‬‫ر‬
‫‪1-760-476-3962‬‬
‫د‪14012 :‬‬‫ق‬
‫ع‬‫ل‬
‫ا‬‫م‬‫ق‬
‫ر‬
‫دث‪334305 :‬‬
‫ا‬‫و‬
‫لح‬‫ل‬
‫ة‬‫ي‬‫م‬
‫ل‬‫ا‬
‫ع‬‫ل‬
‫ا‬‫ة‬‫ب‬
‫ا‬
‫تج‬‫لالس‬‫ول‬
‫وص‬ ‫ل‬
‫ا‬‫ز‬‫م‬‫ر‬

‫ر‬
‫ا‬‫ألخط‬
‫ا‬‫ان‬
‫ي‬‫ب‬
‫‪2.‬‬
‫يف‬
‫ن‬‫تص‬
‫ل‬‫ا‬

‫ة ‪H316 - 3‬‬
‫ئ‬‫ف‬ ‫يج‬
‫ه‬‫د ‪/‬ت‬
‫ل‬‫لج‬
‫ا‬‫وق‬‫ر‬‫ح‬
‫ة ‪H317 - 1‬‬
‫ئ‬‫ف‬ ‫ة‬‫ي‬
‫د‬‫ل‬‫لج‬
‫ا‬ ‫ة‬
‫ي‬‫اس‬
‫لحس‬
‫ا‬

‫ر‬
‫لخط‬
‫ةل‬‫ي‬
‫يح‬‫وض‬
‫ت‬‫ل‬
‫ا‬‫ر‬‫و‬
‫لص‬‫ا‬

‫_____________________________________________________________________________________________‬
‫ة ‪9/1‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪LESUPERMUL‬‬
‫‪19-10-2016‬‬
‫_____________________________________________________________________________________________‬

‫ه‬
‫ي‬‫ب‬
‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫م‬‫ل‬‫ك‬
‫ر‬‫ي‬
‫ذ‬‫تح‬

‫ر‬‫ا‬
‫ألخط‬
‫ا‬‫ات‬
‫ن‬‫ا‬‫ي‬
‫ب‬
‫د‪.‬‬
‫ل‬‫لج‬
‫ل‬‫يط‬
‫يجبس‬‫ه‬‫ببت‬
‫يس‬‫‪H316‬‬
‫د‪.‬‬
‫ل‬‫لج‬
‫ل‬‫ة‬‫ي‬
‫اس‬‫ببحس‬‫أنيس‬‫كن‬‫م‬‫ي‬
‫‪H317‬‬

‫ة‬
‫ي‬‫ر‬‫ي‬
‫ذ‬‫تح‬
‫ل‬‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬

‫ع‬‫ن‬‫م‬‫ل‬
‫ا‬
‫ذ‪.‬‬
‫ا‬‫ذ‬‫ر‬‫ل‬
‫ا‬‫ة‪/‬‬ ‫ر‬
‫بخ‬ ‫األ‬
‫اب ‪/‬‬‫ب‬
‫لض‬‫ا‬ ‫ز‪/‬‬‫ا‬
‫غ‬‫ل‬‫ا‬‫ان ‪/‬‬
‫دخ‬ ‫ل‬
‫ا‬‫ر‪/‬‬ ‫ا‬‫ب‬‫غ‬
‫ل‬‫ا‬‫اق‬‫نش‬‫ت‬
‫نبإس‬ ‫تج‬‫‪P261‬‬
‫مل‪.‬‬‫ع‬‫ل‬‫ا‬‫ان‬
‫ك‬ ‫رجم‬ ‫ا‬‫ةخ‬‫ث‬‫و‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مل‬
‫ع‬‫ل‬‫ا‬‫بس‬ ‫ءمال‬‫ا‬
‫د‬‫ت‬‫ر‬ ‫إ‬
‫محب‬ ‫أنيس‬‫غي‬‫ب‬
‫ن‬‫‪P272‬الي‬
‫ة‪.‬‬‫ي‬‫ق‬
‫ا‬‫و‬
‫ل‬‫ا‬‫ات‬‫ز‬ ‫ا‬
‫ف‬
‫ق‬‫ل‬
‫ا‬‫بس‬ ‫ل‬
‫ت‬‫‪P280‬‬
‫ة‬‫ب‬‫ا‬
‫تج‬‫الس‬
‫ا‬
‫ون‪.‬‬‫ب‬‫ا‬
‫لص‬ ‫ا‬
‫ءو‬‫ا‬‫م‬‫ل‬
‫ا‬‫رمن‬ ‫ي‬‫ث‬
‫عك‬‫غسلم‬ ‫د‪:‬ي‬‫ل‬
‫لج‬‫ا‬ ‫لى‬
‫اع‬ ‫ذ‬‫إ‬
‫‪P302 + P352‬‬
‫ة‬‫ي‬
‫ا‬
‫ن‬‫ة ‪/‬ع‬
‫ي‬‫ب‬
‫لط‬‫ا‬‫ة‬‫ر‬
‫و‬‫مش‬‫ل‬‫ا‬‫لى‬‫إحصلع‬ ‫دي‪:‬‬‫ل‬
‫فحج‬ ‫وط‬‫أ‬ ‫يج‬‫ه‬‫وثت‬ ‫د‬‫ةح‬ ‫ل‬‫ا‬
‫فيح‬ ‫‪P333 + P313‬‬
‫ا‬
‫ه‬‫م‬‫ا‬‫د‬‫تخ‬‫إس‬‫ة‬‫د‬‫ا‬
‫إع‬‫بل‬‫إغسلق‬‫ةو‬ ‫ث‬‫و‬‫ل‬
‫م‬ ‫ل‬
‫ا‬‫بس‬ ‫مال‬
‫ل‬‫ا‬‫ع‬‫ل‬‫إخ‬
‫‪P362 + P364‬‬
‫ين‬‫ز‬‫تخ‬
‫ء‬
‫الشي‬
‫ا‬‫ه‬‫ن‬‫لصم‬ ‫تخ‬‫ل‬
‫ا‬
‫ة‪.‬‬
‫ي‬‫ل‬
‫و‬‫د‬‫ل‬
‫ا‬‫ة‪/‬‬‫ي‬
‫ن‬‫وط‬‫ل‬‫ا‬‫ة‪/‬‬
‫ي‬‫م‬‫ي‬‫ل‬‫ق‬
‫اإل‬‫ة‪/‬‬‫ي‬‫ل‬
‫مح‬‫ل‬‫ا‬‫ئح‬
‫ا‬‫و‬‫ل‬‫ل‬‫ا‬
‫ً‬
‫ق‬‫ف‬
‫اتو‬ ‫ي‬
‫و‬‫ا‬‫لح‬‫ا‬
‫ات ‪/‬‬ ‫ي‬
‫و‬‫ت‬‫مح‬‫ل‬‫ا‬‫لصمن‬ ‫تخ‬‫‪P501‬‬

‫لى‬‫ويع‬ ‫ت‬
‫يح‬
‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬‫ا‬‫مسجل‬ ‫هي‬
‫ت‬‫ن‬
‫نيم‬‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬
‫ح‬
‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬‫ا‬‫مسجل‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬‫ي‬
‫ف‬‫ل‬
‫و‬‫أ‬
‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬
‫ا‬ ‫ني‬
‫ا‬‫م‬‫ث‬
‫‪111-76-2‬‬ ‫ر‬‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫‪112-34-5‬‬ ‫ر‬‫ث‬
‫ي‬‫إ‬
‫يل‬‫ت‬‫و‬
‫ي‬‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬‫ث‬

‫ة‬‫ي‬
‫ف‬‫ا‬
‫إض‬‫ات‬
‫م‬‫و‬‫ل‬‫ع‬
‫م‬
‫ة )‪.(PBT‬‬
‫م‬‫ا‬‫ًوالس‬
‫ا‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫أح‬‫م‬‫ك‬‫ا‬
‫ر‬‫ت‬
‫‪،‬ت‬‫ة‬
‫ر‬‫م‬‫ت‬
‫ونمس‬
‫ك‬‫أنت‬
‫ر‬‫ب‬‫ت‬
‫ع‬‫دت‬
‫ا‬‫و‬
‫لىم‬
‫يطع‬
‫ل‬
‫لخ‬‫ا‬‫ا‬
‫ذ‬‫ويه‬
‫ت‬‫اليح‬
‫ة )‪.(vPvB‬‬
‫ي‬‫ا‬
‫غ‬‫ل‬‫ل‬
‫ئي‬‫ا‬‫ي‬
‫أح‬ ‫م‬
‫ك‬‫ا‬
‫ر‬‫ت‬
‫اتوالت‬‫ب‬
‫ث‬
‫ل‬‫ا‬‫ة‬
‫د‬‫ي‬
‫د‬‫ونش‬
‫ك‬‫أنت‬
‫ر‬‫ب‬‫ت‬
‫ع‬‫دت‬
‫ا‬‫و‬
‫لىم‬
‫يطع‬
‫ل‬
‫لخ‬‫ا‬‫ا‬
‫ذ‬‫ويه‬
‫ت‬‫اليح‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ا‬‫اتعن‬
‫م‬‫و‬‫ل‬
‫ع‬‫يب ‪/‬م‬
‫ك‬‫ر‬‫ت‬
‫ل‬‫ا‬
‫‪3.‬‬
‫يف ‪GHS‬‬ ‫ن‬
‫تص‬ ‫زن )‪(%‬‬ ‫و‬
‫ل‬‫ا‬‫ة‬‫ب‬
‫نس‬ ‫م ‪CAS‬‬ ‫ق‬
‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫)‪Skin Sens. 1 (H317‬‬ ‫‪60 - 100%‬‬ ‫ة‬‫ي‬
‫ك‬‫ل‬‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫هي‬
‫ت‬‫ن‬
‫نيم‬
‫ه‬‫دد‬
‫ي‬‫م‬‫أ‬
‫د‬‫د‬‫ع‬‫ت‬
‫ليم‬‫ي‬
‫كس‬‫و‬ ‫ب‬
‫ر‬‫مضك‬ ‫ا‬
‫ح‬
‫)‪Asp. Tox. 1 (H304‬‬ ‫‪10 - 30%‬‬ ‫ة‬‫ي‬
‫ك‬‫ل‬‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫يب‬‫ك‬‫ر‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫ه‬‫ب‬‫ا‬
‫تش‬‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬
‫ن‬‫ي‬
‫ف‬‫ل‬
‫و‬‫أ‬
‫)‪Asp. Tox. 1 (H304‬‬ ‫‪5 - 10 %‬‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬
‫ا‬‫ني‬
‫ا‬‫م‬‫ث‬
‫)‪Acute Tox. 4 (H302‬‬ ‫‪1 - 5%‬‬ ‫‪111-76-2‬‬ ‫ر‬‫ث‬‫ي‬
‫إ‬‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬ ‫ك‬
‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫)‪Acute Tox. 5 (H313‬‬
‫)‪Acute Tox. 4 (H332‬‬
‫)‪Skin Irrit. 2 (H315‬‬
‫)‪Eye Irrit. 2A (H319‬‬
‫)‪Flam. Liq. 4 (H227‬‬
‫)‪Acute Tox. 5 (H313‬‬ ‫‪1 - 5%‬‬ ‫‪112-34-5‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬
‫ت‬
‫و‬‫ي‬‫دىب‬
‫ا‬‫أح‬
‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬
‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫)‪Skin Irrit. 3 (H316‬‬
‫)‪Eye Irrit. 2A (H319‬‬

‫ة‬
‫ي‬‫ل‬
‫و‬‫أل‬
‫ا‬‫ات‬
‫ف‬‫ا‬
‫ع‬‫إلس‬
‫ا‬‫ر‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪4.‬‬

‫_____________________________________________________________________________________________‬
‫ة ‪9/2‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪LESUPERMUL‬‬
‫‪19-10-2016‬‬
‫_____________________________________________________________________________________________‬

‫ة‬‫ي‬‫ل‬‫و‬
‫أل‬
‫ا‬‫ات‬ ‫ف‬
‫ا‬‫ع‬‫إلس‬
‫ا‬‫ر‬ ‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫اق‬‫نش‬‫ت‬‫إلس‬
‫ا‬
‫يب‪.‬‬‫ب‬‫لط‬‫ا‬‫ر‬‫تش‬
‫إس‬ ‫دو‬‫د‬‫تج‬‫ءم‬‫ا‬
‫و‬‫ةه‬ ‫ق‬‫نط‬‫لىم‬‫إ‬‫اب‬
‫مص‬ ‫ل‬
‫ا‬ ‫قل‬‫ن‬
‫إ‬‫اق‬‫نش‬‫ت‬
‫اإلس‬‫ة‬‫ل‬
‫ا‬‫فيح‬
‫ة‬‫ر‬‫بش‬‫ل‬
‫ا‬
‫ا‪.‬‬
‫ه‬‫م‬‫ا‬
‫د‬‫تخ‬
‫إس‬‫ة‬
‫د‬‫ا‬
‫إع‬‫بل‬‫اق‬
‫ه‬‫ل‬
‫إغس‬‫ةو‬‫ث‬
‫و‬‫ل‬
‫م‬‫ل‬
‫ا‬‫بس‬‫مال‬
‫ل‬‫ا‬‫ة‬
‫ل‬‫ا‬
‫ز‬‫إ‬‫مب‬
‫يب‪.‬ق‬‫ب‬
‫لط‬‫ا‬‫ر‬‫تش‬
‫إس‬‫قلو‬‫األ‬‫لى‬‫ةع‬‫ق‬
‫ي‬‫ق‬
‫ة ‪15‬د‬ ‫د‬‫م‬
‫ل‬‫ر‬ ‫ي‬
‫ف‬‫و‬
‫ل‬‫ا‬‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ونو‬ ‫ب‬‫ا‬
‫لص‬‫ا‬‫رب‬ ‫و‬‫ف‬
‫ل‬
‫ا‬‫لى‬‫دع‬‫ل‬
‫لج‬‫ا‬‫إغسل‬ ‫ة‬‫مس‬‫مال‬
‫ل‬‫ا‬‫ة‬‫ل‬
‫ا‬‫فيح‬
‫ون‬ ‫ي‬
‫ع‬
‫ا‪.‬‬
‫ر‬‫و‬‫يبف‬‫ب‬
‫لط‬‫ا‬‫لى‬
‫فسكع‬‫رضن‬ ‫إع‬‫لك‪.‬‬‫ذ‬
‫هب‬‫ا‬
‫ب‬
‫ت‬‫االش‬
‫و‬‫أ‬‫تج‬
‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬
‫مس‬ ‫ةمال‬‫ل‬
‫ا‬‫قلفيح‬‫األ‬‫لى‬
‫ةع‬ ‫ق‬
‫ي‬‫ق‬‫ة ‪15‬د‬‫د‬‫م‬‫ل‬
‫ء‬‫ا‬‫م‬‫ل‬
‫ا‬‫ةمن‬ ‫ر‬‫ي‬‫ف‬
‫ةو‬‫ي‬‫م‬
‫مك‬‫ا‬‫د‬
‫تخ‬ ‫إس‬
‫اب‬‫د‬‫ي‬
‫ينج‬ ‫ن‬‫ي‬
‫ع‬‫ل‬
‫ا‬ ‫إغسل‬
‫تالع‬‫ب‬
‫إل‬
‫ا‬
‫ة‪.‬‬‫ي‬‫لصح‬‫ا‬‫ة‬
‫ي‬‫ا‬
‫رع‬‫ل‬‫ا‬‫لى‬‫أحصلع‬ ‫م‪.‬‬
‫ف‬‫ل‬
‫ا‬ ‫يق‬‫ر‬‫ءعنط‬ ‫أىشي‬ ‫عطى‬‫ءوالت‬‫قي‬‫ل‬
‫ا‬ ‫لى‬
‫رضع‬ ‫التح‬

‫ة‬
‫ر‬‫أخ‬
‫ت‬‫م‬
‫ل‬‫ا‬
‫و‬‫أ‬‫ة‬
‫د‬‫ا‬‫لح‬
‫ا‬‫نت‬‫ا‬
‫ءك‬‫ا‬‫و‬
‫ة‪,‬س‬‫م‬
‫ا‬‫ه‬‫ل‬
‫ا‬‫ات‬‫ر‬
‫ي‬‫ث‬
‫أ‬‫ت‬
‫ل‬‫ا‬‫اضو‬
‫ر‬‫ألع‬
‫ا‬‫م‬‫عظ‬‫م‬
‫د‪.‬‬
‫ل‬‫لج‬
‫ل‬‫يط‬‫يجبس‬
‫ه‬‫ببت‬
‫د‪.‬يس‬
‫ل‬‫لج‬
‫ا‬‫ةفي‬‫ي‬
‫اس‬‫ببحس‬
‫أنيس‬ ‫كن‬
‫م‬‫ي‬

‫ة‬
‫اص‬‫ةخ‬
‫لج‬‫ا‬
‫ع‬‫م‬‫و‬
‫أ‬‫ة‬‫ي‬
‫ر‬‫و‬‫ةف‬
‫ي‬‫ب‬
‫ةط‬‫ي‬
‫ا‬‫ن‬
‫ةأليع‬
‫اج‬‫لح‬
‫ا‬ ‫لى‬
‫إ‬‫ة‬‫ر‬‫ا‬
‫إش‬
‫يب‬‫ب‬
‫لط‬‫اتل‬‫مالحظ‬
‫اض‪.‬‬‫ر‬
‫األع‬
‫لجحسب‬ ‫ا‬‫ع‬

‫ئق‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬‫ك‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪5.‬‬
‫يق‬
‫ر‬‫لح‬
‫ا‬ ‫ة‬
‫فح‬‫ا‬‫ك‬‫م‬‫ةل‬‫ب‬‫اس‬‫ن‬
‫دم‬‫ا‬‫و‬
‫م‬
‫ة‪.‬‬
‫ف‬‫ا‬
‫لج‬
‫ا‬‫ة‬‫ئ‬
‫ي‬
‫ا‬‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫ة‪,‬‬
‫و‬‫رغ‬
‫ل‬‫ا‬‫ون‪,‬‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬‫أ‬‫ني‬‫ا‬‫ء‪,‬ث‬‫ا‬
‫م‬‫ل‬‫ا‬
‫اب‬‫ب‬‫ض‬
‫يق‬
‫ر‬‫لح‬
‫ا‬‫د‬‫ا‬
‫م‬‫اسبإلخ‬ ‫ن‬‫رم‬‫ي‬‫وسطغ‬
‫وف‪.‬‬ ‫ر‬‫ع‬‫ئىم‬‫الش‬

‫ة‬‫ي‬
‫ئ‬‫ا‬
‫ي‬‫م‬
‫ي‬‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫أمن‬ ‫نش‬
‫ةت‬‫ن‬
‫ي‬‫ع‬
‫رم‬‫ا‬‫أخط‬
‫ة‪.‬‬
‫م‬‫ا‬
‫اتس‬
‫ز‬‫ا‬
‫ونغ‬
‫ك‬‫أني‬
‫كن‬‫م‬
‫يقي‬
‫ر‬‫لح‬
‫ا‬‫ء‬‫ا‬
‫ن‬
‫ث‬‫أ‬‫ري‬
‫ا‬‫ر‬‫لح‬
‫ا‬‫لل‬
‫تح‬
‫ل‬‫ا‬
‫يق‪.‬‬
‫ر‬‫لح‬
‫ل‬‫ة‬‫رض‬‫ع‬‫م‬
‫ل‬‫ا‬‫األسطح‬
‫د‬‫ي‬‫ر‬‫ب‬
‫ت‬
‫ل‬‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫م‬‫د‬
‫تخ‬‫إس‬

‫ء‬‫ا‬
‫ف‬‫إلط‬
‫ا‬‫ل‬‫ا‬
‫رج‬‫ةل‬‫اص‬
‫ةخ‬‫ي‬‫ئ‬
‫ا‬‫ق‬
‫اتو‬‫ء‬
‫ا‬‫ر‬‫إج‬
‫ئق‪.‬‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬
‫ك‬‫دم‬
‫ا‬‫ر‬‫ف‬
‫ةأل‬
‫م‬‫ز‬‫ةال‬
‫د‬‫م‬‫ت‬
‫ع‬‫ةم‬
‫ل‬‫ق‬
‫ت‬‫فسمس‬ ‫ن‬
‫ةت‬‫ز‬
‫ه‬‫أج‬
‫ةو‬‫ل‬
‫م‬‫ا‬
‫ةك‬‫ي‬‫ق‬
‫ا‬
‫بسو‬‫مال‬

‫رض‬
‫ا‬‫ع‬‫ل‬
‫ا‬‫رب‬
‫تس‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫اج‬‫و‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪6.‬‬
‫رئ‬‫ا‬‫و‬‫لط‬
‫ا‬‫ات‬‫ء‬‫ا‬
‫ر‬‫إج‬‫ةو‬‫ي‬
‫ا‬‫ق‬
‫و‬‫ل‬‫ا‬
‫ات‬‫د‬‫ع‬
‫م‬‫ة‪,‬‬
‫ي‬‫لشخص‬‫ا‬
‫ات‬‫اط‬
‫ي‬‫ت‬‫إلح‬
‫ا‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫ةك‬
‫ي‬‫و‬‫ه‬
‫دت‬‫و‬
‫دمنوج‬
‫ك‬‫أ‬
‫ة‪.‬ت‬
‫ر‬‫بخ‬
‫األ‬
‫فس‬‫ن‬
‫نبت‬
‫بس‪.‬تج‬
‫مال‬
‫ل‬‫ا‬
‫ينو‬
‫ن‬
‫ي‬‫ع‬‫ل‬
‫ا‬
‫دو‬ ‫ل‬
‫لج‬
‫ا‬‫ة‬‫مس‬‫نبمال‬
‫ة‪.‬تج‬
‫ب‬‫اس‬
‫ن‬
‫م‬‫ل‬‫ا‬‫ة‬
‫ي‬‫ا‬
‫ق‬‫و‬
‫ل‬‫ا‬‫ات‬
‫د‬‫ع‬‫مم‬
‫د‬‫تخ‬‫إس‬

‫ة‬‫ي‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬‫اط‬
‫ي‬‫ت‬
‫إلح‬
‫ا‬
‫ة‪.‬‬
‫فض‬‫نخ‬
‫م‬‫ل‬
‫ا‬‫اطق‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫و‬‫أ‬‫ة‬
‫ي‬‫ئ‬
‫ا‬‫م‬
‫ل‬‫ا‬‫ري‬
‫ا‬‫مج‬
‫ل‬‫ا‬‫يف‪,‬‬
‫ر‬‫تص‬
‫ل‬
‫ا‬‫ري‬
‫ا‬‫لىمج‬‫إ‬
‫ا‬‫ه‬‫ل‬
‫و‬‫عدخ‬‫ن‬
‫م‬‫إ‬

‫يف‬‫نظ‬
‫ت‬‫ل‬
‫ا‬‫ءو‬‫ا‬
‫و‬‫ت‬
‫ةلالح‬
‫م‬‫ز‬‫لال‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫يبو‬ ‫ل‬
‫ا‬‫ألس‬
‫ا‬
‫ة‪.‬‬
‫ف‬‫ر‬‫غ‬
‫ةم‬‫اسط‬
‫و‬‫ةب‬
‫ل‬‫ا‬
‫ز‬‫اإل‬
‫مب‬‫رى‪.‬ق‬
‫أخ‬‫ة‬
‫ل‬‫م‬
‫ا‬‫ةخ‬
‫د‬‫ا‬
‫أيم‬
‫و‬‫أ‬‫مل‬
‫ر‬‫ل‬‫ا‬
‫م‬‫ا‬‫د‬
‫تخ‬‫إس‬
‫ةب‬‫ب‬
‫ر‬‫تس‬
‫م‬‫ل‬
‫ا‬‫ة‬
‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫وي‬
‫ت‬‫إح‬
‫من‪.‬‬
‫آ‬‫ا‬‫ذ‬
‫انه‬‫اك‬
‫ذ‬‫إ‬‫رب‬‫تس‬
‫ل‬‫ا‬‫قف‬‫و‬‫أ‬‫ةو‬‫ب‬‫ر‬‫تس‬
‫م‬‫ل‬
‫ا‬‫ة‬‫د‬
‫ا‬‫م‬
‫ل‬‫ا‬‫زل‬‫إع‬

‫ة‬‫ي‬
‫ف‬‫ا‬
‫إض‬‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫لىم‬
‫ولع‬
‫لحص‬
‫ل‬‫ات ‪8‬و ‪13‬‬
‫ر‬‫ق‬
‫ف‬‫ل‬
‫ا‬‫ع‬‫اج‬
‫ر‬

‫ين‬
‫ز‬‫تخ‬
‫ل‬‫ا‬
‫ةو‬‫ل‬
‫و‬‫ا‬
‫ن‬‫م‬
‫ل‬‫ا‬
‫‪7.‬‬
‫من‬‫اآل‬
‫ل‬‫م‬‫ا‬
‫ع‬‫ت‬‫ل‬
‫اتل‬‫اط‬‫ي‬
‫ت‬‫إلح‬
‫ا‬
‫ة‬
‫د‬‫ا‬
‫إع‬‫بل‬
‫ةق‬‫ث‬
‫و‬‫ل‬
‫م‬‫ل‬
‫ا‬‫بس‬
‫مال‬
‫ل‬‫ا‬‫إغسل‬
‫م‪.‬‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫د‬‫ع‬‫ينب‬
‫د‬‫ي‬
‫ل‬‫ا‬
‫إغسل‬
‫ة‪.‬‬‫ي‬
‫ف‬‫ا‬
‫ةك‬‫ي‬
‫و‬‫ه‬‫دت‬
‫و‬‫دمنوج‬
‫ك‬‫أ‬
‫ة‪.‬ت‬
‫ر‬‫بخ‬
‫األ‬
‫فس‬‫ن‬
‫نبت‬
‫بس‪.‬تج‬
‫مال‬
‫ل‬‫ا‬‫و‬
‫أ‬‫د‪,‬‬
‫ل‬‫لج‬
‫ا‬‫ين‪,‬‬
‫ع‬‫ل‬
‫ا‬‫ة‬‫مس‬
‫نبمال‬
‫ة‪.‬تج‬
‫ب‬‫اس‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫ة‬ ‫ي‬
‫ا‬
‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬‫د‬
‫ع‬‫مم‬‫د‬‫تخ‬‫إس‬
‫م‪.‬‬
‫ا‬‫د‬‫تخ‬
‫اإلس‬

‫ا‬
‫ً‬‫ع‬‫ينم‬‫ز‬‫تخ‬
‫ل‬‫ا‬
‫نب‬‫تييجبتج‬
‫ل‬‫ا‬‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬‫لك‬‫افيذ‬
‫م‬ ‫من‪,‬ب‬
‫اآل‬
‫ين‬‫ز‬‫تخ‬
‫ل‬‫ا‬‫وط‬‫ر‬‫ش‬
‫ً‪.‬‬
‫ا‬
‫ر‬‫ه‬‫رف ‪12‬ش‬
‫ل‬‫ا‬‫لى‬
‫تجع‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫ر‬‫م‬‫م‪.‬ع‬
‫ا‬‫د‬
‫تخ‬‫اإلس‬
‫م‬‫د‬‫ةع‬‫ل‬
‫ا‬‫ةفيح‬‫ق‬
‫ل‬
‫غ‬‫ةم‬‫ي‬
‫و‬‫ا‬
‫لح‬‫ا‬
‫فظب‬‫ت‬‫إح‬‫ات‪.‬‬
‫د‬‫كس‬‫ؤ‬‫م‬‫ل‬
‫ا‬‫ًعن‬‫ا‬
‫د‬‫ي‬
‫ع‬‫ينب‬‫ز‬
‫تخ‬‫ل‬
‫ا‬

‫ة‬
‫ي‬‫لشخص‬
‫ا‬‫ة‬‫ي‬
‫ا‬‫م‬
‫لح‬‫ا‬
‫رض ‪/‬‬
‫ع‬‫ت‬‫ل‬
‫ا‬‫بط‬
‫ا‬
‫و‬‫‪8.‬ض‬
‫م‬
‫ك‬‫تح‬
‫ل‬‫ا‬‫ر‬
‫ي‬‫ي‬
‫ا‬‫ع‬
‫م‬

‫_____________________________________________________________________________________________‬
‫ة ‪9/3‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪LESUPERMUL‬‬
‫‪19-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫رض‬‫ع‬
‫ت‬‫ل‬
‫ا‬‫د‬‫و‬
‫د‬‫ح‬
‫يجي‬
‫ل‬‫لخ‬‫ا‬‫ون‬
‫ا‬‫ع‬‫ت‬
‫ل‬‫ا‬
‫لس‬ ‫مج‬ ‫يت‬
‫و‬‫ك‬‫ل‬‫ا‬ ‫ين‬
‫ر‬‫بح‬
‫ل‬ ‫ا‬ ‫ة‬‫د‬
‫تح‬‫م‬‫ل‬
‫ا‬‫ة‬‫ي‬
‫ب‬‫ر‬
‫ع‬‫ل‬‫ا‬‫ات‬‫ر‬‫ا‬
‫م‬‫إل‬
‫ا‬ ‫م ‪CAS‬‬ ‫ق‬
‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫‪TWA: 25 ppm‬‬ ‫بق‬
‫نط‬‫الت‬ ‫‪TWA: 25 ppm‬‬ ‫‪TWA: 25 ppm‬‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬
‫ت‬
‫و‬‫ي‬‫دىب‬
‫ا‬‫أح‬
‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬
‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫‪TWA: 121 mg/m3‬‬ ‫‪TWA: 121 mg/m3‬‬ ‫‪TWA: 121 mg/m3‬‬

‫ة‬‫ب‬
‫اس‬‫ن‬
‫م‬‫ل‬‫ا‬
‫ة‬‫ي‬‫دس‬
‫ن‬‫ه‬‫ل‬
‫ا‬‫بط‬
‫ا‬‫و‬‫لض‬‫ا‬
‫ة‪.‬‬
‫ي‬‫ع‬‫ي‬
‫ب‬
‫لط‬‫ا‬
‫ة‬‫ي‬‫و‬
‫ه‬‫ت‬‫ل‬
‫ا‬‫لى‬
‫إ‬‫ر‬‫ق‬
‫ت‬‫ف‬
‫تيت‬
‫ل‬
‫ا‬‫م‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫اطق‬
‫ن‬
‫مفيم‬
‫د‬‫ا‬
‫ةع‬‫ي‬
‫و‬‫ه‬‫الت‬
‫م‬‫ع‬‫ت‬
‫إس‬‫ة‪.‬يجب‬
‫د‬‫ي‬
‫اج‬‫ه‬‫ت‬
‫ي‬
‫و‬‫ه‬‫ةت‬‫ق‬
‫نط‬‫مفيم‬
‫د‬‫تخ‬‫إس‬

‫ة‬‫ي‬‫لشخص‬‫ا‬‫ة‬‫ي‬‫ا‬
‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬‫د‬‫ع‬‫لم‬ ‫ث‬‫م‬‫ة‪,‬‬‫ي‬
‫د‬‫ر‬‫ف‬‫ل‬‫ا‬‫ة‬‫ي‬‫ا‬‫م‬‫لح‬‫ا‬‫ر‬ ‫ي‬‫ب‬‫ا‬
‫د‬‫ت‬
‫و‬‫أ‬‫ة‬‫ي‬‫اع‬
‫ن‬‫ةص‬ ‫ئي صح‬‫ا‬
‫أخص‬ ‫بل‬‫ةمنق‬‫ي‬‫لشخص‬ ‫ا‬‫ة‬
‫ي‬‫ا‬‫ق‬‫و‬‫ل‬
‫ا‬ ‫ات‬‫د‬‫ع‬‫م‬
‫ل‬‫م‬‫ي‬
‫ل‬‫لس‬
‫ا‬‫م‬‫ا‬‫د‬
‫تخ‬‫اإلس‬
‫رو‬ ‫ا‬‫ي‬
‫ت‬
‫اإلخ‬‫د‬
‫ي‬‫د‬
‫غيتح‬ ‫ب‬
‫ن‬‫ي‬ ‫رط‪,‬‬ ‫ف‬
‫م‬‫ل‬
‫ا‬‫رض‬ ‫ع‬‫ت‬
‫ل‬‫ا‬‫ع‬‫ن‬
‫م‬‫أنت‬ ‫كن‬‫م‬‫ملالي‬‫ع‬‫ل‬
‫ا‬‫ات‬‫رس‬‫ا‬
‫م‬ ‫م‬‫ةو‬ ‫ي‬
‫دس‬ ‫ن‬‫ه‬
‫ل‬‫ا‬‫بط‬‫ا‬‫و‬‫لض‬ ‫ا‬‫نت‬ ‫ا‬‫اك‬‫ذ‬‫إ‬
‫تج‪.‬‬
‫ن‬‫م‬‫ل‬
‫ا‬ ‫ا‬
‫ذ‬‫ه‬
‫ل‬‫د‬‫د‬‫مح‬ ‫ل‬
‫ا‬‫يق‬‫ب‬‫تط‬‫ل‬
‫ا‬‫لى‬‫إ‬
‫د‬‫ن‬‫ت‬
‫يثيس‬ ‫ينح‬ ‫ل‬
‫ه‬ ‫ؤ‬‫م‬‫ل‬
‫ا‬‫ين‬ ‫ي‬‫ن‬
‫ف‬‫ل‬‫ا‬‫امن‬ ‫ه‬‫ر‬ ‫ي‬
‫غ‬
‫فسي‬‫ن‬‫ت‬‫ل‬
‫ا‬ ‫ز‬‫ا‬‫ه‬‫لح‬‫ا‬‫ة‬ ‫ي‬
‫ا‬‫م‬‫ح‬
‫دمن‬‫م‬‫ت‬
‫ع‬‫اعيم‬‫ن‬‫فس ص‬‫ن‬‫زت‬‫ا‬
‫ه‬‫ءج‬ ‫ا‬
‫د‬‫ت‬‫ر‬‫إ‬‫يجب‬‫وف‪,‬‬‫ر‬‫ع‬‫م‬‫ل‬‫ا‬‫ر‬‫ي‬‫رضغ‬ ‫ع‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ل‬
‫ا‬‫وفيح‬ ‫أ‬‫ني‬‫ه‬‫م‬‫ل‬‫ا‬‫رض‬ ‫ع‬‫ت‬
‫ل‬
‫ا‬ ‫د‬
‫و‬‫د‬‫قلمنح‬ ‫أ‬‫رض‬ ‫ع‬
‫ت‬‫اظب‬‫ف‬
‫ت‬‫لإلح‬‫ة‬‫ي‬
‫ف‬‫ا‬
‫رك‬ ‫ملغ‬ ‫ع‬‫ل‬
‫ا‬‫ات‬‫رس‬‫ا‬
‫م‬ ‫م‬‫ةو‬ ‫ي‬
‫دس‬ ‫ن‬‫ه‬
‫ل‬‫ا‬‫بط‬‫ا‬‫و‬‫لض‬ ‫ا‬‫نت‬ ‫ا‬‫اك‬‫ذ‬‫إ‬
‫افي‬‫م‬‫ب‬
‫ة‪,‬‬‫ي‬
‫لشخص‬ ‫ا‬‫ة‬
‫ي‬‫ا‬
‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬‫د‬‫ع‬‫عم‬‫ي‬‫م‬‫مج‬‫ا‬
‫د‬‫تخ‬‫اتإلس‬ ‫م‬
‫ي‬‫ل‬
‫ع‬ ‫ت‬
‫ل‬‫ا‬
‫رو‬ ‫ا‬
‫ي‬‫ت‬
‫اإلخ‬
‫تج‪.‬‬‫ن‬
‫م‬‫ل‬‫ا‬‫ا‬
‫ذ‬‫مه‬ ‫ا‬
‫د‬‫تخ‬‫إس‬‫ا‬
‫ه‬‫ل‬
‫د‬‫ا‬
‫ع‬‫اي‬‫وم‬‫أ‬‫ة ‪,EN 149,AS / NZS 1715: 2009‬‬ ‫ي‬
‫ب‬‫و‬
‫ر‬‫و‬ ‫األ‬‫ة‬
‫ي‬‫اس‬‫ي‬‫ق‬‫ل‬
‫ا‬‫بي‬ ‫ل‬
‫وت‬ ‫أ‬
‫‪NIOSH‬‬
‫و‬‫أ‬‫ة‬
‫ر‬‫ف‬‫و‬‫م‬‫ل‬
‫ا‬‫اعي‬‫ن‬‫لص‬‫ا‬‫فس‬‫ن‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ز‬‫ه‬‫أج‬‫ع‪,‬‬‫ف‬
‫ت‬‫ر‬‫م‬‫ل‬‫ا‬
‫ز‬‫ي‬‫ك‬‫ر‬‫ت‬
‫ل‬‫ا‬‫ة‬‫ل‬‫ا‬‫ة‪.‬فيح‬‫ي‬‫و‬‫عض‬‫ل‬‫ا‬‫ة‬
‫ر‬‫بخ‬‫لأل‬‫اعي‬‫ن‬
‫فس ص‬ ‫ن‬
‫زت‬‫ا‬‫ه‬‫ين‪.‬ج‬ ‫ل‬‫ه‬‫ؤ‬‫م‬
‫ل‬‫ا‬‫ين‬
‫ي‬‫ن‬
‫ف‬‫ل‬‫ا‬
‫همن‬ ‫ر‬‫ي‬
‫وغ‬ ‫أ‬
‫ة‬ ‫ئي صح‬‫ا‬‫أخص‬‫ا‬‫ه‬
‫مب‬ ‫و‬‫ق‬‫أني‬‫يجب‬ ‫فس‪,‬‬ ‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬‫ز‬ ‫ه‬
‫أج‬ ‫لك‬‫ذ‬
‫ة‪.‬‬‫ل‬
‫ق‬‫ت‬‫مس‬ ‫ل‬
‫ا‬
‫د‬‫ي‬
‫ل‬‫ا‬‫ة‬ ‫ي‬
‫ا‬‫م‬‫ح‬
‫للحسب ‪: (EN 374‬‬ ‫قتتخ‬‫ةو‬‫ق‬‫ي‬‫ق‬
‫دل‪> 480‬د‬ ‫ا‬
‫ع‬‫اي‬‫أيم‬ ‫ة ‪,6‬‬‫ي‬
‫ا‬‫م‬
‫رح‬ ‫ؤش‬‫ه‪:‬م‬‫وصىب‬ ‫م‬
‫ل‬‫ا‬
‫ر)‬ ‫اش‬
‫ب‬‫م‬
‫ل‬‫ا‬‫ال‬
‫تص‬ ‫اإل‬‫و‬‫ول‪,‬‬‫أط‬‫ة‬‫ر‬‫ت‬‫ف‬
‫ل‬‫ة‬‫ب‬‫اس‬
‫ن‬‫م‬‫ل‬
‫ا‬‫د‬‫ا‬‫و‬‫م‬‫ل‬
‫ا‬‫ة )‪(EN 374‬‬‫ي‬‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬‫ك‬‫ل‬‫ا‬‫د‬‫ا‬
‫و‬‫م‬ ‫ل‬
‫ل‬‫ة‬‫م‬‫و‬‫ا‬‫ق‬‫ةم‬ ‫ي‬
‫ق‬‫ا‬‫اتو‬ ‫ز‬ ‫ا‬
‫ف‬‫ق‬
‫ة‬‫ي‬‫ل‬
‫م‬‫ع‬
‫ل‬‫ا‬‫ة‬‫رس‬‫ا‬‫م‬
‫م‬‫ل‬
‫ا‬‫ة‪.‬في‬‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬‫و‬‫لىم‬‫ًع‬‫ا‬
‫اس‬‫ي‬
‫دق‬ ‫م‬‫ت‬
‫وتس‬‫أ‬‫ات‪,‬‬‫ز‬‫ا‬‫ف‬‫ق‬
‫ل‬
‫ل‬ ‫ة‬
‫ع‬‫ن‬‫مص‬‫ل‬‫ا‬‫ات‬
‫ك‬ ‫ر‬
‫لش‬‫ا‬‫بل‬‫ةمنق‬ ‫م‬‫د‬
‫ق‬‫م‬
‫ل‬‫ا‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬ ‫م‬‫ل‬‫ا‬‫لى‬
‫عوع‬ ‫اج‬‫ر‬‫م‬‫ل‬
‫ا‬‫لى‬‫اتع‬ ‫م‬‫و‬‫ل‬‫ع‬‫م‬‫ل‬
‫ا‬‫ه‬
‫ذ‬‫ده‬‫ن‬‫ت‬
‫ة ‪(<=0.4‬تس‬ ‫ك‬‫ا‬
‫م‬‫مس‬ ‫م‬‫يل‪) .‬‬‫ر‬‫ت‬‫ي‬‫زن‬ ‫ا‬
‫ف‬‫ق‬
‫ة‬‫رج‬‫ثلد‬‫م‬‫ة)‬‫ر‬‫ث‬
‫ؤ‬‫م‬‫ل‬
‫ا‬‫مل‬‫ا‬‫و‬
‫ع‬‫ل‬‫ا‬
‫دمن‬ ‫ي‬‫د‬
‫ع‬‫ل‬‫ا‬‫ة‬
‫يج‬‫ت‬‫لى ‪EN 374‬ن‬ ‫ًإ‬
‫ا‬‫ق‬
‫ف‬‫ذو‬‫ا‬‫ف‬
‫ن‬‫ل‬
‫ا‬‫قت‬‫و‬‫ل‬
‫ا‬‫رمن‬ ‫ي‬
‫ث‬‫ك‬‫رب‬‫قص‬‫أ‬‫ون‬‫ك‬‫دت‬‫ةق‬ ‫ي‬
‫ئ‬‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬‫ا‬‫د‬
‫ا‬‫و‬‫م‬‫ل‬
‫ل‬‫ة‬‫م‬‫و‬‫ا‬
‫ق‬‫م‬‫ل‬
‫ا‬‫ة‬‫ي‬‫ق‬‫ا‬
‫و‬ ‫ل‬
‫ا‬‫ات‬‫ز‬‫ا‬
‫ف‬‫ق‬
‫ل‬‫ل‬‫ة‬
‫ي‬‫ل‬
‫م‬‫ع‬‫ل‬
‫ا‬ ‫ة‬‫ا‬‫ي‬
‫لح‬‫ا‬‫هفي‬ ‫ن‬‫أ‬ ‫ة‬‫مالحظ‬ ‫ل‬
‫ا‬‫رجى‬ ‫ي‬
‫ر‪.‬‬‫ي‬
‫ب‬‫ك‬
‫ل‬‫ا‬‫وع‬ ‫ن‬
‫ت‬
‫ل‬ ‫ا‬‫بب‬‫مبس‬‫ا‬
‫د‬‫تخ‬
‫لإلس‬‫ع‬‫ن‬
‫مص‬ ‫ل‬‫ا‬‫ات‬‫ه‬‫ي‬‫وج‬
‫ةت‬‫ا‬
‫اع‬‫ر‬‫غيم‬ ‫ب‬‫ن‬‫ات‪.‬ي‬‫ز‬‫ا‬
‫ف‬‫ق‬
‫ل‬‫ا‬‫ال‬
‫د‬‫ب‬‫ت‬
‫إس‬‫م‬‫ت‬‫أني‬‫زقيجب‬ ‫م‬‫ت‬
‫ل‬‫ا‬
‫كلو‬‫آ‬‫ت‬
‫ل‬
‫ا‬ ‫ات‬ ‫م‬
‫االحظتعال‬ ‫ذ‬‫إ‬‫ة(‪.‬‬
‫ر‬ ‫ا‬‫ر‬‫لح‬‫ا‬
‫د‬‫ل‬
‫لج‬‫ا‬ ‫ة‬‫ي‬‫ا‬‫ق‬‫و‬
‫اط‪.‬‬‫عطفمط‬ ‫م‬
‫ين‬‫ع‬‫ل‬‫ا‬‫ة‬ ‫ي‬
‫ا‬‫م‬‫ح‬
‫د‪.‬‬‫إنوج‬ ‫ذ‬‫ا‬‫ذ‬
‫ر‬‫ل‬‫ا‬‫ر‬‫ةمنخط‬ ‫ي‬
‫ا‬‫م‬‫لح‬‫ل‬‫ة‬‫وج‬‫ل‬
‫ل‬‫قي‬‫ا‬
‫اعو‬‫ن‬‫عق‬ ‫ة‪ :‬ض‬‫ي‬‫ئ‬‫ا‬
‫ي‬‫م‬
‫ي‬‫ك‬‫ل‬‫ا‬‫ة‬‫ي‬‫ا‬‫ق‬
‫و‬ ‫ل‬
‫ا‬‫ر‬ ‫ي‬‫اظ‬‫ن‬‫م‬
‫رى‬‫أخ‬ ‫ات‬ ‫اط‬‫ي‬‫ت‬‫إح‬
‫وف‪.‬‬ ‫ر‬‫ع‬ ‫ئىم‬ ‫الش‬

‫ة‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ةو‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫ز‬‫ي‬
‫ف‬‫ل‬
‫ا‬‫ئص‬
‫ا‬‫لخص‬
‫ا‬
‫‪9.‬‬
‫ة‪:‬‬‫ي‬‫د‬
‫ا‬‫م‬‫ل‬‫ا‬‫ة‬‫ل‬‫ا‬‫لح‬
‫ا‬
‫ئل‬‫ا‬‫س‬
‫ون‪:‬‬‫ل‬
‫ر‬ ‫ف‬
‫أص‬
‫ة‪:‬‬‫ئح‬ ‫ا‬
‫ر‬
‫دل‬ ‫ت‬
‫ع‬‫م‬
‫ة‪:‬‬‫ئح‬‫ا‬
‫ر‬‫ل‬‫نىل‬‫د‬‫أل‬
‫ا‬ ‫د‬‫لح‬
‫ا‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫‪pH:‬‬
‫‪2.6‬‬
‫ء ‪:(= 1‬‬‫ا‬
‫م‬‫ة)‬ ‫ي‬‫و‬ ‫ئ‬
‫ةم‬ ‫رج‬‫ة @ ‪20‬د‬ ‫ي‬‫وع‬‫ن‬‫ل‬
‫ا‬ ‫ة‬‫ف‬‫ا‬
‫ث‬‫ك‬‫ل‬
‫ا‬
‫‪0.924‬‬
‫ة(‪:‬‬‫ي‬‫و‬‫ئ‬‫م‬‫دى )‬‫د ‪/‬م‬‫م‬‫تج‬‫ل‬‫ا‬‫ة‬‫قط‬‫ن‬
‫‪-6.6‬‬
‫ة(‪:‬‬ ‫ي‬
‫و‬‫ئ‬‫ةم‬ ‫رج‬‫د‬‫دى )‬ ‫م‬‫ل‬
‫ا‬‫ان‬‫ي‬‫ل‬
‫ةغ‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ة(‪:‬‬‫ي‬
‫و‬ ‫ئ‬
‫م‬‫دى )‬ ‫م‬‫ل‬
‫ا‬‫يض ‪/‬‬ ‫م‬‫و‬‫ل‬‫ا‬‫ة‬‫قط‬‫ن‬
‫‪> 100‬‬
‫يض‪:‬‬ ‫م‬‫و‬‫ل‬
‫ا‬‫ة‬‫قط‬‫ةن‬ ‫ق‬‫ي‬‫ر‬‫ط‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫فض )‪(%‬‬ ‫نخ‬
‫دم‬ ‫و ‪-‬ح‬ ‫لج‬
‫ا‬ ‫لفي‬ ‫ا‬
‫ع‬‫ت‬‫إلش‬
‫ا‬ ‫ة‬
‫ي‬‫ل‬‫ب‬
‫ا‬‫دق‬ ‫و‬‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫وي )‪(%‬‬ ‫ل‬
‫دع‬ ‫و ‪-‬ح‬ ‫لج‬
‫ا‬ ‫لفي‬ ‫ا‬
‫ع‬‫ت‬‫إلش‬
‫ا‬ ‫ة‬
‫ي‬‫ل‬‫ب‬
‫ا‬‫دق‬ ‫و‬‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ة(‪:‬‬
‫ي‬‫و‬‫ئ‬
‫ةم‬ ‫رج‬ ‫د‬
‫تي )‬‫ا‬
‫ذ‬ ‫ل‬
‫ا‬ ‫ل‬‫ا‬‫ع‬
‫ت‬‫الش‬‫ا‬‫ة‬‫ر‬‫ا‬
‫ر‬‫ةح‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ل ‪:(= 1‬‬ ‫ي‬‫ت‬
‫و‬ ‫ي‬‫ب‬
‫ل‬‫ا‬‫ر )خالت‬‫بخ‬‫ت‬‫ل‬
‫ا‬ ‫ة‬‫رع‬ ‫س‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫بق(‬
‫ئ‬‫مز‬ ‫ل‬
‫م‬ ‫ة)‬‫ي‬
‫و‬‫ئ‬‫ة ‪20‬م‬ ‫ر‬‫ا‬‫ر‬
‫ةح‬ ‫رج‬ ‫ة @د‬ ‫ر‬‫بخ‬‫أل‬
‫ا‬ ‫غط‬‫ض‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ء‪=1‬‬ ‫ا‬‫و‬‫ر)ه‬ ‫ا‬
‫بخ‬‫ل‬
‫ا‬ ‫ة‬‫ف‬‫ا‬‫ث‬‫ك‬
‫(‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬
‫ء‬‫ا‬‫م‬
‫ل‬‫ا‬‫انفي‬ ‫ب‬‫و‬‫ذ‬‫ل‬
‫ا‬

‫_____________________________________________________________________________________________‬
‫ة ‪9/4‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪LESUPERMUL‬‬
‫‪19-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫ء‬‫ا‬‫م‬
‫ل‬‫ا‬‫انفي‬‫ب‬‫و‬‫ذ‬
‫ل‬‫ل‬‫ة‬‫ل‬
‫ب‬‫ا‬
‫رق‬ ‫ي‬
‫غ‬
‫ة (‪:‬‬‫ي‬‫و‬‫ئ‬‫ل )م‬‫ل‬‫تح‬
‫ل‬‫ا‬‫ة‬
‫ر‬‫ا‬‫ر‬‫ةح‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬
‫ت‬‫اتم‬ ‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫الت‬
‫ز(‪:‬‬
‫و‬‫ي‬‫ب‬
‫ي‬‫ت‬
‫ن‬‫ة )س‬
‫ي‬‫و‬‫ئ‬
‫ةم‬‫رج‬‫ة ‪‌@ 20‬د‬ ‫ي‬
‫ك‬‫ي‬
‫م‬‫ا‬‫ن‬
‫ي‬‫ة‪,‬د‬‫وج‬‫ز‬‫ل‬
‫‪280-300‬‬
‫وك(‪:‬‬ ‫ر‬
‫ت‬‫يس‬
‫ت‬‫ن‬
‫ة )س‬‫ي‬‫و‬
‫ئ‬‫ةم‬‫رج‬‫ة ‪‌‌@ 20‬د‬ ‫ي‬‫ك‬
‫ر‬‫ة‪,‬ح‬ ‫وج‬‫ز‬‫ل‬
‫ة‬‫اح‬
‫ت‬‫اتم‬ ‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫الت‬
‫ء‪:‬‬‫ا‬‫لم‬ ‫و‬‫ن‬‫ا‬‫ت‬
‫ك‬‫أ‬‫عن‪-‬‬ ‫ي‬
‫ز‬‫و‬‫ت‬‫ل‬
‫ا‬‫ل‬‫م‬ ‫ا‬
‫ع‬‫م‬
‫ة‪.‬‬‫اح‬
‫ت‬‫اتم‬ ‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫الت‬
‫زئ (‪:‬‬‫ئى )غج‬ ‫ي‬
‫ز‬‫لج‬‫ا‬‫زن‬ ‫و‬‫ل‬
‫ا‬
‫ة‪.‬‬‫اح‬
‫ت‬‫اتم‬ ‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫الت‬

‫ة‬
‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬‫اتو‬
‫ب‬‫ث‬
‫ل‬‫ا‬
‫‪10.‬‬
‫ة‬‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬
‫يط‬
‫نش‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫د‬
‫ا‬‫إع‬
‫ع‬‫ق‬‫و‬
‫ت‬‫م‬‫ل‬
‫ا‬‫يسمن‬‫ل‬

‫ئي‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ات‬
‫ب‬‫ث‬‫ل‬
‫ا‬
‫ر‬‫ق‬
‫ت‬‫مس‬

‫ة‬
‫ر‬‫لخط‬
‫ا‬‫اعالت‬
‫ف‬‫ت‬
‫ل‬‫ا‬‫ل‬
‫ا‬‫م‬‫ت‬
‫اح‬
‫دث‬‫لنيح‬

‫ا‬
‫ه‬‫ب‬
‫ن‬‫تييجبتج‬
‫ل‬‫ا‬‫وف‬
‫ر‬‫لظ‬‫ا‬
‫ع‪.‬‬‫ق‬
‫و‬‫ت‬
‫يئم‬‫الش‬

‫ا‬‫ه‬‫ن‬
‫ب‬‫ديجبتج‬
‫ا‬‫و‬‫م‬
‫ة‪.‬‬
‫ي‬‫و‬‫ةق‬
‫د‬‫كس‬‫ؤ‬‫ملم‬
‫ا‬‫و‬‫ع‬

‫ة‬
‫ر‬‫لخط‬‫ا‬
‫كك‬‫ف‬
‫ت‬‫ل‬
‫ا‬‫ات‬‫تج‬
‫ن‬‫م‬
‫ون‪.‬‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬
‫أ‬‫ني‬
‫ا‬
‫ث‬‫ونو‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬
‫ا‬‫ول‬‫أ‬‫ين‪.‬‬
‫وج‬‫ر‬
‫ت‬‫ي‬
‫ن‬‫ل‬
‫ا‬‫د‬‫ي‬
‫اس‬‫ك‬
‫أ‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫ه‬‫ي‬
‫وج‬ ‫ت‬
‫بق‬
‫نط‬‫الت‬

‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪11.‬‬
‫ة‬‫ي‬‫م‬‫لس‬‫ا‬‫ات‬
‫ر‬‫ي‬
‫ث‬‫أ‬‫اتعنت‬ ‫م‬‫و‬‫ل‬
‫ع‬‫م‬
‫ة‬
‫د‬‫ا‬‫لح‬
‫ا‬ ‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫اق‬‫نش‬‫ت‬‫إس‬
‫ان‬
‫د‬‫ق‬
‫ف‬‫هن‪,‬و‬‫ذ‬
‫ل‬‫ا‬‫وش‬‫يث‪,‬تش‬
‫د‬‫لح‬
‫ا‬‫مفي‬‫ث‬
‫ع‬‫ل‬
‫ت‬‫ل‬
‫ا‬‫عل‪,‬‬
‫ف‬‫ل‬
‫ا‬‫د‬‫ءر‬‫ال‪,‬يط‬‫ع‬
‫ف‬‫ن‬
‫اإل‬
‫ةو‬‫ك‬‫ر‬‫لح‬
‫ا‬‫فق‬
‫ا‬
‫و‬‫مت‬
‫د‬‫ول‪,‬ع‬‫م‬‫لخ‬
‫ا‬‫ر‪,‬‬
‫ا‬‫و‬‫د‬‫ل‬
‫ا‬‫اع ‪,‬‬
‫د‬‫لص‬‫ا‬‫مل‬
‫ذىبش‬ ‫ل‬
‫ا‬‫زى‬‫ك‬‫ر‬‫م‬‫ل‬
‫ا‬‫بى‬‫عص‬‫ل‬‫ا‬‫ز‬‫ا‬‫ه‬‫لج‬
‫ا‬‫عف‬ ‫بب ض‬‫أنيس‬ ‫كن‬‫م‬‫ي‬
‫وعى‪.‬‬ ‫ل‬
‫ا‬
‫ين‬
‫ع‬‫ل‬‫ا‬‫ة‬‫مس‬‫مال‬
‫ين‪.‬‬
‫ع‬‫ل‬‫ا‬‫دلفي‬ ‫ت‬
‫ع‬‫يجم‬
‫ه‬‫ببت‬ ‫ديس‬‫ق‬
‫د‬‫ل‬
‫لج‬‫ا‬‫ة‬‫مس‬‫مال‬
‫د‪.‬‬
‫ل‬‫لج‬
‫ل‬ ‫يط‬
‫يجبس‬
‫ه‬‫ببت‬‫د‪.‬يس‬‫ل‬‫لج‬‫ل‬
‫ة‬‫ي‬‫اس‬‫ببحس‬‫أنيس‬ ‫كن‬‫م‬‫ي‬
‫تالع‬
‫ب‬‫إل‬
‫ا‬
‫بي‬
‫عص‬‫ل‬‫ا‬
‫ز‬‫ا‬‫ه‬
‫لج‬‫ا‬‫اقفي‬‫ه‬
‫ر‬‫إ‬‫ميو‬‫هض‬‫ل‬
‫ا‬‫ز‬‫ا‬‫ه‬
‫لج‬‫ا‬‫اعبفي‬‫ت‬
‫ئى‪,‬م‬
‫ق‬‫ل‬
‫ا‬‫ة‪,‬‬‫وخ‬‫د‬‫ل‬
‫ا‬‫اع‪,‬‬
‫د‬‫د‬
‫لص‬‫ا‬‫بب‬
‫أنيس‬‫كن‬‫م‬
‫ال‪.‬ي‬
‫ه‬‫اإلس‬
‫ان‪,‬و‬ ‫ي‬
‫ث‬
‫ف‬‫ل‬
‫ا‬‫ء‬‫قي‬‫ل‬
‫ا‬‫بطن‪,‬‬‫ل‬‫ا‬‫مفي‬‫ل‬
‫أ‬‫بب‬‫أنيس‬‫كن‬ ‫م‬
‫ة‪.‬ي‬‫د‬
‫ع‬‫م‬‫ل‬‫ا‬
‫لق‪,‬و‬‫لح‬
‫ا‬‫م‪,‬‬‫ف‬
‫ل‬‫ا‬‫هب‬ ‫ل‬
‫ي‬
‫زي‪.‬‬‫ك‬ ‫ر‬‫م‬‫ل‬
‫ا‬

‫ة‬
‫ي‬‫ن‬‫ا‬
‫رط‬‫ةس‬‫ن‬
‫م‬‫ز‬‫اتم‬
‫ر‬‫ي‬‫ث‬
‫أ‬‫ت‬
‫ة‪.‬‬
‫لصح‬
‫ا‬‫لى‬
‫منع‬
‫ز‬‫ةم‬
‫ر‬‫و‬‫رخط‬
‫د‬‫همص‬
‫ن‬‫أ‬
‫ر‬‫ب‬
‫ك‬‫أ‬‫و‬
‫أ‬‫ة ‪1%‬‬
‫ب‬‫نس‬
‫ةب‬‫ت‬
‫ا‬
‫ن‬‫و‬‫ك‬
‫دىم‬
‫إح‬‫و‬
‫أ‬‫تج‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫د‬‫و‬‫أنوج‬
‫لى‬‫إ‬
‫ر‬‫ي‬‫اتتش‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ةل‬‫ي‬
‫م‬‫لس‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ة‬
‫ي‬‫يس‬
‫ئ‬
‫ر‬‫ل‬‫ا‬

‫اق ‪LC50‬‬
‫نش‬‫ت‬
‫إس‬ ‫د‬
‫ل‬‫لج‬
‫ا‬‫يق‬
‫ر‬‫‪LD50‬عنط‬ ‫م‬
‫ف‬‫ل‬
‫ا‬‫يق‬
‫ر‬‫‪LD50‬عنط‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬

‫_____________________________________________________________________________________________‬
‫ة ‪9/5‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪LESUPERMUL‬‬
‫‪19-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫ن‬‫ا‬
‫ي‬‫دب‬‫وج‬
‫الت‬ ‫)‪>2000 mg/kg-bw (rat‬‬ ‫)‪>2020 mg/kg-bw (rat‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫د مسجل‬
‫ي‬‫م‬
‫أ‬‫د‬‫د‬
‫ع‬‫ت‬‫ليم‬
‫ي‬‫كس‬
‫و‬‫ب‬‫ر‬‫مضك‬ ‫ا‬
‫ح‬
‫هي‬‫ت‬
‫ن‬
‫نيم‬‫ه‬‫د‬
‫‪> 2.1 mg/L‬‬ ‫‪> 5000 mg/kg‬‬ ‫)‪> 5050 mg/kg (Rat‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫يب مسجل‬‫ك‬‫ر‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬‫ب‬
‫ا‬
‫تش‬‫ام‬‫ف‬
‫ل‬
‫أ‬ ‫ات‬
‫ن‬‫ي‬
‫ف‬‫ل‬
‫و‬‫أ‬
‫‪6.35 mg/L (Rat) 4h (similar‬‬ ‫)‪> 2020 mg/kg (Rabbit‬‬
‫)‪substance‬‬
‫‪> 0.06 mg/L (Rat) (similar‬‬ ‫)‪> 2020 mg/kg (Rabbit‬‬ ‫)‪> 5,050 mg/kg (Rat‬‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬
‫ا‬‫ني‬
‫ا‬
‫م‬‫ث‬
‫‪substance) 4h‬‬
‫‪28 mg/L (Rat) 4h (similar‬‬
‫)‪substance‬‬
‫‪28 mg/L (Mouse) 4h (similar‬‬
‫)‪substance‬‬
‫‪40.2 mg/L (Rat) 4h (similar‬‬
‫)‪substance‬‬
‫ة‬‫اح‬
‫ت‬‫اتم‬ ‫ن‬
‫ا‬‫ي‬‫دب‬‫وج‬‫الت‬ ‫)‪>2000 mg/kg (Rabbit‬‬ ‫)‪1414 mg/kg-bw (guinea pig‬‬ ‫ر ‪111-76-2‬‬
‫ث‬‫ي‬
‫إ‬‫يل‬
‫ت‬
‫و‬‫ي‬‫دىب‬
‫ا‬‫أح‬
‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬
‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬

‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫ن‬
‫ا‬‫ي‬
‫دب‬‫وج‬
‫الت‬ ‫)‪2700 mg/kg (Rabbit‬‬ ‫)‪3384 mg/kg (Rat‬‬ ‫‪112-34-5‬‬ ‫دى‬
‫ا‬‫أح‬
‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬
‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫)‪2764 mg/kg (Rabbit‬‬ ‫)‪6560 mg/kg (Rat‬‬ ‫ر‬‫ث‬
‫ي‬
‫إ‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫ب‬
‫)‪5660 mg/kg (Rat‬‬
‫)‪2406 mg/kg (Mouse‬‬
‫)‪2000 mg/kg (Guinea pig‬‬

‫يج‬
‫ه‬‫د ‪/‬ت‬
‫ل‬‫لج‬
‫ا‬‫ل‬‫ك‬
‫آ‬‫ت‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫د‬
‫ل‬‫لج‬
‫ل‬‫ة‬‫يج‬
‫ه‬‫رم‬
‫ُ‬ ‫ي‬
‫غ‬ ‫ني‬
‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫ة(‬‫ل‬
‫ث‬‫ا‬‫م‬
‫دم‬‫ا‬‫و‬
‫م‬‫نب‪) .‬‬‫ا‬
‫ر‬‫األ‬
‫د‬‫ل‬‫يجج‬‫ه‬‫ببت‬‫اليس‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ة(‬‫ل‬
‫ث‬‫ا‬‫م‬
‫دم‬‫ا‬‫و‬
‫م‬‫نب‪) .‬‬‫ا‬
‫ر‬‫األ‬
‫د‬‫ل‬‫يجج‬‫ه‬‫ببت‬‫اليس‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫نب(‬
‫ر‬‫أ‬
‫د‪) .‬‬
‫ل‬‫لج‬
‫ل‬‫ة‬‫وسط‬ ‫ت‬
‫ةم‬‫ق‬‫ي‬‫ا‬
‫ومض‬ ‫أ‬‫يج‬‫ه‬‫ببت‬‫يس‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫نب(‬‫ر‬‫أ‬
‫د)‬‫ل‬‫لج‬
‫ل‬‫يف‬ ‫ف‬
‫يج خ‬‫ه‬‫ت‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫ر‬‫ث‬‫ي‬
‫إ‬

‫يج‬
‫ه‬‫ين ‪/‬ت‬
‫ع‬‫ل‬
‫ا‬‫ر‬‫ر‬
‫تض‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫نب‪.‬‬
‫ر‬‫األ‬
‫ين‬‫ع‬
‫ل‬‫زعج‬
‫رم‬‫ي‬
‫غ‬ ‫ني‬
‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫ة(‬‫ل‬
‫ث‬‫ا‬
‫م‬‫دم‬ ‫ا‬‫و‬‫م‬
‫نب‪) .‬‬
‫ر‬‫األ‬
‫ين‬‫ع‬‫ل‬‫زعج‬‫رم‬
‫ي‬‫غ‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ة(‬‫ل‬
‫ث‬‫ا‬
‫م‬‫دم‬ ‫ا‬‫و‬‫م‬
‫نب‪) .‬‬
‫ر‬‫األ‬
‫ين‬‫ع‬‫ل‬‫زعج‬‫رم‬
‫ي‬‫غ‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫نب(‬
‫ر‬‫أ‬‫ين‪) .‬‬
‫ع‬‫ل‬‫ا‬‫دفي‬‫و‬‫د‬‫دلمح‬‫ت‬
‫ع‬‫ببم‬
‫تس‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫نب(‬
‫ر‬‫أ‬‫ين‪) .‬‬
‫ع‬‫ل‬‫ا‬‫دفي‬‫و‬‫د‬‫دلمح‬‫ت‬
‫ع‬‫ببم‬
‫تس‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫ر‬‫ث‬‫ي‬
‫إ‬

‫ة‬
‫ي‬‫د‬‫ل‬
‫لج‬
‫ا‬‫ة‬‫ي‬
‫اس‬‫لحس‬
‫ا‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ا‪.‬‬
‫ي‬
‫ن‬‫ي‬
‫رغ‬‫ي‬
‫ز‬‫ن‬
‫دفيخ‬
‫ل‬‫لج‬
‫ل‬‫محسس‬ ‫ني‬
‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫ر)‬‫ب‬‫ت‬
‫مخ‬‫ل‬
‫ا‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لىح‬
‫ةع‬‫ي‬
‫اس‬‫ببحس‬
‫متس‬
‫ل‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫ر)‬‫ب‬‫ت‬
‫مخ‬‫ل‬
‫ا‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لىح‬
‫ةع‬‫ي‬
‫اس‬‫ببحس‬
‫متس‬
‫ل‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫ا(‬‫ي‬
‫ن‬
‫ي‬‫رغ‬‫ي‬‫ز‬
‫ن‬‫ر )خ‬
‫ب‬‫ت‬
‫مخ‬‫ل‬
‫ا‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لىح‬
‫ةع‬‫ي‬
‫اس‬‫ببحس‬
‫متس‬
‫ل‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫ا(‬‫ي‬
‫ن‬
‫ي‬‫رغ‬‫ي‬‫ز‬
‫ن‬‫ر )خ‬
‫ب‬‫ت‬
‫مخ‬‫ل‬
‫ا‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لىح‬
‫ةع‬‫ي‬
‫اس‬‫ببحس‬
‫متس‬
‫ل‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫ر‬‫ث‬‫ي‬
‫إ‬

‫فسي‬
‫ن‬‫ت‬
‫ل‬‫ا‬‫تحسس‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ني‬
‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫ر‬‫ث‬‫ي‬
‫إ‬

‫ة‬
‫ي‬‫ر‬‫ف‬
‫لط‬‫ا‬
‫ر‬‫ا‬‫ث‬
‫اآل‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‬
‫ي‬‫ر‬‫ف‬
‫اتط‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫يب "‪"In vitro‬‬
‫ب‬
‫ا‬‫ن‬
‫األ‬
‫ات‬‫اس‬
‫ر‬‫اتد‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬‫ةفي‬
‫ي‬‫ر‬‫ف‬
‫اتط‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫لحي "‪"In vivo‬‬
‫ا‬‫م‬‫لجس‬
‫ا‬‫اتفي‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬‫في‬ ‫ني‬
‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫ري )‬‫ف‬
‫رط‬‫ي‬‫ث‬
‫أ‬‫رتت‬ ‫ه‬‫أظ‬‫يب "‪"In vitro‬‬‫ب‬
‫ا‬‫ن‬
‫األ‬
‫ات‬‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ري‬‫ف‬
‫رط‬‫ي‬‫ث‬
‫أ‬‫رتت‬ ‫ه‬‫أظ‬‫يب "‪"In vitro‬‬‫ب‬
‫ا‬‫ن‬
‫األ‬
‫ات‬‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫ة‬‫ي‬
‫ر‬‫ف‬‫اتط‬
‫ر‬‫ي‬‫ث‬‫أ‬‫رت‬
‫ه‬‫متظ‬
‫ل‬‫لحي "‪"In vivo‬‬‫ا‬ ‫م‬‫لجس‬‫ا‬‫اتفي‬‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬‫في‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫ة‬
‫ي‬‫ر‬‫ف‬
‫اتط‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫يب "‪"In vitro‬‬
‫ب‬
‫ا‬‫ن‬
‫األ‬
‫ات‬‫اس‬
‫ر‬‫اتد‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬‫ةفي‬‫ي‬
‫ر‬‫ف‬‫اتط‬
‫ر‬‫ي‬‫ث‬‫أ‬‫رت‬
‫ه‬‫متظ‬
‫ل‬‫لحي "‪"In vivo‬‬‫ا‬ ‫م‬‫لجس‬‫ا‬‫اتفي‬‫ر‬‫ا‬
‫ب‬‫ت‬
‫إخ‬‫في‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫ر‬‫ث‬‫ي‬
‫إ‬

‫_____________________________________________________________________________________________‬
‫ة ‪9/6‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪LESUPERMUL‬‬
‫‪19-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫ة‬
‫ن‬‫رط‬‫اتمس‬‫ر‬
‫ي‬‫ث‬
‫أ‬‫ت‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ني‬
‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫ة‪.‬‬‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬
‫ل‬‫ع‬‫دم‬
‫وج‬‫الت‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ة‪.‬‬‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬
‫ل‬‫ع‬‫دم‬
‫وج‬‫الت‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫ان‪.‬‬‫رط‬‫لس‬
‫ل‬‫ة‬‫ب‬
‫ب‬
‫رمس‬‫ب‬‫ت‬
‫ع‬‫الت‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫ة‪.‬‬‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬
‫ل‬‫ع‬‫دم‬
‫وج‬‫الت‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫ر‬‫ث‬‫ي‬
‫إ‬

‫ة‬
‫ي‬‫ل‬
‫اس‬‫ن‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ي‬
‫م‬‫لس‬
‫ا‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬‫قيفي‬
‫ل‬
‫هخ‬‫و‬
‫اتتش‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫ة‪.‬‬
‫ب‬‫و‬‫لخص‬
‫ا‬‫لى‬
‫رع‬‫ا‬
‫ث‬
‫آ‬‫أي‬
‫ر‬‫ه‬‫متظ‬
‫ل‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬ ‫ني‬
‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫ات )‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬‫قيفي‬
‫ل‬
‫هخ‬‫و‬
‫اتتش‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫ة‪.‬‬
‫ب‬‫و‬‫لخص‬
‫ا‬‫لى‬
‫رع‬‫ا‬
‫ث‬
‫آ‬‫أي‬
‫ر‬‫ه‬‫متظ‬
‫ل‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫ات )‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬‫قيفي‬
‫ل‬
‫هخ‬‫و‬
‫اتتش‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫ة‪.‬‬
‫ب‬‫و‬‫لخص‬
‫ا‬‫لى‬
‫رع‬‫ا‬
‫ث‬
‫آ‬‫أي‬
‫ر‬‫ه‬‫متظ‬
‫ل‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬‫قيفي‬
‫ل‬
‫هخ‬‫و‬
‫اتتش‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫ة‪.‬‬
‫ب‬‫و‬‫لخص‬
‫ا‬‫لى‬
‫رع‬‫ا‬
‫ث‬
‫آ‬‫أي‬
‫ر‬‫ه‬‫متظ‬
‫ل‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬‫قيفي‬
‫ل‬
‫هخ‬‫و‬
‫اتتش‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬‫ه‬
‫متظ‬
‫ل‬‫ة‪.‬‬
‫ب‬‫و‬‫لخص‬
‫ا‬‫لى‬
‫رع‬‫ا‬
‫ث‬
‫آ‬‫أي‬
‫ر‬‫ه‬‫متظ‬
‫ل‬‫ات‬
‫ن‬
‫ا‬‫و‬‫ي‬
‫لح‬
‫ا‬‫لى‬
‫ربع‬
‫ا‬‫تج‬
‫ل‬
‫ا‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫ر‬‫ث‬‫ي‬
‫إ‬

‫ة‬
‫د‬‫اح‬
‫ةو‬‫ر‬
‫رضم‬
‫ع‬‫ت‬‫م ‪STOT-CAS‬‬
‫ل‬
‫ا‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ني‬
‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫ة‬‫اح‬
‫ت‬‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬ ‫الت‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ة‬‫اح‬
‫ت‬‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬ ‫الت‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫ة‪.‬‬‫ي‬
‫ف‬‫ا‬
‫ةك‬‫د‬
‫و‬‫اتج‬‫اتذ‬‫ن‬
‫ا‬
‫ي‬‫ةب‬
‫ي‬‫أ‬‫ر‬
‫ف‬‫و‬‫ت‬‫الت‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫يف‪.‬‬
‫ن‬
‫تص‬‫ل‬
‫ا‬‫لب‬
‫تط‬‫زت‬
‫ي‬‫ك‬‫ر‬
‫ةفيت‬
‫ي‬‫ن‬
‫ا‬‫و‬
‫ي‬‫لح‬
‫ا‬‫ات‬‫اس‬
‫ر‬‫د‬‫ل‬
‫ا‬‫ةفي‬
‫ر‬‫ي‬‫ب‬
‫ةك‬‫ي‬
‫م‬‫أيس‬‫ميالحظ‬‫ل‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫ر‬‫ث‬‫ي‬
‫إ‬

‫ر‬
‫ر‬‫ك‬‫ت‬
‫م‬‫ل‬
‫ا‬‫رض‬
‫ع‬‫ت‬‫ل‬
‫ا‬
‫‪STOT -‬‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫ةك‬
‫د‬‫و‬‫اتج‬
‫اتذ‬
‫ن‬
‫ا‬‫ي‬
‫ةب‬‫ي‬
‫أ‬‫ر‬‫ف‬
‫و‬‫ت‬
‫الت‬ ‫ني‬
‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫يف‪) .‬‬
‫ن‬
‫تص‬‫ل‬
‫ا‬‫لب‬
‫تط‬‫زت‬
‫ي‬‫ك‬‫ر‬
‫ةفيت‬
‫ي‬‫ن‬
‫ا‬‫و‬
‫ي‬‫لح‬
‫ا‬‫ات‬‫اس‬
‫ر‬‫د‬‫ل‬
‫ا‬‫ةفي‬
‫ر‬‫ي‬‫ب‬
‫ةك‬‫ي‬
‫م‬‫أيس‬‫ميالحظ‬‫ل‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ة(‬
‫ل‬‫ث‬
‫ا‬‫م‬
‫دم‬‫ا‬
‫و‬‫م‬‫يف‪) .‬‬
‫ن‬
‫تص‬‫ل‬
‫ا‬‫لب‬
‫تط‬‫زت‬
‫ي‬‫ك‬‫ر‬
‫ةفيت‬
‫ي‬‫ن‬
‫ا‬‫و‬
‫ي‬‫لح‬
‫ا‬‫ات‬‫اس‬
‫ر‬‫د‬‫ل‬
‫ا‬‫ةفي‬
‫ر‬‫ي‬‫ب‬
‫ةك‬‫ي‬
‫م‬‫أيس‬‫ميالحظ‬‫ل‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫ة‪.‬‬‫ي‬
‫ف‬‫ا‬
‫ةك‬‫د‬
‫و‬‫اتج‬‫اتذ‬‫ن‬
‫ا‬
‫ي‬‫ةب‬
‫ي‬‫أ‬‫ر‬
‫ف‬‫و‬‫ت‬‫الت‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫يف‪.‬‬
‫ن‬
‫تص‬‫ل‬
‫ا‬‫لب‬
‫تط‬‫زت‬
‫ي‬‫ك‬‫ر‬
‫ةفيت‬
‫ي‬‫ن‬
‫ا‬‫و‬
‫ي‬‫لح‬
‫ا‬‫ات‬‫اس‬
‫ر‬‫د‬‫ل‬
‫ا‬‫ةفي‬
‫ر‬‫ي‬‫ب‬
‫ةك‬‫ي‬
‫م‬‫أيس‬‫ميالحظ‬‫ل‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫ر‬‫ث‬‫ي‬
‫إ‬

‫فط‬
‫لس‬‫ا‬
‫ر‬‫خط‬ ‫م ‪CAS‬‬
‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫بق‬
‫نط‬‫الت‬ ‫ني‬
‫ه‬‫دد‬
‫ي‬‫م‬
‫أ‬‫د‬‫د‬
‫ع‬‫ت‬‫ليم‬
‫ي‬‫كس‬
‫و‬‫ب‬‫ر‬
‫مضك‬ ‫ا‬
‫ح‬
‫هي‬‫ت‬
‫ن‬‫م‬
‫وي‬
‫ئ‬‫ر‬‫ل‬
‫ا‬‫اب‬
‫ه‬‫ت‬
‫ل‬‫اإل‬
‫مو‬‫د‬
‫ل‬‫ا‬
‫وبب‬
‫مصح‬
‫ل‬‫ا‬‫ال‬
‫ع‬‫لس‬
‫ا‬
‫ر‪,‬و‬
‫ي‬‫ف‬
‫لص‬‫ا‬
‫فس‪,‬‬
‫ن‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫ب‬
‫و‬‫ع‬‫ال‪ ,‬ص‬
‫ع‬‫لس‬
‫ا‬‫مل‬
‫ذىيش‬
‫ل‬‫ا‬
‫ويو‬
‫ا‬‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ة‬‫ئ‬
‫ر‬‫ل‬
‫ا‬‫اب‬
‫ه‬‫ت‬
‫ل‬‫إ‬
‫بب‬‫أنيس‬‫كن‬‫م‬‫ةي‬‫ئ‬
‫ر‬‫ل‬
‫ا‬ ‫فطفي‬‫لس‬‫ا‬ ‫يب‬‫ك‬‫ر‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬‫ب‬
‫ا‬
‫تش‬‫ام‬
‫ف‬‫ل‬
‫أ‬‫ات‬
‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬‫أ‬
‫ة‪.‬‬
‫ا‬‫ف‬
‫و‬‫ل‬‫ل‬
‫د‬‫و‬‫ق‬‫أني‬‫كن‬‫م‬‫ذىي‬‫ل‬‫ا‬
‫وي‬
‫ئ‬‫ر‬‫ل‬
‫ا‬‫اب‬
‫ه‬‫ت‬
‫ل‬‫اإل‬
‫مو‬‫د‬
‫ل‬‫ا‬
‫وبب‬
‫مصح‬
‫ل‬‫ا‬‫ال‬
‫ع‬‫لس‬
‫ا‬
‫ر‪,‬و‬
‫ي‬‫ف‬
‫لص‬‫ا‬
‫فس‪,‬‬
‫ن‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫ب‬
‫و‬‫ع‬‫ال‪ ,‬ص‬
‫ع‬‫لس‬
‫ا‬‫مل‬
‫ذىيش‬
‫ل‬‫ا‬
‫ويو‬
‫ا‬‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ة‬‫ئ‬
‫ر‬‫ل‬
‫ا‬‫اب‬
‫ه‬‫ت‬
‫ل‬‫إ‬
‫بب‬‫أنيس‬‫كن‬‫م‬‫ةي‬‫ئ‬
‫ر‬‫ل‬
‫ا‬ ‫فطفي‬‫لس‬‫‪ 27070-58-2‬ا‬ ‫ين‬
‫دس‬‫ل‬
‫ا‬‫ني‬
‫ا‬
‫م‬‫ث‬
‫ة‪.‬‬
‫ا‬‫ف‬
‫و‬‫ل‬‫ل‬
‫د‬‫و‬‫ق‬‫أني‬‫كن‬‫م‬‫ذىي‬‫ل‬‫ا‬
‫بق‬‫نط‬‫الت‬ ‫‪111-76-2‬‬ ‫ر‬
‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬
‫بق‬‫نط‬‫الت‬ ‫‪112-34-5‬‬ ‫يل‬
‫ت‬‫و‬‫ي‬
‫دىب‬‫ا‬
‫أح‬‫ول‬
‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬
‫إ‬‫ئى‬
‫ا‬‫ن‬
‫ث‬
‫ر‬‫ث‬
‫ي‬‫إ‬

‫ة‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬
‫ن‬‫و‬
‫ل‬‫ع‬‫م‬
‫‪12.‬‬
‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫ات‬
‫ي‬‫ر‬‫ا‬‫ق‬‫ف‬‫ةال‬
‫ي‬‫م‬‫س‬ ‫ة‬‫ق‬‫ي‬
‫ق‬‫د‬‫ل‬
‫ا‬ ‫ات‬‫ن‬‫ئ‬
‫ا‬‫ك‬‫ل‬
‫ةل‬ ‫ي‬
‫م‬‫س‬ ‫مك‬‫لس‬‫ةل‬‫ي‬
‫م‬‫لس‬ ‫ا‬ ‫لب‬‫ا‬
‫لطح‬‫ةل‬‫ي‬‫م‬‫لس‬ ‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫‪LL50 (48 h) >2000 mg/L‬‬ ‫‪EC50 (3h) > 100 mg/L LL50 (96 h) >1000 mg/L EL50 (72 h) =23.8 mg/L‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫د مسجل‬
‫ي‬‫م‬
‫أ‬‫د‬‫د‬
‫ع‬‫ت‬‫ليم‬
‫ي‬‫كس‬
‫و‬ ‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫)‪(Acartia tonsa‬‬ ‫)‪(Activated sludge) (Scophthalmus maximus) (Skeletonema costatum‬‬ ‫هي‬‫ت‬
‫ن‬‫نيم‬‫ه‬‫د‬
‫)‪(respiration rate‬‬ ‫‪EC50 (72 h) >100 mg/L‬‬
‫‪(Pseudokirchneriella‬‬
‫)‪subcapitata‬‬
‫‪EC50 >1000 mg/L‬‬ ‫ة‬ ‫اح‬
‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫الت‬ ‫‪LC50 > 1000 mg/L EC50 (96h) >1000 mg/L‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫يب مسجل‬‫ك‬‫ر‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬‫ب‬
‫ا‬
‫تش‬‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬
‫و‬‫أ‬
‫)‪(Mysidopsis bahia‬‬ ‫)‪(Cyprinodon variegatus) (Skeletonema costatum‬‬
‫‪LL50 > 1000 mg/L ErC50 (48h) 1000 mg/L‬‬
‫)‪(Oncorhynchus mykiss‬‬ ‫‪(Selenastrum‬‬
‫)‪(similar substance‬‬ ‫‪capricornutum) (similar‬‬
‫)‪substance‬‬
‫‪EC50 (48h) > 1000 mg/L‬‬ ‫ة‬ ‫اح‬
‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬‫ع‬
‫دم‬ ‫وج‬‫‪ EC50 (96h) > 1000 mg/L EC50 (96h) > 1000 mg/L 27070-58-2‬الت‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬
‫م‬‫ث‬

‫_____________________________________________________________________________________________‬
‫ة ‪9/7‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪LESUPERMUL‬‬
‫‪19-10-2016‬‬
‫_____________________________________________________________________________________________‬
‫)‪(similar substance‬‬ ‫)‪(similar substance‬‬ ‫)‪(similar substance‬‬
‫‪EC50 (48 h) =1800 mg/L‬‬ ‫ة‬
‫اح‬ ‫ت‬
‫اتم‬ ‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬ ‫‪LC50 (96 h) =1474 mg/L EC50 (72 h) =1840 mg/L‬الت‬ ‫ر ‪111-76-2‬‬
‫ث‬‫ي‬
‫إ‬‫يل‬
‫ت‬
‫و‬‫ي‬‫دىب‬
‫ا‬‫أح‬
‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬
‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫)‪(Daphnia magna‬‬ ‫)‪(Oncorhynchus mykiss‬‬ ‫‪(Pseudokirchneriella‬‬
‫‪EC50 (21 d) =297 mg/L‬‬ ‫‪NOAEC (21 d) >100 mg/L‬‬ ‫)‪subcapitata‬‬
‫)‪(Daphnia magna‬‬ ‫)‪(Danio rerio‬‬
‫‪EC50 > 100 mg/L‬‬ ‫‪EC10 >1995 mg/L‬‬ ‫‪LC50 1300 mg/L‬‬ ‫‪EC50 > 100 mg/L‬‬ ‫يل ‪112-34-5‬‬
‫ت‬
‫و‬‫ي‬‫دىب‬
‫ا‬‫أح‬
‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬
‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬
‫ئى‬‫ا‬
‫ن‬
‫ث‬
‫)‪(Daphnia magna‬‬ ‫‪(Activated sludge,‬‬ ‫)‪(Lepomis macrochirus‬‬ ‫‪(Desmodesmus‬‬ ‫ر‬‫ث‬‫ي‬
‫إ‬
‫)‪industrial‬‬ ‫)‪subspicatus‬‬

‫ل‬
‫ل‬‫تح‬
‫ل‬‫ا‬
‫ءو‬‫ا‬
‫ق‬‫ب‬
‫ل‬‫ا‬

‫ل‬‫ل‬
‫تح‬‫ل‬
‫ا‬
‫اتو‬‫ب‬‫ث‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬‫ل‬
‫ا‬
‫ا )‪(d28 @ 71%‬‬
‫ي‬
‫ئ‬‫ا‬
‫ق‬‫ل‬
‫للت‬
‫تح‬‫ل‬
‫ل‬‫بل‬
‫ا‬
‫ق‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫هي‬
‫ت‬‫ن‬
‫نيم‬‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫ا )‪(d28 @ 88%‬‬
‫ي‬
‫ئ‬‫ا‬
‫ق‬‫ل‬
‫للت‬
‫تح‬‫ل‬
‫ل‬‫بل‬
‫ا‬
‫ق‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬
‫أ‬
‫ا )‪(d28 @ 80.8%‬‬
‫ي‬
‫ئ‬‫ا‬
‫ق‬‫ل‬
‫للت‬
‫تح‬‫ل‬
‫ل‬‫بل‬
‫ا‬
‫ق‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫ا )‪(d28 @ 88%-75‬‬‫ي‬
‫ئ‬‫ا‬
‫ق‬‫ل‬
‫للت‬
‫تح‬‫ل‬
‫ل‬‫بل‬
‫ا‬
‫ق‬ ‫‪111-76-2‬‬ ‫ر‬‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬
‫ا )‪(d28 @ 85%‬‬
‫ي‬
‫ئ‬‫ا‬
‫ق‬‫ل‬
‫للت‬
‫تح‬‫ل‬
‫ل‬‫بل‬
‫ا‬
‫ق‬ ‫‪112-34-5‬‬ ‫ر‬‫ث‬
‫ي‬‫إ‬
‫يل‬‫ت‬‫و‬
‫ي‬‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬
‫ا‬‫ن‬
‫ث‬

‫ئي‬
‫ا‬‫ي‬
‫ألح‬
‫ا‬‫م‬‫ك‬
‫ا‬‫ر‬‫ت‬
‫ل‬‫ا‬‫لى‬
‫ةع‬‫ر‬
‫د‬‫ق‬‫ل‬
‫ا‬

‫‪Log Pow‬‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬


‫ا‬‫و‬‫م‬‫ل‬
‫ا‬
‫‪2.4‬‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫هي‬
‫ت‬‫ن‬
‫نيم‬‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫‪>6‬‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬
‫أ‬
‫‪>8‬‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫‪LogPow 0.81‬‬ ‫‪111-76-2‬‬ ‫ر‬‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬
‫‪1.0‬‬ ‫‪112-34-5‬‬ ‫ر‬‫ث‬
‫ي‬‫إ‬
‫يل‬‫ت‬‫و‬
‫ي‬‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬
‫ا‬‫ن‬
‫ث‬

‫ة‬
‫ب‬‫ر‬‫ت‬
‫ل‬‫ا‬‫ةفي‬
‫ك‬‫ر‬‫لح‬
‫ا‬

‫ل‬‫ق‬
‫ن‬‫ت‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬‫ل‬
‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫هي‬
‫ت‬‫ن‬
‫نيم‬‫ه‬‫دد‬‫ي‬
‫م‬‫أ‬‫د‬‫د‬
‫ع‬‫ت‬
‫ليم‬‫ي‬‫كس‬‫و‬‫ب‬
‫ر‬‫مضك‬ ‫ا‬‫ح‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ة‬‫ي‬
‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬ ‫مسجل‬ ‫يب‬‫ك‬
‫ر‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫ب‬‫ا‬‫تش‬
‫ام‬‫ف‬
‫ل‬‫أ‬‫ات‬‫ن‬
‫ي‬‫ف‬
‫ل‬‫و‬
‫أ‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫‪27070-58-2‬‬ ‫ين‬
‫دس‬‫ل‬‫ا‬
‫ني‬‫ا‬‫م‬
‫ث‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫‪111-76-2‬‬ ‫ر‬‫ث‬‫ي‬
‫إ‬‫يل‬‫ت‬
‫و‬‫ي‬
‫دىب‬‫ا‬‫أح‬‫ول‬‫ك‬
‫ي‬‫ل‬
‫ينج‬ ‫ل‬
‫ي‬
‫ث‬‫ي‬
‫إ‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫‪112-34-5‬‬ ‫ر‬‫ث‬
‫ي‬‫إ‬
‫يل‬‫ت‬‫و‬
‫ي‬‫دىب‬‫ا‬
‫أح‬‫ول‬‫ك‬‫ي‬‫ل‬
‫ينج‬‫ل‬
‫ي‬‫ث‬
‫ي‬‫إ‬‫ئى‬
‫ا‬‫ن‬
‫ث‬

‫رى‬‫ألخ‬
‫ا‬‫ة‬‫ي‬‫ب‬
‫ل‬‫لس‬
‫ا‬‫ر‬‫ا‬
‫ث‬‫اآل‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬ ‫و‬
‫ل‬‫ع‬‫دم‬
‫وج‬‫الت‬

‫ات‬
‫ي‬‫ا‬
‫ف‬‫ن‬
‫ل‬‫ا‬‫اصمن‬
‫تخ‬‫ل‬
‫ا‬‫ات‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إع‬‫‪13.‬‬
‫ات‬‫ي‬
‫ا‬‫ف‬‫ن‬
‫ل‬‫ا‬‫ة‬‫لج‬
‫ا‬‫ع‬
‫رقم‬ ‫ط‬
‫لص‬ ‫تخ‬‫ل‬
‫ا‬‫ةفي‬‫م‬‫د‬‫تخ‬
‫مس‬ ‫ل‬
‫ا‬‫ة‬‫ق‬‫ي‬
‫ر‬‫لط‬‫ا‬
‫ة‪.‬‬
‫ي‬‫ل‬
‫مح‬‫ل‬
‫ا‬‫ة‬
‫ر‬‫ا‬
‫د‬‫اإل‬
‫ة‪,‬و‬
‫ي‬‫وال‬
‫ل‬‫ا‬
‫ة‪,‬و‬
‫ي‬‫ل‬
‫ا‬‫ر‬
‫د‬‫ي‬‫ف‬
‫ل‬
‫ا‬‫ة‬‫م‬
‫و‬‫ك‬‫لح‬
‫ا‬‫د‬‫اع‬
‫و‬‫ق‬‫ل‬
‫ا‬
‫ً‬‫ق‬‫ب‬
‫مط‬‫ت‬‫اتي‬‫ي‬
‫ا‬‫ف‬‫ن‬
‫ل‬
‫ا‬‫لصمن‬ ‫تخ‬‫ل‬‫ا‬
‫وث‬‫ل‬‫يفم‬‫ل‬‫غ‬‫ت‬
‫ة‪.‬‬‫ي‬
‫ل‬
‫مح‬‫ل‬‫ا‬‫ةو‬‫ي‬
‫م‬‫و‬‫ق‬
‫ل‬‫ا‬‫ئح‬‫ا‬
‫و‬‫ل‬
‫ل‬‫ا‬‫ع‬‫ي‬
‫م‬‫عج‬ ‫ب‬
‫ت‬‫إ‬
‫رى‬‫أخ‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬ ‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬‫الت‬

‫ل‬
‫ق‬‫ن‬‫ل‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪14.‬‬
‫ة"‬
‫د‬‫تح‬
‫م‬‫ل‬
‫ا‬‫م‬‫م‬
‫أل‬
‫ا‬‫م ‪"UN‬‬‫ق‬
‫ر‬
‫د‬‫ي‬
‫ق‬‫رم‬
‫ي‬‫غ‬

‫يح ‪UN:‬‬
‫لصح‬
‫ا‬‫ل‬‫ق‬
‫ن‬‫ل‬
‫ا‬‫م‬‫إس‬
‫د‬‫ي‬
‫ق‬‫رم‬‫ي‬
‫غ‬

‫ل‪:‬‬
‫ق‬‫ئطن‬
‫ا‬‫ةوس‬
‫ر‬‫و‬‫ةخط‬‫ب‬‫ت‬
‫ر‬
‫بق‬
‫نط‬‫الت‬

‫ة‪:‬‬
‫ئ‬‫ب‬
‫ع‬‫ت‬
‫ل‬‫ا‬‫ة‬‫وع‬‫م‬
‫مج‬
‫بق‬‫نط‬
‫الت‬

‫_____________________________________________________________________________________________‬
‫ة ‪9/8‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪LESUPERMUL‬‬
‫‪19-10-2016‬‬
‫_____________________________________________________________________________________________‬

‫ة‪:‬‬
‫ي‬‫ئ‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫اط‬‫مخ‬‫ل‬‫ا‬
‫بق‬‫نط‬‫الت‬

‫م‪:‬‬
‫د‬‫تخ‬
‫مس‬‫ل‬
‫ةل‬‫اص‬
‫اتخ‬
‫اط‬‫ي‬
‫ت‬‫إح‬
‫ء‬
‫الشي‬

‫ة ‪IBC:‬‬
‫ن‬‫و‬‫د‬
‫ل ‪78/73‬وم‬
‫و‬‫ب‬‫ر‬
‫ا‬‫نيمن )‪(MARPOL‬م‬
‫ا‬‫ث‬
‫ل‬‫ا‬
‫فق‬‫ر‬
‫م‬‫ل‬‫ال‬
‫ق‬‫ف‬
‫ةو‬‫ر‬
‫ي‬‫ب‬
‫اتك‬
‫ي‬‫م‬‫ك‬
‫لب‬‫ق‬‫ن‬
‫ل‬‫ا‬
‫بق‬‫نط‬
‫الت‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫اتت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪15.‬‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫ت‬
‫ل‬‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬
‫ا‪.‬‬
‫ه‬‫ت‬
‫يال‬
‫د‬‫ع‬
‫ت‬‫ا )‪"(GHS‬و‬
‫ه‬‫م‬‫وس‬
‫ةو‬‫ي‬
‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫يف‬
‫ن‬
‫تص‬‫ل‬
‫ا‬
‫ً‬‫ي‬
‫م‬‫ل‬
‫ا‬‫نسقع‬
‫م‬‫ل‬
‫ا‬‫م‬‫ا‬
‫نظ‬‫ل‬
‫ا‬
‫ة"‬‫د‬
‫تح‬‫م‬
‫ل‬‫ا‬‫م‬
‫م‬‫لأل‬
‫ا‬‫ق‬
‫ف‬‫ه ‪SDS‬و‬‫ذ‬‫ده‬
‫ا‬‫د‬
‫إع‬‫م‬‫ت‬

‫رى‬
‫أخ‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪16.‬‬
‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫د‬‫ا‬‫مص‬
‫ةو‬‫ي‬
‫يس‬‫ئ‬
‫ر‬‫ل‬
‫ا‬‫ات‬
‫ي‬‫ب‬
‫د‬‫أل‬
‫ا‬‫ع‬‫اج‬
‫ر‬‫م‬
‫‪[Link]/‬‬

‫ة‬‫ع‬‫اج‬‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪19-10-2016‬‬
‫يح‬‫ق‬‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫وظ‬‫لح‬‫م‬
‫ا‪2‬‬
‫ه‬‫د‬‫ي‬
‫د‬‫متج‬
‫تيت‬‫ل‬
‫ا‬ ‫م ‪SDS‬‬‫ا‬
‫قس‬‫أ‬

‫ة‬‫ي‬
‫ل‬‫و‬
‫ؤ‬‫مس‬‫ل‬
‫ا‬‫ء‬‫إخال‬‫ان‬
‫ي‬‫ب‬
‫دال‬
‫اق‬‫يض‬
‫أ‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬‫ل‬‫ا‬‫رى‪.‬‬‫األخ‬
‫اف‬‫ر‬‫األط‬
‫عض‬ ‫ب‬
‫تج‪,‬و‬‫ن‬
‫م‬‫ل‬‫ا‬‫مل‬
‫تىتش‬‫ل‬
‫ا‬ ‫ر‬
‫د‬‫ا‬‫مص‬‫ل‬
‫ا‬‫ةمن‬‫ف‬‫ل‬
‫ت‬
‫ةمخ‬‫وع‬‫م‬
‫امنمج‬
‫ه‬‫ي‬
‫ل‬‫ولع‬‫لحص‬‫ا‬
‫م‬‫ةت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬‫أن‬‫يث‬‫ةح‬‫د‬
‫و‬‫ز‬‫م‬‫ل‬
‫ا‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬‫م‬
‫ل‬‫ا‬‫ال‬
‫م‬‫ت‬
‫ك‬‫إ‬‫و‬
‫أ‬‫ة‬‫ق‬‫د‬
‫انب‬
‫م‬‫دض‬ ‫وج‬
‫الي‬
‫م‪.‬‬‫د‬
‫تخ‬‫مس‬‫ل‬‫ا‬
‫ة‬‫ي‬‫ل‬
‫و‬ ‫ؤ‬
‫ةهيمس‬ ‫د‬‫ا‬
‫أيم‬‫ة‬
‫م‬‫ء‬‫مال‬
‫ل‬‫ئي‬‫ا‬
‫ه‬‫ن‬‫ل‬
‫ا‬‫د‬‫ي‬
‫د‬‫تح‬
‫ل‬‫ا‬‫رى‪.‬‬
‫األخ‬
‫ات‬‫لج‬
‫ا‬‫ع‬
‫م‬‫ل‬
‫ا‬‫وفي‬‫أ‬
‫رى‬‫أخ‬‫د‬
‫ا‬‫و‬
‫دم‬‫و‬‫وفيوج‬‫أ‬‫ع‬
‫متم‬ ‫د‬
‫تخ‬‫إس‬‫ا‬
‫ذ‬‫إ‬‫و‬
‫أ‬‫م‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫وف‬ ‫ر‬‫ةتحتكلظ‬‫يح‬
‫ون صح‬ ‫ك‬‫ت‬

‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫ةو‬
‫ي‬‫ا‬
‫ه‬‫ن‬

‫_____________________________________________________________________________________________‬
‫ة ‪9/9‬‬
‫فح‬‫ص‬
SAFETY DATA SHEET
Product Trade Name:
LESUPERMUL™
Revision Date: Revision Number:
19-Oct-2016 22

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE


COMPANY/UNDERTAKING
Product Identifier
Product Trade Name:
LESUPERMUL™
Synonyms
None
Chemical Family:
Blend
Internal ID Code
HM003680

Recommended use and restrictions on use


Application:
Emulsifier
Uses advised against
No information available

Manufacturer's Name and Contact Details


Manufacturer/Supplier
Halliburton Energy Services
14th Floor, CitiBank Tower, Al-Qutayat Street
Dubai, UAE
Telephone Number : +971 43036666

Additional Information

Prepared By
Chemical Stewardship
Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

Emergency Telephone Number


+1-760-476-3962
Global Incident Response Access Code: 334305
Contract Number: 14012

2. HAZARDS IDENTIFICATION
Classification

Skin Corrosion / Irritation Category 3 - H316


Skin Sensitization Category 1 - H317

Hazard Pictograms

_____________________________________________________________________________________________
Page 1 / 10
LESUPERMUL™ Revision Date:
19-Oct-2016
_____________________________________________________________________________________________

Signal Word
Warning

Hazard Statements
H316 - Causes mild skin irritation
H317 - May cause an allergic skin reaction

Precautionary Statements

Prevention
P261 - Avoid breathing dust/fume/gas/mist/vapors/spray
P272 - Contaminated work clothing should not be allowed out of the workplace
P280 - Wear protective gloves
Response
P302 + P352 - IF ON SKIN: Wash with plenty of soap and water
P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention
P362 + P364 - Take off contaminated clothing and wash before reuse
Storage
None
Disposal
P501 - Dispose of contents/container in accordance with local/regional/national/international regulations

Contains
Substances CAS Number
Carboxylic acid terminated fatty polyamide Proprietary
Isomerized alpha olefins Proprietary
Octadecene 27070-58-2
Ethylene glycol monobutyl ether 111-76-2
Diethylene glycol monobutyl ether 112-34-5

Additional Information
This mixture contains no substance considered to be persistent, bioaccumulating nor toxic (PBT).
This mixture contains no substance considered to be very persistent nor very bioaccumulating (vPvB).

3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances CAS Number PERCENT (w/w) GHS Classification
Carboxylic acid terminated fatty Proprietary 60 - 100% Skin Sens. 1 (H317)
polyamide
Isomerized alpha olefins Proprietary 10 - 30% Asp. Tox. 1 (H304)
Octadecene 27070-58-2 5 - 10 % Asp. Tox. 1 (H304)
Ethylene glycol monobutyl ether 111-76-2 1 - 5% Acute Tox. 4 (H302)
Acute Tox. 5 (H313)
Acute Tox. 4 (H332)
Skin Irrit. 2 (H315)
Eye Irrit. 2A (H319)
Flam. Liq. 4 (H227)
Diethylene glycol monobutyl ether 112-34-5 1 - 5% Acute Tox. 5 (H313)
Skin Irrit. 3 (H316)
Eye Irrit. 2A (H319)

_____________________________________________________________________________________________
Page 2 / 10
LESUPERMUL™ Revision Date:
19-Oct-2016
_____________________________________________________________________________________________
4. FIRST AID MEASURES
First-aid Measures
Inhalation
If inhaled, move victim to fresh air and seek medical attention.
Skin
In case of contact, immediately flush skin with plenty of soap and water for at least 15 minutes. Get medical attention. Remove
contaminated clothing and launder before reuse.
Eyes
In case of contact, or suspected contact, immediately flush eyes with plenty of water for at least 15 minutes and get medical
attention immediately after flushing.
Ingestion
Do NOT induce vomiting. Give nothing by mouth. Obtain immediate medical attention.

Most important symptoms and effects, both acute and delayed


May cause allergic skin reaction. Causes mild skin irritation.

Indication of any immediate medical attention and special treatment needed


Notes to Physician
Treat symptomatically.

5. FIRE FIGHTING MEASURES


Suitable Extinguishing Media
Water fog, carbon dioxide, foam, dry chemical.
Extinguishing media which must not be used for safety reasons
None known.

Specific hazards arising from the chemical


Use water spray to cool fire exposed surfaces. Decomposition in fire may produce harmful gases.

Special protective actions for fire-fighters


Full protective clothing and approved self-contained breathing apparatus required for fire fighting personnel.

6. ACCIDENTAL RELEASE MEASURES


Personal precautions, protective equipment and emergency procedures
Use appropriate protective equipment. Avoid contact with skin, eyes and clothing. Avoid breathing vapors. Ensure adequate
ventilation.

Environmental Precautions
Prevent from entering sewers, waterways, or low areas.

Methods and material for containment and cleaning up


Isolate spill and stop leak where safe. Contain spill with sand or other inert materials. Scoop up and remove.

Additional Information
See Section 8 and 13 for additional information.

7. HANDLING AND STORAGE


Precautions for safe handling
Use appropriate protective equipment. Avoid contact with eyes, skin, or clothing. Avoid breathing vapors. Ensure adequate
ventilation. Wash hands after use. Launder contaminated clothing before reuse.

Conditions for safe storage, including any incompatibilities


Store away from oxidizers. Keep container closed when not in use. Product has a shelf life of 12 months.

_____________________________________________________________________________________________
Page 3 / 10
LESUPERMUL™ Revision Date:
19-Oct-2016
_____________________________________________________________________________________________

8. EXPOSURE CONTROLS/PERSONAL PROTECTION


Control parameters
Exposure Limits
Substances CAS Number United Arab Bahrain Kuwait Gulf Cooperation
Emirates Council
Ethylene glycol monobutyl ether 111-76-2 TWA: 25 ppm TWA: 25 ppm Not applicable TWA: 25 ppm
TWA: 121 mg/m3 TWA: 121 mg/m3 TWA: 121 mg/m3

Appropriate engineering controls


Use in a well ventilated area. Local exhaust ventilation should be used in areas without good cross ventilation.

Individual protection measures, such as personal protective equipment


If engineering controls and work practices cannot prevent excessive exposures, the selection and proper use of personal protective
equipment should be determined by an industrial hygienist or other qualified professional based on the specific application of this
product.
Respiratory Protection
If engineering controls and work practices cannot keep exposure below occupational exposure limits or if exposure is unknown,
wear a NIOSH certified, European Standard EN 149, AS/NZS 1715:2009, or equivalent respirator when using this product.
Selection of and instruction on using all personal protective equipment, including respirators, should be performed by an Industrial
Hygienist or other qualified professional.
Organic vapor respirator.
In high concentrations, supplied air respirator or a self-contained breathing apparatus.
Hand Protection
Chemical-resistant protective gloves (EN 374) Suitable materials for longer, direct contact (recommended: protection index 6,
corresponding to > 480 minutes permeation time as per EN 374): Nitrile gloves. (>= 0.4 mm thickness)
This information is based on literature references and on information provided by glove manufacturers, or is derived by analogy
with similar substances. Please note that in practice the working life of chemical-resistant protective gloves may be considerably
shorter than the permeation time determined in accordance with EN 374 as a result of the many influencing factors (e.g.
temperature). If signs of wear and tear are noticed then the gloves should be replaced. Manufacturer's directions for use should be
observed because of great diversity of types.
Skin Protection
Rubber apron.
Eye Protection
Chemical goggles; also wear a face shield if splashing hazard exists.
Other Precautions
None known.

9. PHYSICAL AND CHEMICAL PROPERTIES


Physical State:
Liquid
Color
Amber
Odor:
Mild
Odor Threshold:
No information available
pH:
2.6
Specific Gravity @ 20 C (Water=1):
0.924
Freezing Point/Range (°C):
-6.6
Boiling Point/Range (C):
No information available
Flash Point/Range (°C):
> 100
Flash Point Method:
No information available
Flammability Limits in Air - Lower (%):

_____________________________________________________________________________________________
Page 4 / 10
LESUPERMUL™ Revision Date:
19-Oct-2016
_____________________________________________________________________________________________
No information available
Flammability Limits in Air - Upper (%):
No information available
Autoignition Temperature (°C):
No information available
Evaporation Rate (Butyl Acetate=1):
No information available
Vapor Pressure @ 20 C (mmHg):
No information available
Vapor Density (Air=1):
No information available
Water Solubility
Insoluble in water
Decomposition Temperature (C):
No information available
Viscosity, Dynamic @ 20 C (centipoise):
280-300
Viscosity, Kinematic @ 20 C (centistokes):
No information available
Partition Coefficient/n-Octanol/Water:
No information available
Molecular Weight (g/mole):
No information available

10. STABILITY AND REACTIVITY


Reactivity
Not expected to be reactive.

Chemical Stability
Stable

Possibility of hazardous reactions


Will Not Occur

Conditions to Avoid
None anticipated

Incompatible materials
Strong oxidizers.

Hazardous decomposition products


Oxides of nitrogen. Carbon monoxide and carbon dioxide.

Additional Guidelines
Not Applicable

11. TOXICOLOGICAL INFORMATION


Information on Toxicological Effects
Acute Toxicity
Inhalation
May cause central nervous system depression including headache, dizziness, drowsiness, incoordination, slowed reaction
time, slurred speech, giddiness and unconsciousness.
Eye Contact
May cause mild eye irritation.
Skin Contact
May cause an allergic skin reaction. Causes mild skin irritation.

_____________________________________________________________________________________________
Page 5 / 10
LESUPERMUL™ Revision Date:
19-Oct-2016
_____________________________________________________________________________________________
Ingestion
Irritation of the mouth, throat, and stomach. May cause abdominal pain, vomiting, nausea, and diarrhea. May cause headache,
dizziness, nausea, vomiting, gastrointestinal irritation and central nervous system depression.

Chronic Effects/Carcinogenicity
No data available to indicate product or components present at greater than 0.1% are chronic health hazards.

Toxicology data for the components

Substances CAS Number LD50 Oral LD50 Dermal LC50 Inhalation


Carboxylic acid Proprietary >2020 mg/kg-bw (rat) >2000 mg/kg-bw (rat) No data available
terminated fatty
polyamide
Isomerized alpha olefins Proprietary > 5050 mg/kg (Rat) > 5000 mg/kg > 2.1 mg/L
> 2020 mg/kg (Rabbit) 6.35 mg/L (Rat) 4h (similar
substance)
Octadecene 27070-58-2 > 5,050 mg/kg (Rat) > 2020 mg/kg (Rabbit) > 0.06 mg/L (Rat) (similar
substance) 4h
28 mg/L (Rat) 4h (similar
substance)
28 mg/L (Mouse) 4h (similar
substance)
40.2 mg/L (Rat) 4h (similar
substance)
Ethylene glycol 111-76-2 1414 mg/kg-bw (guinea pig) >2000 mg/kg (Rabbit) No data available
monobutyl ether
Diethylene glycol 112-34-5 3384 mg/kg (Rat) 2700 mg/kg (Rabbit) No data available
monobutyl ether 6560 mg/kg (Rat) 2764 mg/kg (Rabbit)
5660 mg/kg (Rat)
2406 mg/kg (Mouse)
2000 mg/kg (Guinea pig)

Substances CAS Number Skin corrosion/irritation


Carboxylic acid terminated Non-irritating to the skin
fatty polyamide
Isomerized alpha olefins Not irritating to skin in rabbits. (similar substances)
Octadecene 27070-58-2 Not irritating to skin in rabbits. (similar substances)
Ethylene glycol monobutyl 111-76-2 Causes moderate skin irritation. (Rabbit)
ether
Diethylene glycol monobutyl 112-34-5 Mild skin irritation (Rabbit)
ether

Substances CAS Number Serious eye damage/irritation


Carboxylic acid terminated Non-irritating to rabbit's eye
fatty polyamide
Isomerized alpha olefins Non-irritating to rabbit's eye (similar substances)
Octadecene 27070-58-2 Non-irritating to rabbit's eye (similar substances)
Ethylene glycol monobutyl 111-76-2 Causes moderate eye irritation (Rabbit)
ether
Diethylene glycol monobutyl 112-34-5 Causes moderate eye irritation (Rabbit)
ether

Substances CAS Number Skin Sensitization


Carboxylic acid terminated Skin sensitizer in guinea pig.
fatty polyamide
Isomerized alpha olefins Did not cause sensitization on laboratory animals (similar substances)
Octadecene 27070-58-2 Did not cause sensitization on laboratory animals (similar substances)
Ethylene glycol monobutyl 111-76-2 Did not cause sensitization on laboratory animals (guinea pig)
ether
Diethylene glycol monobutyl 112-34-5 Did not cause sensitization on laboratory animals (guinea pig)
ether

Substances CAS Number Respiratory Sensitization

_____________________________________________________________________________________________
Page 6 / 10
LESUPERMUL™ Revision Date:
19-Oct-2016
_____________________________________________________________________________________________
Carboxylic acid terminated No information available
fatty polyamide
Isomerized alpha olefins No information available
Octadecene 27070-58-2 No information available
Ethylene glycol monobutyl 111-76-2 No information available
ether
Diethylene glycol monobutyl 112-34-5 No information available
ether

Substances CAS Number Mutagenic Effects


Carboxylic acid terminated In vivo tests did not show mutagenic effects. In vitro tests did not show mutagenic effects.
fatty polyamide
Isomerized alpha olefins In vitro tests have shown mutagenic effects (similar substances)
Octadecene 27070-58-2 In vitro tests have shown mutagenic effects
Ethylene glycol monobutyl 111-76-2 In vivo tests did not show mutagenic effects.
ether
Diethylene glycol monobutyl 112-34-5 In vivo tests did not show mutagenic effects. In vitro tests did not show mutagenic effects.
ether

Substances CAS Number Carcinogenic Effects


Carboxylic acid terminated No information available
fatty polyamide
Isomerized alpha olefins No information available
Octadecene 27070-58-2 No information available
Ethylene glycol monobutyl 111-76-2 Not regarded as carcinogenic.
ether
Diethylene glycol monobutyl 112-34-5 No information available
ether

Substances CAS Number Reproductive toxicity


Carboxylic acid terminated Animal testing did not show any effects on fertility. Did not show teratogenic effects in animal
fatty polyamide experiments.
Isomerized alpha olefins Animal testing did not show any effects on fertility. Did not show teratogenic effects in animal
experiments. (similar substances)
Octadecene 27070-58-2 Animal testing did not show any effects on fertility. Did not show teratogenic effects in animal
experiments. (similar substances)
Ethylene glycol monobutyl 111-76-2 Animal testing did not show any effects on fertility. Did not show teratogenic effects in animal
ether experiments.
Diethylene glycol monobutyl 112-34-5 Animal testing did not show any effects on fertility. Did not show teratogenic effects in animal
ether experiments.

Substances CAS Number STOT - single exposure


Carboxylic acid terminated No information available
fatty polyamide
Isomerized alpha olefins No information available
Octadecene 27070-58-2 No information available
Ethylene glycol monobutyl 111-76-2 No data of sufficient quality are available.
ether
Diethylene glycol monobutyl 112-34-5 No significant toxicity observed in animal studies at concentration requiring classification.
ether

Substances CAS Number STOT - repeated exposure


Carboxylic acid terminated No data of sufficient quality are available.
fatty polyamide
Isomerized alpha olefins No significant toxicity observed in animal studies at concentration requiring classification. (similar
substances)
Octadecene 27070-58-2 No significant toxicity observed in animal studies at concentration requiring classification. (similar
substances)
Ethylene glycol monobutyl 111-76-2 No data of sufficient quality are available.
ether
Diethylene glycol monobutyl 112-34-5 No significant toxicity observed in animal studies at concentration requiring classification.
ether

Substances CAS Number Aspiration hazard


Carboxylic acid terminated Not applicable
fatty polyamide

_____________________________________________________________________________________________
Page 7 / 10
LESUPERMUL™ Revision Date:
19-Oct-2016
_____________________________________________________________________________________________
Isomerized alpha olefins Aspiration into the lungs may cause chemical pneumonitis including coughing, difficulty breathing,
wheezing, coughing up blood and pneumonia, which can be fatal.
Octadecene 27070-58-2 Aspiration into the lungs may cause chemical pneumonitis including coughing, difficulty breathing,
wheezing, coughing up blood and pneumonia, which can be fatal.
Ethylene glycol monobutyl 111-76-2 Not applicable
ether
Diethylene glycol monobutyl 112-34-5 Not applicable
ether

12. ECOLOGICAL INFORMATION


Toxicity
Substances CAS Number Toxicity to Algae Toxicity to Fish Toxicity to Toxicity to Invertebrates
Microorganisms
Carboxylic acid Proprietary EL50 (72 h) =23.8 mg/L LL50 (96 h) >1000 mg/L EC50 (3h) > 100 mg/L LL50 (48 h) >2000 mg/L
terminated fatty (Skeletonema costatum) (Scophthalmus maximus) (Activated sludge) (Acartia tonsa)
polyamide EC50 (72 h) >100 mg/L (respiration rate)
(Pseudokirchneriella
subcapitata)
Isomerized alpha olefins Proprietary EC50 (96h) >1000 mg/L LC50 > 1000 mg/L No information available EC50 >1000 mg/L
(Skeletonema costatum) (Cyprinodon variegatus) (Mysidopsis bahia)
ErC50 (48h) 1000 mg/L LL50 > 1000 mg/L
(Selenastrum (Oncorhynchus mykiss)
capricornutum) (similar (similar substance)
substance)
Octadecene 27070-58-2 EC50 (96h) > 1000 mg/L EC50 (96h) > 1000 mg/L No information available EC50 (48h) > 1000 mg/L
(similar substance) (similar substance) (similar substance)
Ethylene glycol 111-76-2 EC50 (72 h) =1840 mg/L LC50 (96 h) =1474 mg/L No information available EC50 (48 h) =1800 mg/L
monobutyl ether (Pseudokirchneriella (Oncorhynchus mykiss) (Daphnia magna)
subcapitata) NOAEC (21 d) >100 mg/L EC50 (21 d) =297 mg/L
(Danio rerio) (Daphnia magna)
Diethylene glycol 112-34-5 EC50 > 100 mg/L LC50 1300 mg/L EC10 >1995 mg/L EC50 > 100 mg/L
monobutyl ether (Desmodesmus (Lepomis macrochirus) (Activated sludge, (Daphnia magna)
subspicatus) industrial)

Persistence and degradability

Substances CAS Number Persistence and Degradability


Carboxylic acid terminated fatty polyamide Proprietary Readily biodegradable (71% @ 28d)
Isomerized alpha olefins Proprietary Readily biodegradable (88% @ 28d)
Octadecene 27070-58-2 Readily biodegradable (80.8% @ 28d)
Ethylene glycol monobutyl ether 111-76-2 Readily biodegradable (75-88% @ 28d)
Diethylene glycol monobutyl ether 112-34-5 Readily biodegradable (85% @ 28d)

Bioaccumlation potential

Substances CAS Number Log Pow


Carboxylic acid terminated fatty polyamide Proprietary 2.4
Isomerized alpha olefins Proprietary >6
Octadecene 27070-58-2 >8
Ethylene glycol monobutyl ether 111-76-2 LogPow 0.81
Diethylene glycol monobutyl ether 112-34-5 1.0

Mobility in soil

Substances CAS Number Mobility


Carboxylic acid terminated fatty polyamide Proprietary No information available
Isomerized alpha olefins Proprietary No information available
Octadecene 27070-58-2 No information available
Ethylene glycol monobutyl ether 111-76-2 No information available
Diethylene glycol monobutyl ether 112-34-5 No information available

Other adverse effects

_____________________________________________________________________________________________
Page 8 / 10
LESUPERMUL™ Revision Date:
19-Oct-2016
_____________________________________________________________________________________________
No information available

13. DISPOSAL CONSIDERATIONS


Waste treatment methods
Disposal methods
Disposal should be made in accordance with federal, state, and local regulations.
Contaminated Packaging
Follow all applicable national or local regulations.
Other Information
No information available

14. TRANSPORT INFORMATION


UN Number
Not restricted

UN proper shipping name:


Not restricted

Transport Hazard Class(es):


Not applicable

Packing Group:
Not applicable

Environmental Hazards:
Not applicable

Special Precautions for User


None

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
Not applicable

15. REGULATORY INFORMATION

Regulatory Information
This SDS was prepared in accordance with United Nations "Globally Harmonized System of Classification and Labelling of
Chemicals (GHS)" and its revisions.

16. OTHER INFORMATION


Key literature references and sources for data
[Link]/

Revision Date:
19-Oct-2016
Revision Note
SDS sections updated: 2

Disclaimer Statement
This information is furnished without warranty, expressed or implied, as to accuracy or completeness. The information is obtained
from various sources including the manufacturer and other third party sources. The information may not be valid under all
conditions nor if this material is used in combination with other materials or in any process. Final determination of suitability of any
material is the sole responsibility of the user.

_____________________________________________________________________________________________
Page 9 / 10
LESUPERMUL™ Revision Date:
19-Oct-2016
_____________________________________________________________________________________________
End of Safety Data Sheet

_____________________________________________________________________________________________
Page 10 / 10
SAFETY DATA SHEET
Product Trade Name:
Micromax
Revision Date: Revision Number:
08-Jan-2019 2

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE


COMPANY/UNDERTAKING
Product Identifier
Product Trade Name:
Micromax
Synonyms
None
Chemical Family
Mineral
Internal ID Code
HM520146

Recommended use and restrictions on use


Application
Weight Additive
Uses advised against
No information available

Manufacturer's Name and Contact Details


Manufacturer/Supplier
Halliburton Energy Services
14th Floor, CitiBank Tower, Al-Qutayat Street
Dubai, UAE
Telephone Number : +971 43036666

Additional Information

Prepared By
Chemical Stewardship
Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

Emergency Telephone Number


1-760-476-3959
Global Incident Response Access Code: 334305
Contract Number: 14012

2. HAZARDS IDENTIFICATION
Classification

Specific Target Organ Toxicity - (Repeated Exposure) Category 2 - H373

Hazard Pictograms

_____________________________________________________________________________________________
Page 1 / 7
Micromax Revision Date:
08-Jan-2019
_____________________________________________________________________________________________

Signal Word
Warning

Hazard Statements
H373 - May cause damage to organs through prolonged or repeated exposure

Precautionary Statements

Prevention
P260 - Do not breathe dust/fume/gas/mist/vapors/spray
Response
P314 - Get medical attention/advice if you feel unwell
Storage
None
Disposal
P501 - Dispose of contents/container in accordance with local/regional/national/international regulations

Contains
Substances CAS Number
Manganese tetraoxide 1317-35-7

Additional Information
This substance is not considered to be persistent, bioaccumulating nor toxic (PBT).
This substance is not considered to be very persistent nor very bioaccumulating (vPvB).

3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances CAS Number PERCENT (w/w) GHS Classification
Manganese tetraoxide 1317-35-7 60 - 100% STOT RE 2 (H373)

4. FIRST AID MEASURES


First-aid Measures
Inhalation
If inhaled, remove from area to fresh air. Get medical attention if respiratory irritation develops or if breathing becomes difficult.
Skin
Wash with soap and water. Get medical attention if irritation persists.
Eyes
In case of contact, immediately flush eyes with plenty of water for at least 15 minutes and get medical attention if irritation persists.
Ingestion
Do NOT induce vomiting. Give nothing by mouth. Obtain immediate medical attention.

Most important symptoms and effects, both acute and delayed


May cause damage to organs through prolonged or repeated exposure.

Indication of any immediate medical attention and special treatment needed


Notes to Physician
Treat symptomatically.

5. FIRE FIGHTING MEASURES

_____________________________________________________________________________________________
Page 2 / 7
Micromax Revision Date:
08-Jan-2019
_____________________________________________________________________________________________

Suitable Extinguishing Media


All standard fire fighting media
Extinguishing media which must not be used for safety reasons
None known.

Specific hazards arising from the chemical


Not determined

Special protective actions for fire-fighters


Full protective clothing and approved self-contained breathing apparatus required for fire fighting personnel.

6. ACCIDENTAL RELEASE MEASURES


Personal precautions, protective equipment and emergency procedures
Use appropriate protective equipment. Avoid creating and breathing dust. Ensure adequate ventilation. Avoid contact with skin,
eyes and clothing.

Environmental Precautions
Prevent from entering sewers, waterways, or low areas.

Methods and material for containment and cleaning up


Scoop up and remove.

Additional Information
See Section 8 and 13 for additional information.

7. HANDLING AND STORAGE


Precautions for safe handling
Avoid contact with eyes, skin, or clothing. Avoid creating or inhaling dust. Ensure adequate ventilation. Wash hands after use.
Launder contaminated clothing before reuse. Use appropriate protective equipment.

Conditions for safe storage, including any incompatibilities


Store in a cool, dry location. Product has a shelf life of 24 months.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION


Control parameters
Exposure Limits
Substances CAS Number United Arab Bahrain Kuwait Gulf Cooperation
Emirates Council
Manganese tetraoxide 1317-35-7 Not applicable Not applicable Not applicable TWA: 0.2 mg/m3

Appropriate engineering controls


Use in a well ventilated area. Localized ventilation should be used to control dust levels.

Individual protection measures, such as personal protective equipment


If engineering controls and work practices cannot prevent excessive exposures, the selection and proper use of personal protective
equipment should be determined by an industrial hygienist or other qualified professional based on the specific application of this
product.
Respiratory Protection
If engineering controls and work practices cannot keep exposure below occupational exposure limits or if exposure is unknown,
wear a NIOSH certified, European Standard EN 149, AS/NZS 1715:2009, or equivalent respirator when using this product.
Selection of and instruction on using all personal protective equipment, including respirators, should be performed by an Industrial
Hygienist or other qualified professional.
Dust/mist respirator. (N95, P2/P3)
Hand Protection

_____________________________________________________________________________________________
Page 3 / 7
Micromax Revision Date:
08-Jan-2019
_____________________________________________________________________________________________
Normal work gloves.
Skin Protection
Normal work coveralls.
Eye Protection
Safety glasses.
Other Precautions
None known.

9. PHYSICAL AND CHEMICAL PROPERTIES


Physical State:
Solid
Color
Red brown
Odor:
Odorless
Odor Threshold:
No information available
pH:
7-10
Specific Gravity
4.8
Freezing Point/Range (°C):
1550 - 1650
Pour Point/Range (C):
No information available
Boiling Point/Range (C):
No information available
Flash Point/Range (°C):
No information available
Flash Point Method:
Not determined
Flammability Limits in Air - Lower (%):
No information available
Flammability Limits in Air - Upper (%):
No information available
Autoignition Temperature (°C):
No information available
Evaporation Rate (Butyl Acetate=1):
No information available
Vapor Pressure @ 20 C (mmHg):
No information available
Vapor Density (Air=1):
No information available
Water Solubility
Insoluble in water
Decomposition Temperature (C):
No information available
Viscosity, Dynamic @ 20 C (centipoise):
No information available
Viscosity, Kinematic @ 20 C (centistokes):
No information available
Partition Coefficient/n-Octanol/Water:
No information available
Molecular Weight (g/mole):
No information available

10. STABILITY AND REACTIVITY


Reactivity

_____________________________________________________________________________________________
Page 4 / 7
Micromax Revision Date:
08-Jan-2019
_____________________________________________________________________________________________
Not expected to be reactive.

Chemical Stability
Stable

Possibility of hazardous reactions


Will Not Occur

Conditions to Avoid
Avoid contact with hydrochloric acid. Can react to release chlorine gas.

Incompatible materials
None known.

Hazardous decomposition products


None known.

Additional Guidelines
Not Applicable

11. TOXICOLOGICAL INFORMATION


Information on Toxicological Effects
Acute Toxicity
Inhalation
May cause respiratory irritation.
Eye Contact
May cause mechanical irritation to eye.
Skin Contact
None known.
Ingestion
May cause abdominal pain, vomiting, nausea, and diarrhea. May cause hypoglycemia.

Chronic Effects/Carcinogenicity
Prolonged or repeated exposure may cause central nervous system and brain effects. Prolonged or repeated exposure may result
in manganism. Symptoms are similar to Parkinson's disease.

Toxicology data for the components

Substances CAS Number LD50 Oral LD50 Dermal LC50 Inhalation


Manganese tetraoxide 1317-35-7 > 2000 mg/kg (Rat) No data available >5.17 mg/L (rat, 4 h, dust)

Substances CAS Number Skin corrosion/irritation


Manganese tetraoxide 1317-35-7 Non-irritating to the skin (Rabbit)

Substances CAS Number Serious eye damage/irritation


Manganese tetraoxide 1317-35-7 Non-irritating to the eye (Rabbit)

Substances CAS Number Skin Sensitization


Manganese tetraoxide 1317-35-7 No information available

Substances CAS Number Respiratory Sensitization


Manganese tetraoxide 1317-35-7 No information available

Substances CAS Number Mutagenic Effects


Manganese tetraoxide 1317-35-7 In vitro tests did not show mutagenic effects. In vivo tests did not show mutagenic effects. (similar
substances)

_____________________________________________________________________________________________
Page 5 / 7
Micromax Revision Date:
08-Jan-2019
_____________________________________________________________________________________________
Substances CAS Number Carcinogenic Effects
Manganese tetraoxide 1317-35-7 Not regarded as carcinogenic.

Substances CAS Number Reproductive toxicity


Manganese tetraoxide 1317-35-7 No data of sufficient quality are available.

Substances CAS Number STOT - single exposure


Manganese tetraoxide 1317-35-7 No significant toxicity observed in animal studies at concentration requiring classification.

Substances CAS Number STOT - repeated exposure


Manganese tetraoxide 1317-35-7 Causes damage to organs through prolonged or repeated exposure if inhaled: Central Nervous
System (CNS)

Substances CAS Number Aspiration hazard


Manganese tetraoxide 1317-35-7 No information available

12. ECOLOGICAL INFORMATION


Toxicity
Substances CAS Number Toxicity to Algae Toxicity to Fish Toxicity to Toxicity to Invertebrates
Microorganisms
Manganese tetraoxide 1317-35-7 EC50 (72h) > 100% LC50 (96h) > 100% EC50 (3 h)>1000 mg/L EC50 (48 h)>0.022 mg/L
saturated solution saturated (activated sludge of a (Daphnia magna)
(Desmodesmus solution(orhynchus predominantly domestic NOAEC (21 d)>100 mg/L
subspicatus) mykiss) sewage) (Daphnia magna)

Persistence and degradability

Substances CAS Number Persistence and Degradability


Manganese tetraoxide 1317-35-7 The methods for determining biodegradability are
not applicable to inorganic substances.

Bioaccumlation potential

Substances CAS Number Bioaccumulation


Manganese tetraoxide 1317-35-7 No information available

Mobility in soil

Substances CAS Number Mobility


Manganese tetraoxide 1317-35-7 No information available

Other adverse effects


No information available

13. DISPOSAL CONSIDERATIONS


Waste treatment methods
Disposal methods
Bury in a licensed landfill according to federal, state, and local regulations.
Contaminated Packaging
Follow all applicable national or local regulations.
Other Information
No information available

14. TRANSPORT INFORMATION


UN Number
Not restricted

_____________________________________________________________________________________________
Page 6 / 7
Micromax Revision Date:
08-Jan-2019
_____________________________________________________________________________________________

UN proper shipping name:


Not restricted

Transport Hazard Class(es):


Not applicable

Packing Group:
Not applicable

Environmental Hazards:
Not applicable

Special Precautions for User


None

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
Not applicable

15. REGULATORY INFORMATION

Regulatory Information
This SDS was prepared in accordance with United Nations "Globally Harmonized System of Classification and Labelling of
Chemicals (GHS)" and its revisions.

16. OTHER INFORMATION


Key literature references and sources for data
[Link]/

Revision Date:
08-Jan-2019
Revision Note
SDS sections updated:
2

Disclaimer Statement
This information is furnished without warranty, expressed or implied, as to accuracy or completeness. The information is obtained
from various sources including the manufacturer and other third party sources. The information may not be valid under all
conditions nor if this material is used in combination with other materials or in any process. Final determination of suitability of any
material is the sole responsibility of the user.

End of Safety Data Sheet

_____________________________________________________________________________________________
Page 7 / 7
RHEMODL™
Manufacturer/Supplier
Expiration Date:
Energy Services
14th Floor, CitiBank Tower, Al-
Qutayat Street
Dubai, UAE
Telephone Number : +971 43036666
Emergency Telephone Number
1-760-476-3959 Revision Date: 14-02-2017
Global Incident Response Access
‫�ﺔ‬
‫�و�ﺟ‬
‫�ز‬
‫�ﻟ‬

‫�د‬
‫�ﯾ‬
‫�ز‬
‫�ﻣ‬

:�
‫�ﯾ�ﻖ‬
‫�ﺑ‬
‫�ﺗ�ط‬
‫�ﻟ‬
‫�ا‬ �
:�
‫�ﺗ�ﺞ‬
‫�ﻧ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

‫�ة‬
‫�ر‬
‫�ﻔ‬
‫� �ﺷ‬
‫�و‬
‫�أ‬

‫�ز‬
‫�ﻣ‬
‫�ر‬Code: 334305
AR: Arabic & EN: English
Application Viscosifier Hazardous Material Number: HM004610 Contract Number: 14012

Contains ‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�و�ي‬
‫�ﺗ‬
‫�ﯾ�ﺣ‬
Signal Word Warning ‫�ر‬
‫�ﯾ‬
‫�ذ‬
‫�ﺗ�ﺣ‬

‫�ﮫ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻧ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�ﻣ‬
‫�ﻠ‬
‫�ﻛ‬
Chemical Name CAS Number Hazard Pictograms ‫�ر‬
‫�ﻠ�ﺧ�ط‬
‫�ﻟ‬

‫�ﺔ‬
‫�ﯾ‬
‫�ﯾ�ﺣ‬
‫�و�ﺿ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ر‬
‫�و‬
‫�ﻟ�ﺻ‬
‫�ا‬
Hazard Statements : Response �
Proprietary Component -
‫�ﺔ‬
‫�ﺑ‬
‫�ﺎ‬
‫�ﺗ�ﺟ‬
‫�ﻻ�ﺳ‬
‫�ا‬ :�
‫�ر‬
‫�ﺎ‬
‫�ﻷ�ﺧ�ط‬
‫�ا‬

‫�ﺎ�ت‬
‫�ﻧ‬
‫�ﺎ‬
‫�ﯾ‬
‫�ﺑ‬
H316 - Causes mild skin irritation P332 + P313 - If skin irritation

‫�ﯾ�ﺞ‬
‫�ﮭ‬
‫�ﺗ‬

‫�و�ث‬‫�د‬
‫� �ﺣ‬
‫�ﺔ‬
‫�ﻟ‬
‫�ﺎ‬
‫� �ﺣ‬
‫�ﻓ�ﻲ‬


P332 + P313 � .�
‫�د‬
‫�ﻠ‬
‫�ﻠ�ﺟ‬
‫�ﻟ‬

‫�ﯾ�ط‬
‫�ﺑ�ﺳ‬

‫�ﯾ�ﺞ‬
‫�ﮭ‬
‫�ﺗ‬

‫�ﺑ�ب‬
‫�ﯾ�ﺳ‬


H316 �
Prevention occurs: Get medical
advice/attention
‫�ﺔ‬
‫�ﯾ‬
‫�ﺎ‬
‫�ﻧ‬
‫� �ﻋ‬
/�

‫�ﺔ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻟ�ط‬
‫�ا‬

‫�ة‬
‫�و�ر‬‫�ﻣ�ﺷ‬‫�ﻟ‬
‫�ا‬

‫�ﻠ�ﻰ‬
‫� �ﻋ‬
‫�إ�ﺣ�ﺻ�ل‬

:�
‫�د‬
‫�ﻠ‬
‫�ﻟ�ﺟ‬
‫�ا‬ ‫�ﻊ‬
‫�ﻧ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

None
Storage ‫�ﯾ�ن‬
‫�ز‬
‫�ﺗ�ﺧ‬
� ‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬
None �
‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬
Disposal ‫�ﺎ‬
‫�ﮭ‬
‫�ﻧ‬
‫�ﻣ‬

‫�ﻠ�ص‬
‫�ﺗ�ﺧ‬
‫�ﻟ‬
‫�ا‬

None ‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬

Chemical Name CAS Number



Unsaturated fatty acids �
-

‫�ة‬
‫�د‬
‫�ﺎ‬
‫�ﻣ‬
‫�ﻟ‬
‫�ا‬

‫�م‬‫�ر‬SAP Part Number(s):
‫�ﻗ‬

:�
‫�و�ط‬
‫�ﻠ‬
‫�ﻟ‬
‫�ا‬

‫�م‬‫�ر‬Lot Number:
‫�ﻗ‬


/�

‫�ﻓ�ﻲ‬
‫�ﺎ‬
‫�ﻟ�ﺻ‬
‫�ا‬

‫�ز�ن‬
‫�و‬‫�ا‬Net/Gross Package Weight:
‫�ﻟ‬

UN proper shipping name: Not �




‫�د‬
‫�ﯾ‬
‫�ﻘ‬
‫�ﻣ‬

‫�ر‬‫�ﯾ‬
‫� �ﻏ‬
:�
UN � ‫�ﯾ�ﺢ‬
‫�ﻟ�ﺻ�ﺣ‬
‫�ا‬

‫�ﻘ�ل‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�م‬
‫�إ�ﺳ‬ Transport Classification: �
‫�د‬
‫�ﺎ‬
‫�ﺗ�ﺣ‬
‫�ا‬

/�

(�
IATA)�

‫�ﺔ‬
‫�ﯾ‬
‫�ﻟ‬
‫�و‬
‫�د‬‫�ﻟ‬
‫�ا‬

‫�ﻧ�ﻲ‬
‫�د‬
‫�ﻣ‬‫�ﻟ‬
‫�ا‬

‫�ا�ن‬
‫�ر‬
‫�ﯾ‬
‫�ﻟ�ط‬
‫�ا‬

‫�ﺔ‬
‫�ﻣ‬
‫�ﻧ�ظ‬
‫�ﻣ‬
‫�و‬ �
(�
ADR)�

‫�ر�ق‬
‫�ﻟ�ط‬
:�
(�
‫�ا‬

‫�ﻠ�ﻰ‬
IMO)�
‫� �ﻋ‬

‫�ة‬
‫�ر‬
‫�ﺔ‬
‫�ﻟ�ﺧ�ط‬
‫�ﯾ‬
‫�ﻟ‬
‫�و‬
‫�د‬
‫�ﻟ‬
‫�ا‬
‫�ا‬


‫�ﻊ‬
‫�ﺔ‬
‫�ﺋ‬
‫�ﯾ‬
‫�ﺎ‬
‫�ﺑ�ﺿ‬
‫�ر‬
‫�ﻠ‬
‫�ﺑ�ﺣ‬
‫�ﻟ‬
‫�ﻟ‬
‫�ا‬


‫�ﻟ�ﻲ‬
‫�ﺔ‬
‫�ﻣ‬
‫�و‬‫�د‬
‫�ﻟ‬
‫�ا‬
‫�ﻧ�ظ‬
‫�ﻣ‬

‫�ﻟ‬
‫�ل‬
‫�ا‬
‫�ﻘ‬
‫�و‬
‫�ﻧ‬

‫�ﻟ‬
‫�ا‬
،�

(�
‫�ﺔ‬
‫�ﯾ‬
‫�ﻗ‬
‫�ﺎ‬
‫�ﻔ‬
‫�ﺗ‬
ICAO)�
‫�ﻻ‬

‫�ﺎ‬

‫�ﻘ‬
ً�
‫�ﻓ‬
‫�و‬
‫�ﻟ�ﻲ‬

‫�و‬
‫�ل‬
‫�د‬
‫�ﻘ‬
‫�ﻟ‬
‫�ﻧ‬
‫�ا‬

‫�ﻟ‬
‫�ا‬

‫�ﯾ�ف‬
‫�و�ي‬
‫�ﻧ‬
‫�ﺗ�ﺻ‬
‫�ﻟ�ﺟ‬
‫�ا‬

‫�ل‬
‫�ﻘ‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬
restricted Transport Hazard



‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﻘ�ل‬
‫�ﻧ‬

‫�ﺋ�ط‬
‫�ﺎ‬
‫�و�ﺳ‬

‫�ة‬
‫�ر‬‫�و‬
‫� �ﺧ�ط‬
‫�ﺔ‬‫�ﺑ‬
‫�ﺗ‬
‫�ر‬
Class(es): Not applicable Packing

‫�ر‬‫�ﺎ�ط‬
‫�ﻣ�ﺧ‬
‫�ﻟ‬
‫�ا‬

‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﺔ‬
‫�ﺋ‬
‫�ﺑ‬
‫�ﻌ‬
‫�ﺗ‬
‫�ﻟ‬
‫�ا‬

‫�ﺔ‬
‫�و�ﻋ‬‫�ﻣ‬
‫�ﻣ�ﺟ‬

Not restricted
Group: Not applicable
Environmental Hazards: Not �
‫�ﺔ‬‫�ﺎ�ﺻ‬
‫� �ﺧ‬
‫�ﺎ�ت‬‫�ﺎ�ط‬
‫�ﯾ‬
‫�ﺗ‬
‫�إ�ﺣ‬

‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬

‫� �ﻻ‬
:�
‫�ﺔ‬
‫�ﯾ‬
‫�ﺋ‬
‫�ﯾ‬
‫�ﺑ‬
‫�ﻟ‬
‫�ا‬
applicable Special Precautions for �
‫�ة‬
‫�ر‬‫�ﯾ‬
‫�ﺑ‬
‫�ﻛ‬

‫�ﺎ�ت‬‫�ﯾ‬
‫�ﻣ‬
‫�ﻛ‬
‫�ﺑ‬

‫�ﻘ�ل‬
‫�ﻧ‬
‫�ﻟ‬
‫�ا‬

‫�ء‬
‫� �ﺷ�ﻲ‬
‫� �ﻻ‬
:�
‫�م‬
‫�د‬‫�ﺗ�ﺧ‬
‫�ﻣ�ﺳ‬
‫�ﻠ‬
‫�ﻟ‬
User None Transport in bulk �
(�
MARPOL )� �
‫�ﻣ�ن‬

‫�ﻧ�ﻲ‬
‫�ﺎ‬
‫�ﺛ‬
‫�ﻟ‬
‫�ا‬

‫�ﻓ�ﻖ‬
‫�ر‬‫�ﻣ‬‫�ﻠ‬
‫�ﻟ‬

‫�ﺎ‬
‫�ﻘ‬
‫�ﻓ‬
‫�و‬
according to Annex II of MARPOL
73/78 and the IBC Code Not

‫� �ﻻ‬
:�
IBC � ‫�ﺔ‬
‫�ﻧ‬
‫�و‬
‫�د‬‫�ﻣ‬

‫�و‬ �
7�3�/�
7�8� �
‫�و�ل‬‫�ﺑ‬
‫�ر‬
‫�ﺎ‬
‫�ﻣ‬
applicable ‫�ﺑ�ﻖ‬
‫�ﻧ�ط‬
‫�ﺗ‬
‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫و‬
‫تج‪:‬‬
‫ن‬‫م‬
‫ل‬‫ريل‬
‫ا‬‫تج‬
‫ل‬‫ا‬‫م‬
‫إلس‬
‫ا‬
‫™‪RHEMODL‬‬
‫ة‪:‬‬
‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫م‬‫ق‬‫ر‬ ‫ة‬‫ع‬‫اج‬‫ر‬‫م‬
‫ل‬‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪30‬‬ ‫‪14-02-2017‬‬

‫وع‬
‫ر‬‫مش‬
‫ل‬‫ا‬‫ة‬
‫ك‬‫ر‬‫لش‬
‫ا‬‫رو‬
‫ي‬‫ةتحض‬
‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫يف‬
‫ر‬‫ع‬‫ت‬
‫‪1.‬‬
‫تج‬‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬‫ي‬
‫و‬‫ه‬
‫تج‪:‬‬‫ن‬
‫م‬‫ل‬
‫ريل‬ ‫ا‬
‫تج‬‫ل‬‫ا‬‫م‬
‫إلس‬‫ا‬
‫™‪RHEMODL‬‬
‫ات‪:‬‬‫ف‬
‫د‬‫ا‬
‫ر‬‫م‬
‫يئ‬
‫الش‬
‫ة‬‫ي‬‫ئ‬
‫ا‬‫م‬‫ي‬
‫ةك‬ ‫ل‬
‫ئ‬‫ا‬
‫ع‬
‫نج‬
‫ت‬
‫ا‬‫ر‬‫ل‬‫ا‬‫يت‬‫ز‬‫ل‬
‫ة‬‫ي‬‫ن‬‫ه‬
‫وضد‬ ‫م‬‫ح‬
‫لي‬‫اخ‬
‫د‬‫ل‬
‫ا‬‫رف‬ ‫ع‬‫م‬‫ل‬‫ا‬
‫ز‬‫م‬‫ر‬
‫‪HM004610‬‬

‫ه‬
‫ي‬‫ل‬
‫ةع‬‫وض‬
‫ر‬‫ف‬‫م‬
‫ل‬‫ا‬‫د‬
‫و‬‫ي‬‫ق‬
‫ل‬‫ا‬
‫هو‬‫وصىب‬‫م‬‫ل‬‫ا‬‫م‬‫ا‬
‫د‬‫تخ‬
‫الس‬‫ا‬
‫يق‪:‬‬‫ب‬
‫تط‬‫ل‬‫ا‬
‫ة‬‫وج‬‫ز‬‫ل‬‫د‬‫ي‬
‫ز‬‫م‬
‫‪Uses advised against‬‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬‫الت‬

‫ل‬ ‫ا‬‫تص‬‫إل‬
‫ا‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬‫ةو‬ ‫ع‬‫ن‬
‫مص‬ ‫ل‬
‫ا‬ ‫ة‬‫ك‬
‫ر‬‫لش‬ ‫ا‬
‫زع‬ ‫و‬‫تجم‬‫ن‬
‫م‬
‫‪Halliburton Energy Services‬‬
‫‪14th Floor, CitiBank Tower‬‬
‫‪Al-Qutayat Street‬‬
‫‪Dubai, UAE‬‬

‫‪Telephone Number : +971 43036666‬‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬

‫ة‬‫اسط‬
‫و‬‫رب‬‫حض‬
‫‪Chemical Stewardship‬‬
‫‪Telephone: 1-281-871-6107‬‬
‫‪e-mail: fdunexchem@[Link]‬‬

‫رئ‬‫ا‬‫و‬
‫لط‬‫ا‬‫تف‬‫ا‬
‫مه‬‫ق‬‫ر‬
‫‪1-760-476-3959‬‬
‫د‪14012 :‬‬‫ق‬
‫ع‬‫ل‬
‫ا‬‫م‬‫ق‬
‫ر‬
‫دث‪334305 :‬‬
‫ا‬‫و‬
‫لح‬‫ل‬
‫ة‬‫ي‬‫م‬
‫ل‬‫ا‬
‫ع‬‫ل‬
‫ا‬‫ة‬‫ب‬
‫ا‬
‫تج‬‫لالس‬‫ول‬
‫وص‬ ‫ل‬
‫ا‬‫ز‬‫م‬‫ر‬

‫ر‬
‫ا‬‫ألخط‬
‫ا‬‫ان‬
‫ي‬‫ب‬
‫‪2.‬‬
‫يف‬
‫ن‬‫تص‬
‫ل‬‫ا‬

‫ة‬‫ف‬
‫ن‬‫ُص‬
‫رم‬‫ي‬
‫غ‬
‫ة ‪H316 - 3‬‬
‫ئ‬‫ف‬ ‫يج‬
‫ه‬‫د ‪/‬ت‬
‫ل‬‫لج‬
‫ا‬‫وق‬
‫ر‬‫ح‬

‫ر‬
‫لخط‬
‫ةل‬‫ي‬
‫يح‬‫وض‬
‫ت‬‫ل‬
‫ا‬‫ر‬‫و‬
‫لص‬‫ا‬

‫ه‬
‫ي‬‫ب‬
‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫م‬‫ل‬‫ك‬
‫ر‬‫ي‬
‫ذ‬‫تح‬

‫_____________________________________________________________________________________________‬
‫ة ‪6/1‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪RHEMODL‬‬
‫‪14-02-2017‬‬
‫_____________________________________________________________________________________________‬
‫ر‬‫ا‬‫ألخط‬
‫ا‬‫ات‬
‫ن‬‫ا‬‫ي‬
‫ب‬
‫د‪.‬‬
‫ل‬‫لج‬
‫ل‬‫يط‬
‫يجبس‬‫ه‬
‫ببت‬‫يس‬‫‪H316‬‬

‫ة‬
‫ي‬‫ر‬‫ي‬
‫ذ‬‫تح‬
‫ل‬‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬

‫ع‬‫ن‬‫م‬‫ل‬
‫ا‬
‫ء‬
‫الشي‬
‫ة‬‫ب‬‫ا‬
‫تج‬‫الس‬
‫ا‬
‫ة‬
‫ي‬‫ا‬
‫ن‬‫ة ‪/‬ع‬
‫ي‬‫ب‬
‫لط‬‫ا‬
‫ة‬‫ر‬‫و‬
‫مش‬‫ل‬
‫ا‬‫لى‬
‫إحصلع‬
‫د‪:‬‬‫ل‬
‫لج‬
‫ا‬‫يج‬
‫ه‬‫وثت‬
‫د‬‫ةح‬
‫ل‬‫ا‬
‫فيح‬
‫‪P332 + P313‬‬
‫ين‬‫ز‬‫تخ‬
‫ء‬
‫الشي‬
‫ا‬
‫ه‬‫ن‬‫لصم‬ ‫تخ‬‫ل‬
‫ا‬
‫ء‬
‫الشي‬

‫لى‬‫ويع‬‫ت‬‫يح‬
‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬‫ل‬‫ا‬
‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫‪Proprietary Component‬‬

‫ة‬‫ي‬
‫ف‬‫ا‬
‫إض‬‫ات‬
‫م‬‫و‬‫ل‬‫ع‬
‫م‬
‫ة )‪.(PBT‬‬
‫م‬‫ا‬‫ًوالس‬
‫ا‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫أح‬‫م‬‫ك‬‫ا‬
‫ر‬‫ت‬
‫‪،‬ت‬‫ة‬
‫ر‬‫م‬‫ت‬
‫ونمس‬
‫ك‬‫أنت‬
‫ر‬‫ب‬‫ت‬
‫ع‬‫دت‬
‫ا‬‫و‬
‫لىم‬
‫يطع‬
‫ل‬
‫لخ‬‫ا‬‫ا‬
‫ذ‬‫ويه‬
‫ت‬‫اليح‬
‫ة )‪.(vPvB‬‬
‫ي‬‫ا‬
‫غ‬‫ل‬‫ل‬
‫ئي‬‫ا‬‫ي‬
‫أح‬ ‫م‬
‫ك‬‫ا‬
‫ر‬‫ت‬
‫اتوالت‬‫ب‬
‫ث‬
‫ل‬‫ا‬‫ة‬
‫د‬‫ي‬
‫د‬‫ونش‬
‫ك‬‫أنت‬
‫ر‬‫ب‬‫ت‬
‫ع‬‫دت‬
‫ا‬‫و‬
‫لىم‬
‫يطع‬
‫ل‬
‫لخ‬‫ا‬‫ا‬
‫ذ‬‫ويه‬
‫ت‬‫اليح‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ا‬‫اتعن‬
‫م‬‫و‬‫ل‬
‫ع‬‫يب ‪/‬م‬
‫ك‬‫ر‬‫ت‬
‫ل‬‫ا‬
‫‪3.‬‬
‫يف ‪GHS‬‬ ‫ن‬
‫تص‬ ‫زن )‪(%‬‬ ‫و‬
‫ل‬‫ا‬‫ة‬
‫ب‬‫نس‬ ‫م ‪CAS‬‬ ‫ق‬
‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬ ‫ا‬
‫)‪Skin Irrit. 3 (H316‬‬ ‫‪10 - 30%‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫‪Proprietary Component‬‬

‫ة‬
‫ي‬‫ل‬
‫و‬‫أل‬
‫ا‬‫ات‬
‫ف‬‫ا‬
‫ع‬‫إلس‬
‫ا‬‫ر‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪4.‬‬
‫ة‬ ‫ي‬‫ل‬
‫و‬‫أل‬
‫ا‬‫ات‬ ‫ف‬‫ا‬‫ع‬
‫إلس‬‫ا‬‫ر‬‫ي‬‫ب‬
‫ا‬‫د‬‫ت‬
‫اق‬‫نش‬‫ت‬‫إلس‬‫ا‬
‫فسي‪.‬‬‫ن‬
‫ت‬
‫ل‬‫ا‬‫ز‬‫ا‬
‫ه‬‫لج‬
‫ا‬‫يج‬
‫ه‬‫وت‬
‫أ‬ ‫فس‬‫ن‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫ب‬‫و‬
‫ع‬‫ةص‬ ‫ل‬
‫ا‬‫يبفيح‬‫ب‬
‫لط‬ ‫ا‬
‫ر‬ ‫تش‬‫إس‬‫د‪.‬‬
‫د‬‫تج‬
‫ءم‬ ‫ا‬
‫و‬‫ةه‬‫ق‬
‫نط‬‫لىم‬
‫إ‬ ‫قل‬‫ن‬‫إ‬‫اق‬‫نش‬‫ت‬‫اإلس‬
‫ة‬‫ل‬‫ا‬
‫فيح‬
‫ة‬‫ر‬‫بش‬ ‫ل‬
‫ا‬
‫يج‪.‬‬
‫ه‬‫ت‬‫ل‬‫ا‬‫ر‬‫م‬‫ت‬‫إس‬‫ة‬‫ل‬
‫ا‬‫يبفيح‬‫ب‬‫لط‬
‫ا‬‫ر‬‫تش‬
‫إس‬ ‫ون‪.‬‬‫ب‬‫ا‬
‫لص‬ ‫ا‬‫ءو‬‫ا‬‫م‬‫ل‬
‫ا‬‫إغسلب‬
‫ون‬‫ي‬‫ع‬
‫يب‪.‬‬
‫ب‬
‫لط‬‫ا‬
‫لى‬‫فسكع‬
‫رضن‬
‫إع‬ ‫ين‬
‫ن‬
‫ي‬‫ع‬‫ل‬
‫ا‬‫يج‬‫ه‬
‫رت‬‫م‬
‫ت‬‫إس‬
‫ا‬‫ذ‬‫إ‬‫تج‪.‬‬
‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬
‫مس‬‫ةمال‬‫ل‬‫ا‬
‫قلفيح‬‫األ‬‫لى‬‫ةع‬‫ق‬‫ي‬‫ق‬
‫ة ‪15‬د‬‫د‬
‫م‬‫ل‬‫ء‬‫ا‬
‫م‬‫ل‬
‫ا‬‫ةمن‬
‫ر‬ ‫ي‬
‫ف‬‫ةو‬‫ي‬‫م‬‫ك‬‫ينب‬‫ن‬‫ي‬‫ع‬
‫ل‬‫ا‬‫إغسل‬
‫تالع‬
‫ب‬‫إل‬
‫ا‬
‫ة‪.‬‬
‫ي‬‫لصح‬‫ا‬‫ة‬‫ي‬
‫ا‬‫رع‬‫ل‬
‫ا‬ ‫لى‬
‫أحصلع‬ ‫م‪.‬‬‫ف‬‫ل‬
‫ا‬‫يق‬ ‫ر‬
‫ءعنط‬ ‫أىشي‬‫عطى‬‫ءوالت‬ ‫قي‬‫ل‬
‫ا‬ ‫لى‬‫رضع‬ ‫التح‬

‫ة‬
‫ر‬‫أخ‬
‫ت‬‫م‬
‫ل‬‫ا‬
‫و‬‫أ‬‫ة‬
‫د‬‫ا‬
‫لح‬
‫ا‬‫نت‬
‫ا‬‫ءك‬
‫ا‬‫و‬‫ة‪,‬س‬
‫م‬‫ا‬‫ه‬
‫ل‬ ‫ا‬
‫ات‬‫ر‬‫ي‬
‫ث‬‫أ‬
‫ت‬‫ل‬
‫ا‬
‫اضو‬‫ر‬‫ألع‬
‫ا‬‫م‬‫عظ‬‫م‬
‫ة‪.‬‬‫ع‬
‫ق‬‫و‬‫ت‬
‫رم‬‫ي‬
‫ةغ‬‫غ‬
‫ل‬‫ا‬
‫ب‬‫ل‬
‫ا‬‫ة‬
‫ر‬‫و‬ ‫لخط‬
‫ا‬

‫ة‬
‫اص‬‫ةخ‬
‫لج‬‫ا‬
‫ع‬‫م‬‫و‬
‫أ‬‫ة‬‫ي‬
‫ر‬‫و‬‫ةف‬
‫ي‬‫ب‬
‫ةط‬‫ي‬
‫ا‬‫ن‬
‫ةأليع‬
‫اج‬‫لح‬
‫ا‬ ‫لى‬
‫إ‬‫ة‬‫ر‬‫ا‬
‫إش‬
‫يب‬‫ب‬
‫لط‬‫اتل‬‫مالحظ‬
‫اض‪.‬‬‫ر‬
‫األع‬
‫لجحسب‬ ‫ا‬‫ع‬

‫ئق‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬‫ك‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪5.‬‬
‫يق‬
‫ر‬‫لح‬
‫ا‬ ‫ة‬
‫فح‬‫ا‬‫ك‬‫م‬‫ةل‬‫ب‬‫اس‬‫ن‬
‫دم‬‫ا‬‫و‬
‫م‬
‫ة‪.‬‬
‫ف‬‫ا‬
‫لج‬
‫ا‬‫ة‬‫ئ‬
‫ي‬
‫ا‬‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫ة‪,‬‬
‫و‬‫رغ‬
‫ل‬‫ا‬‫ون‪,‬‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬‫أ‬‫ني‬‫ا‬‫ء‪,‬ث‬‫ا‬
‫م‬‫ل‬‫ا‬
‫اب‬‫ب‬‫ض‬
‫يق‬
‫ر‬‫لح‬
‫ا‬‫د‬‫ا‬
‫م‬‫اسبإلخ‬ ‫ن‬‫رم‬‫ي‬‫وسطغ‬
‫وف‪.‬‬ ‫ر‬‫ع‬‫ئىم‬‫الش‬

‫ة‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬‫ا‬
‫د‬‫ا‬‫و‬
‫م‬‫ل‬‫ا‬
‫أمن‬‫نش‬‫ةت‬
‫ن‬‫ي‬
‫ع‬‫رم‬‫ا‬
‫أخط‬
‫ة‪.‬‬
‫م‬‫ا‬‫اتس‬
‫ز‬‫ا‬
‫ونغ‬
‫ك‬‫أني‬‫كن‬‫م‬
‫يقي‬‫ر‬‫لح‬
‫ا‬‫ء‬‫ا‬
‫ن‬
‫ث‬‫أ‬‫ري‬‫ا‬
‫ر‬‫لح‬
‫ا‬‫لل‬
‫تح‬‫ل‬
‫ا‬

‫ء‬‫ا‬
‫ف‬‫إلط‬
‫ا‬‫ل‬‫ا‬
‫رج‬‫ةل‬‫اص‬
‫ةخ‬‫ي‬‫ئ‬
‫ا‬‫ق‬
‫اتو‬‫ء‬
‫ا‬‫ر‬‫إج‬
‫ئق‪.‬‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬
‫ك‬‫دم‬
‫ا‬‫ر‬‫ف‬
‫ةأل‬
‫م‬‫ز‬‫ةال‬
‫د‬‫م‬‫ت‬
‫ع‬‫ةم‬
‫ل‬‫ق‬
‫ت‬‫فسمس‬ ‫ن‬
‫ةت‬‫ز‬
‫ه‬‫أج‬
‫ةو‬‫ل‬
‫م‬‫ا‬
‫ةك‬‫ي‬‫ق‬
‫ا‬
‫بسو‬‫مال‬

‫_____________________________________________________________________________________________‬
‫ة ‪6/2‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪RHEMODL‬‬
‫‪14-02-2017‬‬
‫_____________________________________________________________________________________________‬

‫رض‬
‫ا‬‫ع‬‫ل‬
‫ا‬‫رب‬
‫تس‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫اج‬‫و‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪6.‬‬
‫رئ‬‫ا‬‫و‬‫لط‬
‫ا‬‫ات‬‫ء‬‫ا‬
‫ر‬‫إج‬‫ةو‬‫ي‬
‫ا‬‫ق‬
‫و‬‫ل‬‫ا‬
‫ات‬‫د‬‫ع‬
‫م‬‫ة‪,‬‬
‫ي‬‫لشخص‬‫ا‬
‫ات‬‫اط‬
‫ي‬‫ت‬‫إلح‬
‫ا‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫ةك‬
‫ي‬‫و‬‫ه‬
‫دت‬‫و‬
‫دمنوج‬
‫ك‬‫أ‬
‫ة‪.‬ت‬
‫ر‬‫بخ‬
‫األ‬
‫فس‬‫ن‬
‫نبت‬
‫بس‪.‬تج‬
‫مال‬
‫ل‬‫ا‬
‫ينو‬
‫ن‬
‫ي‬‫ع‬‫ل‬
‫ا‬
‫دو‬ ‫ل‬
‫لج‬
‫ا‬‫ة‬‫مس‬‫نبمال‬
‫ة‪.‬تج‬
‫ب‬‫اس‬
‫ن‬
‫م‬‫ل‬‫ا‬‫ة‬
‫ي‬‫ا‬
‫ق‬‫و‬
‫ل‬‫ا‬‫ات‬
‫د‬‫ع‬‫مم‬
‫د‬‫تخ‬‫إس‬

‫ة‬‫ي‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬‫اط‬
‫ي‬‫ت‬
‫إلح‬
‫ا‬
‫ة‪.‬‬
‫فض‬‫نخ‬
‫م‬‫ل‬
‫ا‬‫اطق‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫و‬‫أ‬‫ة‬
‫ي‬‫ئ‬
‫ا‬‫م‬
‫ل‬‫ا‬‫ري‬
‫ا‬‫مج‬
‫ل‬‫ا‬‫يف‪,‬‬
‫ر‬‫تص‬
‫ل‬
‫ا‬‫ري‬
‫ا‬‫لىمج‬‫إ‬
‫ا‬‫ه‬‫ل‬
‫و‬‫عدخ‬‫ن‬
‫م‬‫إ‬

‫يف‬‫نظ‬
‫ت‬‫ل‬
‫ا‬‫ءو‬‫ا‬
‫و‬‫ت‬
‫ةلالح‬
‫م‬‫ز‬‫لال‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫يبو‬ ‫ل‬
‫ا‬‫ألس‬
‫ا‬
‫ة‪.‬‬
‫ف‬‫ر‬‫غ‬
‫ةم‬‫اسط‬
‫و‬‫ةب‬
‫ل‬‫ا‬
‫ز‬‫اإل‬
‫مب‬‫رى‪.‬ق‬
‫أخ‬‫ة‬
‫ل‬‫م‬
‫ا‬‫ةخ‬
‫د‬‫ا‬
‫أيم‬
‫و‬‫أ‬‫مل‬
‫ر‬‫ل‬‫ا‬
‫م‬‫ا‬‫د‬
‫تخ‬‫إس‬
‫ةب‬‫ب‬
‫ر‬‫تس‬
‫م‬‫ل‬
‫ا‬‫ة‬
‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫وي‬
‫ت‬‫إح‬
‫من‪.‬‬
‫آ‬‫ا‬‫ذ‬
‫انه‬‫اك‬
‫ذ‬‫إ‬‫رب‬‫تس‬
‫ل‬‫ا‬‫قف‬‫و‬‫أ‬‫ةو‬‫ب‬‫ر‬‫تس‬
‫م‬‫ل‬
‫ا‬‫ة‬‫د‬
‫ا‬‫م‬
‫ل‬‫ا‬‫زل‬‫إع‬

‫ة‬‫ي‬
‫ف‬‫ا‬
‫إض‬‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫لىم‬
‫ولع‬
‫لحص‬
‫ل‬‫ات ‪8‬و ‪13‬‬
‫ر‬‫ق‬
‫ف‬‫ل‬
‫ا‬‫ع‬‫اج‬
‫ر‬

‫ين‬
‫ز‬‫تخ‬
‫ل‬‫ا‬
‫ةو‬‫ل‬
‫و‬‫ا‬
‫ن‬‫م‬
‫ل‬‫ا‬
‫‪7.‬‬
‫من‬‫اآل‬‫ل‬
‫م‬‫ا‬‫ع‬
‫ت‬‫ل‬
‫اتل‬ ‫اط‬
‫ي‬‫ت‬
‫إلح‬
‫ا‬
‫ة‬
‫ي‬‫ا‬
‫ق‬‫و‬
‫ل‬‫ا‬‫ات‬
‫د‬‫ع‬
‫مم‬‫د‬
‫تخ‬‫إس‬
‫م‪.‬‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫ة‬‫د‬‫ا‬
‫إع‬‫بل‬
‫ةق‬‫ث‬
‫و‬‫ل‬
‫م‬‫ل‬
‫ا‬‫بس‬
‫مال‬
‫ل‬‫ا‬‫إغسل‬
‫ة‪.‬‬‫ي‬
‫ف‬‫ا‬
‫ةك‬‫ي‬
‫و‬‫ه‬‫دت‬
‫و‬‫دمنوج‬
‫ك‬‫أ‬
‫ة‪.‬ت‬
‫ر‬‫بخ‬
‫األ‬
‫فس‬‫ن‬
‫نبت‬
‫م‪.‬تج‬
‫ا‬‫د‬
‫تخ‬‫اإلس‬
‫د‬‫ع‬‫ينب‬
‫د‬‫ي‬
‫ل‬‫ا‬
‫إغسل‬
‫بس‪.‬‬
‫مال‬
‫ل‬‫ا‬‫و‬
‫أ‬‫د‪,‬‬
‫ل‬‫لج‬
‫ا‬‫ين‪,‬‬‫ع‬
‫ل‬‫ا‬‫ة‬
‫مس‬‫نبمال‬‫تج‬
‫ة‪.‬‬‫ب‬
‫اس‬‫ن‬
‫م‬‫ل‬
‫ا‬

‫ا‬
‫ً‬‫ع‬
‫ينم‬‫ز‬‫تخ‬
‫ل‬‫ا‬
‫نب‬‫تييجبتج‬
‫ل‬‫ا‬‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬‫لك‬
‫افيذ‬‫م‬‫من‪,‬ب‬‫اآل‬
‫ين‬‫ز‬‫تخ‬
‫ل‬‫ا‬‫وط‬‫ر‬‫ش‬
‫ً‪.‬‬
‫ا‬
‫ر‬‫ه‬‫رف ‪36‬ش‬‫ل‬
‫ا‬‫لى‬‫تجع‬
‫ن‬‫م‬
‫ل‬‫ا‬‫ر‬
‫م‬‫اف‪.‬ع‬‫ءوج‬ ‫ا‬
‫و‬‫ه‬‫ل‬
‫ا‬‫يف‬ ‫ك‬
‫انم‬ ‫ك‬‫ينفيم‬‫ز‬
‫تخ‬‫ل‬
‫ا‬

‫ة‬
‫ي‬‫لشخص‬
‫ا‬‫ة‬‫ي‬
‫ا‬‫م‬
‫لح‬‫ا‬
‫رض ‪/‬‬
‫ع‬‫ت‬‫ل‬
‫ا‬‫بط‬
‫ا‬
‫و‬‫‪8.‬ض‬
‫م‬‫ك‬
‫تح‬‫ل‬
‫ا‬‫ر‬‫ي‬
‫ي‬‫ا‬
‫ع‬‫م‬
‫رض‬‫ع‬‫ت‬
‫ل‬‫ا‬‫د‬
‫و‬‫د‬‫ح‬

‫ة‬‫ب‬
‫اس‬‫ن‬
‫م‬‫ل‬‫ا‬
‫ة‬‫ي‬‫دس‬
‫ن‬‫ه‬‫ل‬
‫ا‬‫بط‬
‫ا‬‫و‬‫لض‬‫ا‬
‫ة‪.‬‬
‫د‬‫ي‬
‫اج‬‫ه‬‫ت‬
‫ي‬
‫و‬‫ه‬‫ةت‬‫ق‬
‫نط‬‫مفيم‬
‫د‬‫تخ‬‫إس‬

‫ة‬‫ي‬‫لشخص‬‫ا‬‫ة‬‫ي‬
‫ا‬‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬‫د‬
‫ع‬‫لم‬ ‫ث‬‫م‬
‫ة‪,‬‬‫ي‬‫د‬
‫ر‬‫ف‬‫ل‬‫ا‬‫ة‬‫ي‬
‫ا‬‫م‬‫لح‬
‫ا‬ ‫ر‬
‫ي‬‫ب‬‫ا‬‫د‬
‫ت‬
‫و‬‫أ‬‫ة‬
‫ي‬ ‫اع‬
‫ن‬
‫ةص‬ ‫ئي صح‬‫ا‬
‫أخص‬‫بل‬
‫ةمنق‬‫ي‬‫لشخص‬‫ا‬‫ة‬
‫ي‬‫ا‬
‫ق‬‫و‬
‫ل‬‫ا‬‫ات‬
‫د‬‫ع‬‫م‬‫ل‬
‫م‬ ‫ي‬
‫ل‬‫لس‬
‫ا‬‫م‬‫ا‬
‫د‬‫تخ‬‫اإلس‬
‫رو‬ ‫ا‬‫ي‬
‫ت‬
‫اإلخ‬‫د‬
‫ي‬‫د‬
‫غيتح‬‫ب‬
‫ن‬
‫ي‬‫رط‪,‬‬‫ف‬
‫م‬‫ل‬
‫ا‬‫رض‬ ‫ع‬ ‫ت‬
‫ل‬
‫ا‬‫ع‬‫ن‬‫م‬‫أنت‬‫كن‬‫م‬‫ملالي‬
‫ع‬‫ل‬‫ا‬‫ات‬‫رس‬‫ا‬
‫م‬‫م‬‫ةو‬ ‫ي‬
‫دس‬‫ن‬‫ه‬
‫ل‬‫ا‬‫بط‬‫ا‬‫و‬
‫لض‬ ‫ا‬‫نت‬‫ا‬
‫اك‬ ‫ذ‬
‫إ‬
‫تج‪.‬‬‫ن‬‫م‬‫ل‬
‫ا‬‫ا‬‫ذ‬
‫ه‬‫ل‬‫د‬‫د‬‫مح‬‫ل‬
‫ا‬‫يق‬‫ب‬
‫تط‬‫ل‬‫ا‬
‫لى‬‫إ‬‫د‬‫ن‬‫ت‬
‫يثيس‬‫ينح‬ ‫ل‬
‫ه‬‫ؤ‬‫م‬‫ل‬
‫ا‬‫ين‬ ‫ي‬
‫ن‬‫ف‬
‫ل‬‫ا‬
‫امن‬ ‫ه‬‫ر‬‫ي‬‫غ‬
‫فسي‬‫ن‬‫ت‬‫ل‬
‫ا‬‫ز‬‫ا‬‫ه‬‫لح‬
‫ا‬ ‫ة‬
‫ي‬‫ا‬‫م‬‫ح‬
‫دمن‬‫م‬
‫ت‬‫ع‬‫اعيم‬‫ن‬
‫فس ص‬‫ن‬‫زت‬‫ا‬
‫ه‬‫ءج‬‫ا‬
‫د‬‫ت‬
‫ر‬‫إ‬‫يجب‬
‫وف‪,‬‬‫ر‬‫ع‬‫م‬‫ل‬
‫ا‬‫ر‬‫ي‬
‫رضغ‬ ‫ع‬‫ت‬‫ل‬
‫ا‬‫ة‬‫ل‬
‫ا‬‫وفيح‬ ‫أ‬‫ني‬‫ه‬‫م‬‫ل‬‫ا‬‫رض‬ ‫ع‬‫ت‬
‫ل‬
‫ا‬‫د‬‫و‬
‫د‬‫قلمنح‬‫أ‬‫رض‬ ‫ع‬‫ت‬‫اظب‬‫ف‬
‫ت‬‫لإلح‬‫ة‬
‫ي‬‫ف‬
‫ا‬‫رك‬‫ملغ‬‫ع‬‫ل‬‫ا‬‫ات‬‫رس‬‫ا‬
‫م‬‫م‬‫ةو‬ ‫ي‬
‫دس‬‫ن‬‫ه‬
‫ل‬‫ا‬‫بط‬‫ا‬‫و‬
‫لض‬ ‫ا‬‫نت‬‫ا‬
‫اك‬ ‫ذ‬
‫إ‬
‫افي‬
‫م‬‫ب‬‫ة‪,‬‬‫ي‬
‫لشخص‬‫ا‬
‫ة‬‫ي‬‫ا‬
‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬
‫د‬‫ع‬
‫عم‬ ‫ي‬
‫م‬‫مج‬‫ا‬
‫د‬‫تخ‬
‫اتإلس‬
‫م‬‫ي‬‫ل‬
‫ع‬‫ت‬
‫ل‬‫ا‬
‫رو‬‫ا‬‫ي‬
‫ت‬‫اإلخ‬
‫تج‪.‬‬
‫ن‬‫م‬‫ل‬
‫ا‬ ‫ا‬
‫ذ‬‫مه‬ ‫ا‬
‫د‬‫تخ‬‫إس‬
‫ا‬‫ه‬‫ل‬
‫د‬‫ا‬
‫ع‬‫اي‬
‫وم‬‫أ‬
‫ة ‪,EN 149,AS / NZS 1715: 2009‬‬ ‫ي‬
‫ب‬‫و‬
‫ر‬‫و‬‫األ‬‫ة‬‫ي‬
‫اس‬‫ي‬
‫ق‬‫ل‬
‫ا‬‫بي‬ ‫ل‬
‫وت‬‫أ‬
‫‪NIOSH‬‬
‫ة‪.‬‬‫ي‬
‫و‬‫عض‬ ‫ل‬‫ا‬
‫ة‬‫ر‬‫بخ‬‫لأل‬‫اعي‬‫ن‬
‫فس ص‬ ‫ن‬
‫زت‬‫ا‬
‫ه‬‫ين‪.‬ج‬‫ل‬
‫ه‬‫ؤ‬‫م‬
‫ل‬‫ا‬‫ين‬
‫ي‬ ‫ن‬
‫ف‬‫ل‬
‫ا‬‫همن‬ ‫ر‬‫ي‬
‫وغ‬ ‫أ‬‫ة‬‫ئي صح‬‫ا‬
‫أخص‬ ‫ا‬‫ه‬
‫مب‬‫و‬‫ق‬‫أني‬‫يجب‬‫فس‪,‬‬ ‫ن‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ز‬‫ه‬‫أج‬‫لك‬‫ذ‬
‫د‬‫ي‬‫ل‬
‫ا‬ ‫ة‬
‫ي‬‫ا‬‫م‬‫ح‬
‫دي‪.‬‬ ‫ا‬
‫ع‬‫ل‬
‫ا‬‫مل‬‫ع‬‫ل‬‫ل‬‫ز‬‫ا‬‫ف‬
‫ق‬
‫د‬
‫ل‬‫لج‬‫ا‬‫ة‬‫ي‬
‫ا‬‫ق‬‫و‬
‫ة‪.‬‬‫ي‬
‫د‬‫ا‬‫ملع‬‫اطفع‬ ‫ع‬‫م‬
‫ين‬‫ع‬‫ل‬
‫ا‬ ‫ة‬
‫ي‬‫ا‬‫م‬‫ح‬
‫ة‪.‬‬
‫ي‬‫ا‬‫ق‬
‫اتو‬ ‫ر‬‫ا‬‫ونظ‬‫أ‬‫ة‬‫ي‬
‫ن‬
‫ه‬‫م‬‫ل‬‫ا‬
‫ة‬‫م‬‫لسال‬
‫ا‬‫ات‬‫ر‬‫ا‬‫عنظ‬‫رض ض‬ ‫ع‬‫ت‬‫ل‬
‫ا‬‫ةمن‬ ‫ي‬
‫ا‬‫م‬‫لح‬
‫ل‬
‫رى‬‫أخ‬‫ات‬‫اط‬‫ي‬
‫ت‬‫إح‬
‫وف‪.‬‬‫ر‬‫ع‬‫ئىم‬ ‫الش‬

‫ة‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ةو‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫ز‬‫ي‬
‫ف‬‫ل‬
‫ا‬‫ئص‬
‫ا‬‫لخص‬
‫ا‬
‫‪9.‬‬
‫ة‪:‬‬
‫ي‬‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬ ‫ة‬‫ل‬‫ا‬
‫لح‬‫ا‬
‫ئل‬‫ا‬
‫س‬
‫ون‪:‬‬‫ل‬
‫كن‬‫ا‬
‫د‬
‫ة‪:‬‬‫ئح‬‫ا‬
‫ر‬
‫ني‬‫ه‬‫مضد‬ ‫ح‬
‫ة‪:‬‬‫ئح‬
‫ا‬
‫ر‬ ‫ل‬
‫نىل‬‫د‬‫أل‬
‫ا‬ ‫د‬
‫لح‬‫ا‬
‫ة‬
‫اح‬‫ت‬‫اتم‬‫م‬‫و‬‫ل‬
‫ع‬‫دم‬ ‫وج‬‫الت‬

‫_____________________________________________________________________________________________‬
‫ة ‪6/3‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪RHEMODL‬‬
‫‪14-02-2017‬‬
‫_____________________________________________________________________________________________‬
‫‪pH:‬‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬
‫ة‬‫ي‬‫وع‬‫ن‬
‫ل‬‫ا‬‫ة‬‫ي‬‫ب‬‫ذ‬‫ا‬‫لج‬
‫ا‬
‫‪0.96‬‬
‫ة(‪:‬‬ ‫ي‬‫و‬‫ئ‬‫م‬‫دى )‬ ‫د ‪/‬م‬‫م‬‫تج‬‫ل‬
‫ا‬ ‫ة‬‫قط‬‫ن‬
‫‪< 25‬‬
‫ة(‪:‬‬ ‫ي‬‫و‬‫ئ‬‫ةم‬ ‫رج‬‫د‬‫دى )‬ ‫م‬ ‫ل‬
‫ا‬‫ان‬‫ي‬‫ل‬
‫ةغ‬ ‫رج‬‫د‬
‫‪> 300‬‬
‫ة(‪:‬‬‫ي‬‫و‬ ‫ئ‬
‫م‬ ‫دى )‬ ‫م‬‫ل‬
‫ا‬ ‫يض ‪/‬‬ ‫م‬‫و‬‫ل‬
‫ا‬ ‫ة‬‫قط‬‫ن‬
‫‪270‬‬
‫يض‪:‬‬ ‫م‬‫و‬ ‫ل‬
‫ا‬‫ة‬‫قط‬‫ةن‬ ‫ق‬‫ي‬‫ر‬‫ط‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬
‫فض )‪(%‬‬ ‫نخ‬‫دم‬ ‫و ‪-‬ح‬ ‫لج‬‫ا‬ ‫لفي‬ ‫ا‬‫ع‬
‫ت‬‫إلش‬ ‫ا‬‫ة‬
‫ي‬‫ل‬‫ب‬
‫ا‬‫دق‬‫و‬ ‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬
‫وي )‪(%‬‬‫ل‬‫دع‬ ‫و ‪-‬ح‬ ‫لج‬‫ا‬ ‫لفي‬ ‫ا‬‫ع‬
‫ت‬‫إلش‬ ‫ا‬‫ة‬
‫ي‬‫ل‬‫ب‬
‫ا‬‫دق‬‫و‬ ‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬
‫ة(‪:‬‬‫ي‬
‫و‬‫ئ‬‫ةم‬ ‫رج‬ ‫د‬‫تي )‬‫ا‬‫ذ‬ ‫ل‬
‫ا‬ ‫ل‬‫ا‬‫ع‬‫ت‬
‫الش‬ ‫ا‬‫ة‬‫ر‬‫ا‬
‫ر‬‫ةح‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬
‫ل ‪:(= 1‬‬ ‫ي‬‫ت‬‫و‬ ‫ي‬‫ب‬
‫ل‬‫ا‬‫ر )خالت‬ ‫بخ‬‫ت‬‫ل‬
‫ا‬‫ة‬ ‫رع‬ ‫س‬
‫‪0‬‬
‫بق(‬‫ئ‬‫مز‬‫ل‬‫م‬‫ة)‬‫ي‬‫و‬‫ئ‬
‫ة ‪20‬م‬ ‫ر‬‫ا‬‫ر‬‫ةح‬ ‫رج‬ ‫ة @د‬ ‫ر‬‫بخ‬‫أل‬
‫ا‬‫غط‬ ‫ض‬
‫‪< 0.001‬‬
‫ء‪=1‬‬ ‫ا‬
‫و‬ ‫ر)ه‬ ‫ا‬
‫بخ‬‫ل‬
‫ا‬ ‫ة‬‫ف‬‫ا‬‫ث‬‫ك‬
‫(‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬
‫ء‬ ‫ا‬‫م‬‫ل‬
‫ا‬‫انفي‬ ‫ب‬‫و‬‫ذ‬‫ل‬
‫ا‬
‫ء‬ ‫ا‬‫م‬
‫ل‬‫ا‬ ‫انفي‬ ‫ب‬
‫و‬‫ذ‬‫ل‬
‫ل‬ ‫ة‬
‫ل‬‫ب‬
‫ا‬‫رق‬ ‫ي‬‫غ‬
‫ة (‪:‬‬‫ي‬‫و‬ ‫ئ‬‫ل )م‬ ‫ل‬‫تح‬‫ل‬‫ا‬‫ة‬‫ر‬‫ا‬
‫ر‬‫ةح‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬
‫ز(‪:‬‬
‫و‬ ‫ي‬
‫ب‬‫ي‬‫ت‬
‫ن‬‫ة )س‬‫ي‬
‫و‬‫ئ‬‫ةم‬ ‫رج‬ ‫ة ‪‌@ 20‬د‬ ‫ي‬‫ك‬‫ي‬‫م‬
‫ا‬‫ن‬
‫ي‬‫ة‪,‬د‬‫وج‬ ‫ز‬
‫ل‬
‫‪1849 @ 25C‬‬
‫وك(‪:‬‬ ‫ر‬
‫ت‬‫يس‬ ‫ت‬
‫ن‬‫ة )س‬
‫ي‬‫و‬‫ئ‬
‫ةم‬ ‫رج‬ ‫ة ‪‌‌@ 20‬د‬ ‫ي‬
‫ك‬‫ر‬‫ة‪,‬ح‬‫وج‬ ‫ز‬
‫ل‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬
‫ء‪:‬‬ ‫ا‬
‫لم‬ ‫و‬‫ن‬‫ا‬‫ت‬
‫ك‬ ‫أ‬‫عن‪-‬‬ ‫ي‬
‫ز‬‫و‬‫ت‬‫ل‬‫ا‬‫ل‬‫م‬ ‫ا‬
‫ع‬‫م‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬
‫زئ (‪:‬‬ ‫ئى )غج‬ ‫ي‬‫ز‬‫لج‬‫ا‬‫زن‬ ‫و‬‫ل‬
‫ا‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬ ‫الت‬

‫ة‬
‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬‫اتو‬
‫ب‬‫ث‬
‫ل‬‫ا‬
‫‪10.‬‬
‫ة‬‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬
‫يط‬
‫نش‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫د‬
‫ا‬‫إع‬
‫ع‬‫ق‬‫و‬
‫ت‬‫م‬‫ل‬
‫ا‬‫يسمن‬‫ل‬

‫ئي‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ات‬
‫ب‬‫ث‬‫ل‬
‫ا‬
‫ر‬‫ق‬
‫ت‬‫مس‬

‫ة‬
‫ر‬‫لخط‬
‫ا‬‫اعالت‬
‫ف‬‫ت‬
‫ل‬‫ا‬‫ل‬
‫ا‬‫م‬‫ت‬
‫اح‬
‫دث‬‫لنيح‬

‫ا‬
‫ه‬‫ب‬
‫ن‬‫تييجبتج‬
‫ل‬‫ا‬‫وف‬
‫ر‬‫لظ‬‫ا‬
‫ع‪.‬‬‫ق‬
‫و‬‫ت‬
‫يئم‬‫الش‬

‫ا‬‫ه‬
‫ن‬‫ب‬
‫ديجبتج‬
‫ا‬‫و‬‫م‬
‫وف‪.‬‬‫ر‬‫ع‬
‫ءم‬‫الشي‬

‫ة‬‫ر‬
‫لخط‬
‫ا‬‫كك‬‫ف‬
‫ت‬‫ل‬
‫ا‬‫ات‬‫تج‬‫ن‬
‫م‬
‫ون‪.‬‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬
‫أ‬‫ني‬
‫ا‬
‫ث‬‫ونو‬
‫ب‬‫ر‬‫ك‬
‫ل‬‫ا‬‫د‬
‫ي‬‫كس‬
‫ا‬ ‫ول‬
‫أ‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫ه‬‫ي‬
‫وج‬ ‫ت‬
‫بق‬
‫نط‬‫الت‬

‫_____________________________________________________________________________________________‬
‫ة ‪6/4‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪RHEMODL‬‬
‫‪14-02-2017‬‬
‫_____________________________________________________________________________________________‬

‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪11.‬‬
‫ة‬‫ي‬
‫م‬‫لس‬‫ا‬‫ات‬
‫ر‬‫ي‬‫ث‬
‫أ‬‫اتعنت‬ ‫م‬‫و‬‫ل‬
‫ع‬‫م‬
‫ة‬
‫د‬‫ا‬‫لح‬
‫ا‬ ‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫اق‬‫نش‬‫ت‬
‫إس‬
‫فسي‪.‬‬
‫ن‬‫ت‬
‫ل‬‫ا‬
‫ز‬‫ا‬‫ه‬
‫لج‬‫ا‬‫يطفي‬‫يجبس‬
‫ه‬‫أنت‬ ‫كن‬‫م‬‫ي‬
‫ين‬
‫ع‬‫ل‬‫ا‬‫ة‬‫مس‬‫مال‬
‫نب‪.‬‬
‫ر‬‫األ‬
‫ين‬‫ع‬‫ل‬
‫زعج‬ ‫رم‬ ‫ي‬
‫غ‬
‫د‬‫ل‬
‫لج‬‫ا‬‫ة‬‫مس‬‫مال‬
‫نب‪.‬‬‫ا‬‫ر‬
‫األ‬‫د‬
‫ل‬‫يجج‬
‫ه‬‫ببت‬ ‫اليس‬
‫تالع‬
‫ب‬‫إل‬
‫ا‬
‫ة‪.‬‬
‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫تالع‬
‫ب‬‫إ‬‫ة‬‫ل‬
‫ا‬
‫ًفيح‬‫ا‬
‫ر‬‫ي‬‫ونخط‬ ‫ك‬
‫أني‬‫كن‬‫م‬‫فطي‬‫لس‬‫ا‬

‫ة‬
‫ي‬‫ن‬‫ا‬
‫رط‬‫ةس‬‫ن‬
‫م‬‫ز‬‫اتم‬
‫ر‬‫ي‬‫ث‬
‫أ‬‫ت‬
‫ة‪.‬‬
‫لصح‬
‫ا‬‫لى‬
‫منع‬
‫ز‬‫ةم‬
‫ر‬‫و‬‫رخط‬
‫د‬‫همص‬
‫ن‬‫أ‬
‫ر‬‫ب‬
‫ك‬‫أ‬‫و‬
‫أ‬‫ة ‪1%‬‬
‫ب‬‫نس‬
‫ةب‬‫ت‬
‫ا‬
‫ن‬‫و‬‫ك‬
‫دىم‬
‫إح‬‫و‬
‫أ‬‫تج‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫د‬‫و‬‫أنوج‬
‫لى‬‫إ‬
‫ر‬‫ي‬‫اتتش‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ةل‬‫ي‬
‫م‬‫لس‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ة‬
‫ي‬‫يس‬
‫ئ‬
‫ر‬‫ل‬‫ا‬

‫اق ‪LC50‬‬
‫نش‬‫ت‬
‫إس‬ ‫د‬
‫ل‬‫لج‬
‫ا‬‫يق‬
‫ر‬‫‪LD50‬عنط‬ ‫م‬
‫ف‬‫ل‬
‫ا‬ ‫يق‬
‫ر‬‫‪LD50‬عنط‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬ ‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫ن‬
‫ا‬
‫ي‬‫دب‬
‫وج‬‫الت‬ ‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫ن‬‫ا‬
‫ي‬‫دب‬
‫وج‬‫الت‬ ‫ة‬‫اح‬‫ت‬
‫اتم‬
‫ن‬‫ا‬
‫ي‬‫دب‬
‫وج‬‫الت‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫‪ Proprietary Component‬مسجل‬

‫ة‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬
‫ن‬‫و‬
‫ل‬‫ع‬‫م‬
‫‪12.‬‬
‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫ات‬
‫ي‬‫ر‬‫ا‬‫ق‬‫ف‬‫ةال‬
‫ي‬‫م‬‫س‬ ‫ة‬‫ق‬
‫ي‬‫ق‬
‫د‬‫ل‬
‫ا‬‫ات‬
‫ن‬‫ئ‬‫ا‬
‫ك‬‫ل‬
‫ةل‬‫ي‬
‫م‬‫س‬ ‫مك‬‫لس‬
‫ةل‬‫ي‬
‫م‬‫لس‬ ‫ا‬ ‫لب‬‫ا‬
‫لطح‬‫ةل‬‫ي‬‫م‬
‫لس‬ ‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬ ‫ا‬
‫‪LC50: 295.3 mg/L‬‬ ‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬
‫الت‬ ‫‪LC50: > 1000 mg/L‬‬ ‫‪EC50: 237.1 mg/L‬‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫‪ Proprietary Component‬مسجل‬
‫)‪(Acartia tonsa‬‬ ‫)‪(Scophthalmus maximus) (Skeletonema costatum‬‬

‫ل‬
‫ل‬‫تح‬
‫ل‬‫ا‬
‫ءو‬‫ا‬
‫ق‬‫ب‬
‫ل‬‫ا‬

‫ل‬
‫ل‬‫تح‬
‫ل‬‫ا‬
‫اتو‬‫ب‬‫ث‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬ ‫ا‬
‫ا‬
‫ي‬
‫ئ‬‫ا‬
‫ق‬‫ل‬
‫للت‬
‫تح‬‫ل‬
‫ل‬‫بل‬
‫ا‬‫رق‬
‫ي‬‫غ‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫‪Proprietary Component‬‬

‫ئي‬
‫ا‬‫ي‬
‫ألح‬
‫ا‬‫م‬‫ك‬
‫ا‬‫ر‬‫ت‬
‫ل‬‫ا‬‫لى‬
‫ةع‬‫ر‬
‫د‬‫ق‬‫ل‬
‫ا‬

‫‪Log Pow‬‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬


‫ا‬‫و‬‫م‬
‫ل‬ ‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬
‫الت‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫‪Proprietary Component‬‬

‫ة‬
‫ب‬‫ر‬‫ت‬
‫ل‬‫ا‬‫ةفي‬
‫ك‬‫ر‬‫لح‬
‫ا‬

‫ل‬‫ق‬
‫ن‬‫ت‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬ ‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫ة‬
‫ي‬‫ك‬‫ل‬
‫م‬‫ل‬
‫ا‬‫مسجل‬ ‫‪Proprietary Component‬‬

‫رى‬‫ألخ‬
‫ا‬‫ة‬‫ي‬‫ب‬
‫ل‬‫لس‬
‫ا‬‫ر‬‫ا‬
‫ث‬‫اآل‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬ ‫و‬
‫ل‬‫ع‬‫دم‬
‫وج‬‫الت‬

‫ات‬
‫ي‬‫ا‬
‫ف‬‫ن‬
‫ل‬‫ا‬‫اصمن‬
‫تخ‬‫ل‬
‫ا‬‫ات‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إع‬‫‪13.‬‬

‫_____________________________________________________________________________________________‬
‫ة ‪6/5‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫™‪RHEMODL‬‬
‫‪14-02-2017‬‬
‫_____________________________________________________________________________________________‬

‫ات‬‫ي‬
‫ا‬‫ف‬‫ن‬
‫ل‬‫ا‬‫ة‬‫لج‬
‫ا‬‫ع‬
‫رقم‬ ‫ط‬
‫لص‬ ‫تخ‬‫ل‬
‫ا‬‫ةفي‬‫م‬‫د‬‫تخ‬
‫مس‬ ‫ل‬
‫ا‬‫ة‬‫ق‬‫ي‬
‫ر‬‫لط‬‫ا‬
‫ة‪.‬‬
‫ي‬‫ل‬
‫مح‬‫ل‬
‫ا‬‫ة‬
‫ر‬‫ا‬
‫د‬‫اإل‬
‫ة‪,‬و‬
‫ي‬‫وال‬
‫ل‬‫ا‬
‫ة‪,‬و‬
‫ي‬‫ل‬
‫ا‬‫ر‬
‫د‬‫ي‬‫ف‬
‫ل‬
‫ا‬‫ة‬‫م‬
‫و‬‫ك‬‫لح‬
‫ا‬‫د‬‫اع‬
‫و‬‫ق‬‫ل‬
‫ا‬
‫ً‬‫ق‬‫ب‬
‫مط‬‫ت‬‫اتي‬‫ي‬
‫ا‬‫ف‬‫ن‬
‫ل‬
‫ا‬‫لصمن‬ ‫تخ‬‫ل‬‫ا‬
‫وث‬‫ل‬‫يفم‬‫ل‬‫غ‬‫ت‬
‫ة‪.‬‬‫ي‬
‫ل‬
‫مح‬‫ل‬‫ا‬‫ةو‬‫ي‬
‫م‬‫و‬‫ق‬
‫ل‬‫ا‬‫ئح‬‫ا‬
‫و‬‫ل‬
‫ل‬‫ا‬‫ع‬‫ي‬
‫م‬‫عج‬ ‫ب‬
‫ت‬‫إ‬
‫رى‬‫أخ‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬ ‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬‫الت‬

‫ل‬
‫ق‬‫ن‬‫ل‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪14.‬‬
‫ة"‬
‫د‬‫تح‬
‫م‬‫ل‬
‫ا‬‫م‬‫م‬
‫أل‬
‫ا‬‫م ‪"UN‬‬‫ق‬
‫ر‬
‫د‬‫ي‬
‫ق‬‫رم‬
‫ي‬‫غ‬

‫يح ‪UN:‬‬
‫لصح‬
‫ا‬‫ل‬‫ق‬
‫ن‬‫ل‬
‫ا‬‫م‬‫إس‬
‫د‬‫ي‬
‫ق‬‫رم‬‫ي‬
‫غ‬

‫ل‪:‬‬
‫ق‬‫ئطن‬
‫ا‬‫ةوس‬
‫ر‬‫و‬‫ةخط‬‫ب‬‫ت‬
‫ر‬
‫بق‬
‫نط‬‫الت‬

‫ة‪:‬‬
‫ئ‬‫ب‬
‫ع‬‫ت‬
‫ل‬‫ا‬‫ة‬‫وع‬‫م‬
‫مج‬
‫بق‬‫نط‬
‫الت‬

‫ة‪:‬‬
‫ي‬‫ئ‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫اط‬‫مخ‬‫ل‬‫ا‬
‫بق‬‫نط‬‫الت‬

‫م‪:‬‬
‫د‬‫تخ‬
‫مس‬‫ل‬
‫ةل‬‫اص‬
‫اتخ‬
‫اط‬‫ي‬
‫ت‬‫إح‬
‫ء‬
‫الشي‬

‫ة ‪IBC:‬‬
‫ن‬‫و‬‫د‬
‫ل ‪78/73‬وم‬
‫و‬‫ب‬‫ر‬
‫ا‬‫نيمن )‪(MARPOL‬م‬
‫ا‬‫ث‬
‫ل‬‫ا‬
‫فق‬‫ر‬
‫م‬‫ل‬‫ال‬
‫ق‬‫ف‬
‫ةو‬‫ر‬
‫ي‬‫ب‬
‫اتك‬
‫ي‬‫م‬‫ك‬
‫لب‬‫ق‬‫ن‬
‫ل‬‫ا‬
‫بق‬‫نط‬
‫الت‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫اتت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪15.‬‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫ت‬
‫ل‬‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬
‫ا‪.‬‬
‫ه‬‫ت‬
‫يال‬
‫د‬‫ع‬
‫ت‬‫ا )‪"(GHS‬و‬
‫ه‬‫م‬‫وس‬
‫ةو‬‫ي‬
‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫يف‬
‫ن‬
‫تص‬‫ل‬
‫ا‬
‫ً‬‫ي‬
‫م‬‫ل‬
‫ا‬‫نسقع‬
‫م‬‫ل‬
‫ا‬‫م‬‫ا‬
‫نظ‬‫ل‬
‫ا‬
‫ة"‬‫د‬
‫تح‬‫م‬
‫ل‬‫ا‬‫م‬
‫م‬‫لأل‬
‫ا‬‫ق‬
‫ف‬‫ه ‪SDS‬و‬‫ذ‬‫ده‬
‫ا‬‫د‬
‫إع‬‫م‬‫ت‬

‫رى‬
‫أخ‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪16.‬‬
‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫د‬‫ا‬‫مص‬
‫ةو‬‫ي‬
‫يس‬‫ئ‬
‫ر‬‫ل‬
‫ا‬‫ات‬
‫ي‬‫ب‬
‫د‬‫أل‬
‫ا‬‫ع‬‫اج‬
‫ر‬‫م‬
‫‪[Link]/‬‬
‫‪NZ CCID‬‬

‫ة‬‫ع‬‫اج‬‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪14-02-2017‬‬
‫يح‬‫ق‬‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫وظ‬‫لح‬‫م‬
‫ا‪2‬‬
‫ه‬‫د‬‫ي‬
‫د‬‫متج‬
‫تيت‬‫ل‬
‫ا‬ ‫م ‪SDS‬‬‫ا‬
‫قس‬‫أ‬

‫ة‬‫ي‬
‫ل‬‫و‬
‫ؤ‬‫مس‬‫ل‬
‫ا‬‫ء‬‫إخال‬‫ان‬
‫ي‬‫ب‬
‫دال‬
‫اق‬‫يض‬
‫أ‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬‫ل‬‫ا‬‫رى‪.‬‬‫األخ‬
‫اف‬‫ر‬‫األط‬
‫عض‬ ‫ب‬
‫تج‪,‬و‬‫ن‬
‫م‬‫ل‬‫ا‬‫مل‬
‫تىتش‬‫ل‬
‫ا‬ ‫ر‬
‫د‬‫ا‬‫مص‬‫ل‬
‫ا‬‫ةمن‬‫ف‬‫ل‬
‫ت‬
‫ةمخ‬‫وع‬‫م‬
‫امنمج‬
‫ه‬‫ي‬
‫ل‬‫ولع‬‫لحص‬‫ا‬
‫م‬‫ةت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬‫أن‬‫يث‬‫ةح‬‫د‬
‫و‬‫ز‬‫م‬‫ل‬
‫ا‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬‫م‬
‫ل‬‫ا‬‫ال‬
‫م‬‫ت‬
‫ك‬‫إ‬‫و‬
‫أ‬‫ة‬‫ق‬‫د‬
‫انب‬
‫م‬‫دض‬ ‫وج‬
‫الي‬
‫م‪.‬‬‫د‬
‫تخ‬‫مس‬‫ل‬‫ا‬
‫ة‬‫ي‬‫ل‬
‫و‬ ‫ؤ‬
‫ةهيمس‬ ‫د‬‫ا‬
‫أيم‬‫ة‬
‫م‬‫ء‬‫مال‬
‫ل‬‫ئي‬‫ا‬
‫ه‬‫ن‬‫ل‬
‫ا‬‫د‬‫ي‬
‫د‬‫تح‬
‫ل‬‫ا‬‫رى‪.‬‬
‫األخ‬
‫ات‬‫لج‬
‫ا‬‫ع‬
‫م‬‫ل‬
‫ا‬‫وفي‬‫أ‬
‫رى‬‫أخ‬‫د‬
‫ا‬‫و‬
‫دم‬‫و‬‫وفيوج‬‫أ‬‫ع‬
‫متم‬ ‫د‬
‫تخ‬‫إس‬‫ا‬
‫ذ‬‫إ‬‫و‬
‫أ‬‫م‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫وف‬ ‫ر‬‫ةتحتكلظ‬‫يح‬
‫ون صح‬ ‫ك‬‫ت‬

‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫ةو‬
‫ي‬‫ا‬
‫ه‬‫ن‬

‫_____________________________________________________________________________________________‬
‫ة ‪6/6‬‬
‫فح‬‫ص‬
SAFETY DATA SHEET
Product Trade Name:
RHEMODL™
Revision Date: Revision Number:
14-Feb-2017 30

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE


COMPANY/UNDERTAKING
Product Identifier
Product Trade Name:
RHEMODL™
Synonyms
None
Chemical Family
Tall oil fatty acid
Internal ID Code
HM004610

Recommended use and restrictions on use


Application:
Viscosifier
Uses advised against
No information available

Manufacturer's Name and Contact Details


Manufacturer/Supplier
Halliburton Energy Services
14th Floor, CitiBank Tower, Al-Qutayat Street
Dubai, UAE
Telephone Number : +971 43036666

Additional Information

Prepared By
Chemical Stewardship
Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

Emergency Telephone Number


1-760-476-3959
Global Incident Response Access Code: 334305
Contract Number: 14012

2. HAZARDS IDENTIFICATION
Classification

Not classified
Skin Corrosion / Irritation Category 3 - H316

Hazard Pictograms

Signal Word
Warning

Hazard Statements

_____________________________________________________________________________________________
Page 1 / 7
RHEMODL™ Revision Date:
14-Feb-2017
_____________________________________________________________________________________________
H316 - Causes mild skin irritation

Precautionary Statements

Prevention
None
Response
P332 + P313 - If skin irritation occurs: Get medical advice/attention
Storage
None
Disposal
None

Contains
Substances CAS Number
Proprietary Component Proprietary

Additional Information
This mixture contains no substance considered to be persistent, bioaccumulating nor toxic (PBT).
This mixture contains no substance considered to be very persistent nor very bioaccumulating (vPvB).

3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances CAS Number PERCENT (w/w) GHS Classification
Proprietary Component Proprietary 10 - 30% Skin Irrit. 3 (H316)

4. FIRST AID MEASURES


First-aid Measures
Inhalation
If inhaled, remove from area to fresh air. Get medical attention if respiratory irritation develops or if breathing becomes difficult.
Skin
Wash with soap and water. Get medical attention if irritation persists.
Eyes
In case of contact, immediately flush eyes with plenty of water for at least 15 minutes and get medical attention if irritation persists.
Ingestion
Do NOT induce vomiting. Give nothing by mouth. Obtain immediate medical attention.

Most important symptoms and effects, both acute and delayed


No significant hazards expected.

Indication of any immediate medical attention and special treatment needed


Notes to Physician
Treat symptomatically.

5. FIRE FIGHTING MEASURES


Suitable Extinguishing Media
Water fog, carbon dioxide, foam, dry chemical.
Extinguishing media which must not be used for safety reasons
None known.

Specific hazards arising from the chemical


Decomposition in fire may produce harmful gases.

Special protective actions for fire-fighters


Full protective clothing and approved self-contained breathing apparatus required for fire fighting personnel.

_____________________________________________________________________________________________
Page 2 / 7
RHEMODL™ Revision Date:
14-Feb-2017
_____________________________________________________________________________________________

6. ACCIDENTAL RELEASE MEASURES


Personal precautions, protective equipment and emergency procedures
Use appropriate protective equipment. Avoid contact with skin, eyes and clothing. Avoid breathing vapors. Ensure adequate
ventilation.

Environmental Precautions
Prevent from entering sewers, waterways, or low areas.

Methods and material for containment and cleaning up


Isolate spill and stop leak where safe. Contain spill with sand or other inert materials. Scoop up and remove.

Additional Information
See Section 8 and 13 for additional information.

7. HANDLING AND STORAGE


Precautions for safe handling
Avoid contact with eyes, skin, or clothing. Wash hands after use. Avoid breathing vapors. Ensure adequate ventilation. Launder
contaminated clothing before reuse. Use appropriate protective equipment.

Conditions for safe storage, including any incompatibilities


Store in a cool, dry location. Product has a shelf life of 36 months.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION


Control parameters
Exposure Limits

Appropriate engineering controls


Use in a well ventilated area.

Individual protection measures, such as personal protective equipment


If engineering controls and work practices cannot prevent excessive exposures, the selection and proper use of personal protective
equipment should be determined by an industrial hygienist or other qualified professional based on the specific application of this
product.
Respiratory Protection
If engineering controls and work practices cannot keep exposure below occupational exposure limits or if exposure is unknown,
wear a NIOSH certified, European Standard EN 149, AS/NZS 1715:2009, or equivalent respirator when using this product.
Selection of and instruction on using all personal protective equipment, including respirators, should be performed by an Industrial
Hygienist or other qualified professional.
Organic vapor respirator.

Hand Protection
Normal work gloves.
Skin Protection
Normal work coveralls.
Eye Protection
Wear safety glasses or goggles to protect against exposure.
Other Precautions
None known.

9. PHYSICAL AND CHEMICAL PROPERTIES


Physical State:
Liquid
Color
Dark

_____________________________________________________________________________________________
Page 3 / 7
RHEMODL™ Revision Date:
14-Feb-2017
_____________________________________________________________________________________________
Odor:
Fatty acid
Odor Threshold:
No information available
pH:
No information available
Specific Gravity
0.96
Freezing Point/Range (°C):
< 25
Boiling Point/Range (C):
> 300
Flash Point/Range (°C):
270
Flash Point Method:
No information available
Flammability Limits in Air - Lower (%):
No information available
Flammability Limits in Air - Upper (%):
No information available
Autoignition Temperature (°C):
No information available
Evaporation Rate (Butyl Acetate=1):
0
Vapor Pressure @ 20 C (mmHg):
< 0.001
Vapor Density (Air=1):
No information available
Water Solubility
Insoluble in water
Decomposition Temperature (C):
No information available
Viscosity, Dynamic @ 20 C (centipoise):
1849 @ 25C
Viscosity, Kinematic @ 20 C (centistokes):
No information available
Partition Coefficient/n-Octanol/Water:
No information available
Molecular Weight (g/mole):
No information available

10. STABILITY AND REACTIVITY


Reactivity
Not expected to be reactive.

Chemical Stability
Stable

Possibility of hazardous reactions


Will Not Occur

Conditions to Avoid
None anticipated

Incompatible materials
None known.

Hazardous decomposition products


Carbon monoxide and carbon dioxide.

_____________________________________________________________________________________________
Page 4 / 7
RHEMODL™ Revision Date:
14-Feb-2017
_____________________________________________________________________________________________
Additional Guidelines
Not Applicable

11. TOXICOLOGICAL INFORMATION


Information on Toxicological Effects
Acute Toxicity
Inhalation
May cause mild respiratory irritation.
Eye Contact
Non-irritating to rabbit's eye
Skin Contact
Not irritating to skin in rabbits.
Ingestion
Aspiration can be a hazard if this material is swallowed.

Chronic Effects/Carcinogenicity
No data available to indicate product or components present at greater than 0.1% are chronic health hazards.

Toxicology data for the components

Substances CAS Number LD50 Oral LD50 Dermal LC50 Inhalation


Proprietary Component Proprietary No data available No data available No data available

12. ECOLOGICAL INFORMATION


Toxicity
Substances CAS Number Toxicity to Algae Toxicity to Fish Toxicity to Toxicity to Invertebrates
Microorganisms
Proprietary Component Proprietary EC50: 237.1 mg/L LC50: > 1000 mg/L No information available LC50: 295.3 mg/L
(Skeletonema costatum) (Scophthalmus maximus) (Acartia tonsa)

Persistence and degradability

Substances CAS Number Persistence and Degradability


Proprietary Component Proprietary Not readily biodegradable

Bioaccumlation potential

Substances CAS Number Log Pow


Proprietary Component Proprietary No information available

Mobility in soil

Substances CAS Number Mobility


Proprietary Component Proprietary No information available

_____________________________________________________________________________________________
Page 5 / 7
RHEMODL™ Revision Date:
14-Feb-2017
_____________________________________________________________________________________________

Other adverse effects


No information available

13. DISPOSAL CONSIDERATIONS


Waste treatment methods
Disposal methods
Disposal should be made in accordance with federal, state, and local regulations.
Contaminated Packaging
Follow all applicable national or local regulations.
Other Information
No information available

14. TRANSPORT INFORMATION


UN Number
Not restricted

UN proper shipping name:


Not restricted

Transport Hazard Class(es):


Not applicable

Packing Group:
Not applicable

Environmental Hazards:
Not applicable

Special Precautions for User


None

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
Not applicable

15. REGULATORY INFORMATION

Regulatory Information
This SDS was prepared in accordance with United Nations "Globally Harmonized System of Classification and Labelling of
Chemicals (GHS)" and its revisions.

16. OTHER INFORMATION


Key literature references and sources for data
[Link]/
NZ CCID

Revision Date:
14-Feb-2017
Revision Note
SDS sections updated: 2

Disclaimer Statement
This information is furnished without warranty, expressed or implied, as to accuracy or completeness. The information is obtained
from various sources including the manufacturer and other third party sources. The information may not be valid under all

_____________________________________________________________________________________________
Page 6 / 7
RHEMODL™ Revision Date:
14-Feb-2017
_____________________________________________________________________________________________
conditions nor if this material is used in combination with other materials or in any process. Final determination of suitability of any
material is the sole responsibility of the user.

End of Safety Data Sheet

_____________________________________________________________________________________________
Page 7 / 7
Hazard Pictograms
Halliburton Energy Services
Halliburton House, Howemoss

TAU-MOD®
Place
Kirkhill Industrial Estate
Dyce
Aberdeen, AB21 0GN
United Kingdom
+44 1224 776888 Made in Country:
[Link]
Emergency Telephone
Application: Viscosifier Number : +44 8 08 189 0979 /
Hazardous Material Number: HM006276 1-760-476-3961 Revision Date:
Global Incident Response
05-Mar-2019
Denmark PR No. 2314979 Access Code: 334305
Contract Number: 14012
EUROPEAN LABEL

Signal Word: Warning Contains


Chemical Name CAS Number
Hazard Statements:
Crystalline silica, quartz 14808 -60-7
H351 - Suspected of causing cancer if inhaled
H373 - May cause damage to organs through prolonged or repeated
exposure if inhaled

Precautionary Statements:
P201 - Obtain special instructions before use
P202 - Do not handle until all safety precautions have been read and
understood
P260 - Do not breathe dust/fume/gas/mist/vapors/spray
P280 - Wear protective gloves/protective clothing/eye
protection/face protection
P308 + P313 - IF exposed or concerned: Get medical
advice/attention
P314 - Get medical attention/advice if you feel unwell
Net/Gross Package Weight:

SAP Part Number(s): Lot Number:

UN proper shipping name: Transport Classification:

Not restricted Packing


Group Not applicable
Environmental Hazards: Not
applicable
Not restricted
‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫و‬
‫تج‪:‬‬
‫ن‬‫م‬
‫ل‬‫ريل‬
‫ا‬‫تج‬
‫ل‬‫ا‬‫م‬
‫إلس‬
‫ا‬
‫®‪TAU-MOD‬‬
‫ة‪:‬‬
‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫م‬‫ق‬‫ر‬ ‫ة‬‫ع‬‫اج‬‫ر‬‫م‬
‫ل‬‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪39‬‬ ‫‪05-03-2019‬‬

‫وع‬
‫ر‬‫مش‬
‫ل‬‫ا‬‫ة‬
‫ك‬‫ر‬‫لش‬
‫ا‬‫رو‬
‫ي‬‫ةتحض‬
‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫يف‬
‫ر‬‫ع‬‫ت‬
‫‪1.‬‬
‫تج‬‫ن‬ ‫م‬
‫ل‬‫ا‬‫ة‬‫ي‬‫و‬
‫ه‬
‫تج‪:‬‬
‫ن‬‫م‬‫ل‬
‫ريل‬‫ا‬‫تج‬‫ل‬‫ا‬‫م‬‫إلس‬
‫ا‬
‫®‪TAU-MOD‬‬
‫ات‪:‬‬‫ف‬
‫د‬‫ا‬‫ر‬‫م‬
‫يئ‬‫الش‬
‫ة‬
‫ي‬‫ئ‬
‫ا‬‫م‬ ‫ي‬
‫ةك‬ ‫ل‬
‫ئ‬‫ا‬
‫ع‬
‫دن‬‫ع‬‫م‬
‫لي‬
‫اخ‬‫د‬‫ل‬
‫ا‬‫رف‬ ‫ع‬‫م‬‫ل‬‫ا‬‫ز‬‫م‬‫ر‬
‫‪HM006276‬‬

‫ه‬
‫ي‬‫ل‬
‫ةع‬‫وض‬
‫ر‬‫ف‬‫م‬
‫ل‬‫ا‬‫د‬
‫و‬‫ي‬‫ق‬
‫ل‬‫ا‬
‫هو‬‫وصىب‬‫م‬‫ل‬‫ا‬‫م‬‫ا‬
‫د‬‫تخ‬
‫الس‬‫ا‬
‫يق‪:‬‬‫ب‬
‫تط‬‫ل‬‫ا‬
‫ة‬‫وج‬‫ز‬‫ل‬‫د‬‫ي‬
‫ز‬‫م‬
‫‪Uses advised against‬‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬‫الت‬

‫ل‬ ‫ا‬‫تص‬‫إل‬
‫ا‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬‫ةو‬ ‫ع‬‫ن‬
‫مص‬ ‫ل‬
‫ا‬ ‫ة‬‫ك‬
‫ر‬‫لش‬ ‫ا‬
‫زع‬ ‫و‬‫تجم‬‫ن‬
‫م‬
‫‪Halliburton Energy Services‬‬
‫‪14th Floor, CitiBank Tower‬‬
‫‪Al-Qutayat Street‬‬
‫‪Dubai, UAE‬‬

‫‪Telephone Number : +971 43036666‬‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬

‫ة‬‫اسط‬
‫و‬‫رب‬‫حض‬
‫‪Chemical Stewardship‬‬
‫‪Telephone: 1-281-871-6107‬‬
‫‪e-mail: fdunexchem@[Link]‬‬

‫رئ‬‫ا‬‫و‬
‫لط‬‫ا‬‫تف‬‫ا‬
‫مه‬‫ق‬‫ر‬
‫‪1-760-476-3959‬‬
‫د‪14012 :‬‬‫ق‬
‫ع‬‫ل‬
‫ا‬‫م‬‫ق‬
‫ر‬
‫دث‪334305 :‬‬
‫ا‬‫و‬
‫لح‬‫ل‬
‫ة‬‫ي‬‫م‬
‫ل‬‫ا‬
‫ع‬‫ل‬
‫ا‬‫ة‬‫ب‬
‫ا‬
‫تج‬‫لالس‬‫ول‬
‫وص‬ ‫ل‬
‫ا‬‫ز‬‫م‬‫ر‬

‫ر‬
‫ا‬‫ألخط‬
‫ا‬‫ان‬
‫ي‬‫ب‬
‫‪2.‬‬
‫يف‬
‫ن‬‫تص‬
‫ل‬‫ا‬

‫ة ‪A - H350 1‬‬
‫ئ‬‫ف‬ ‫ة‬‫ن‬‫رط‬‫لس‬
‫ا‬
‫ة ‪H373 - 2‬‬‫ئ‬‫ف‬ ‫ر(‬
‫ر‬‫ك‬‫ت‬
‫م‬‫ل‬
‫ا‬‫رض‬
‫ع‬‫ت‬‫ل‬
‫ا‬
‫ة ‪)-‬‬
‫ن‬‫ي‬
‫ع‬‫م‬‫ل‬
‫ا‬‫ة‬‫ف‬
‫د‬‫ه‬‫ت‬
‫مس‬‫ل‬
‫ا‬‫ء‬‫ا‬
‫األعض‬‫ة‬
‫ي‬‫م‬‫س‬

‫ر‬
‫لخط‬
‫ةل‬‫ي‬
‫يح‬‫وض‬
‫ت‬‫ل‬
‫ا‬‫ر‬‫و‬
‫لص‬‫ا‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/1‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪TAU-MOD‬‬
‫‪05-03-2019‬‬
‫_____________________________________________________________________________________________‬

‫ه‬
‫ي‬‫ب‬
‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫م‬‫ل‬‫ك‬
‫ر‬‫خط‬

‫ر‬‫ا‬
‫ألخط‬
‫ا‬‫ات‬
‫ن‬‫ا‬‫ي‬
‫ب‬
‫ان‪.‬‬
‫رط‬‫لس‬‫ا‬‫بب‬
‫ديس‬
‫ق‬‫‪H350‬‬
‫نشق‪.‬‬
‫ت‬
‫إس‬‫ا‬
‫ذ‬‫إ‬‫ة‬
‫ر‬‫ر‬‫ك‬
‫ت‬‫وم‬
‫أ‬‫ة‬‫ل‬
‫ي‬
‫و‬‫اتط‬
‫ر‬‫ت‬
‫ف‬‫ل‬
‫رض‬‫ع‬
‫ت‬‫ل‬
‫ا‬‫ءمنخالل‬
‫ا‬‫لألعض‬
‫ا‬
‫ً‬‫ف‬
‫ل‬‫ببت‬
‫ديس‬
‫ق‬‫‪H373‬‬

‫ة‬
‫ي‬‫ر‬‫ي‬
‫ذ‬‫تح‬
‫ل‬‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬

‫ع‬‫ن‬‫م‬‫ل‬
‫ا‬
‫م‪.‬‬‫ا‬
‫د‬‫تخ‬‫اإلس‬‫بل‬ ‫ةق‬‫اص‬‫اتخ‬ ‫م‬‫ي‬‫ل‬
‫ع‬‫لىت‬‫ولع‬ ‫لحص‬‫ا‬‫يجب‬ ‫‪P201‬‬
‫ا‪.‬‬
‫ه‬‫م‬‫ه‬‫ف‬
‫ةو‬ ‫م‬‫لسال‬‫ا‬‫ات‬ ‫اط‬‫ي‬
‫ت‬‫اح‬ ‫ع‬‫ي‬
‫م‬‫ةج‬‫ء‬‫ا‬
‫ر‬ ‫مق‬‫ت‬‫تىي‬‫اح‬‫ه‬‫ع‬‫ملم‬‫ا‬
‫ع‬‫ت‬‫‪P202‬الت‬
‫ذ‪.‬‬
‫ا‬‫ذ‬
‫ر‬‫ل‬‫ا‬‫ة‪/‬‬‫ر‬ ‫بخ‬‫األ‬‫اب ‪/‬‬
‫ب‬‫لض‬ ‫ا‬‫ز‪/‬‬‫ا‬
‫غ‬‫ل‬‫ا‬‫ان ‪/‬‬‫دخ‬
‫ل‬‫ا‬‫ر‪/‬‬‫ا‬‫ب‬
‫غ‬‫ل‬‫ا‬
‫فس‬‫ن‬‫ت‬‫‪P260‬الت‬
‫ه‪.‬‬
‫وج‬ ‫ل‬
‫ا‬‫ة‬‫ي‬
‫ا‬
‫م‬‫لح‬‫اع‬‫ن‬
‫ين ‪/‬ق‬‫ع‬ ‫ل‬
‫ل‬‫ة‬‫ي‬‫ا‬‫م‬‫ة ‪/‬ح‬‫ي‬‫ق‬‫ا‬
‫و‬‫ل‬
‫ا‬‫بس‬‫مال‬‫ل‬‫ا‬‫ة‪/‬‬‫ي‬
‫ق‬‫ا‬
‫و‬‫ل‬‫ا‬‫ات‬‫ز‬‫ا‬
‫ف‬‫ق‬
‫ل‬‫ا‬‫بس‬ ‫ل‬
‫ت‬‫‪P280‬‬
‫ة‬‫ب‬‫ا‬
‫تج‬‫الس‬
‫ا‬
‫يب‪.‬‬‫ب‬‫لط‬‫ا‬‫ًب‬
‫ا‬
‫ر‬‫و‬ ‫تصلف‬‫إ‬‫رض‪:‬‬ ‫ع‬‫دثت‬‫اح‬ ‫ذ‬
‫إ‬‫‪P308 + P313‬‬
‫وعك‪.‬‬‫ت‬
‫رب‬ ‫ع‬‫نتتش‬ ‫اك‬‫ذ‬
‫إ‬ ‫يب‬‫ب‬
‫لط‬‫ا‬
‫تصلب‬ ‫إ‬‫‪P314‬‬
‫ين‬‫ز‬‫تخ‬
‫لق‪.‬‬‫غ‬‫انم‬‫ك‬
‫م‬‫زنب‬ ‫تخ‬‫‪P405‬‬
‫ا‬‫ه‬‫ن‬‫لصم‬ ‫تخ‬‫ل‬
‫ا‬
‫ة‪.‬‬
‫ي‬‫ل‬
‫و‬‫د‬
‫ل‬‫ا‬‫ة‪/‬‬‫ي‬
‫ن‬‫وط‬‫ل‬
‫ا‬‫ة‪/‬‬‫ي‬
‫م‬‫ي‬
‫ل‬‫ق‬
‫اإل‬‫ة‪/‬‬‫ي‬‫ل‬‫مح‬‫ل‬‫ا‬‫ئح‬ ‫ا‬
‫و‬‫ل‬
‫ل‬ ‫ا‬
‫ً‬
‫ق‬‫ف‬‫اتو‬‫ي‬‫و‬
‫ا‬‫لح‬‫ا‬‫ات ‪/‬‬‫ي‬
‫و‬‫ت‬‫مح‬‫ل‬
‫ا‬‫لصمن‬ ‫تخ‬‫‪P501‬‬

‫لى‬
‫ويع‬ ‫ت‬
‫يح‬
‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫‪14808-60-7‬‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬‫ت‬
‫ام‬‫ك‬
‫ي‬‫ل‬
‫س‬

‫ة‬‫ي‬
‫ف‬‫ا‬
‫إض‬‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬
‫ء‬
‫ا‬‫و‬‫ه‬
‫ل‬‫ا‬‫رفي‬‫فج‬
‫ت‬‫يجم‬‫ز‬
‫كلم‬
‫أنيش‬‫كن‬
‫م‬‫ري‬‫ا‬
‫ب‬‫غ‬
‫ل‬‫ا‬
‫ة )‪.(PBT‬‬
‫م‬‫ا‬‫ًوالس‬
‫ا‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫أح‬‫م‬‫ك‬‫ا‬
‫ر‬‫ت‬
‫‪،‬ت‬‫ة‬
‫ر‬‫م‬‫ت‬
‫ونمس‬
‫ك‬‫أنت‬‫ر‬‫ب‬‫ت‬
‫ع‬‫دت‬
‫ا‬‫و‬‫لىم‬
‫يطع‬
‫ل‬‫لخ‬
‫ا‬‫ا‬
‫ذ‬‫ويه‬‫ت‬
‫اليح‬
‫ة )‪.(vPvB‬‬
‫ي‬‫ا‬
‫غ‬‫ل‬‫ل‬
‫ئي‬‫ا‬‫ي‬
‫أح‬ ‫م‬
‫ك‬‫ا‬
‫ر‬‫ت‬
‫اتوالت‬‫ب‬
‫ث‬
‫ل‬‫ا‬‫ة‬
‫د‬‫ي‬
‫د‬‫ونش‬
‫ك‬‫أنت‬‫ر‬‫ب‬‫ت‬
‫ع‬‫دت‬
‫ا‬‫و‬‫لىم‬
‫يطع‬
‫ل‬‫لخ‬
‫ا‬‫ا‬
‫ذ‬‫ويه‬‫ت‬
‫اليح‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ا‬‫اتعن‬
‫م‬‫و‬‫ل‬
‫ع‬‫يب ‪/‬م‬
‫ك‬‫ر‬‫ت‬
‫ل‬‫ا‬
‫‪3.‬‬
‫يف ‪GHS‬‬ ‫ن‬
‫تص‬ ‫زن )‪(%‬‬ ‫و‬
‫ل‬‫ا‬‫ة‬
‫ب‬‫نس‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫)‪Carc. 1A (H350‬‬ ‫‪1 - 5%‬‬ ‫‪14808-60-7‬‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬
‫)‪STOT RE 1 (H372‬‬

‫ة‬
‫ي‬‫ل‬
‫و‬‫أل‬
‫ا‬‫ات‬
‫ف‬‫ا‬
‫ع‬‫إلس‬
‫ا‬‫ر‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪4.‬‬
‫ة‬‫ي‬‫ل‬
‫و‬‫أل‬
‫ا‬‫ات‬ ‫ف‬
‫ا‬‫ع‬‫إلس‬
‫ا‬‫ر‬ ‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫اق‬‫نش‬‫ت‬‫إلس‬‫ا‬
‫فسي‪.‬‬‫ن‬
‫ت‬
‫ل‬‫ا‬‫ز‬‫ا‬
‫ه‬‫لج‬
‫ا‬‫يج‬
‫ه‬‫وت‬
‫أ‬‫فس‬‫ن‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫ب‬‫و‬
‫ع‬‫ةص‬ ‫ل‬
‫ا‬
‫يبفيح‬ ‫ب‬
‫لط‬ ‫ا‬‫ر‬‫تش‬‫إس‬‫د‪.‬‬
‫د‬‫تج‬
‫ءم‬‫ا‬‫و‬
‫ةه‬ ‫ق‬
‫نط‬‫لىم‬
‫إ‬‫قل‬‫ن‬‫إ‬‫اق‬‫نش‬‫ت‬
‫اإلس‬‫ة‬‫ل‬
‫ا‬‫فيح‬
‫ة‬‫ر‬‫بش‬‫ل‬‫ا‬
‫يج‪.‬‬
‫ه‬‫ت‬‫ل‬‫ا‬‫ر‬‫م‬‫ت‬‫إس‬‫ة‬‫ل‬
‫ا‬‫يبفيح‬‫ب‬
‫لط‬‫ا‬‫ر‬‫تش‬
‫إس‬‫ون‪.‬‬‫ب‬
‫ا‬‫لص‬ ‫ا‬
‫ءو‬ ‫ا‬
‫م‬‫ل‬‫ا‬
‫إغسلب‬
‫ون‬ ‫ي‬
‫ع‬
‫يب‪.‬‬
‫ب‬
‫لط‬‫ا‬
‫لى‬‫فسكع‬
‫رضن‬
‫إع‬ ‫ين‬
‫ن‬
‫ي‬‫ع‬‫ل‬
‫ا‬‫يج‬‫ه‬
‫رت‬‫م‬
‫ت‬‫إس‬
‫ا‬‫ذ‬‫إ‬
‫تج‪.‬‬
‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬
‫مس‬‫ةمال‬‫ل‬
‫ا‬‫قلفيح‬‫األ‬‫لى‬‫ةع‬‫ق‬‫ي‬‫ق‬
‫ة ‪15‬د‬
‫د‬‫م‬‫ل‬
‫ء‬‫ا‬‫م‬
‫ل‬‫ا‬‫ةمن‬
‫ر‬ ‫ي‬
‫ف‬‫ةو‬‫ي‬‫م‬‫ك‬‫ينب‬‫ن‬‫ي‬
‫ع‬‫ل‬
‫ا‬ ‫إغسل‬
‫تالع‬‫ب‬
‫إل‬‫ا‬
‫ة‪.‬‬‫ي‬
‫د‬‫ا‬‫ع‬‫ل‬
‫ا‬‫وف‬ ‫ر‬
‫لظ‬‫ا‬‫ةتحت‬‫ي‬
‫ر‬‫و‬‫ر‬‫رض‬ ‫ي‬‫ةغ‬ ‫ي‬‫ل‬
‫و‬‫األ‬
‫ات‬‫ف‬‫ا‬‫ع‬‫اإلس‬

‫ة‬‫ر‬
‫أخ‬‫ت‬
‫م‬‫ل‬
‫ا‬‫و‬‫أ‬‫ة‬
‫د‬‫ا‬
‫لح‬
‫ا‬‫نت‬‫ا‬
‫ءك‬‫ا‬
‫و‬‫ة‪,‬س‬
‫م‬‫ا‬‫ه‬
‫ل‬‫ا‬‫ات‬
‫ر‬‫ي‬
‫ث‬‫أ‬
‫ت‬‫ل‬
‫ا‬‫اضو‬‫ر‬‫ألع‬
‫ا‬‫م‬‫عظ‬‫م‬
‫ة‪.‬‬
‫ي‬‫ل‬
‫ك‬‫ل‬
‫ا‬‫رض‬
‫دوم‬
‫ل‬‫لج‬
‫ا‬‫لب‬
‫رضتص‬
‫م‬‫ةب‬
‫ق‬‫اعال‬
‫ه‬‫ل‬‫ا‬
‫يض‬‫أ‬
‫ري‬‫و‬
‫ل‬‫ب‬
‫ل‬‫ا‬
‫ا‬‫ك‬‫ي‬
‫ل‬
‫ي‬‫لس‬
‫ا‬‫ة‪.‬‬
‫ئ‬‫ر‬‫ل‬
‫ا‬‫ان‬
‫رط‬‫نيوس‬
‫و‬‫ك‬‫ي‬
‫ل‬
‫ي‬‫لس‬
‫ا‬‫ر‬‫ا‬
‫لسح‬
‫ا‬‫لك‬‫افيذ‬
‫م‬‫ب‬
‫ة‪,‬‬
‫ئ‬‫ر‬‫ل‬
‫ا‬‫رض‬‫ببم‬‫ديس‬‫ريق‬‫و‬
‫ل‬‫ب‬
‫ل‬‫ا‬‫ا‬
‫ك‬‫ي‬
‫ل‬‫ي‬
‫لس‬
‫ا‬‫اق‬‫نش‬‫ت‬
‫إس‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/2‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪TAU-MOD‬‬
‫‪05-03-2019‬‬
‫_____________________________________________________________________________________________‬

‫ة‬
‫اص‬‫ةخ‬
‫لج‬‫ا‬
‫ع‬‫م‬‫و‬
‫أ‬‫ة‬‫ي‬
‫ر‬‫و‬‫ةف‬
‫ي‬‫ب‬
‫ةط‬‫ي‬
‫ا‬‫ن‬
‫ةأليع‬
‫اج‬‫لح‬
‫ا‬ ‫لى‬
‫إ‬‫ة‬‫ر‬‫ا‬
‫إش‬
‫يب‬‫ب‬
‫لط‬‫اتل‬‫مالحظ‬
‫اض‪.‬‬‫ر‬
‫األع‬
‫لجحسب‬ ‫ا‬‫ع‬

‫ئق‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬‫ك‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪5.‬‬
‫يق‬‫ر‬
‫لح‬‫ا‬‫ة‬
‫فح‬ ‫ا‬
‫ك‬‫م‬‫ةل‬‫ب‬
‫اس‬‫ن‬
‫دم‬‫ا‬
‫و‬‫م‬
‫يق‬‫ر‬‫لح‬‫ا‬
‫ة‬‫فح‬‫ا‬
‫ك‬‫دم‬‫ا‬
‫و‬‫كلم‬
‫يق‬‫ر‬
‫لح‬‫ا‬‫د‬
‫ا‬‫م‬
‫اسبإلخ‬ ‫ن‬
‫رم‬‫ي‬‫وسطغ‬
‫يق‪.‬‬
‫ر‬‫لح‬
‫ا‬‫ات‬
‫ي‬
‫ا‬‫ف‬
‫مط‬‫ا‬
‫د‬‫تخ‬
‫إس‬‫ء‬
‫ا‬‫ن‬
‫ث‬‫أ‬
‫ر‬‫ا‬‫ب‬
‫غ‬‫ل‬
‫ا‬ ‫ينسحب‬‫و‬‫ك‬‫نبت‬
‫تج‬

‫ة‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫أمن‬
‫نش‬‫ةت‬
‫ن‬‫ي‬
‫ع‬‫رم‬‫ا‬
‫أخط‬
‫د‬‫د‬
‫رمح‬‫ي‬
‫غ‬

‫ء‬‫ا‬
‫ف‬‫إلط‬
‫ا‬‫ل‬‫ا‬
‫رج‬‫ةل‬‫اص‬
‫ةخ‬‫ي‬‫ئ‬
‫ا‬‫ق‬
‫اتو‬‫ء‬
‫ا‬‫ر‬‫إج‬
‫ئق‪.‬‬
‫ا‬
‫ر‬‫لح‬
‫ا‬‫ة‬‫فح‬
‫ا‬
‫ك‬‫دم‬
‫ا‬‫ر‬‫ف‬
‫ةأل‬
‫م‬‫ز‬‫ةال‬
‫د‬‫م‬‫ت‬
‫ع‬‫ةم‬
‫ل‬‫ق‬
‫ت‬‫فسمس‬ ‫ن‬
‫ةت‬‫ز‬
‫ه‬‫أج‬
‫ةو‬‫ل‬
‫م‬‫ا‬
‫ةك‬‫ي‬‫ق‬
‫ا‬
‫بسو‬‫مال‬

‫رض‬
‫ا‬‫ع‬‫ل‬
‫ا‬‫رب‬
‫تس‬‫ل‬
‫ا‬‫ة‬‫ه‬
‫اج‬‫و‬
‫رم‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫‪6.‬‬
‫رئ‬‫ا‬‫و‬
‫لط‬‫ا‬‫ات‬
‫ء‬‫ا‬‫ر‬
‫إج‬‫ةو‬
‫ي‬‫ا‬
‫ق‬‫و‬‫ل‬‫ا‬
‫ات‬‫د‬‫ع‬
‫م‬‫ة‪,‬‬
‫ي‬‫لشخص‬‫ا‬
‫ات‬‫اط‬
‫ي‬‫ت‬‫إلح‬
‫ا‬
‫بس‪.‬‬
‫مال‬
‫ل‬‫ا‬
‫ينو‬
‫ن‬
‫ي‬‫ع‬‫ل‬
‫ا‬
‫دو‬‫ل‬
‫لج‬
‫ا‬‫ة‬‫مس‬
‫نبمال‬
‫ه‪.‬تج‬
‫فس‬‫ن‬
‫روت‬
‫ا‬‫ب‬
‫غ‬‫ل‬
‫ا‬‫ين‬
‫و‬‫ك‬‫نبت‬
‫ة‪.‬تج‬
‫ي‬‫ف‬
‫ا‬‫ةك‬‫ي‬
‫و‬‫ه‬‫دت‬
‫و‬‫دمنوج‬‫ك‬
‫أ‬‫ة‪.‬ت‬
‫ب‬‫اس‬
‫ن‬
‫م‬‫ل‬‫ا‬‫ة‬
‫ي‬‫ا‬
‫ق‬‫و‬
‫ل‬‫ا‬‫ات‬
‫د‬‫ع‬‫مم‬
‫د‬‫تخ‬‫إس‬

‫ة‬‫ي‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬‫اط‬
‫ي‬‫ت‬
‫إلح‬
‫ا‬
‫ة‪.‬‬
‫فض‬‫نخ‬
‫م‬‫ل‬
‫ا‬‫اطق‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫و‬‫أ‬‫ة‬
‫ي‬‫ئ‬
‫ا‬‫م‬
‫ل‬‫ا‬‫ري‬
‫ا‬‫مج‬
‫ل‬‫ا‬‫يف‪,‬‬
‫ر‬‫تص‬
‫ل‬
‫ا‬‫ري‬
‫ا‬‫لىمج‬‫إ‬
‫ا‬‫ه‬‫ل‬
‫و‬‫عدخ‬‫ن‬
‫م‬‫إ‬

‫يف‬‫نظ‬
‫ت‬‫ل‬
‫ا‬‫ءو‬‫ا‬
‫و‬‫ت‬
‫ةلالح‬
‫م‬‫ز‬‫لال‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬
‫يبو‬ ‫ل‬
‫ا‬‫ألس‬
‫ا‬
‫ا‪.‬‬
‫ه‬‫ن‬
‫لصم‬
‫تخ‬
‫ل‬‫ا‬
‫ينو‬
‫ز‬‫تخ‬
‫ل‬
‫ا‬‫عو‬
‫م‬‫لج‬
‫ل‬‫ة‬‫م‬
‫ئ‬‫رقمال‬
‫ملط‬
‫ع‬‫ت‬‫إس‬
‫دو‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫وث‬
‫ل‬‫ت‬
‫بطب‬
‫ت‬
‫ر‬‫يقم‬
‫ر‬‫رح‬
‫وخط‬
‫أ‬‫ا‬‫ه‬
‫ت‬‫ي‬
‫م‬‫الس‬
‫م‬‫ت‬
‫اح‬‫ر‬
‫ب‬‫ت‬
‫اع‬‫اسب‪.‬‬
‫ن‬
‫م‬‫ل‬‫ا‬
‫لص‬‫تخ‬
‫ل‬
‫ا‬‫ين‬
‫لح‬‫ا‬‫ه‬
‫فظ‬‫اح‬
‫ةو‬‫ي‬
‫ر‬‫ا‬
‫ب‬‫ةالغ‬‫ق‬‫ي‬‫ر‬‫الط‬‫م‬
‫ع‬‫ت‬‫اس‬
‫عب‬‫م‬‫اج‬

‫ة‬‫ي‬
‫ف‬‫ا‬
‫إض‬‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬
‫ة‪.‬‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫م‬
‫و‬‫ل‬‫ع‬
‫لىم‬
‫ولع‬
‫لحص‬
‫ل‬‫ات ‪8‬و ‪13‬‬
‫ر‬‫ق‬
‫ف‬‫ل‬
‫ا‬‫ع‬‫اج‬
‫ر‬

‫ين‬
‫ز‬‫تخ‬
‫ل‬‫ا‬
‫ةو‬‫ل‬
‫و‬‫ا‬
‫ن‬‫م‬
‫ل‬‫ا‬
‫‪7.‬‬
‫من‬‫اآل‬
‫ل‬‫م‬‫ا‬‫ع‬‫ت‬
‫ل‬‫اتل‬
‫اط‬‫ي‬‫ت‬
‫إلح‬
‫ا‬
‫ع‬‫قطم‬‫ملف‬‫ع‬‫ت‬
‫إس‬‫ة‪.‬‬‫ي‬
‫ر‬‫ا‬
‫ب‬‫االتغ‬
‫لقح‬‫نبخ‬‫ر‪.‬تج‬
‫ا‬‫ب‬
‫غ‬‫ل‬
‫ا‬‫فس‬‫ن‬
‫نبت‬‫ة‪.‬تج‬‫ي‬
‫ئ‬‫ر‬
‫ةم‬‫م‬
‫ي‬‫ونغ‬
‫د‬‫ءب‬‫ا‬
‫و‬‫ه‬‫ل‬
‫ا‬‫ةفي‬
‫ق‬‫ل‬
‫ا‬‫بحع‬
‫دتص‬
‫تيق‬‫ل‬
‫ا‬‫يت‬‫م‬
‫ي‬‫د‬‫ي‬
‫ر‬‫وت‬
‫أ‬‫و‪/‬‬
‫بالت‪,‬‬
‫و‬‫ت‬
‫يس‬‫ر‬‫ك‬
‫ز‪,‬‬‫ت‬
‫ر‬‫ا‬‫و‬‫ك‬
‫ل‬‫ا‬‫ة‬
‫د‬‫ا‬
‫لىم‬ ‫تجع‬‫ن‬‫م‬
‫ل‬‫ا‬‫ا‬
‫ذ‬‫ويه‬‫ت‬‫يح‬
‫ا‬
‫ذ‬‫مه‬
‫ا‬‫د‬
‫تخ‬‫إس‬‫د‬‫ن‬
‫فئع‬‫ا‬‫ك‬‫فسم‬‫ن‬
‫زت‬‫ا‬
‫ه‬‫وج‬ ‫أ‬
‫بي ‪,EN149‬‬‫و‬
‫ر‬‫و‬‫أ‬
‫ر‬‫ا‬‫ي‬
‫ع‬‫وم‬‫أ‬‫“‪,‬‬
‫‪NI‬‬‫بل”‪OSH‬‬
‫همنق‬‫ي‬
‫ل‬‫دقع‬‫فسمص‬‫ن‬
‫زت‬‫ا‬
‫ه‬‫بسج‬‫ل‬
‫إ‬‫ا‪.‬‬
‫ه‬‫وصىب‬‫م‬‫ل‬
‫ا‬‫رض‬ ‫ع‬‫ت‬
‫ل‬‫ا‬
‫د‬‫و‬‫د‬
‫رضتحتح‬ ‫ع‬
‫ت‬‫ل‬
‫ا‬ ‫ء‬‫ا‬
‫ق‬‫ب‬
‫ةإل‬‫ي‬
‫ف‬‫ا‬
‫ك‬‫ل‬
‫ا‬‫ة‬‫ي‬‫و‬
‫ه‬‫ت‬‫ل‬
‫ا‬
‫ة‪.‬‬
‫ل‬‫ل‬
‫ب‬‫ونم‬‫ك‬
‫ات‬‫م‬‫د‬
‫ن‬‫ةع‬ ‫ق‬
‫ل‬‫ةز‬‫د‬‫ا‬
‫م‬‫ل‬
‫ا‬‫تج‪.‬‬
‫ن‬‫م‬‫ل‬
‫ا‬

‫ا‬
‫ً‬‫ع‬
‫ينم‬‫ز‬
‫تخ‬‫ل‬
‫ا‬‫نب‬‫تييجبتج‬‫ل‬‫ا‬‫د‬
‫ا‬‫و‬‫م‬‫ل‬
‫ا‬‫لك‬
‫افيذ‬‫م‬‫من‪,‬ب‬‫اآل‬
‫ين‬‫ز‬‫تخ‬
‫ل‬‫ا‬‫وط‬‫ر‬‫ش‬
‫ة‬
‫ي‬‫ن‬
‫ا‬‫ملث‬
‫ع‬‫ت‬‫ة‪.‬التس‬
‫ل‬‫م‬
‫ع‬‫ت‬‫ونمس‬
‫ك‬‫االت‬
‫م‬‫د‬
‫ن‬‫ةع‬
‫ي‬‫و‬‫ا‬
‫لح‬
‫ا‬‫لق‬
‫أغ‬
‫ر‪.‬‬
‫ا‬‫ب‬
‫غ‬‫ل‬
‫ا‬‫ع‬‫م‬
‫عتج‬
‫ن‬‫م‬‫ل‬
‫ين‬‫ز‬
‫تخ‬‫ل‬
‫ا‬
‫ملو‬
‫ع‬‫ل‬
‫ا‬‫كن‬
‫ا‬‫م‬‫أ‬
‫دفي‬
‫ي‬‫ليج‬
‫ز‬‫ن‬
‫رم‬‫ي‬
‫ب‬
‫د‬‫ملت‬
‫ع‬‫ت‬‫إس‬
‫لق‬‫غ‬
‫انم‬‫ك‬‫م‬‫زنب‬‫اف‪..‬تخ‬
‫ءوج‬ ‫ا‬
‫و‬‫ه‬‫ل‬
‫ا‬‫يف‬ ‫ك‬
‫انم‬ ‫ك‬‫ينفيم‬‫ز‬
‫تخ‬‫ل‬
‫ا‬
‫ً‪.‬‬
‫ا‬
‫ر‬‫ه‬‫رف ‪36‬ش‬ ‫ل‬
‫ا‬‫لى‬
‫تجع‬ ‫ن‬
‫م‬‫ل‬‫ا‬‫ر‬‫م‬‫ة‪.‬ع‬‫رغ‬‫ا‬
‫ةف‬‫ي‬
‫و‬‫ا‬‫ح‬

‫ة‬
‫ي‬‫لشخص‬
‫ا‬‫ة‬‫ي‬
‫ا‬‫م‬
‫لح‬‫ا‬
‫رض ‪/‬‬
‫ع‬‫ت‬‫ل‬
‫ا‬‫بط‬
‫ا‬
‫و‬‫‪8.‬ض‬
‫م‬‫ك‬
‫تح‬‫ل‬
‫ا‬‫ر‬‫ي‬
‫ي‬‫ا‬
‫ع‬‫م‬
‫رض‬‫ع‬‫ت‬
‫ل‬‫ا‬‫د‬
‫و‬‫د‬‫ح‬
‫يجي‬
‫ل‬‫لخ‬
‫ا‬‫ون‬‫ا‬‫ع‬‫ت‬
‫ل‬‫ا‬
‫لس‬ ‫مج‬ ‫يت‬‫و‬‫ك‬
‫ل‬ ‫ا‬ ‫ين‬
‫ر‬‫بح‬
‫ل‬ ‫ا‬ ‫ة‬
‫د‬‫تح‬
‫م‬‫ل‬
‫ا‬‫ة‬‫ي‬‫ب‬
‫ر‬‫ع‬‫ل‬‫ا‬‫ات‬
‫ر‬‫ا‬
‫م‬‫إل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫‪TWA: 0.1 mg/m3‬‬ ‫‪TWA: 0.1 mg/m3‬‬ ‫‪TWA: 0.1 mg/m3‬‬ ‫‪TWA: 0.1 mg/m3‬‬ ‫‪14808-60-7‬‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫ة‬‫ب‬‫اس‬
‫ن‬‫م‬
‫ل‬‫ا‬‫ة‬
‫ي‬‫دس‬
‫ن‬‫ه‬‫ل‬
‫ا‬‫بط‬‫ا‬
‫و‬‫لض‬‫ا‬
‫ا‪.‬‬
‫ه‬‫ولب‬
‫م‬‫ع‬‫م‬
‫ل‬‫ا‬‫رض‬
‫ع‬‫ت‬‫ل‬
‫ا‬‫د‬‫و‬
‫د‬‫رضتحتح‬
‫ع‬‫ت‬‫ل‬
‫ا‬‫لى‬
‫اظع‬
‫ف‬
‫لح‬‫ل‬
‫وب‬‫ل‬
‫ومط‬
‫اه‬‫م‬
‫ليك‬
‫ممح‬
‫د‬‫ا‬
‫ةوع‬
‫د‬‫م‬‫ت‬
‫ع‬‫ةم‬
‫ي‬‫اع‬
‫ن‬‫ةص‬‫ي‬‫و‬
‫ه‬‫ةت‬
‫ز‬‫ه‬‫أج‬‫مل‬‫ع‬
‫ت‬‫إس‬

‫ة‬‫ي‬
‫لشخص‬ ‫ا‬‫ة‬‫ي‬
‫ا‬‫ق‬
‫و‬‫ل‬‫ا‬
‫ات‬‫د‬‫ع‬
‫لم‬‫ث‬
‫م‬‫ة‪,‬‬‫ي‬
‫د‬‫ر‬‫ف‬‫ل‬
‫ا‬‫ة‬‫ي‬‫ا‬
‫م‬‫لح‬
‫ا‬‫ر‬‫ي‬
‫ب‬‫ا‬
‫د‬‫ت‬
‫و‬
‫أ‬‫ة‬‫ي‬
‫اع‬‫ن‬
‫ةص‬‫ئي صح‬
‫ا‬
‫أخص‬
‫بل‬‫ةمنق‬
‫ي‬‫لشخص‬
‫ا‬‫ة‬‫ي‬
‫ا‬
‫ق‬‫و‬‫ل‬
‫ا‬‫ات‬
‫د‬‫ع‬
‫م‬‫ل‬‫م‬
‫ي‬‫ل‬
‫لس‬
‫ا‬‫م‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫رو‬‫ا‬
‫ي‬
‫ت‬‫اإلخ‬
‫د‬‫ي‬‫د‬
‫غيتح‬
‫ب‬‫ن‬
‫ي‬‫رط‪,‬‬
‫ف‬‫م‬‫ل‬
‫ا‬‫رض‬ ‫ع‬‫ت‬‫ل‬
‫ا‬‫ع‬‫ن‬
‫م‬‫أنت‬‫كن‬‫م‬‫ملالي‬
‫ع‬‫ل‬‫ا‬
‫ات‬‫رس‬‫ا‬‫م‬
‫م‬‫ةو‬‫ي‬
‫دس‬‫ن‬‫ه‬
‫ل‬‫ا‬‫بط‬
‫ا‬‫و‬‫لض‬‫ا‬‫نت‬
‫ا‬‫اك‬
‫ذ‬‫إ‬
‫تج‪.‬‬
‫ن‬
‫م‬‫ل‬‫ا‬‫ا‬
‫ذ‬‫ه‬
‫ل‬‫د‬‫د‬‫مح‬‫ل‬
‫ا‬‫يق‬‫ب‬
‫تط‬‫ل‬‫ا‬
‫لى‬‫إ‬‫د‬‫ن‬
‫ت‬
‫يثيس‬‫ينح‬‫ل‬
‫ه‬‫ؤ‬‫م‬‫ل‬
‫ا‬‫ين‬‫ي‬
‫ن‬‫ف‬
‫ل‬‫ا‬‫امن‬
‫ه‬‫ر‬‫ي‬
‫غ‬
‫فسي‬‫ن‬‫ت‬
‫ل‬‫ا‬‫ز‬
‫ا‬‫ه‬‫لح‬
‫ا‬‫ة‬‫ي‬
‫ا‬‫م‬
‫ح‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/3‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪TAU-MOD‬‬
‫‪05-03-2019‬‬
‫_____________________________________________________________________________________________‬
‫فئ‬
‫ا‬
‫ك‬‫فسم‬‫ن‬‫زت‬
‫ا‬‫ه‬‫وج‬‫أ‬‫و ‪,AS/NZS 1715‬‬
‫أ‬‫بي‪,(EN 149 (FFP2/FFP3‬‬‫و‬
‫ر‬‫و‬‫أ‬‫ر‬‫ا‬‫ي‬
‫ع‬‫م‬‫“‪,‬‬
‫‪NI‬‬ ‫ة”‪OSH‬‬‫ي‬
‫ف‬‫ي‬
‫وظ‬‫ل‬
‫ا‬‫ة‬‫لصح‬‫ا‬‫ةو‬‫م‬
‫لسال‬
‫ل‬‫ني‬
‫وط‬‫ل‬‫ا‬ ‫د‬
‫ه‬‫ع‬‫م‬
‫ل‬‫ا‬‫بل‬
‫همنق‬
‫ي‬‫ل‬
‫دقع‬ ‫فسمص‬ ‫ن‬‫زت‬‫ا‬
‫ه‬‫بسج‬ ‫ل‬
‫إ‬
‫تج‪.‬‬
‫ن‬‫م‬‫ل‬‫ا‬‫ا‬
‫ذ‬‫مه‬‫ا‬
‫د‬‫تخ‬‫إس‬‫د‬‫ن‬‫ع‬
‫د‬‫ي‬‫ل‬
‫ا‬ ‫ة‬
‫ي‬‫ا‬‫م‬‫ح‬
‫دي‪.‬‬‫ا‬
‫ع‬‫ل‬
‫ا‬‫مل‬‫ع‬‫ل‬‫ل‬‫ز‬‫ا‬‫ف‬
‫ق‬
‫د‬
‫ل‬‫لج‬‫ا‬‫ة‬‫ي‬
‫ا‬‫ق‬‫و‬
‫اس‪.‬‬
‫ب‬
‫ل‬‫ل‬
‫ا‬‫وغسل‬ ‫أ‬‫ة‬‫ل‬
‫ا‬‫ز‬
‫إ‬‫د‬‫ن‬‫رع‬‫ا‬‫ب‬‫لقغ‬
‫نبخ‬ ‫تج‬
‫ل‬‫ة‬‫ي‬
‫اط‬‫ي‬
‫ت‬
‫اإلح‬
‫ات‬‫ء‬‫ا‬
‫ر‬ ‫اإلج‬
‫مل‬‫ع‬
‫ت‬‫إس‬
‫ً‪.‬‬
‫ة‬‫ي‬
‫ن‬
‫ا‬‫اث‬
‫ه‬‫ل‬
‫ا‬‫م‬‫ع‬‫ت‬
‫إس‬‫بل‬
‫ةق‬‫ب‬‫ر‬‫ت‬
‫م‬‫ل‬
‫ا‬‫ة‬‫بس‬
‫ل‬‫األ‬
‫مل‪.‬يجبغسل‬‫ع‬
‫ل‬‫ا‬‫ة‬
‫ئ‬‫ي‬‫ب‬
‫ل‬‫ة‬‫ب‬‫اس‬
‫ن‬‫بسم‬‫بسمال‬ ‫ل‬
‫أ‬
‫ين‬‫ع‬‫ل‬
‫ا‬ ‫ة‬
‫ي‬‫ا‬‫م‬‫ح‬
‫ة‪.‬‬
‫ي‬‫ا‬
‫ق‬‫اتو‬
‫ر‬ ‫ا‬
‫ونظ‬‫أ‬‫ة‬‫ي‬
‫ن‬
‫ه‬ ‫م‬‫ل‬
‫ا‬‫ة‬‫م‬
‫لسال‬
‫ا‬‫ات‬
‫ر‬‫ا‬
‫عنظ‬‫رض ض‬ ‫ع‬‫ت‬‫ل‬
‫ا‬‫ةمن‬ ‫ي‬
‫ا‬‫م‬‫لح‬
‫ل‬
‫رى‬‫أخ‬‫ات‬‫اط‬‫ي‬
‫ت‬‫إح‬
‫وف‪.‬‬‫ر‬‫ع‬‫ئىم‬ ‫الش‬

‫ة‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ةو‬
‫ي‬‫ئ‬
‫ا‬‫ي‬
‫ز‬‫ي‬
‫ف‬‫ل‬
‫ا‬‫ئص‬
‫ا‬‫لخص‬
‫ا‬
‫‪9.‬‬
‫ة‪:‬‬ ‫ي‬‫د‬
‫ا‬‫م‬‫ل‬‫ا‬‫ة‬‫ل‬‫ا‬‫لح‬‫ا‬
‫وق‬ ‫مسح‬
‫ون‪:‬‬ ‫ل‬
‫دي‬‫ا‬‫م‬
‫لىر‬ ‫إ‬‫ر‬ ‫م‬‫أس‬ ‫لى‬‫إ‬‫دي‬ ‫ر‬‫و‬
‫ة‪:‬‬‫ئح‬ ‫ا‬
‫ر‬
‫دل‬‫ت‬‫ع‬
‫بيم‬ ‫ا‬‫ر‬‫ت‬
‫ة‪:‬‬‫ئح‬‫ا‬
‫ر‬ ‫ل‬
‫نىل‬ ‫د‬‫أل‬
‫ا‬ ‫د‬‫لح‬‫ا‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫‪pH:‬‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫ة‬‫ي‬‫وع‬ ‫ن‬
‫ل‬‫ا‬‫ة‬‫ي‬‫ب‬‫ذ‬‫ا‬‫لج‬‫ا‬
‫‪1.9 - 2.4‬‬
‫ة(‪:‬‬‫ي‬‫و‬‫ئ‬‫م‬‫دى )‬‫د ‪/‬م‬ ‫م‬‫تج‬‫ل‬‫ا‬‫ة‬‫قط‬ ‫ن‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫ة‬ ‫قط‬‫ن‬‫ل‬
‫ة‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫ة(‪:‬‬ ‫ي‬
‫و‬‫ئ‬‫ةم‬ ‫رج‬‫د‬‫دى )‬ ‫م‬‫ل‬
‫ا‬ ‫ان‬‫ي‬‫ل‬
‫ةغ‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫ة(‪:‬‬‫ي‬
‫و‬ ‫ئ‬
‫م‬‫دى )‬ ‫م‬‫ل‬
‫ا‬‫يض ‪/‬‬ ‫م‬‫و‬‫ل‬‫ا‬‫ة‬‫قط‬ ‫ن‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫يض‪:‬‬ ‫م‬‫و‬‫ل‬
‫ا‬ ‫ة‬‫قط‬‫ةن‬ ‫ق‬‫ي‬‫ر‬‫ط‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫فض )‪(%‬‬ ‫نخ‬‫دم‬ ‫و ‪-‬ح‬ ‫لج‬‫ا‬‫لفي‬ ‫ا‬
‫ع‬‫ت‬‫إلش‬‫ا‬ ‫ة‬
‫ي‬‫ل‬‫ب‬
‫ا‬‫دق‬ ‫و‬‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫وي )‪(%‬‬‫ل‬
‫دع‬ ‫و ‪-‬ح‬ ‫لج‬‫ا‬‫لفي‬ ‫ا‬
‫ع‬‫ت‬‫إلش‬‫ا‬ ‫ة‬
‫ي‬‫ل‬‫ب‬
‫ا‬‫دق‬ ‫و‬‫د‬‫ح‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫ة(‪:‬‬‫ي‬
‫و‬‫ئ‬
‫ةم‬ ‫رج‬ ‫د‬
‫تي )‬‫ا‬
‫ذ‬ ‫ل‬
‫ا‬ ‫ل‬‫ا‬‫ع‬
‫ت‬‫الش‬‫ا‬‫ة‬ ‫ر‬‫ا‬
‫ر‬‫ةح‬ ‫رج‬‫د‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫ل ‪:(= 1‬‬ ‫ي‬‫ت‬‫و‬‫ي‬‫ب‬
‫ل‬‫ا‬‫ر )خالت‬ ‫بخ‬‫ت‬‫ل‬
‫ا‬ ‫ة‬‫رع‬ ‫س‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫بق(‬
‫ئ‬‫مز‬‫ل‬‫م‬‫ة)‬‫ي‬‫و‬
‫ئ‬‫ة ‪20‬م‬ ‫ر‬‫ا‬‫ر‬‫ةح‬ ‫رج‬ ‫ة @د‬ ‫ر‬‫بخ‬‫أل‬
‫ا‬ ‫غط‬ ‫ض‬
‫ة‪.‬‬‫اح‬‫ت‬‫اتم‬ ‫م‬‫و‬ ‫ل‬
‫ع‬‫دم‬ ‫وج‬ ‫الت‬
‫ء‪=1‬‬ ‫ا‬‫و‬‫ر)ه‬ ‫ا‬‫بخ‬‫ل‬
‫ا‬ ‫ة‬‫ف‬‫ا‬‫ث‬‫ك‬
‫(‬

‫ء‬‫ا‬‫م‬
‫ل‬‫ا‬‫انفي‬‫ب‬‫و‬‫ذ‬
‫ل‬‫ا‬
‫ء‬‫ا‬‫م‬
‫ل‬‫ا‬‫انفي‬‫ب‬
‫و‬‫ذ‬‫ل‬
‫ل‬‫ة‬‫ل‬
‫ب‬‫ا‬
‫رق‬ ‫ي‬
‫غ‬
‫ة (‪:‬‬
‫ي‬‫و‬‫ئ‬‫ل )م‬‫ل‬
‫تح‬‫ل‬
‫ا‬‫ة‬‫ر‬
‫ا‬‫ر‬‫ةح‬ ‫رج‬
‫د‬
‫ة‪.‬‬‫اح‬
‫ت‬‫اتم‬‫م‬‫و‬‫ل‬
‫ع‬‫دم‬‫وج‬‫الت‬
‫ز(‪:‬‬
‫و‬‫ي‬‫ب‬
‫ي‬‫ت‬
‫ن‬‫ة )س‬
‫ي‬‫و‬‫ئ‬
‫ةم‬‫رج‬‫ة ‪‌@ 20‬د‬ ‫ي‬
‫ك‬‫ي‬‫م‬
‫ا‬‫ن‬
‫ي‬‫ة‪,‬د‬‫وج‬‫ز‬‫ل‬

‫وك(‪:‬‬
‫ر‬‫ت‬‫يس‬
‫ت‬‫ن‬
‫ة )س‬
‫ي‬‫و‬‫ئ‬
‫ةم‬‫رج‬
‫ة ‪‌‌@ 20‬د‬
‫ي‬‫ك‬‫ر‬
‫ة‪,‬ح‬
‫وج‬‫ز‬
‫ل‬

‫ء‪:‬‬
‫ا‬‫لم‬ ‫و‬‫ن‬
‫ا‬‫ت‬
‫ك‬‫أ‬‫عن‪-‬‬‫ي‬
‫ز‬‫و‬‫ت‬‫ل‬
‫ا‬‫ل‬‫م‬
‫ا‬‫ع‬‫م‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬
‫الت‬
‫زئ (‪:‬‬‫ئى )غج‬
‫ي‬‫ز‬
‫لج‬‫ا‬‫زن‬‫و‬‫ل‬
‫ا‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬
‫الت‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/4‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪TAU-MOD‬‬
‫‪05-03-2019‬‬
‫_____________________________________________________________________________________________‬
‫ة‬
‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬‫اتو‬
‫ب‬‫ث‬
‫ل‬‫ا‬
‫‪10.‬‬
‫ة‬‫ي‬‫ل‬
‫اع‬‫ف‬
‫ت‬‫ل‬
‫ا‬
‫يط‬
‫نش‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫د‬
‫ا‬‫إع‬
‫ع‬‫ق‬‫و‬
‫ت‬‫م‬‫ل‬
‫ا‬‫يسمن‬‫ل‬

‫ئي‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫ات‬
‫ب‬‫ث‬‫ل‬
‫ا‬
‫ر‬‫ق‬
‫ت‬‫مس‬

‫ة‬
‫ر‬‫لخط‬
‫ا‬‫اعالت‬
‫ف‬‫ت‬
‫ل‬‫ا‬‫ل‬
‫ا‬‫م‬‫ت‬
‫اح‬
‫دث‬‫لنيح‬

‫ا‬
‫ه‬‫ب‬
‫ن‬‫تييجبتج‬
‫ل‬‫ا‬‫وف‬
‫ر‬‫لظ‬‫ا‬
‫ع‪.‬‬‫ق‬
‫و‬‫ت‬
‫يئم‬‫الش‬

‫ا‬
‫ه‬‫ن‬
‫ب‬‫ديجبتج‬
‫ا‬‫و‬‫م‬
‫ء‬
‫ا‬‫م‬‫ل‬
‫ا‬‫ر‬‫و‬‫ل‬
‫مضف‬‫ح‬

‫ة‬‫ر‬
‫لخط‬
‫ا‬‫كك‬‫ف‬‫ت‬
‫ل‬‫ا‬‫ات‬‫تج‬‫ن‬
‫م‬
‫ة(‬
‫ي‬‫و‬‫ئ‬
‫بالت )‪1470‬م‬
‫و‬‫ت‬
‫يس‬‫ر‬
‫ك‬‫ل‬‫ا‬
‫و‬‫أ‬‫ة(‬
‫ي‬‫و‬‫ئ‬
‫يت )‪870‬م‬
‫م‬‫د‬
‫ي‬‫ر‬‫ت‬
‫ل‬
‫ا‬‫ة‬‫د‬
‫ا‬‫لىم‬
‫إ‬‫ة‬‫ع‬
‫ف‬‫ت‬
‫ر‬‫ةم‬
‫ر‬‫ا‬
‫ر‬‫اتح‬
‫رج‬‫ولفيد‬
‫تح‬‫دت‬
‫ةق‬‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫م‬‫ل‬
‫ا‬‫ر‬‫ي‬
‫اغ‬ ‫ك‬
‫ي‬‫ل‬‫ي‬
‫لس‬
‫ا‬

‫ة‬
‫ي‬‫ف‬
‫ا‬‫إض‬
‫ات‬‫ه‬‫ي‬
‫وج‬ ‫ت‬
‫بق‬
‫نط‬‫الت‬

‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪11.‬‬
‫ة‬ ‫ي‬
‫م‬‫لس‬‫ا‬‫ات‬‫ر‬‫ي‬
‫ث‬‫أ‬‫اتعنت‬ ‫م‬‫و‬‫ل‬
‫ع‬‫م‬
‫ة‬
‫د‬‫ا‬‫لح‬
‫ا‬ ‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫اق‬‫نش‬‫ت‬‫إس‬
‫د‬
‫ة‪.‬ق‬
‫ئ‬‫ر‬‫ل‬
‫ل‬‫ة‬‫م‬
‫ئ‬‫ا‬
‫رد‬‫ا‬
‫ر‬‫أض‬
‫دث‬‫دتح‬
‫هق‬‫ن‬
‫أ‬‫ممن‬
‫رغ‬‫ل‬
‫ا‬
‫وظب‬
‫لح‬‫رضم‬ ‫وم‬‫أ‬‫رح‬‫لحقج‬‫دالي‬
‫اق‬‫ك‬
‫ي‬‫ل‬
‫ي‬‫لس‬
‫ا‬‫ر‬‫ا‬
‫ب‬‫اقغ‬‫نش‬
‫ت‬‫ة‪.‬إس‬
‫ي‬‫فس‬
‫ن‬‫ت‬
‫ل‬‫ا‬
‫ات‬‫ر‬
‫م‬‫م‬‫ل‬‫ا‬
‫و‬‫ة‪,‬‬
‫ر‬‫نج‬
‫لح‬‫ا‬‫نف‪,‬‬‫األ‬‫يج‬
‫ه‬‫ببت‬ ‫ديس‬
‫اق‬ ‫ك‬
‫ي‬‫ل‬
‫ي‬‫لس‬‫ا‬
‫ر‬ ‫ا‬
‫ب‬‫اقغ‬‫نش‬‫ت‬‫إس‬
‫ه(‪" .‬‬
‫ا‬‫ن‬
‫د‬‫أ‬‫م‬
‫قس‬‫ل‬
‫ا‬‫ان "‬
‫رط‬‫لس‬
‫ا‬‫ببفي‬‫ة‪/‬تس‬
‫ن‬‫م‬‫ز‬
‫م‬‫ل‬‫ا‬
‫ات‬‫ر‬‫ي‬‫ث‬
‫أ‬
‫ت‬‫ل‬
‫ا‬‫ع‬‫اج‬
‫ر‬‫ة)‬
‫ر‬‫ي‬‫ةخط‬‫ن‬‫م‬‫ز‬‫ةم‬ ‫ي‬
‫ات صح‬ ‫ر‬‫ي‬
‫ث‬‫أ‬
‫رت‬ ‫ا‬‫ب‬
‫غ‬‫ل‬
‫ا‬ ‫اق‬
‫نش‬‫ت‬‫إس‬‫ال‬‫يض‬ ‫أ‬‫ون‬‫ك‬‫ي‬
‫ين‬
‫ع‬‫ل‬‫ا‬‫ة‬‫مس‬‫مال‬
‫ين‪.‬‬‫ع‬‫ل‬
‫ل‬‫كي‬ ‫ي‬
‫ن‬‫ا‬
‫ك‬‫ي‬‫ًم‬
‫ا‬‫يج‬
‫ه‬‫ببت‬ ‫ديس‬‫ق‬
‫د‬‫ل‬
‫لج‬‫ا‬‫ة‬‫مس‬‫مال‬
‫د‪.‬‬
‫ل‬‫لج‬‫ل‬‫يط‬‫يجبس‬‫ه‬‫ببت‬‫أنيس‬ ‫كن‬‫م‬‫ي‬
‫تالع‬
‫ب‬‫إل‬
‫ا‬
‫ال‪.‬‬
‫ه‬‫اإلس‬
‫ان‪,‬و‬‫ي‬‫ث‬‫ف‬
‫ل‬
‫ا‬ ‫ء‬
‫قي‬‫ل‬
‫ا‬ ‫بطن‪,‬‬
‫ل‬‫ا‬‫مفي‬ ‫ل‬
‫أ‬‫بب‬‫أنيس‬ ‫كن‬‫م‬‫ي‬

‫ة‬‫ي‬
‫ن‬‫ا‬
‫رط‬‫ةس‬ ‫ن‬
‫م‬‫ز‬‫اتم‬‫ر‬
‫ي‬‫ث‬‫أ‬
‫ت‬
‫د‬
‫ريق‬‫و‬‫ل‬
‫ب‬‫ل‬
‫ا‬‫ا‬
‫ك‬‫ي‬‫ل‬
‫ي‬‫لس‬
‫ا‬‫ر‬‫ا‬
‫ب‬
‫غ‬‫ل‬‫رط‬‫ف‬‫م‬
‫ل‬‫ا‬‫اق‬
‫نش‬‫ت‬
‫اإلس‬
‫ني‪:‬‬
‫و‬‫ك‬‫ي‬
‫ل‬
‫لس‬ ‫ا‬‫ر‬
‫ا‬‫ّح‬
‫لس‬
‫ا‬‫ة‬
‫ر‬‫ر‬‫ك‬‫ت‬
‫وم‬‫أ‬‫ة‬‫ل‬
‫ي‬
‫و‬‫اتط‬ ‫ر‬‫ت‬
‫ف‬‫ل‬‫رض‬‫ع‬‫ت‬‫ل‬
‫ا‬ ‫ءمنخالل‬‫ا‬
‫لألعض‬‫ا‬
‫ً‬
‫ف‬‫ل‬
‫ببت‬‫ديس‬‫اق‬
‫ه‬‫هب‬
‫ب‬‫ت‬
‫ومش‬ ‫أ‬
‫ة‬ ‫ف‬
‫و‬‫ر‬‫ع‬‫ةم‬ ‫ن‬
‫رط‬‫دمس‬‫ا‬
‫و‬‫لىم‬‫ويع‬‫ت‬‫يح‬
‫ة‪.‬‬
‫ي‬‫و‬‫ئ‬
‫ر‬‫ل‬
‫ا‬‫ة‬‫ف‬
‫ي‬‫وظ‬
‫ل‬‫ا‬‫يضفي‬‫ف‬‫تخ‬
‫و‬‫د‪,‬‬
‫د‬‫رمح‬‫ي‬
‫ريغ‬ ‫د‬
‫رض ص‬ ‫م‬‫فسي‪,‬‬‫ن‬
‫زت‬‫ي‬
‫ز‬‫أ‬
‫فس‪,‬‬
‫ن‬‫ت‬
‫ل‬‫ا‬
‫يق‬‫ال‪,‬ض‬‫ع‬‫لس‬
‫ا‬‫اض‬‫ر‬‫األع‬‫من‬‫تض‬‫ر‪.‬ت‬
‫ا‬‫ّح‬
‫لس‬
‫ا‬‫دعى‬‫يني‬
‫ت‬‫ئ‬
‫ر‬‫ل‬‫ل‬‫يت‬
‫م‬‫رضم‬ ‫ام‬‫ن‬‫ا‬
‫ي‬‫أح‬
‫و‬‫عطال‪,‬‬‫م‬
‫يجي‪,‬‬
‫ر‬‫د‬‫ات‬
‫رض‬ ‫ببم‬‫يس‬
‫لسل‪.‬‬
‫ا‬‫رض‬ ‫رم‬‫ي‬
‫و‬ ‫تط‬‫ل‬‫د‬‫ا‬
‫د‬‫ع‬
‫ت‬‫اس‬‫م‬
‫ه‬‫ي‬‫د‬
‫ل‬‫ر‬‫ا‬
‫ّح‬
‫لس‬‫ا‬
‫ينب‬‫ب‬
‫ا‬‫مص‬‫ل‬
‫ا‬‫د‬‫ا‬
‫ر‬‫ف‬
‫األ‬
‫ين‪.‬‬‫دخ‬‫ت‬
‫ل‬
‫ا‬ ‫يق‬‫ر‬‫رضعنط‬ ‫م‬‫ل‬
‫ا‬‫ا‬‫ذ‬
‫مه‬‫ق‬‫ا‬
‫ف‬‫ت‬
‫ي‬

‫ات‬
‫ن‬‫و‬
‫ك‬‫م‬‫ل‬
‫ةل‬‫ي‬
‫م‬‫لس‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ة‬
‫ي‬‫يس‬
‫ئ‬
‫ر‬‫ل‬‫ا‬

‫اق ‪LC50‬‬
‫نش‬‫ت‬
‫إس‬ ‫د‬
‫ل‬‫لج‬
‫ا‬‫يق‬
‫ر‬‫‪LD50‬عنط‬ ‫م‬‫ف‬
‫ل‬‫ا‬‫يق‬‫ر‬
‫‪LD50‬عنط‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫ن‬
‫ا‬
‫ي‬‫دب‬
‫وج‬‫الت‬ ‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫ن‬‫ا‬
‫ي‬‫دب‬
‫وج‬‫الت‬ ‫)‪> 15000 mg/kg (human‬‬ ‫‪14808-60-7‬‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫يج‬
‫ه‬‫د ‪/‬ت‬
‫ل‬‫لج‬
‫ا‬‫ل‬‫ك‬
‫آ‬‫ت‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫د‬
‫ل‬‫لج‬
‫ل‬‫ة‬‫يج‬
‫ه‬‫رم‬
‫ُ‬ ‫ي‬
‫‪ 14808-60-7‬غ‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫يج‬‫ه‬‫ين ‪/‬ت‬
‫ع‬‫ل‬‫ا‬
‫ر‬‫ر‬‫تض‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫ينالت‬
‫ع‬‫ل‬‫ل‬‫ة‬
‫زعج‬‫رم‬
‫ي‬‫‪ 14808-60-7‬غ‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫ة‬
‫ي‬‫د‬‫ل‬
‫لج‬
‫ا‬‫ة‬‫ي‬‫اس‬
‫لحس‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬‫وج‬
‫‪ 14808-60-7‬الت‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫فسي‬
‫ن‬‫ت‬
‫ل‬‫ا‬‫تحسس‬‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫‪ 14808-60-7‬الت‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/5‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪TAU-MOD‬‬
‫‪05-03-2019‬‬
‫_____________________________________________________________________________________________‬

‫ة‬
‫ي‬‫ر‬‫ف‬‫لط‬
‫ا‬‫ر‬‫ا‬
‫ث‬‫اآل‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ر‪.‬‬‫ف‬
‫مط‬‫رك‬‫ب‬
‫ت‬‫ع‬
‫‪ 14808-60-7‬الي‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫ة‬‫ن‬
‫رط‬‫اتمس‬ ‫ر‬‫ي‬‫ث‬
‫أ‬‫ت‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ان‬
‫رط‬‫لس‬
‫ا‬‫وث‬‫ةبح‬
‫ر‬‫ا‬
‫د‬‫إ‬‫نت‬‫ق‬
‫ي‬‫دت‬
‫ق‬‫ة(‪,‬و‬
‫ئ‬‫ر‬‫ل‬
‫ا‬‫ر‬‫تحج‬‫ة)‬
‫ئ‬‫ر‬‫ل‬
‫ل‬‫ة‬‫ل‬
‫ؤج‬‫ةم‬
‫ي‬‫د‬‫اع‬
‫ةتص‬ ‫ب‬
‫ا‬
‫إص‬ ‫ر‪,‬‬
‫ا‬‫لسح‬
‫ا‬‫بب‬‫أنتس‬‫مل‬
‫ت‬‫تىيح‬‫ل‬
‫ا‬‫ة‬‫ر‬‫و‬‫ل‬
‫ب‬‫ت‬
‫وم‬‫أ‬
‫ة‬‫ي‬‫ر‬
‫و‬‫ل‬‫اب‬
‫ك‬‫ل‬
‫ي‬‫لىس‬
‫وىع‬ ‫ت‬‫‪ 14808-60-7‬تح‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬
‫فسي‪.‬‬
‫ن‬‫ت‬
‫ل‬
‫ا‬‫ز‬‫ا‬
‫ه‬‫لج‬
‫ل‬‫ر‬‫ر‬‫ك‬‫ت‬
‫م‬‫ل‬
‫ا‬‫رض‬ ‫ع‬‫ت‬
‫ل‬‫ا‬‫د‬‫ن‬
‫ةع‬‫ن‬
‫رط‬ ‫ةمس‬‫ر‬
‫و‬‫ل‬‫ب‬
‫ت‬
‫م‬‫ل‬‫ا‬
‫و‬‫أ‬‫ة‬‫ي‬
‫ر‬‫و‬‫ل‬‫ب‬
‫ل‬
‫ا‬‫ا‬‫ك‬
‫ل‬‫ي‬
‫لس‬‫ا‬‫أن‬‫بت‬‫ث‬
‫تىت‬‫ل‬
‫ا‬‫ة‬‫ي‬
‫ف‬‫ا‬
‫ك‬‫ل‬
‫ا‬‫ة‬‫ل‬
‫د‬‫األ‬
‫ا‬‫ه‬‫ي‬
‫د‬‫ل‬‫أن‬
‫لك ‪NTP‬‬‫ذ‬
‫ك‬‫ة "‪IARC",‬و‬
‫ي‬‫ل‬
‫و‬‫د‬‫ل‬
‫ا‬

‫ة‬‫ي‬‫ل‬
‫اس‬‫ن‬
‫ت‬‫ل‬
‫ا‬‫ة‬‫ي‬‫م‬
‫لس‬ ‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬‫وج‬‫‪ 14808-60-7‬الت‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫ة‬‫د‬
‫اح‬‫ةو‬‫ر‬‫رضم‬ ‫ع‬‫ت‬
‫ل‬‫م ‪STOT-CAS‬‬
‫ا‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫يف‪.‬‬
‫ن‬
‫تص‬‫ل‬
‫ا‬‫لب‬
‫تط‬‫زت‬
‫ي‬‫ك‬‫ر‬
‫ةفيت‬
‫ي‬‫ن‬
‫ا‬‫و‬
‫ي‬‫لح‬
‫ا‬‫ات‬
‫اس‬
‫ر‬‫د‬‫ل‬
‫ا‬‫ةفي‬
‫ر‬‫ي‬‫ب‬
‫ةك‬‫ي‬
‫م‬‫أيس‬‫ميالحظ‬
‫‪ 14808-60-7‬ل‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫ر‬‫ر‬‫ك‬
‫ت‬‫م‬‫ل‬
‫ا‬‫رض‬ ‫ع‬‫ت‬‫ل‬
‫ا‬
‫‪STOT -‬‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ين‬
‫ت‬
‫ئ‬‫ر‬‫ل‬
‫ا‬‫ه‬‫ق‬
‫ا‬‫نش‬
‫ت‬
‫ةإس‬
‫ل‬‫ا‬
‫ةفيح‬
‫ر‬‫ر‬‫ك‬
‫ت‬‫م‬‫ل‬
‫ا‬‫و‬‫أ‬
‫ة‬‫ل‬‫ي‬
‫و‬‫اتط‬
‫ر‬‫ت‬
‫ف‬‫ل‬
‫رض‬‫ع‬
‫ت‬‫ل‬
‫ا‬‫ءمنخالل‬‫ا‬
‫األعض‬
‫رب‬‫ا‬
‫ر‬‫اإلض‬
‫بب‬‫‪ 14808-60-7‬يس‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫فط‬
‫لس‬‫ا‬
‫ر‬‫خط‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫بق‬
‫نط‬‫‪ 14808-60-7‬الت‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫ة‬
‫ئ‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫ات‬
‫ن‬‫و‬
‫ل‬‫ع‬‫م‬
‫‪12.‬‬
‫ة‬
‫ي‬‫م‬‫لس‬
‫ا‬
‫ات‬
‫ي‬‫ر‬
‫ا‬‫ق‬‫ف‬
‫ةال‬
‫ي‬‫م‬‫س‬ ‫ة‬‫ق‬
‫ي‬‫ق‬
‫د‬‫ل‬
‫ا‬‫ات‬
‫ن‬‫ئ‬‫ا‬
‫ك‬‫ل‬
‫ةل‬‫ي‬
‫م‬‫س‬ ‫مك‬‫لس‬‫ةل‬‫ي‬‫م‬‫لس‬ ‫ا‬ ‫لب‬‫ا‬
‫لطح‬‫ةل‬‫ي‬‫م‬‫لس‬ ‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫‪LL50(24 h)>10000 mg/L‬‬ ‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬
‫‪ LL0(96 h)=10000 mg/L‬الت‬ ‫‪EC50(72 h)=440 mg/L‬‬ ‫‪14808-60-7‬‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬
‫)‪(Daphnia magna‬‬ ‫)‪(Danio rerio‬‬ ‫‪(Pseudokirchneriella‬‬
‫)‪subcapitata‬‬

‫ل‬
‫ل‬‫تح‬
‫ل‬‫ا‬
‫ءو‬‫ا‬
‫ق‬‫ب‬
‫ل‬‫ا‬

‫ل‬‫ل‬
‫تح‬‫ل‬
‫ا‬‫اتو‬
‫ب‬‫ث‬‫ل‬
‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‪.‬‬
‫ي‬‫و‬‫عض‬
‫ل‬‫ا‬‫ر‬
‫ي‬‫دغ‬
‫ا‬‫و‬
‫م‬‫ل‬‫ا‬
‫لى‬‫بقع‬
‫نط‬‫وجيالت‬
‫ل‬‫و‬‫ي‬
‫ب‬
‫ل‬‫ا‬‫لل‬
‫تح‬
‫ل‬‫ا‬
‫د‬‫ي‬‫د‬
‫تح‬‫ل‬‫رق‬
‫لط‬‫ا‬ ‫‪14808-60-7‬‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫ئي‬
‫ا‬‫ي‬
‫ألح‬
‫ا‬‫م‬‫ك‬
‫ا‬‫ر‬‫ت‬
‫ل‬‫ا‬‫لى‬
‫ةع‬‫ر‬
‫د‬‫ق‬‫ل‬
‫ا‬

‫وجي‬
‫ل‬‫و‬‫ي‬
‫ب‬‫ل‬
‫ا‬‫م‬‫ك‬
‫ا‬‫ر‬‫ت‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬
‫و‬‫ل‬‫ع‬
‫دم‬‫وج‬‫الت‬ ‫‪14808-60-7‬‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫ة‬
‫ب‬‫ر‬‫ت‬
‫ل‬‫ا‬‫ةفي‬
‫ك‬‫ر‬‫لح‬
‫ا‬

‫ل‬‫ق‬
‫ن‬‫ت‬
‫ل‬‫ا‬ ‫م ‪CAS‬‬ ‫ق‬‫ر‬ ‫د‬
‫ا‬‫و‬‫م‬
‫ل‬‫ا‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬
‫م‬‫و‬‫ل‬
‫ع‬‫دم‬
‫وج‬‫الت‬ ‫‪14808-60-7‬‬ ‫ز‬
‫ت‬‫ر‬‫ا‬
‫و‬‫ة‪,‬ك‬
‫ر‬‫و‬‫ل‬
‫ب‬
‫ت‬‫ام‬
‫ك‬‫ي‬
‫ل‬‫س‬

‫رى‬‫ألخ‬
‫ا‬‫ة‬‫ي‬‫ب‬
‫ل‬‫لس‬
‫ا‬‫ر‬‫ا‬
‫ث‬‫اآل‬
‫ة‬
‫اح‬‫ت‬
‫اتم‬‫م‬ ‫و‬
‫ل‬‫ع‬‫دم‬
‫وج‬‫الت‬

‫ات‬
‫ي‬‫ا‬
‫ف‬‫ن‬
‫ل‬‫ا‬‫اصمن‬
‫تخ‬‫ل‬
‫ا‬‫ات‬
‫ر‬‫ا‬
‫ب‬‫ت‬
‫إع‬‫‪13.‬‬
‫ات‬‫ي‬
‫ا‬‫ف‬‫ن‬
‫ل‬‫ا‬‫ة‬
‫لج‬‫ا‬‫ع‬
‫رقم‬ ‫ط‬
‫لص‬‫تخ‬‫ل‬
‫ا‬ ‫ةفي‬‫م‬‫د‬‫تخ‬
‫مس‬‫ل‬‫ا‬‫ة‬‫ق‬‫ي‬
‫ر‬‫لط‬‫ا‬
‫ا‪.‬‬
‫ه‬‫ن‬
‫لصم‬
‫تخ‬
‫ل‬‫ا‬
‫اتو‬
‫ي‬
‫ا‬‫ف‬
‫ن‬‫ل‬
‫ا‬‫ة‬
‫ر‬‫ا‬
‫د‬‫إ‬‫رق‬
‫لط‬‫ا‬
‫ه‬‫ولب‬‫م‬‫ع‬
‫م‬‫ل‬
‫ا‬‫ة‬‫ي‬
‫ل‬‫مح‬‫ل‬‫ا‬
‫ةو‬‫ي‬
‫م‬ ‫و‬‫ق‬
‫ل‬
‫ا‬‫د‬‫اع‬‫و‬‫ق‬
‫ل‬‫ا‬‫ع‬‫ب‬
‫ت‬‫إ‬
‫وث‬‫ل‬‫يفم‬‫ل‬‫غ‬‫ت‬
‫ة‪.‬‬
‫ي‬‫ل‬
‫مح‬‫ل‬
‫ا‬‫ةو‬ ‫ي‬
‫م‬‫و‬‫ق‬
‫ل‬‫ا‬‫ئح‬‫ا‬
‫و‬‫ل‬
‫ل‬‫ا‬‫ع‬‫ي‬
‫م‬‫عج‬ ‫ب‬
‫ت‬‫إ‬
‫رى‬‫أخ‬‫ات‬‫م‬‫و‬‫ل‬‫ع‬
‫م‬
‫ة‪.‬‬
‫اح‬‫ت‬
‫اتم‬ ‫م‬‫و‬
‫ل‬‫ع‬‫دم‬‫وج‬‫الت‬

‫ل‬
‫ق‬‫ن‬‫ل‬
‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪14.‬‬
‫ة"‬
‫د‬‫تح‬
‫م‬‫ل‬
‫ا‬‫م‬‫م‬
‫أل‬
‫ا‬‫م ‪"UN‬‬
‫ق‬‫ر‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/6‬‬
‫فح‬‫ص‬
‫ة‬‫ع‬‫اج‬
‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬‫ر‬‫ا‬‫ت‬ ‫®‪TAU-MOD‬‬
‫‪05-03-2019‬‬
‫_____________________________________________________________________________________________‬
‫د‬
‫ي‬‫ق‬
‫رم‬‫ي‬
‫غ‬

‫يح ‪UN:‬‬
‫لصح‬
‫ا‬‫ل‬‫ق‬
‫ن‬‫ل‬
‫ا‬‫م‬‫إس‬
‫د‬‫ي‬
‫ق‬‫رم‬‫ي‬
‫غ‬

‫ل‪:‬‬
‫ق‬‫ئطن‬
‫ا‬‫ةوس‬
‫ر‬‫و‬‫ةخط‬‫ب‬‫ت‬
‫ر‬
‫بق‬
‫نط‬‫الت‬

‫ة‪:‬‬
‫ئ‬‫ب‬
‫ع‬‫ت‬
‫ل‬‫ا‬‫ة‬‫وع‬‫م‬
‫مج‬
‫بق‬‫نط‬
‫الت‬

‫ة‪:‬‬
‫ي‬‫ئ‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫اط‬‫مخ‬‫ل‬‫ا‬
‫بق‬‫نط‬‫الت‬

‫م‪:‬‬
‫د‬‫تخ‬
‫مس‬‫ل‬
‫ةل‬‫اص‬
‫اتخ‬
‫اط‬‫ي‬
‫ت‬‫إح‬
‫ء‬
‫الشي‬

‫ة ‪IBC:‬‬
‫ن‬‫و‬‫د‬
‫ل ‪78/73‬وم‬
‫و‬‫ب‬‫ر‬
‫ا‬‫نيمن )‪(MARPOL‬م‬
‫ا‬‫ث‬
‫ل‬‫ا‬
‫فق‬‫ر‬
‫م‬‫ل‬‫ال‬
‫ق‬‫ف‬
‫ةو‬‫ر‬
‫ي‬‫ب‬
‫اتك‬
‫ي‬‫م‬‫ك‬
‫لب‬‫ق‬‫ن‬
‫ل‬‫ا‬
‫بق‬‫نط‬
‫الت‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫اتت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪15.‬‬

‫ة‬
‫ي‬‫م‬‫ي‬
‫نظ‬‫ت‬
‫ل‬‫ا‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬
‫ا‪.‬‬
‫ه‬‫ت‬
‫يال‬
‫د‬‫ع‬
‫ت‬‫ا )‪"(GHS‬و‬
‫ه‬‫م‬‫وس‬
‫ةو‬‫ي‬
‫ئ‬
‫ا‬‫ي‬
‫م‬‫ي‬
‫ك‬‫ل‬
‫ا‬‫د‬‫ا‬
‫و‬‫م‬‫ل‬
‫ا‬‫يف‬
‫ن‬
‫تص‬‫ل‬
‫ا‬
‫ً‬‫ي‬
‫م‬‫ل‬
‫ا‬‫نسقع‬
‫م‬‫ل‬
‫ا‬‫م‬‫ا‬
‫نظ‬‫ل‬
‫ا‬
‫ة"‬‫د‬
‫تح‬‫م‬
‫ل‬‫ا‬‫م‬
‫م‬‫لأل‬
‫ا‬‫ق‬
‫ف‬‫ه ‪SDS‬و‬‫ذ‬‫ده‬
‫ا‬‫د‬
‫إع‬‫م‬‫ت‬

‫رى‬
‫أخ‬‫ات‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫‪16.‬‬
‫ات‬
‫ن‬‫ا‬
‫ي‬‫ب‬
‫ل‬‫ا‬‫ر‬
‫د‬‫ا‬‫مص‬
‫ةو‬‫ي‬
‫يس‬‫ئ‬
‫ر‬‫ل‬
‫ا‬‫ات‬
‫ي‬‫ب‬
‫د‬‫أل‬
‫ا‬‫ع‬‫اج‬
‫ر‬‫م‬
‫‪[Link]/‬‬
‫‪NZ CCID‬‬

‫ة‬‫ع‬‫اج‬‫ر‬‫م‬‫ل‬
‫ا‬‫يخ‬
‫ر‬ ‫ا‬
‫ت‬
‫‪05-03-2019‬‬
‫يح‬‫ق‬‫ن‬‫ت‬
‫ل‬‫ا‬‫ة‬
‫وظ‬‫لح‬‫م‬
‫ا‬
‫ه‬‫د‬‫ي‬
‫د‬‫متج‬
‫تيت‬‫ل‬
‫ا‬ ‫م ‪SDS‬‬‫ا‬
‫قس‬‫أ‬
‫‪2‬‬

‫ة‬‫ي‬
‫ل‬‫و‬
‫ؤ‬‫مس‬‫ل‬
‫ا‬‫ء‬‫إخال‬‫ان‬
‫ي‬‫ب‬
‫دال‬
‫اق‬‫يض‬
‫أ‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬
‫م‬‫ل‬‫ا‬‫رى‪.‬‬‫األخ‬
‫اف‬‫ر‬‫األط‬
‫عض‬ ‫ب‬
‫تج‪,‬و‬‫ن‬
‫م‬‫ل‬‫ا‬‫مل‬
‫تىتش‬‫ل‬
‫ا‬ ‫ر‬
‫د‬‫ا‬‫مص‬‫ل‬
‫ا‬‫ةمن‬‫ف‬‫ل‬
‫ت‬
‫ةمخ‬‫وع‬‫م‬
‫امنمج‬
‫ه‬‫ي‬
‫ل‬‫ولع‬‫لحص‬‫ا‬
‫م‬‫ةت‬
‫م‬‫و‬‫ل‬
‫ع‬‫م‬‫ل‬
‫ا‬‫أن‬‫يث‬‫ةح‬‫د‬
‫و‬‫ز‬‫م‬‫ل‬
‫ا‬‫ة‬‫م‬
‫و‬‫ل‬‫ع‬‫م‬
‫ل‬‫ا‬‫ال‬
‫م‬‫ت‬
‫ك‬‫إ‬‫و‬
‫أ‬‫ة‬‫ق‬‫د‬
‫انب‬
‫م‬‫دض‬ ‫وج‬
‫الي‬
‫م‪.‬‬‫د‬
‫تخ‬‫مس‬‫ل‬‫ا‬
‫ة‬‫ي‬‫ل‬
‫و‬ ‫ؤ‬
‫ةهيمس‬ ‫د‬‫ا‬
‫أيم‬‫ة‬
‫م‬‫ء‬‫مال‬
‫ل‬‫ئي‬‫ا‬
‫ه‬‫ن‬‫ل‬
‫ا‬‫د‬‫ي‬
‫د‬‫تح‬
‫ل‬‫ا‬‫رى‪.‬‬
‫األخ‬
‫ات‬‫لج‬
‫ا‬‫ع‬
‫م‬‫ل‬
‫ا‬‫وفي‬‫أ‬
‫رى‬‫أخ‬‫د‬
‫ا‬‫و‬
‫دم‬‫و‬‫وفيوج‬‫أ‬‫ع‬
‫متم‬ ‫د‬
‫تخ‬‫إس‬‫ا‬
‫ذ‬‫إ‬‫و‬
‫أ‬‫م‬‫ا‬
‫د‬‫تخ‬
‫اإلس‬
‫وف‬ ‫ر‬‫ةتحتكلظ‬‫يح‬
‫ون صح‬ ‫ك‬‫ت‬

‫ة‬
‫م‬‫لسال‬
‫ا‬‫ات‬
‫ن‬‫ا‬
‫ي‬‫ةب‬
‫ق‬‫ر‬‫ةو‬
‫ي‬‫ا‬
‫ه‬‫ن‬

‫_____________________________________________________________________________________________‬
‫ة ‪7/7‬‬
‫فح‬‫ص‬
SAFETY DATA SHEET
Product Trade Name:
TAU-MOD®
Revision Date: Revision Number:
05-Mar-2019 39

1. IDENTIFICATION OF THE SUBSTANCE/PREPARATION AND OF THE


COMPANY/UNDERTAKING
Product Identifier
Product Trade Name:
TAU-MOD®
Synonyms
None
Chemical Family
Mineral
Internal ID Code
HM006276

Recommended use and restrictions on use


Application
Viscosifier
Uses advised against
No information available

Manufacturer's Name and Contact Details


Manufacturer/Supplier
Halliburton Energy Services
14th Floor, CitiBank Tower, Al-Qutayat Street
Dubai, UAE
Telephone Number : +971 43036666

Additional Information

Prepared By
Chemical Stewardship
Telephone: 1-281-871-6107
e-mail: fdunexchem@[Link]

Emergency Telephone Number


1-760-476-3959
Global Incident Response Access Code: 334305
Contract Number: 14012

2. HAZARDS IDENTIFICATION
Classification

Carcinogenicity Category 1A - H350


Specific Target Organ Toxicity - (Repeated Exposure) Category 2 - H373

Hazard Pictograms

_____________________________________________________________________________________________
Page 1 / 8
TAU-MOD® Revision Date:
05-Mar-2019
_____________________________________________________________________________________________

Signal Word
Danger

Hazard Statements
H350 - May cause cancer
H373 - May cause damage to organs through prolonged or repeated exposure if inhaled

Precautionary Statements

Prevention
P201 - Obtain special instructions before use
P202 - Do not handle until all safety precautions have been read and understood
P260 - Do not breathe dust/fume/gas/mist/vapors/spray
P280 - Wear protective gloves/protective clothing/eye protection/face protection
Response
P308 + P313 - IF exposed or concerned: Get medical advice/attention
P314 - Get medical attention/advice if you feel unwell
Storage
P405 - Store locked up
Disposal
P501 - Dispose of contents/container in accordance with local/regional/national/international regulations

Contains
Substances CAS Number
Crystalline silica, quartz 14808-60-7

Additional Information
Dust can form an explosive mixture in air
This mixture contains no substance considered to be persistent, bioaccumulating nor toxic (PBT).
This mixture contains no substance considered to be very persistent nor very bioaccumulating (vPvB).

3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances CAS Number PERCENT (w/w) GHS Classification
Crystalline silica, quartz 14808-60-7 1 - 5% Carc. 1A (H350)
STOT RE 1 (H372)

4. FIRST AID MEASURES


First-aid Measures
Inhalation
If inhaled, remove from area to fresh air. Get medical attention if respiratory irritation develops or if breathing becomes difficult.
Skin
Wash with soap and water. Get medical attention if irritation persists.
Eyes
In case of contact, immediately flush eyes with plenty of water for at least 15 minutes and get medical attention if irritation persists.
Ingestion
Under normal conditions, first aid procedures are not required.

Most important symptoms and effects, both acute and delayed


Breathing crystalline silica can cause lung disease, including silicosis and lung cancer. Crystalline silica has also been associated

_____________________________________________________________________________________________
Page 2 / 8
TAU-MOD® Revision Date:
05-Mar-2019
_____________________________________________________________________________________________
with scleroderma and kidney disease.

Indication of any immediate medical attention and special treatment needed


Notes to Physician
Treat symptomatically.

5. FIRE FIGHTING MEASURES


Suitable Extinguishing Media
All standard fire fighting media
Extinguishing media which must not be used for safety reasons
Avoid creating dust clouds with extinguishers.

Specific hazards arising from the chemical


Not determined

Special protective actions for fire-fighters


Full protective clothing and approved self-contained breathing apparatus required for fire fighting personnel.

6. ACCIDENTAL RELEASE MEASURES


Personal precautions, protective equipment and emergency procedures
Use appropriate protective equipment. Ensure adequate ventilation. Avoid creating and breathing dust. Avoid contact with skin,
eyes and clothing.

Environmental Precautions
Prevent from entering sewers, waterways, or low areas.

Methods and material for containment and cleaning up


Collect using dustless method and hold for appropriate disposal. Consider possible toxic or fire hazards associated with
contaminating substances and use appropriate methods for collection, storage and disposal.

Additional Information
See Section 8 and 13 for additional information.

7. HANDLING AND STORAGE


Precautions for safe handling
This product contains quartz, cristobalite, and/or tridymite which may become airborne without a visible cloud. Avoid breathing
dust. Avoid creating dusty conditions. Use only with adequate ventilation to keep exposure below recommended exposure limits.
Wear a NIOSH certified, European Standard En 149, or equivalent respirator when using this product. Material is slippery when
wet.

Conditions for safe storage, including any incompatibilities


Store in a cool, dry location. Store locked up. Use good housekeeping in storage and work areas to prevent accumulation of dust.
Close container when not in use. Do not reuse empty container. Product has a shelf life of 36 months.

8. EXPOSURE CONTROLS/PERSONAL PROTECTION


Control parameters
Exposure Limits
Substances CAS Number United Arab Bahrain Kuwait Gulf Cooperation
Emirates Council
Crystalline silica, quartz 14808-60-7 TWA: 0.1 mg/m3 TWA: 0.1 mg/m3 TWA: 0.1 mg/m3 TWA: 0.1 mg/m3

Appropriate engineering controls


Use approved industrial ventilation and local exhaust as required to maintain exposures below applicable exposure limits.

_____________________________________________________________________________________________
Page 3 / 8
TAU-MOD® Revision Date:
05-Mar-2019
_____________________________________________________________________________________________

Individual protection measures, such as personal protective equipment


If engineering controls and work practices cannot prevent excessive exposures, the selection and proper use of personal protective
equipment should be determined by an industrial hygienist or other qualified professional based on the specific application of this
product.
Respiratory Protection
Wear a NIOSH certified, European Standard EN 149 (FFP2/FFP3), AS/NZS 1715, or equivalent respirator when using this product.

Hand Protection
Normal work gloves.
Skin Protection
Wear clothing appropriate for the work environment. Dusty clothing should be laundered before reuse. Use precautionary
measures to avoid creating dust when removing or laundering clothing.
Eye Protection
Wear safety glasses or goggles to protect against exposure.
Other Precautions
None known.

9. PHYSICAL AND CHEMICAL PROPERTIES


Physical State:
Powder
Color
Pink to tan to gray
Odor:
Mild earthy
Odor Threshold:
No information available
pH:
No information available
Specific Gravity
1.9 - 2.4
Freezing Point/Range (°C):
No information available
Pour Point/Range (C):
No information available
Boiling Point/Range (C):
No information available
Flash Point/Range (°C):
No information available
Flash Point Method:
No information available
Flammability Limits in Air - Lower (%):
No information available
Flammability Limits in Air - Upper (%):
No information available
Autoignition Temperature (°C):
No information available
Evaporation Rate (Butyl Acetate=1):
No information available
Vapor Pressure @ 20 C (mmHg):
No information available
Vapor Density (Air=1):

Water Solubility
Insoluble in water
Decomposition Temperature (C):
No information available
Viscosity, Dynamic @ 20 C (centipoise):

Viscosity, Kinematic @ 20 C (centistokes):

Partition Coefficient/n-Octanol/Water:

_____________________________________________________________________________________________
Page 4 / 8
TAU-MOD® Revision Date:
05-Mar-2019
_____________________________________________________________________________________________
No information available
Molecular Weight (g/mole):
No information available

10. STABILITY AND REACTIVITY


Reactivity
Not expected to be reactive.

Chemical Stability
Stable

Possibility of hazardous reactions


Will Not Occur

Conditions to Avoid
None anticipated

Incompatible materials
Hydrofluoric acid.

Hazardous decomposition products


Amorphous silica may transform at elevated temperatures to tridymite (870 C) or cristobalite (1470 C).

Additional Guidelines
Not Applicable

11. TOXICOLOGICAL INFORMATION


Information on Toxicological Effects
Acute Toxicity
Inhalation
Breathing silica dust may cause irritation of the nose, throat, and respiratory passages. Breathing silica dust may not cause
noticeable injury or illness even though permanent lung damage may be occurring. Inhalation of dust may also have serious
chronic health effects (See "Chronic Effects/Carcinogenicity" subsection below).

Eye Contact
May cause mechanical irritation to eye.
Skin Contact
May cause mild skin irritation.
Ingestion
May cause abdominal pain, vomiting, nausea, and diarrhea.

Chronic Effects/Carcinogenicity
Contains known or suspected carcinogens. May cause damage to organs through prolonged or repeated exposure. Silicosis:
Excessive inhalation of respirable crystalline silica dust may cause a progressive, disabling, and sometimes-fatal lung disease
called silicosis. Symptoms include cough, shortness of breath, wheezing, non-specific chest illness, and reduced pulmonary
function. This disease is exacerbated by smoking. Individuals with silicosis are predisposed to develop tuberculosis.

Toxicology data for the components

Substances CAS Number LD50 Oral LD50 Dermal LC50 Inhalation


Crystalline silica, quartz 14808-60-7 > 15000 mg/kg (human) No data available No data available

_____________________________________________________________________________________________
Page 5 / 8
TAU-MOD® Revision Date:
05-Mar-2019
_____________________________________________________________________________________________

Substances CAS Number Skin corrosion/irritation


Crystalline silica, quartz 14808-60-7 Non-irritating to the skin

Substances CAS Number Serious eye damage/irritation


Crystalline silica, quartz 14808-60-7 Non-irritating to the eye No information available

Substances CAS Number Skin Sensitization


Crystalline silica, quartz 14808-60-7 No information available.

Substances CAS Number Respiratory Sensitization


Crystalline silica, quartz 14808-60-7 No information available

Substances CAS Number Mutagenic Effects


Crystalline silica, quartz 14808-60-7 Not regarded as mutagenic.

Substances CAS Number Carcinogenic Effects


Crystalline silica, quartz 14808-60-7 Contains crystalline silica which may cause silicosis, a delayed and progressive lung disease. The
IARC and NTP have determined there is sufficient evidence in humans of the carcinogenicity of
crystalline silica with repeated respiratory exposure.

Substances CAS Number Reproductive toxicity


Crystalline silica, quartz 14808-60-7 No information available

Substances CAS Number STOT - single exposure


Crystalline silica, quartz 14808-60-7 No significant toxicity observed in animal studies at concentration requiring classification.

Substances CAS Number STOT - repeated exposure


Crystalline silica, quartz 14808-60-7 Causes damage to organs through prolonged or repeated exposure if inhaled: (Lungs)

Substances CAS Number Aspiration hazard


Crystalline silica, quartz 14808-60-7 Not applicable

12. ECOLOGICAL INFORMATION


Toxicity
Substances CAS Number Toxicity to Algae Toxicity to Fish Toxicity to Toxicity to Invertebrates
Microorganisms
Crystalline silica, quartz 14808-60-7 EC50(72 h)=440 mg/L LL0(96 h)=10000 mg/L No information available LL50(24 h)>10000 mg/L
(Pseudokirchneriella (Danio rerio) (Daphnia magna)
subcapitata)

Persistence and degradability

Substances CAS Number Persistence and Degradability


Crystalline silica, quartz 14808-60-7 The methods for determining biodegradability are
not applicable to inorganic substances.

Bioaccumlation potential

Substances CAS Number Bioaccumulation


Crystalline silica, quartz 14808-60-7 No information available

Mobility in soil

Substances CAS Number Mobility


Crystalline silica, quartz 14808-60-7 No information available

Other adverse effects


No information available

_____________________________________________________________________________________________
Page 6 / 8
TAU-MOD® Revision Date:
05-Mar-2019
_____________________________________________________________________________________________

13. DISPOSAL CONSIDERATIONS


Waste treatment methods
Disposal methods
Follow all applicable community, national or regional regulations regarding waste management methods.

Contaminated Packaging
Follow all applicable national or local regulations.
Other Information
No information available

14. TRANSPORT INFORMATION


UN Number
Not restricted

UN proper shipping name:


Not restricted

Transport Hazard Class(es):


Not applicable

Packing Group:
Not applicable

Environmental Hazards:
Not applicable

Special Precautions for User


None

Transport in bulk according to Annex II of MARPOL 73/78 and the IBC Code
Not applicable

15. REGULATORY INFORMATION

Regulatory Information
This SDS was prepared in accordance with United Nations "Globally Harmonized System of Classification and Labelling of
Chemicals (GHS)" and its revisions.

16. OTHER INFORMATION


Key literature references and sources for data
[Link]/
NZ CCID

Revision Date:
05-Mar-2019
Revision Note
SDS sections updated:
2

Disclaimer Statement
This information is furnished without warranty, expressed or implied, as to accuracy or completeness. The information is obtained
from various sources including the manufacturer and other third party sources. The information may not be valid under all
conditions nor if this material is used in combination with other materials or in any process. Final determination of suitability of any

_____________________________________________________________________________________________
Page 7 / 8
TAU-MOD® Revision Date:
05-Mar-2019
_____________________________________________________________________________________________
material is the sole responsibility of the user.

End of Safety Data Sheet

_____________________________________________________________________________________________
Page 8 / 8

Vous aimerez peut-être aussi